URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Submission: On May 28 via manual from US — Scanned from US

Summary

This website contacted 116 IPs in 11 countries across 84 domains to perform 450 HTTP transactions. The main IP is 104.18.14.141, located in and belongs to CLOUDFLARENET, US. The main domain is www.fiercepharma.com. The Cisco Umbrella rank of the primary domain is 188079.
TLS certificate: Issued by GTS CA 1P5 on April 13th 2024. Valid for: 3 months.
This is the only time www.fiercepharma.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
15 104.18.14.141 13335 (CLOUDFLAR...)
1 35.201.104.135 396982 (GOOGLE-CL...)
13 142.250.64.66 15169 (GOOGLE)
1 2a04:4e42:200... 54113 (FASTLY)
5 45.133.44.3 39572 (ADVANCEDH...)
22 142.250.176.194 15169 (GOOGLE)
2 2607:f8b0:400... 15169 (GOOGLE)
5 104.16.151.166 13335 (CLOUDFLAR...)
1 2607:f8b0:400... 15169 (GOOGLE)
3 2a04:4e42:400... 54113 (FASTLY)
1 34.194.162.133 14618 (AMAZON-AES)
1 18.164.101.60 16509 (AMAZON-02)
1 5 2600:9000:23c... 16509 (AMAZON-02)
1 18.164.96.73 16509 (AMAZON-02)
2 2600:9000:26f... ()
1 2600:141b:b00... 20940 (AKAMAI-ASN1)
2 3 34.198.180.12 14618 (AMAZON-AES)
1 6 34.117.77.79 396982 (GOOGLE-CL...)
6 151.101.65.91 54113 (FASTLY)
1 52.205.167.202 14618 (AMAZON-AES)
3 2620:100:a00b::4 19750 (AS-CRITEO)
1 34.102.146.192 396982 (GOOGLE-CL...)
1 104.18.35.167 13335 (CLOUDFLAR...)
4 23.227.151.194 55081 (24SHELLS)
2 2607:f8b0:400... 15169 (GOOGLE)
1 52.86.216.206 14618 (AMAZON-AES)
4 7 2620:1ec:21::14 8068 (MICROSOFT...)
1 13.107.42.14 8068 (MICROSOFT...)
2 2607:f8b0:400... 15169 (GOOGLE)
1 2607:f8b0:400... 15169 (GOOGLE)
2 142.251.41.2 15169 (GOOGLE)
18 35 68.67.161.182 29990 (ASN-APPNEX)
3 54.157.213.254 14618 (AMAZON-AES)
2 204.180.130.165 53866 (QTS-AS)
5 204.180.130.159 53866 (QTS-AS)
1 2 34.120.135.53 396982 (GOOGLE-CL...)
1 3 2620:100:a00b... 19750 (AS-CRITEO)
1 2 184.73.251.44 14618 (AMAZON-AES)
6 9 35.244.154.8 15169 (GOOGLE)
6 6 3.33.220.150 16509 (AMAZON-02)
3 4 34.195.242.242 14618 (AMAZON-AES)
13 15 2600:1f18:61c... 14618 (AMAZON-AES)
4 2606:4700:10:... 13335 (CLOUDFLAR...)
2 2606:4700:10:... 13335 (CLOUDFLAR...)
1 54.211.183.138 14618 (AMAZON-AES)
3 51.222.39.184 16276 (OVH)
3 3 67.202.105.24 32748 (STEADFAST)
1 4 67.202.105.34 32748 (STEADFAST)
1 1 23.195.92.23 16625 (AKAMAI-AS)
8 23.227.146.18 55081 (24SHELLS)
2 2607:4f00:968::2 55081 (24SHELLS)
4 23.51.57.13 16625 (AKAMAI-AS)
1 2 37.157.6.237 198622 (ADFORM)
1 1 8.2.110.161 46636 (NATCOWEB)
1 193.200.65.5 6681 (GIVEME-CLOUD)
2 6 52.201.41.85 14618 (AMAZON-AES)
4 4 69.194.240.13 26120 (RHYTHMONE)
2 2 2620:112:f008... 26120 (RHYTHMONE)
1 1 51.83.220.94 16276 (OVH)
2 8 147.28.129.140 54825 (PACKET)
1 1 8.28.7.82 62713 (AS-PUBMATIC)
2 2 2606:ae80:147... 25751 (VALUECLICK)
1 3 8.28.7.83 62713 (AS-PUBMATIC)
6 7 142.250.72.98 15169 (GOOGLE)
1 1 107.178.254.65 15169 (GOOGLE)
1 35.244.159.8 396982 (GOOGLE-CL...)
2 2a03:2880:f07... 32934 (FACEBOOK)
5 6 35.211.178.172 15169 (GOOGLE)
1 8 172.64.151.101 13335 (CLOUDFLAR...)
1 2 34.98.64.218 396982 (GOOGLE-CL...)
2 3 69.173.146.5 26667 (RUBICONPR...)
1 6 70.42.32.223 22075 (AS-OUTBRAIN)
1 2 34.200.65.202 14618 (AMAZON-AES)
1 141.226.224.48 200478 (TABOOLA-AS)
1 3 52.223.22.214 16509 (AMAZON-02)
1 12 2606:4700:10:... 13335 (CLOUDFLAR...)
6 8 34.111.113.62 396982 (GOOGLE-CL...)
1 11 2607:f350:3:2... 27630 (AS-XFERNET)
3 2607:f8b0:400... 15169 (GOOGLE)
1 142.250.72.104 15169 (GOOGLE)
2 2a03:2880:f17... 32934 (FACEBOOK)
14 69.194.240.11 26120 (RHYTHMONE)
9 34.193.219.68 14618 (AMAZON-AES)
9 74.214.194.131 19189 (PULSEPOINT)
5 37.157.6.233 198622 (ADFORM)
6 54.197.117.43 14618 (AMAZON-AES)
2 107.151.11.18 55081 (24SHELLS)
10 34.120.63.153 396982 (GOOGLE-CL...)
10 207.65.37.179 62713 (AS-PUBMATIC)
5 52.90.26.195 14618 (AMAZON-AES)
13 74.119.117.6 19750 (AS-CRITEO)
5 147.135.119.114 16276 (OVH)
5 34.206.91.202 14618 (AMAZON-AES)
9 2607:f350:3:2... 27630 (AS-XFERNET)
5 185.184.8.90 204995 (RTB-HOUSE...)
5 44.216.173.212 14618 (AMAZON-AES)
5 34.149.20.76 15169 (GOOGLE)
8 2602:803:c002... 26667 (RUBICONPR...)
4 185.106.140.18 7979 (SERVERS-COM)
4 51.222.39.186 16276 (OVH)
8 34.237.106.71 14618 (AMAZON-AES)
8 34.102.246.198 396982 (GOOGLE-CL...)
5 212.36.83.246 15699 (AS_ADAM A...)
2 23.227.151.242 55081 (24SHELLS)
1 2a0c:5c87:524... 55081 (24SHELLS)
3 104.154.142.214 15169 (GOOGLE)
2 52.216.215.120 16509 (AMAZON-02)
10 2607:f8b0:400... 15169 (GOOGLE)
2 142.250.72.97 15169 (GOOGLE)
1 35.244.193.51 15169 (GOOGLE)
2 74.119.117.17 19750 (AS-CRITEO)
2 162.19.138.116 16276 (OVH)
3 23.199.48.215 16625 (AKAMAI-AS)
1 104.18.38.76 13335 (CLOUDFLAR...)
2 23.47.168.66 16625 (AKAMAI-AS)
1 172.67.138.13 13335 (CLOUDFLAR...)
2 4 198.148.27.131 19189 (PULSEPOINT)
1 1 3.227.67.62 14618 (AMAZON-AES)
1 3.81.175.178 14618 (AMAZON-AES)
1 18.164.116.122 16509 (AMAZON-02)
1 3 104.18.41.104 13335 (CLOUDFLAR...)
2 4 216.22.16.73 30633 (LEASEWEB-...)
1 67.220.226.233 16509 (AMAZON-02)
1 51.222.241.106 16276 (OVH)
2 2 34.36.216.150 396982 (GOOGLE-CL...)
1 1 198.8.71.131 54312 (ROCKETFUEL)
3 212.36.83.245 15699 (AS_ADAM A...)
1 1 216.200.232.249 30419 (PAEDAE-INC)
1 1 2600:1f18:4e9... 14618 (AMAZON-AES)
1 1 54.204.12.49 14618 (AMAZON-AES)
1 1 37.157.6.254 198622 (ADFORM)
1 1 8.28.7.81 62713 (AS-PUBMATIC)
1 141.95.98.65 16276 (OVH)
450 116
Apex Domain
Subdomains
Transfer
38 adnxs.com
ib.adnxs.com — Cisco Umbrella Rank: 257
secure.adnxs.com — Cisco Umbrella Rank: 482
acdn.adnxs.com — Cisco Umbrella Rank: 614
71 KB
32 doubleclick.net
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 205
stats.g.doubleclick.net — Cisco Umbrella Rank: 89
googleads.g.doubleclick.net — Cisco Umbrella Rank: 35
cm.g.doubleclick.net — Cisco Umbrella Rank: 272
304 KB
27 googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 103
690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com
tpc.googlesyndication.com — Cisco Umbrella Rank: 164
820 KB
21 adroll.com
s.adroll.com — Cisco Umbrella Rank: 3361
d.adroll.com — Cisco Umbrella Rank: 1556
ipv4.d.adroll.com — Cisco Umbrella Rank: 12135
45 KB
20 sonobi.com
sync.go.sonobi.com — Cisco Umbrella Rank: 969
apex.go.sonobi.com — Cisco Umbrella Rank: 1818
22 KB
19 pubmatic.com
ads.pubmatic.com — Cisco Umbrella Rank: 540
image8.pubmatic.com — Cisco Umbrella Rank: 648
simage2.pubmatic.com — Cisco Umbrella Rank: 898
image2.pubmatic.com — Cisco Umbrella Rank: 964
hbopenbid.pubmatic.com — Cisco Umbrella Rank: 465
image6.pubmatic.com — Cisco Umbrella Rank: 851
42 KB
18 ad.gt
id.hadron.ad.gt — Cisco Umbrella Rank: 1612
a.ad.gt — Cisco Umbrella Rank: 2168
p.ad.gt — Cisco Umbrella Rank: 2469
ids.ad.gt — Cisco Umbrella Rank: 1786
pixels.ad.gt — Cisco Umbrella Rank: 2404
74 KB
15 unrulymedia.com
sync.targeting.unrulymedia.com — Cisco Umbrella Rank: 1260
targeting.unrulymedia.com — Cisco Umbrella Rank: 836
3 KB
15 fiercepharma.com
www.fiercepharma.com — Cisco Umbrella Rank: 188079
250 KB
14 criteo.com
gum.criteo.com — Cisco Umbrella Rank: 444
bidder.criteo.com — Cisco Umbrella Rank: 587
mug.criteo.com — Cisco Umbrella Rank: 3039
21 KB
14 mediafuse.com
player.mediafuse.com — Cisco Umbrella Rank: 94357
player.hbmp.mediafuse.com — Cisco Umbrella Rank: 62373
sghb.hbmp.mediafuse.com — Cisco Umbrella Rank: 77281
sync.hbmp.mediafuse.com — Cisco Umbrella Rank: 124657
240 KB
13 contextweb.com
bid.contextweb.com — Cisco Umbrella Rank: 5776
bh.contextweb.com — Cisco Umbrella Rank: 576
10 KB
13 media.net
hbx.media.net — Cisco Umbrella Rank: 1285
prebid.media.net — Cisco Umbrella Rank: 1111
contextual.media.net — Cisco Umbrella Rank: 759
42 KB
11 rubiconproject.com
pixel.rubiconproject.com — Cisco Umbrella Rank: 404
token.rubiconproject.com — Cisco Umbrella Rank: 481
fastlane.rubiconproject.com — Cisco Umbrella Rank: 506
7 KB
10 servenobid.com
ads.servenobid.com — Cisco Umbrella Rank: 2850
public.servenobid.com — Cisco Umbrella Rank: 7551
7 KB
10 bidswitch.net
x.bidswitch.net — Cisco Umbrella Rank: 368
grid.bidswitch.net — Cisco Umbrella Rank: 1233
4 KB
10 33across.com
cdn-ima.33across.com — Cisco Umbrella Rank: 1200
ssc-cms.33across.com — Cisco Umbrella Rank: 944
ssc.33across.com — Cisco Umbrella Rank: 4205
lexicon.33across.com — Cisco Umbrella Rank: 1392
10 KB
9 smartadserver.com
prg.smartadserver.com — Cisco Umbrella Rank: 1751
rtb-csync.smartadserver.com — Cisco Umbrella Rank: 698
9 KB
9 rlcdn.com
idsync.rlcdn.com — Cisco Umbrella Rank: 456
1 KB
9 omeda.com
olytics.omeda.com — Cisco Umbrella Rank: 23554
oqs.omeda.com — Cisco Umbrella Rank: 23968
cdp.omeda.com — Cisco Umbrella Rank: 23511
79 KB
8 lhmos.com
trc.lhmos.com — Cisco Umbrella Rank: 10413
3 KB
8 360yield.com
ad.360yield.com — Cisco Umbrella Rank: 716
4 KB
8 tapad.com
pixel.tapad.com — Cisco Umbrella Rank: 493
2 KB
8 3lift.com
eb2.3lift.com — Cisco Umbrella Rank: 413
tlx.3lift.com — Cisco Umbrella Rank: 536
4 KB
8 casalemedia.com
dsum-sec.casalemedia.com — Cisco Umbrella Rank: 635
ssum-sec.casalemedia.com — Cisco Umbrella Rank: 524
htlb.casalemedia.com — Cisco Umbrella Rank: 477
4 KB
8 a-mo.net
prebid.a-mo.net — Cisco Umbrella Rank: 764
2 KB
8 lijit.com
ap.lijit.com — Cisco Umbrella Rank: 737
ce.lijit.com — Cisco Umbrella Rank: 891
3 KB
8 vidoomy.com
vid.vidoomy.com Failed
d.vidoomy.com — Cisco Umbrella Rank: 18281
a.vidoomy.com — Cisco Umbrella Rank: 3154
a-prebid.vidoomy.com — Cisco Umbrella Rank: 21208
4 KB
8 adform.net
cm.adform.net — Cisco Umbrella Rank: 1150
adx.adform.net — Cisco Umbrella Rank: 5226
4 KB
8 linkedin.com
px.ads.linkedin.com — Cisco Umbrella Rank: 338
www.linkedin.com — Cisco Umbrella Rank: 619
px4.ads.linkedin.com — Cisco Umbrella Rank: 6419
4 KB
8 adtelligent.com
player.adtelligent.com — Cisco Umbrella Rank: 8038
sync.adtelligent.com — Cisco Umbrella Rank: 5859
ghb.adtelligent.com — Cisco Umbrella Rank: 6918
ghb1.adtelligent.com — Cisco Umbrella Rank: 10145
ghb2.adtelligent.com — Cisco Umbrella Rank: 12127
11 KB
8 ml314.com
vi.ml314.com — Cisco Umbrella Rank: 7465
ml314.com — Cisco Umbrella Rank: 1937
in.ml314.com — Cisco Umbrella Rank: 10753
13 KB
7 onetag-sys.com
onetag-sys.com — Cisco Umbrella Rank: 722
2 KB
7 ketchcdn.com
global.ketchcdn.com — Cisco Umbrella Rank: 5137
26 KB
6 disqus.com
ssp.disqus.com — Cisco Umbrella Rank: 1409
1 KB
6 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 358
3 KB
5 zemanta.com
b1h.zemanta.com — Cisco Umbrella Rank: 5170
1 KB
5 minutemedia-prebid.com
hb.minutemedia-prebid.com — Cisco Umbrella Rank: 3713
2 KB
5 creativecdn.com
prebid-eu.creativecdn.com — Cisco Umbrella Rank: 7556
911 B
5 smaato.net
prebid.ad.smaato.net — Cisco Umbrella Rank: 6094
2 KB
5 openx.net
oajs.openx.net — Cisco Umbrella Rank: 2619
google-bidout-d.openx.net — Cisco Umbrella Rank: 2580
us-u.openx.net — Cisco Umbrella Rank: 527
1 KB
5 qtxasset.com
qtxasset.com — Cisco Umbrella Rank: 73720
82 KB
4 adxpremium.services
rtb.adxpremium.services — Cisco Umbrella Rank: 17881
9 KB
4 tynt.com
de.tynt.com — Cisco Umbrella Rank: 1497
hde.tynt.com — Cisco Umbrella Rank: 3669
758 B
4 crwdcntrl.net
sync.crwdcntrl.net — Cisco Umbrella Rank: 857
id.crwdcntrl.net — Cisco Umbrella Rank: 2416
2 KB
4 dpmsrv.com
s.dpmsrv.com — Cisco Umbrella Rank: 29419
a.dpmsrv.com — Cisco Umbrella Rank: 24091
18 KB
3 connatix.com
capi.connatix.com — Cisco Umbrella Rank: 850
621 B
3 lockerdome.com
lockerdome.com — Cisco Umbrella Rank: 10884
1020 B
3 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 32
23 KB
3 yahoo.com
ups.analytics.yahoo.com — Cisco Umbrella Rank: 435
pr-bh.ybp.yahoo.com — Cisco Umbrella Rank: 517
1 KB
3 1rx.io
sync.1rx.io — Cisco Umbrella Rank: 539
2 KB
3 criteo.net
static.criteo.net — Cisco Umbrella Rank: 664
44 KB
3 rdcdn.com
rdcdn.com — Cisco Umbrella Rank: 47800
835 B
3 parsely.com
api.parsely.com — Cisco Umbrella Rank: 9153
cdn.parsely.com — Cisco Umbrella Rank: 3249
p1.parsely.com — Cisco Umbrella Rank: 2383
24 KB
3 ketchjs.com
cdn.ketchjs.com — Cisco Umbrella Rank: 5610
253 KB
3 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 39
264 KB
2 sitescout.com
pixel-sync.sitescout.com — Cisco Umbrella Rank: 669
1 KB
2 id5-sync.com
id5-sync.com — Cisco Umbrella Rank: 509
2 KB
2 amazonaws.com
s3.amazonaws.com
68 KB
2 facebook.com
www.facebook.com — Cisco Umbrella Rank: 101
4 KB
2 facebook.net
connect.facebook.net — Cisco Umbrella Rank: 183
71 KB
2 dotomi.com
pubmatic-match.dotomi.com — Cisco Umbrella Rank: 3680
665 B
2 turn.com
ad.turn.com — Cisco Umbrella Rank: 916
d.turn.com — Cisco Umbrella Rank: 1314
878 B
2 adtarget.com.tr
s.console.adtarget.com.tr — Cisco Umbrella Rank: 5763
2 demdex.net
dpm.demdex.net — Cisco Umbrella Rank: 243
1 KB
2 google.com
analytics.google.com — Cisco Umbrella Rank: 154
www.google.com Failed
294 B
1 eu-1-id5-sync.com
lb.eu-1-id5-sync.com — Cisco Umbrella Rank: 885
280 B
1 stackadapt.com
sync.srv.stackadapt.com — Cisco Umbrella Rank: 727
227 B
1 mathtag.com
sync.mathtag.com — Cisco Umbrella Rank: 1167
507 B
1 rfihub.com
p.rfihub.com — Cisco Umbrella Rank: 826
746 B
1 rqtrk.eu
wt.rqtrk.eu — Cisco Umbrella Rank: 1584
350 B
1 amazon-adsystem.com
aax-eu.amazon-adsystem.com — Cisco Umbrella Rank: 1075
s.amazon-adsystem.com Failed
855 B
1 adxbid.info
adxbid.info — Cisco Umbrella Rank: 24051
1 indexww.com
js-sec.indexww.com — Cisco Umbrella Rank: 699
1 taboola.com
sync.taboola.com — Cisco Umbrella Rank: 1380
366 B
1 outbrain.com
sync.outbrain.com — Cisco Umbrella Rank: 918
360 B
1 pippio.com
pippio.com — Cisco Umbrella Rank: 767
634 B
1 adpartner.pro
a4p.adpartner.pro — Cisco Umbrella Rank: 9397
325 B
1 trafmag.com
t.trafmag.com — Cisco Umbrella Rank: 10135
349 B
1 mgid.com
cm-x.mgid.com — Cisco Umbrella Rank: 5049
658 B
1 openxcdn.net
oa.openxcdn.net — Cisco Umbrella Rank: 2042
8 KB
1 licdn.com
snap.licdn.com — Cisco Umbrella Rank: 803
17 KB
1 gstatic.com
fonts.gstatic.com
14 KB
0 admanmedia.com Failed
cs.admanmedia.com Failed
450 84
Domain Requested by
23 ib.adnxs.com 6 redirects www.fiercepharma.com
player.hbmp.mediafuse.com
22 securepubads.g.doubleclick.net www.fiercepharma.com
securepubads.g.doubleclick.net
olytics.omeda.com
pagead2.googlesyndication.com
15 d.adroll.com 13 redirects s.adroll.com
www.fiercepharma.com
15 www.fiercepharma.com www.fiercepharma.com
14 targeting.unrulymedia.com player.hbmp.mediafuse.com
13 pagead2.googlesyndication.com www.fiercepharma.com
pagead2.googlesyndication.com
olytics.omeda.com
securepubads.g.doubleclick.net
12 tpc.googlesyndication.com securepubads.g.doubleclick.net
www.fiercepharma.com
12 secure.adnxs.com 12 redirects
11 sync.go.sonobi.com 1 redirects www.fiercepharma.com
11 ids.ad.gt 1 redirects www.fiercepharma.com
10 hbopenbid.pubmatic.com player.hbmp.mediafuse.com
10 prebid.media.net player.hbmp.mediafuse.com
9 apex.go.sonobi.com player.hbmp.mediafuse.com
9 bidder.criteo.com player.hbmp.mediafuse.com
9 bid.contextweb.com player.hbmp.mediafuse.com
9 ads.servenobid.com player.hbmp.mediafuse.com
9 idsync.rlcdn.com 6 redirects www.fiercepharma.com
8 trc.lhmos.com www.fiercepharma.com
8 ad.360yield.com player.hbmp.mediafuse.com
8 fastlane.rubiconproject.com player.hbmp.mediafuse.com
8 pixel.tapad.com 6 redirects www.fiercepharma.com
8 prebid.a-mo.net 2 redirects player.hbmp.mediafuse.com
7 cm.g.doubleclick.net 6 redirects www.fiercepharma.com
7 ap.lijit.com 3 redirects player.hbmp.mediafuse.com
7 onetag-sys.com player.hbmp.mediafuse.com
7 global.ketchcdn.com www.fiercepharma.com
cdn.ketchjs.com
6 ssp.disqus.com player.hbmp.mediafuse.com
6 x.bidswitch.net 5 redirects www.fiercepharma.com
6 sync.hbmp.mediafuse.com player.hbmp.mediafuse.com
www.fiercepharma.com
6 match.adsrvr.org 6 redirects
6 px.ads.linkedin.com 3 redirects snap.licdn.com
www.fiercepharma.com
6 ml314.com 1 redirects www.fiercepharma.com
ml314.com
5 b1h.zemanta.com 1 redirects player.hbmp.mediafuse.com
www.fiercepharma.com
5 ssc.33across.com player.hbmp.mediafuse.com
5 hb.minutemedia-prebid.com player.hbmp.mediafuse.com
5 prebid-eu.creativecdn.com player.hbmp.mediafuse.com
5 tlx.3lift.com player.hbmp.mediafuse.com
5 prg.smartadserver.com player.hbmp.mediafuse.com
5 prebid.ad.smaato.net player.hbmp.mediafuse.com
5 htlb.casalemedia.com player.hbmp.mediafuse.com
5 adx.adform.net player.hbmp.mediafuse.com
5 cdp.omeda.com olytics.omeda.com
5 s.adroll.com 1 redirects www.googletagmanager.com
www.fiercepharma.com
s.adroll.com
5 qtxasset.com www.fiercepharma.com
4 rtb-csync.smartadserver.com 2 redirects www.fiercepharma.com
4 bh.contextweb.com 2 redirects player.hbmp.mediafuse.com
4 d.vidoomy.com player.hbmp.mediafuse.com
4 grid.bidswitch.net player.hbmp.mediafuse.com
4 rtb.adxpremium.services player.hbmp.mediafuse.com
4 ads.pubmatic.com player.hbmp.mediafuse.com
www.fiercepharma.com
4 sghb.hbmp.mediafuse.com player.hbmp.mediafuse.com
3 a.vidoomy.com www.fiercepharma.com
3 capi.connatix.com 1 redirects www.fiercepharma.com
3 acdn.adnxs.com player.hbmp.mediafuse.com
3 lockerdome.com player.hbmp.mediafuse.com
3 www.google-analytics.com p.ad.gt
www.google-analytics.com
3 eb2.3lift.com 1 redirects www.fiercepharma.com
player.hbmp.mediafuse.com
3 sync.1rx.io 3 redirects
3 cm.adform.net 2 redirects player.hbmp.mediafuse.com
3 de.tynt.com 1 redirects player.hbmp.mediafuse.com
3 ssc-cms.33across.com 3 redirects
3 id.hadron.ad.gt player.hbmp.mediafuse.com
id.hadron.ad.gt
3 sync.crwdcntrl.net 3 redirects
3 gum.criteo.com 1 redirects static.criteo.net
3 a.dpmsrv.com www.fiercepharma.com
s.dpmsrv.com
3 static.criteo.net securepubads.g.doubleclick.net
player.hbmp.mediafuse.com
static.criteo.net
3 rdcdn.com 2 redirects www.fiercepharma.com
3 cdn.ketchjs.com global.ketchcdn.com
3 www.googletagmanager.com www.fiercepharma.com
www.googletagmanager.com
p.ad.gt
2 pixel-sync.sitescout.com 2 redirects
2 contextual.media.net player.hbmp.mediafuse.com
2 id5-sync.com player.hbmp.mediafuse.com
2 mug.criteo.com www.fiercepharma.com
2 s3.amazonaws.com www.fiercepharma.com
2 ghb1.adtelligent.com player.hbmp.mediafuse.com
2 ghb.adtelligent.com player.hbmp.mediafuse.com
2 www.facebook.com www.fiercepharma.com
2 ups.analytics.yahoo.com 1 redirects www.fiercepharma.com
2 image2.pubmatic.com 1 redirects www.fiercepharma.com
2 pixel.rubiconproject.com 1 redirects www.fiercepharma.com
2 us-u.openx.net 1 redirects www.fiercepharma.com
2 dsum-sec.casalemedia.com 1 redirects www.fiercepharma.com
2 connect.facebook.net d.adroll.com
connect.facebook.net
2 pubmatic-match.dotomi.com 2 redirects
2 sync.adtelligent.com www.fiercepharma.com
player.hbmp.mediafuse.com
2 s.console.adtarget.com.tr player.hbmp.mediafuse.com
2 a.ad.gt player.hbmp.mediafuse.com
p.ad.gt
2 dpm.demdex.net 1 redirects www.fiercepharma.com
2 oajs.openx.net 1 redirects www.fiercepharma.com
2 oqs.omeda.com olytics.omeda.com
2 googleads.g.doubleclick.net pagead2.googlesyndication.com
2 analytics.google.com www.googletagmanager.com
2 690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com securepubads.g.doubleclick.net
2 olytics.omeda.com www.fiercepharma.com
www.googletagmanager.com
2 player.hbmp.mediafuse.com player.mediafuse.com
2 player.mediafuse.com www.fiercepharma.com
1 lb.eu-1-id5-sync.com player.hbmp.mediafuse.com
1 image6.pubmatic.com 1 redirects
1 a-prebid.vidoomy.com www.fiercepharma.com
1 sync.srv.stackadapt.com 1 redirects
1 pr-bh.ybp.yahoo.com 1 redirects
1 sync.mathtag.com 1 redirects
1 p.rfihub.com 1 redirects
1 wt.rqtrk.eu www.fiercepharma.com
1 aax-eu.amazon-adsystem.com www.fiercepharma.com
1 public.servenobid.com player.hbmp.mediafuse.com
1 ce.lijit.com player.hbmp.mediafuse.com
1 adxbid.info player.hbmp.mediafuse.com
1 js-sec.indexww.com player.hbmp.mediafuse.com
1 id.crwdcntrl.net player.hbmp.mediafuse.com
1 lexicon.33across.com player.hbmp.mediafuse.com
1 ghb2.adtelligent.com player.hbmp.mediafuse.com
1 pixels.ad.gt p.ad.gt
1 ssum-sec.casalemedia.com www.fiercepharma.com
1 d.turn.com 1 redirects
1 token.rubiconproject.com 1 redirects
1 p.ad.gt a.ad.gt
1 sync.taboola.com www.fiercepharma.com
1 sync.outbrain.com www.fiercepharma.com
1 google-bidout-d.openx.net oa.openxcdn.net
1 pippio.com 1 redirects
1 simage2.pubmatic.com www.fiercepharma.com
1 image8.pubmatic.com 1 redirects
1 a4p.adpartner.pro 1 redirects
1 sync.targeting.unrulymedia.com 1 redirects
1 ad.turn.com 1 redirects
1 t.trafmag.com www.fiercepharma.com
1 cm-x.mgid.com 1 redirects
1 hbx.media.net 1 redirects
1 hde.tynt.com player.hbmp.mediafuse.com
1 ipv4.d.adroll.com www.fiercepharma.com
1 stats.g.doubleclick.net www.googletagmanager.com
1 px4.ads.linkedin.com www.fiercepharma.com
1 www.linkedin.com 1 redirects
1 in.ml314.com ml314.com
1 cdn-ima.33across.com securepubads.g.doubleclick.net
1 oa.openxcdn.net securepubads.g.doubleclick.net
1 player.adtelligent.com player.hbmp.mediafuse.com
1 p1.parsely.com www.fiercepharma.com
1 snap.licdn.com www.fiercepharma.com
1 s.dpmsrv.com www.fiercepharma.com
1 cdn.parsely.com www.googletagmanager.com
1 api.parsely.com www.fiercepharma.com
1 fonts.gstatic.com www.fiercepharma.com
1 vi.ml314.com www.fiercepharma.com
0 cs.admanmedia.com Failed www.fiercepharma.com
0 s.amazon-adsystem.com Failed www.fiercepharma.com
0 www.google.com Failed securepubads.g.doubleclick.net
www.fiercepharma.com
0 vid.vidoomy.com Failed www.fiercepharma.com
450 149
Subject Issuer Validity Valid
fiercepharma.com
GTS CA 1P5
2024-04-13 -
2024-07-12
3 months crt.sh
vi.ml314.com
WR3
2024-05-18 -
2024-08-16
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2024-05-06 -
2024-07-29
3 months crt.sh
global.ketchcdn.com
R3
2024-05-11 -
2024-08-09
3 months crt.sh
player.mediafuse.com
R3
2024-05-09 -
2024-08-07
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2024-05-06 -
2024-07-29
3 months crt.sh
qtxasset.com
E1
2024-04-01 -
2024-06-30
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2024-05-06 -
2024-07-29
3 months crt.sh
cdn.ketchjs.com
R3
2024-04-21 -
2024-07-20
3 months crt.sh
*.parsely.com
Amazon RSA 2048 M03
2024-04-05 -
2025-05-04
a year crt.sh
player.hbmp.mediafuse.com
R3
2024-03-31 -
2024-06-29
3 months crt.sh
s.adroll.com
Amazon RSA 2048 M02
2024-05-03 -
2025-06-01
a year crt.sh
*.dpmsrv.com
Amazon RSA 2048 M02
2024-02-16 -
2025-03-16
a year crt.sh
*.omeda.com
SSL.com RSA SSL subCA
2023-06-18 -
2024-06-23
a year crt.sh
snap.licdn.com
DigiCert SHA2 Secure Server CA
2023-12-13 -
2024-12-12
a year crt.sh
event-horizon.gcp.bomm.in
GTS CA 1D4
2024-04-26 -
2024-07-25
3 months crt.sh
player.adtelligent.com
R3
2024-05-13 -
2024-08-11
3 months crt.sh
*.criteo.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-04-25 -
2024-07-19
3 months crt.sh
oa.openxcdn.net
WR3
2024-05-19 -
2024-08-17
3 months crt.sh
*.33across.com
Sectigo RSA Domain Validation Secure Server CA
2023-09-06 -
2024-09-30
a year crt.sh
sghb.hbmp.mediafuse.com
ZeroSSL ECC Domain Secure Site CA
2024-05-21 -
2024-08-19
3 months crt.sh
*.ml314.com
Amazon RSA 2048 M02
2023-10-16 -
2024-11-12
a year crt.sh
www.linkedin.com
DigiCert SHA2 Secure Server CA
2024-01-30 -
2024-07-30
6 months crt.sh
*.google.com
GTS CA 1C3
2024-05-06 -
2024-07-29
3 months crt.sh
*.criteo.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-04-15 -
2024-07-10
3 months crt.sh
d.adroll.com
Amazon RSA 2048 M01
2023-10-09 -
2024-11-06
a year crt.sh
id.hadron.ad.gt
E1
2024-05-25 -
2024-08-23
3 months crt.sh
a.ad.gt
E1
2024-04-11 -
2024-07-10
3 months crt.sh
*.onetag-sys.com
DigiCert Global G3 TLS ECC SHA384 2020 CA1
2024-01-23 -
2025-01-29
a year crt.sh
*.tynt.com
Sectigo RSA Domain Validation Secure Server CA
2023-09-05 -
2024-09-30
a year crt.sh
sync.hbmp.mediafuse.com
ZeroSSL ECC Domain Secure Site CA
2024-04-26 -
2024-07-25
3 months crt.sh
s.console.adtarget.com.tr
ZeroSSL ECC Domain Secure Site CA
2024-05-17 -
2024-08-15
3 months crt.sh
*.pubmatic.com
DigiCert TLS RSA SHA256 2020 CA1
2023-11-26 -
2024-11-26
a year crt.sh
*.adform.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-05-25 -
2024-06-18
a year crt.sh
*.trafmag.com
Sectigo RSA Domain Validation Secure Server CA
2023-06-13 -
2024-06-13
a year crt.sh
*.openx.net
RapidSSL TLS RSA CA G1
2023-08-18 -
2024-08-18
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2024-03-06 -
2024-06-04
3 months crt.sh
p.ad.gt
Cloudflare Inc ECC CA-3
2023-11-09 -
2024-11-07
a year crt.sh
ids.ad.gt
E1
2024-05-10 -
2024-08-08
3 months crt.sh
casalemedia.com
E1
2024-04-19 -
2024-07-18
3 months crt.sh
pixels.ad.gt
E1
2024-05-10 -
2024-08-08
3 months crt.sh
*.targeting.unrulymedia.com
Sectigo RSA Domain Validation Secure Server CA
2024-04-30 -
2025-05-31
a year crt.sh
ads.servenobid.com
Amazon RSA 2048 M03
2024-03-29 -
2025-04-27
a year crt.sh
*.contextweb.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-04-11 -
2025-05-11
a year crt.sh
track.adform.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-09-06 -
2024-09-19
a year crt.sh
ssp.disqus.com
Amazon RSA 2048 M03
2023-10-21 -
2024-11-17
a year crt.sh
ghb.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2024-05-27 -
2024-08-25
3 months crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2024-02-14 -
2025-03-16
a year crt.sh
prebid.media.net
GTS CA 1D4
2024-04-17 -
2024-07-16
3 months crt.sh
smaato.net
Sectigo ECC Domain Validation Secure Server CA
2023-08-25 -
2024-08-24
a year crt.sh
*.smartadserver.com
DigiCert Global G3 TLS ECC SHA384 2020 CA1
2024-01-17 -
2025-01-16
a year crt.sh
*.3lift.com
Amazon RSA 2048 M02
2024-03-13 -
2025-04-10
a year crt.sh
*.go.sonobi.com
Go Daddy Secure Certificate Authority - G2
2023-12-07 -
2025-01-07
a year crt.sh
*.creativecdn.com
RapidSSL TLS RSA CA G1
2024-04-05 -
2025-04-30
a year crt.sh
*.a-mo.net
R3
2024-05-05 -
2024-08-03
3 months crt.sh
*.minutemedia-prebid.com
Amazon ECDSA 256 M03
2024-03-09 -
2025-04-08
a year crt.sh
ssc.33across.com
GTS CA 1D4
2024-04-20 -
2024-07-19
3 months crt.sh
*.rubiconproject.com
DigiCert TLS RSA SHA256 2020 CA1
2024-03-04 -
2025-04-03
a year crt.sh
*.adxpremium.services
Sectigo RSA Domain Validation Secure Server CA
2023-07-11 -
2024-08-05
a year crt.sh
*.360yield.com
Amazon RSA 2048 M01
2023-07-17 -
2024-08-13
a year crt.sh
*.bidswitch.net
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2024-05-15 -
2024-08-07
3 months crt.sh
*.lijit.com
Amazon RSA 2048 M03
2024-02-11 -
2025-03-12
a year crt.sh
*.vidoomy.com
Sectigo RSA Domain Validation Secure Server CA
2023-09-06 -
2024-10-06
a year crt.sh
ghb1.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2024-03-30 -
2024-06-28
3 months crt.sh
*.zemanta.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-08-16 -
2024-09-05
a year crt.sh
ghb2.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2024-03-30 -
2024-06-28
3 months crt.sh
*.lockerdome.com
Go Daddy Secure Certificate Authority - G2
2023-09-27 -
2024-10-28
a year crt.sh
s3.amazonaws.com
Amazon RSA 2048 M01
2024-02-08 -
2025-01-11
a year crt.sh
tpc.googlesyndication.com
GTS CA 1C3
2024-05-06 -
2024-07-29
3 months crt.sh
lexicon.33across.com
WR3
2024-05-15 -
2024-08-13
3 months crt.sh
*.id5-sync.com
R3
2024-05-01 -
2024-07-30
3 months crt.sh
*.crwdcntrl.net
Amazon RSA 2048 M01
2023-10-08 -
2024-11-05
a year crt.sh
cdn.adnxs.com
GeoTrust RSA CA 2018
2023-08-24 -
2024-08-24
a year crt.sh
indexww.com
Cloudflare Inc ECC CA-3
2023-09-05 -
2024-09-03
a year crt.sh
sync.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2024-05-18 -
2024-08-16
3 months crt.sh
*.media.net
DigiCert TLS RSA SHA256 2020 CA1
2023-12-21 -
2024-12-21
a year crt.sh
adxbid.info
E1
2024-04-01 -
2024-06-30
3 months crt.sh
*.servenobid.com
Amazon RSA 2048 M02
2023-12-08 -
2025-01-05
a year crt.sh
capi.connatix.com
GTS CA 1P5
2024-05-13 -
2024-08-11
3 months crt.sh
*.eu-1-id5-sync.com
R3
2024-05-01 -
2024-07-30
3 months crt.sh

This page contains 40 frames:

Primary Page: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Frame ID: 8B0D2EC2EE4C9AAD4E649721E2C9408B
Requests: 369 HTTP requests in this frame

Frame: https://690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: CF6C0014AF315133188076EB6AE43E2F
Requests: 1 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/html/r20240522/r20110914/zrt_lookup_fy2021.html
Frame ID: 3B6A1726B16D9CB59CCFB12BAC7E75D9
Requests: 1 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&client=ca-pub-1234567890123456&output=html&adk=1812271804&adf=3025194257&abgtt=6&lmt=1716905156&plat=1%3A64%2C2%3A64%2C8%3A64%2C9%3A32776%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C41%3A32%2C42%3A32&plas=140x675_l%7C140x675_r&format=0x0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&pra=5&wgl=1&easpi=1&aihb=0&asro=0&ailel=1~2~4~6~7~8~9~10~11~12~13~14~15~16~17~18~19~20~21~24&aslmct=0.7&asamct=0.7&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&dt=1716905854732&bpp=4&bdt=381&idt=467&shv=r20240522&mjsv=m202405230101&ptt=9&saldr=aa&abxe=1&cookie_enabled=1&eoidce=1&nras=1&correlator=58514614378&frm=20&pv=2&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C31083869%2C31083908%2C42532524%2C44795922%2C95331696%2C95331983%2C31078668&oid=2&pvsid=60943146494634&tmod=196357801&uas=0&nvt=1&fsapi=1&fc=1920&brdim=50%2C50%2C50%2C50%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=32768&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&ifi=1&uci=a!1&fsb=1&dtd=506
Frame ID: 49B063CC8847F3D6983E9BCBDEAC8872
Requests: 1 HTTP requests in this frame

Frame: https://gum.criteo.com/syncframe?origin=publishertagids&topUrl=www.fiercepharma.com&gdpr=0&gdpr_consent=
Frame ID: 69D5F644326822F048BDE04E421B83C3
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?pubId=59a18369e249bfb
Frame ID: BEB507D43C8EC4DCDCDF5E27AF9C9901
Requests: 1 HTTP requests in this frame

Frame: https://hde.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26extuid%3D33XUSERID33X&b=1
Frame ID: B497610A5BE0C8FB79C1A6870E9E31DA
Requests: 1 HTTP requests in this frame

Frame: https://sync.hbmp.mediafuse.com/csync?t=g&ep=142&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=764727&a=754412&extuid=3599074556634654000V10
Frame ID: 84441CE67B3CE979E92B26A5E178B9B6
Requests: 1 HTTP requests in this frame

Frame: https://s.console.adtarget.com.tr/sync.html?aid=748067
Frame ID: E32B5A53C017436ECA657961CE2A4601
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?gdpr=0&gdpr_consent=undefined&us_privacy={us_privacy}&predirect=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Da%26ep%3D558003%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D765040%26a%3D558003%26extuid%3D
Frame ID: D0721553EB5ADADB335A9F46F9DA3662
Requests: 1 HTTP requests in this frame

Frame: https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D50%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D764710%26a%3D743293%26extuid%3D%24UID
Frame ID: 78B344A8A0D23CC8746445F34014D53F
Requests: 1 HTTP requests in this frame

Frame: https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Frame ID: 046EBD7963F06A1BCEC14BC092145875
Requests: 1 HTTP requests in this frame

Frame: https://690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Frame ID: 4376E06A1FBFC72B21A33E2CAB4AD9E0
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvNeT03nldGxevCtpq5krYlZuzL87eTXDdzeJYUqybVhiR4ciBEmVvD9ONfVXkp1bXt7HcG3KOjNBZ9GuQ1XOh2mD3SwZ0NPsDYSiahjXBOhYQow40TYvEQofWpNJsi7A56tGmD0vFv4wNh2nqIj11_Tz5dwBU0Z6u4hv5T5-M7dMc1_hJCpkwF_OxXDRdaToD0QMyN47r5vtEjQKDaVH9seNm775zNkJkVR1pJxrgge9aBLUNEmmWb2VpeD_0hxuVuQWeH04iV5hT_M0KbeL7FncN9mppCPjxXCfNHccnr732EcuiX_VHnRtuBRqyMxDBcUL92pQa4zxHndkzWaHnkXsX7GBD-WUyuAT3bMOPy5WHRMdpJfRfwKpUqy7qpyalF1_BzLxYr3KUTF-f-iMZ20WB7g-7_bJ-o52Rx&sai=AMfl-YTTmvz-jNgrY3AtdI4tcPDdwtivIMHg2gu-5DuT1R-m-u3lXfNK1q0-qZfOpvu1nqh5LnszQtexE8Bt_T1ktIu-ewENh2epVqfNQ8dWYhbBWZfbpuAblO48JMU-pQ&sig=Cg0ArKJSzKPmp4rTggTEEAE&uach_m=%5BUACH%5D&adurl=
Frame ID: CBE8B35A630B5F0654E478C91340E460
Requests: 10 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvczJlM49elCQ5VwndO6Lo_bRvzBP5hAfKmBwWPxN-iY5XEJBjo1TsYZshtd-m25Il5ozzoXi0WBPjgf3dOKm9f7l4x9lnpZv7lwmdEDUkv6sjE0nb5BuuOKldLmqQUWm85uysgsa5d4UwGw2sBM-OmqUPrBv2yltXz7R52OcGgVEFwvhCcL3BscfmWWchniMaRSmfM6TaIAxeY6qTHWsI-O5_G49ME6WZms6Kobr2Czvto-ZuHWOb9sIyR1ALaPDf-SOHT8tR1DMDjQR5W9tHwSV5yZx3pgZhrIX0tDDdSWxSEsAxvl-HGdbq3kqZPEATOTp2ISBr9_3cTgi19g8GyxXbHM4PXhiYJnbh0knU2wzIBcwzSW5sObajo07vNqXvcGsUVZnBFG2vX0VcOk4IkrpFChC3q5NZ6VySS&sai=AMfl-YRVKweY0R82IAorX0ey2IYvP0QbzAZJsUgKwjMalxoffcgE4FOL_05YkXhIWPDX52_8WV0eHelM2vbQUbZxaMwThF8MyUE0X-YeUcF_u1XvmtZm0JXkvJV7MQMU7Q&sig=Cg0ArKJSzEvOA6aJonJ_EAE&uach_m=%5BUACH%5D&adurl=
Frame ID: 6283E925C7FCEB46289143ABB340DCB2
Requests: 10 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuKZYqm683g24l47Za6cTHy7t0jJUG1IMskzlVevtX_rnJ9WP5WXyF9KVKt-jxG3TD2q5GXYbMdxwKpBNNw28z7ZeRSFx7ZuooEJiqdNuM_Q-qv3Wl42uZxoAwfOUY5mdl8NMI3UDDlze_vGbT6h12tvoxXaVu-O6qSfr7vuylwRop95C8kB41h8I2WNiVS7SLV6NozzP-OdErTFwd3-vqMHsO0LS-dmWWFqkszDvNkntKDXazIKxO8yvoqGn9gqfhowT-E9NySU-qaQyzBQ296lMVOmkSSFJmbWzZsT_reNweys6beooIotS5W22zuPEEPyT_JbTMypwZCW7ccM6vcCHg9haemIqvsOp22irpOLT-SQEq9rKg_JnFHArWxkhPVy-EAkS0xs34F2F4dTb36isAgTD4sdu7GKjPJ&sai=AMfl-YQTkgmGoZ9q7dU1OF3_Qiwmbnj27KWltMitZe4qvcHE_UtHvinEkC56YMQDrbtQ0yJOwbAA6hzqZaBzVK4utA7r0IkYPPmg1dTBoqxTlqKfeLG9V2CA_FWWnZIS1g&sig=Cg0ArKJSzIgJcqwpDSEKEAE&uach_m=%5BUACH%5D&adurl=
Frame ID: 146B853D0A29308A91837FBE82BBA2BC
Requests: 9 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssJiLL0yEtJ7cMQyFyUuMLKONzdujRD8u5phTJ2zd3EaKGdAqWKPil88OlpByivPtRt9dk_MiEmGta2g2Qx_XTeq9GJdrVDba3H4VNrh1TO0vSA6lFjlhdaZKYtbOB_Rfx6OwDZUxh2EpxzSKOHLr6HF-Rr134XTNotTyf4QFd-zDcsvNRX7LwhIQwH6eqo2LZsUOuZCk0_fRJ5K-DIhnfXsf7kAxxK1mH1krhmB6uJYNRps8yfcy6h5ioZvp9YrZ6uOySfRyZ41O9ZGK5u8StyKZZ7yUTuzfAD_rXnzR5Hl84CfFbsJDbd-X9OCql8HgXqWPpwgMPLadzvrRw_2JhMI-BnTSHL0zfGryUyQB41LCt3IF5_EySPNcxyRJdCO-Y-6OmrFKBBxhdup4mbv3NRO7ZFV6MCrCim16M7&sai=AMfl-YQd4Zw6AChoKVW-MSHD7h2gngh6Pg0qQvVZufCKdkPRGgKrtCj0dbQdm6elRN_x3Xw4BEdvzwiZQcQazdvQSJr5mkTDfnWwBar4ZY8aLEjvrnPAqD_De7tY4jJLmQ&sig=Cg0ArKJSzMKR7Pq5hkbNEAE&uach_m=%5BUACH%5D&adurl=
Frame ID: 9139CD055962E068B9049C314C72F890
Requests: 9 HTTP requests in this frame

Frame: https://de.tynt.com/deb/?m=xch&rt=html&ru=deb&id=b-64TSyTCr7RPcrkHcnnVW&gdpr_consent=undefined&us_privacy=undefined&gpp=&gpp_sid=
Frame ID: F7CFE984AFD6D6CAF9DA41BEBB6AADDC
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 6139C429D67383A64DE104006B08EE37
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 7EFF701180C3F5C5C016DA2FDFF1E7E3
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: 89C4DBFC512D79834F64BE5BDAC79DEE
Requests: 1 HTTP requests in this frame

Frame: https://prebid.a-mo.net/isyn?gdpr_consent=&gdpr=0&us_privacy=&gpp=&gpp_sid=
Frame ID: FD90385B2BC7288AE2C92BBF1487E5C7
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=159302
Frame ID: A6FE8ABA646714AC86DCFE80E00AEF00
Requests: 1 HTTP requests in this frame

Frame: https://sync.adtelligent.com/csync?t=g&ep=50&traffic_source=snippet&session=41CE24396FE8317E&sp=852559&pb=753264&c=764710&a=743293&domain=https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&extuid=5414751822788295032
Frame ID: 4497906416ABA3884FEFAA23038DF307
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?vsSync=1&cs=8&cv=31&https=1&cid=8CU816538&prvid=2034%2C2033%2C2110%2C2030%2C590%2C273%2C2107%2C233%2C2027%2C2026%2C2025%2C237%2C556%2C117%2C359%2C97%2C2109%2C55%2C99%2C3012%2C3011%2C3010%2C3007%2C246%2C4%2C521%2C126%2C203%2C2113%2C446%2C404%2C9%2C2090%2C2011%2C2055%2C2099%2C3022%2C3020%2C251%2C175%2C450%2C2009%2C178%2C255%2C3018%2C3017%2C214%2C3014%2C459%2C77%2C38%2C2022%2C182%2C261%2C141%2C262%2C461%2C222%2C542%2C301%2C345%2C225%2C468%2C10000%2C80%2C108%2C229&itype=PREBID&purpose1=1&gdprconsent=1&gdpr=0&coppa=0&usp_status=0&usp_consent=1
Frame ID: EAF9FA802BDB8B7F2959777C26E3EDD1
Requests: 1 HTTP requests in this frame

Frame: https://ssp.disqus.com/sync?type=iframe
Frame ID: 17B5912BF86530456D1CF7677571B361
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?vsSync=1&cs=8&cv=31&https=1&cid=8CUO2I9ST&prvid=2034%2C590%2C159%2C236%2C237%2C117%2C359%2C97%2C55%2C99%2C3012%2C3010%2C244%2C201%2C3007%2C246%2C4%2C521%2C126%2C203%2C446%2C9%2C208%2C173%2C294%2C251%2C175%2C450%2C178%2C255%2C3018%2C3017%2C214%2C3016%2C337%2C338%2C459%2C70%2C77%2C2022%2C182%2C261%2C141%2C262%2C186%2C461%2C222%2C10000%2C80%2C108%2C229%2C109%2C307&itype=PREBID&purpose1=1&gdprconsent=1&gdpr=0&coppa=0&usp_status=0&usp_consent=1
Frame ID: 1AF0F1B95EAA193F456477898F1FF6D1
Requests: 1 HTTP requests in this frame

Frame: https://de.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D33XUSERID33X
Frame ID: 14356FD816D35DE9EC6C9017BA7A162D
Requests: 1 HTTP requests in this frame

Frame: https://adxbid.info/sync-all.html?gdpr=0&gdpr_consent=&us_privacy=
Frame ID: AF625D54562AD0AB71AF88E1ECFDF8D3
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?pubId=59a18369e249bfb
Frame ID: 093EBCA613116668DFA1F11227C8F362
Requests: 1 HTTP requests in this frame

Frame: https://bh.contextweb.com/visitormatch
Frame ID: FCEA008C66A443198252892211657E22
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: FA050555ABC621AB64F4BF19712B445C
Requests: 1 HTTP requests in this frame

Frame: https://ce.lijit.com/beacon?informer=13459965
Frame ID: 13A6A085D2DAB6B3FD9703176942F4EC
Requests: 1 HTTP requests in this frame

Frame: https://s.console.adtarget.com.tr/sync.html?aid=748067
Frame ID: 69DD086B77D0975A86D1639E99399BCC
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=159302
Frame ID: 6580CF841C0400E70AD0750B14A06ABA
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1716905856400
Frame ID: 86658D50CA7CEBCE9700D367461E4CAD
Requests: 1 HTTP requests in this frame

Frame: https://eb2.3lift.com/sync
Frame ID: 59E6699FD6722D5214B734F82ACBAD81
Requests: 1 HTTP requests in this frame

Frame: https://bh.contextweb.com/visitormatch
Frame ID: 5D3A0E001B0542865822B2F65D2BB006
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/user_sync.html?gdpr=0&gdpr_consent={gdpr_consent}&us_privacy={us_privacy}&predirect=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D558003%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D765040%26a%3D558003%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D
Frame ID: E39B69F361B421BB38872A7AD2FF5389
Requests: 1 HTTP requests in this frame

Frame: https://public.servenobid.com/sync.html
Frame ID: EEF18C22FDCAB677192878520C785CDA
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

AZ told to pay Pfizer $107.5M for patent infringement

Detected technologies

Overall confidence: 100%
Detected patterns
  • (?:a|s)\.adroll\.com

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • //connect\.facebook\.([a-z]+)/[^/]*/[a-z]*\.js

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.openx\.net

Overall confidence: 100%
Detected patterns
  • adnxs\.com/[^"]*(?:prebid|/pb\.js)

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.pubmatic\.com

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.rubiconproject\.com

Page Statistics

450
Requests

82 %
HTTPS

22 %
IPv6

84
Domains

149
Subdomains

116
IPs

11
Countries

3002 kB
Transfer

9084 kB
Size

382
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 42
  • https://rdcdn.com/rt?aid=19932&e=1&img=1 HTTP 302
  • https://rdcdn.com/eow HTTP 302
  • https://rdcdn.com/images/blank.gif
Request Chain 64
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookiesTest=true HTTP 302
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D4973674%26time%3D1716905855147%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26cookiesTest%3Dtrue%26liSync%3Dtrue HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookiesTest=true&liSync=true HTTP 302
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookiesTest=true&liSync=true&e_ipv6=AQImulZyW4HBPAAAAY-_kEpx9kD-KheRQCKfcZ1oTuAcmkko2EKj09NAbYxl3vWlPYQ2yg
Request Chain 69
  • https://s.adroll.com/j/pre/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/fpconsent.js HTTP 302
  • https://s.adroll.com/j/pre/index.js
Request Chain 71
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&zn%3D%26sn%3D%26q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D354724%26tzOffset%3D600%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26zn%253D%2526sn%253D%2526q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D354724%2526tzOffset%253D600%2526url%253Dhttps%25253A%25252F%25252Fwww.fiercepharma.com%25252Fpharma%25252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=7532885200230356581&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=354724&tzOffset=600&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Request Chain 78
  • https://oajs.openx.net/esp?url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rid=esp HTTP 302
  • https://oajs.openx.net/esp?url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rid=esp&cc=1
Request Chain 80
  • https://dpm.demdex.net/ibs:dpid=22052&dpuuid=3644478246682624013&redir= HTTP 302
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3644478246682624013&redir=
Request Chain 81
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3644478246682624013 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzY0NDQ3ODI0NjY4MjYyNDAxMxAAGg0I_87XsgYSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=970d03b0b853457d33f36d5c029f60cdd1335e18ea8abc42211ff2d1b2cdc9eef4cb09cee1a4f8eb&person_id=3644478246682624013&eid=50082
Request Chain 82
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=d0tro1j&ttd_tpi=1 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=d0tro1j&ttd_tpi=1 HTTP 302
  • https://ml314.com/utsync.ashx?eid=53819&et=0&fp=5bd0543e-1516-41ce-8e0f-a61e663146fe&gdpr=0&gdpr_consent= HTTP 302
  • https://ml314.com/csync.ashx?fp=5bd0543e-1516-41ce-8e0f-a61e663146fe&person_id=3644478246682624013&eid=53819
Request Chain 83
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3644478246682624013 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3644478246682624013 HTTP 302
  • https://ml314.com/csync.ashx?fp=7b3b6951c8d34345f65c3dff8743ea8f&eid=50146&person_id=3644478246682624013
Request Chain 90
  • https://d.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookie=&adroll_s_ref=&keyw=&p0=898 HTTP 302
  • https://s.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/EM6JRDVVXJDHHMOGWQDHR4.js
Request Chain 93
  • https://ssc-cms.33across.com/ps/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26extuid%3D33XUSERID33X HTTP 302
  • https://de.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26extuid%3D33XUSERID33X HTTP 307
  • https://hde.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26extuid%3D33XUSERID33X&b=1
Request Chain 94
  • https://hbx.media.net/cksync.php?cs=1&type=pbs&ovsid=setstatuscode&gdpr=0&gdpr_consent=undefined&gpp={gpp}&gpp_sid={gpp_sid}&redirect=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D142%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D764727%26a%3D754412%26extuid%3D%3Cvsid%3E HTTP 302
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=142&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=764727&a=754412&extuid=3599074556634654000V10
Request Chain 98
  • https://cm-x.mgid.com/7d2fea400064b22652273d22c2e07bad.gif?puid=[UID]&redir=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D358%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D765043%26a%3D753378%26extuid%3D%5BUID%5D HTTP 302
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=358&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765043&a=753378&extuid=fb4ec714-f08c-4bc1-a3c8-ad51a5f824f3
Request Chain 100
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D32%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D770090%26a%3D758001%26extuid%3D%24UID HTTP 302
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=770090&a=758001&extuid=7532885200230356581
Request Chain 102
  • https://ap.lijit.com/pixel?redir=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D13%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D675886%26a%3D310570%26extuid%3D%24UID HTTP 307
  • https://ap.lijit.com/pixel?redir=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D13%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D675886%26a%3D310570%26extuid%3D%24UID&sovrn_retry=true HTTP 307
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=13&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=675886&a=310570&extuid=Iu15ALZHFmXOcih3Q3CI14ZT
Request Chain 103
  • https://sync.1rx.io/usersync2/rmpssp?sub=adtelligent HTTP 302
  • https://sync.1rx.io/usersync2/rmpssp?sub=adtelligent&zcc=1&cb=1716905854182 HTTP 302
  • https://ad.turn.com/r/cs?pid=45&rndcb=8993946724 HTTP 302
  • https://sync.1rx.io/usersync/turn/3393522997715204143?dspret=1&gdpr=&gdpr_consent=&us_privacy= HTTP 302
  • https://sync.targeting.unrulymedia.com/csync/RX-c1b27d11-0298-4776-8523-332ed0612207-005?redir=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D541630%26extuid%3DRX-c1b27d11-0298-4776-8523-332ed0612207-005 HTTP 302
  • https://sync.adtelligent.com/csync?t=a&ep=541630&extuid=RX-c1b27d11-0298-4776-8523-332ed0612207-005
Request Chain 104
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D32%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D765041%26a%3D297253%26extuid%3D%24UID HTTP 302
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765041&a=297253&extuid=7532885200230356581
Request Chain 105
  • https://a4p.adpartner.pro/ssp/match?redirect=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Da%26ep%3D307558%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D765812%26a%3D307558%26extuid%3D%7Buser_id%7D HTTP 302
  • https://sync.hbmp.mediafuse.com/csync?t=a&ep=307558&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765812&a=307558&extuid=961c6ad5-9512-4395-ae74-449abe757ba1
Request Chain 106
  • https://prebid.a-mo.net/cchain/0?cb=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D737%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D764723%26a%3D310531%26extuid%3D HTTP 302
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fprebid.a-mo.net%2Fcchain%2F0%2F7240%3Fgpp%3D%26gdpr_consent%3D%26gdpr%3D%26gpp_sid%3D%26us_privacy%3D%26A%3D794bc344-a4fa-440c-895e-7f9d938486d6%26bidder%3Dappnexus%26cbx%3DaHR0cHM6Ly9zeW5jLmhibXAubWVkaWFmdXNlLmNvbS9jc3luYz90PWcmZXA9NzM3JnRyYWZmaWNfc291cmNlPXNuaXBwZXQmc2Vzc2lvbj0xM0NFMjQ1MTY5QzJDOTE3JnNwPTg1MjU1OSZwYj03NTMyNjQmYz03NjQ3MjMmYT0zMTA1MzEmZXh0dWlkPQ%253D%253D%26uid%3D%24UID HTTP 302
  • https://prebid.a-mo.net/cchain/0/7240?gpp=&gdpr_consent=&gdpr=&gpp_sid=&us_privacy=&A=794bc344-a4fa-440c-895e-7f9d938486d6&bidder=appnexus&cbx=aHR0cHM6Ly9zeW5jLmhibXAubWVkaWFmdXNlLmNvbS9jc3luYz90PWcmZXA9NzM3JnRyYWZmaWNfc291cmNlPXNuaXBwZXQmc2Vzc2lvbj0xM0NFMjQ1MTY5QzJDOTE3JnNwPTg1MjU1OSZwYj03NTMyNjQmYz03NjQ3MjMmYT0zMTA1MzEmZXh0dWlkPQ%3D%3D&uid=7532885200230356581 HTTP 302
  • https://image8.pubmatic.com/AdServer/ImgSync?p=158355&gdpr=0&us_privacy=1---&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D158355%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fprebid.a-mo.net%252Fcchain%252F3%252F7240%253Fgpp%253D%2526gdpr_consent%253D%2526gdpr%253D%2526gpp_sid%253D%2526us_privacy%253D%2526A%253D794bc344-a4fa-440c-895e-7f9d938486d6%2526bidder%253Dpubmatic%2526cbx%253DaHR0cHM6Ly9zeW5jLmhibXAubWVkaWFmdXNlLmNvbS9jc3luYz90PWcmZXA9NzM3JnRyYWZmaWNfc291cmNlPXNuaXBwZXQmc2Vzc2lvbj0xM0NFMjQ1MTY5QzJDOTE3JnNwPTg1MjU1OSZwYj03NTMyNjQmYz03NjQ3MjMmYT0zMTA1MzEmZXh0dWlkPQ%25253D%25253D%2526uid%253D%2523PMUID HTTP 302
  • https://pubmatic-match.dotomi.com/match/bounce/current?networkId=17100&version=1&nuid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent= HTTP 302
  • https://pubmatic-match.dotomi.com/match/bounce/current?DotomiTest=7acf054160a60506&is_secure=true&networkId=17100&version=1&nuid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent= HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AQAAzdFcyPINugIh58W8AQEBAQEBAQCOvpFMgwEBAI6-kUyD&expiration=1716992256&nuid=A1C42EB9-955D-4866-B405-509F11DA5631&is_secure=true&gdpr_consent=&gdpr=0
Request Chain 107
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=7532885200230356581&pixelIndex=0 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=7532885200230356581&pixelIndex=0&google_gid=CAESEJdcZcrZuSUBq3djmb_dCdE&google_cver=1
Request Chain 108
  • https://idsync.rlcdn.com/423396.gif?partner_uid=7532885200230356581 HTTP 307
  • https://pippio.com/api/sync?pid=5324&it=1&iv=968eaf830204b100b092706fd34c08a4cd6128dc6b37e86074810383de542d9e791426b5417dce21&_=2 HTTP 307
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=968eaf830204b100b092706fd34c08a4cd6128dc6b37e86074810383de542d9e791426b5417dce21&rand=06422672
Request Chain 111
  • https://d.adroll.com/cm/b/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=44&user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI HTTP 302
  • https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
Request Chain 112
  • https://d.adroll.com/cm/g/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_sc&google_nid=artb&google_hm=kMcxeYwsG87Hi11R3aNYmw HTTP 302
  • https://d.adroll.com/cm/g/in
Request Chain 113
  • https://d.adroll.com/cm/index/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expiration=1748441855 HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expiration=1748441855&C=1
Request Chain 114
  • https://d.adroll.com/cm/l/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://idsync.rlcdn.com/377928.gif?partner_uid=90c731798c2c1bcec78b5d51dda3589b HTTP 307
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fidsync.rlcdn.com%2F396846.gif%3Fserved_by%3Devergreen%26partner_uid%3D HTTP 302
  • https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=f29451ea-abb3-47f4-ab39-092fdea4367e
Request Chain 115
  • https://d.adroll.com/cm/n/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expires=365
Request Chain 116
  • https://d.adroll.com/cm/o/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537103138&val=90c731798c2c1bcec78b5d51dda3589b&gdpr=0&gdpr_consent=
Request Chain 117
  • https://d.adroll.com/cm/outbrain/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://sync.outbrain.com/cookie-sync?p=adroll&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=&us_privacy=1---
Request Chain 118
  • https://d.adroll.com/cm/pubmatic/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDYmdGw9MTI5NjAw&piggybackCookie=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENAkwAAAAXyACACYAIIA
Request Chain 119
  • https://d.adroll.com/cm/r/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://ups.analytics.yahoo.com/ups/55980/sync?_origin=1&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA HTTP 302
  • https://ups.analytics.yahoo.com/ups/55980/sync?_origin=1&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&verify=true
Request Chain 120
  • https://d.adroll.com/cm/taboola/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://sync.taboola.com/sg/adroll-network/1/rtb-h?taboola_hm=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
Request Chain 121
  • https://d.adroll.com/cm/triplelift/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://eb2.3lift.com/xuid?mid=4714&xuid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&dongle=c85e HTTP 302
  • https://eb2.3lift.com/xuid?ld=1&mid=4714&xuid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&dongle=c85e&gdpr=0&cmp_cs=&us_privacy=
Request Chain 122
  • https://d.adroll.com/cm/x/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&advertisable=5J7LBS7TXZCZDFENFCAXF7 HTTP 302
  • https://ib.adnxs.com/setuid?entity=172&code=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
Request Chain 128
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&adnxs_id=$UID&gdpr=0 HTTP 302
  • https://ids.ad.gt/api/v1/match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&adnxs_id=7532885200230356581&gdpr=0
Request Chain 129
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&ttd_puid=AU1D-0100-001716905856-UP2ANVC2-NLBB&gdpr=0 HTTP 302
  • https://ids.ad.gt/api/v1/t_match?tdid=5bd0543e-1516-41ce-8e0f-a61e663146fe&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
Request Chain 130
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3DAU1D-0100-001716905856-UP2ANVC2-NLBB HTTP 302
  • https://ids.ad.gt/api/v1/pbm_match?pbm=E4A7B065-4DC2-43F6-A8C4-5C5C45F703C1&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
Request Chain 131
  • https://token.rubiconproject.com/token?pid=50242&puid=AU1D-0100-001716905856-UP2ANVC2-NLBB&gdpr=0 HTTP 302
  • https://ids.ad.gt/api/v1/rub_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&rub=LWQHF0YD-F-3YJX&gdpr=0
Request Chain 132
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3185&partner_device_id=AU1D-0100-001716905856-UP2ANVC2-NLBB&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001716905856-UP2ANVC2-NLBB%26tapad_id%3D%24%7BTA_DEVICE_ID%7D HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive/check?partner_id=3185&partner_device_id=AU1D-0100-001716905856-UP2ANVC2-NLBB&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001716905856-UP2ANVC2-NLBB%26tapad_id%3D%24%7BTA_DEVICE_ID%7D HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=tapad&ttd_tpi=1&ttd_puid=8b9295b3-715d-4cf4-8e2c-6688206c4e63%252Chttps%25253A%25252F%25252Fids.ad.gt%25252Fapi%25252Fv1%25252Ftapad_match%25253Fid%25253DAU1D-0100-001716905856-UP2ANVC2-NLBB%252526tapad_id%25253D8b9295b3-715d-4cf4-8e2c-6688206c4e63%252C&gdpr=0&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=1830&partner_device_id=5bd0543e-1516-41ce-8e0f-a61e663146fe&ttd_puid=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2Chttps%253A%252F%252Fids.ad.gt%252Fapi%252Fv1%252Ftapad_match%253Fid%253DAU1D-0100-001716905856-UP2ANVC2-NLBB%2526tapad_id%253D8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C HTTP 302
  • https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&tapad_id=8b9295b3-715d-4cf4-8e2c-6688206c4e63
Request Chain 133
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=AU1D-0100-001716905856-UP2ANVC2-NLBB HTTP 302
  • https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&google_gid=CAESEGdKy5wjygqFerowi0S0fOA&google_cver=1&google_ula=450542624,0
Request Chain 134
  • https://ids.ad.gt/api/v1/g_hosted?id=AU1D-0100-001716905856-UP2ANVC2-NLBB HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcxNjkwNTg1Ni1VUDJBTlZDMi1OTEJC
Request Chain 135
  • https://d.turn.com/r/dd/id/L2NzaWQvMS9jaWQvMTc0ODI0MTY1OC90LzA/url/https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Famo_match%3Fturn_id%3D%24!%7BTURN_UUID%7D%26id%3DAU1D-0100-001716905856-UP2ANVC2-NLBB HTTP 302
  • https://ids.ad.gt/api/v1/amo_match?turn_id=4562344477781617569&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
Request Chain 137
  • https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&uid=[UID]&gdpr=0 HTTP 302
  • https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&uid=37e0b433-a139-49aa-b81e-736192785b62&gdpr=0
Request Chain 196
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=100d53f499bfa2fb&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=970%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223361%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=100d53f499bfa2fb&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=970,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223361%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 197
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=101a28add0e57218&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=970%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223362%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=101a28add0e57218&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=970,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223362%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 256
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=22556416f223472&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=300%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223271%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=22556416f223472&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223271%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 257
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=226996940196f19f&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=300%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223272%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=226996940196f19f&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223272%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 289
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=29649fd8642b63b9&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=300%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223271%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=29649fd8642b63b9&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223271%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 290
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=297bf352112d90df&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=300%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223272%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=297bf352112d90df&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223272%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 326
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=3657fdbcc27d4ea&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=300%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223271%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=3657fdbcc27d4ea&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223271%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 327
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=36633953aabfd85f&transactionId=undefined&device=%257B%2522ua%2522%253A%2522Mozilla%252F5.0%2520(Windows%2520NT%252010.0%253B%2520Win64%253B%2520x64)%2520AppleWebKit%252F537.36%2520(KHTML%252C%2520like%2520Gecko)%2520Chrome%252F125.0.0.0%2520Safari%252F537.36%2522%252C%2522width%2522%253A1600%252C%2522height%2522%253A1200%252C%2522browserLanguage%2522%253A%2522en-US%2522%257D&sizes=300%2C250&aimXR=null&uid=%24UID&params=%7B%22adUnitId%22%3A%223272%22%7D&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined HTTP 302
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=36633953aabfd85f&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223272%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Request Chain 395
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1 HTTP 302
  • https://mug.criteo.com/sid?cpp=8yUVtHwyV0c1WTNxOXNyemtaaDdSa05NbXR0Qk1xM3FRaXRRbmd6ZjRGU05CZnF5bGVBcENuV29nQnljY3JTUjdEQlZBcVErMlRYU0Z5Y1F4RUYvdFNMZEpxbHhQTjc1UzJDanJ6ZU4vRENWR2k4RlMzRk5GbGs4YkxPWEdwVVdnMEQyeGRTR2tvTmh3eDIyeFRxSFpJYVhuSC9VOWMzd2I5SnJabERuR2p0SEk5eDlId3JOYjZrMnVkcmRqeUJDOEZxSXhvSUczR0l4OHVyOEVvQWdBb0ZORk5ybzhENzl3RXAwZXRkU1VMcTNaRnU5V1FMTGhEemtOd3pVc2laTkVDZVNlTXpxR0x5VVZDaW5qeG9BcTlLRFo4c0JiZjF4R0JPcEJobGZ4Z1ZxWGQwT3lKYXJUZnFGM0pwR0JoS2N6SWhMd3w&cppv=2
Request Chain 398
  • https://ssc-cms.33across.com/ps/?m=xch&rt=html&ru=deb&id=b-64TSyTCr7RPcrkHcnnVW&gdpr_consent=undefined&us_privacy=undefined&gpp=&gpp_sid= HTTP 302
  • https://de.tynt.com/deb/?m=xch&rt=html&ru=deb&id=b-64TSyTCr7RPcrkHcnnVW&gdpr_consent=undefined&us_privacy=undefined&gpp=&gpp_sid=
Request Chain 404
  • https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D50%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D764710%26a%3D743293%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D%24UID HTTP 302
  • https://sync.adtelligent.com/csync?t=g&ep=50&traffic_source=snippet&session=41CE24396FE8317E&sp=852559&pb=753264&c=764710&a=743293&domain=https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&extuid=5414751822788295032
Request Chain 408
  • https://ssc-cms.33across.com/ps/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D33XUSERID33X HTTP 302
  • https://de.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D33XUSERID33X
Request Chain 413
  • https://ap.lijit.com/beacon?informer=13459965 HTTP 302
  • https://ce.lijit.com/beacon?informer=13459965
Request Chain 421
  • https://capi.connatix.com/us/pixel?puid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&pId=43&gdpr_consent=&callback=&us_privacy= HTTP 302
  • https://capi.connatix.com/us/pixel?puid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&pId=43&gdpr_consent=&callback=&us_privacy=&final=true
Request Chain 422
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=135&partneruserid=TAM_OK&redirurl=https%3A%2F%2Faax-eu.amazon-adsystem.com%2Fs%2Fdcm%3Fpid%3Df7a5db36-1d5c-4c26-81b6-b4d0807faffb%26id%3DSMART_USER_ID&gdpr=0&gdpr_consent= HTTP 302
  • https://aax-eu.amazon-adsystem.com/s/dcm?pid=f7a5db36-1d5c-4c26-81b6-b4d0807faffb&id=5033829378062940454&gdpr=0&gdpr_consent=
Request Chain 423
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=150&partneruserid=0&redirurl=https%3A%2F%2Fwt.rqtrk.eu%3Fpid%3D58a76248-f101-4e52-b8f7-c4de9362ea12%26src%3Dwww%26type%3D100%26sid%3D0%26uid%3DSMART_USER_ID%26gdpr_pd%3D0&gdpr=0&gdpr_consent= HTTP 302
  • https://wt.rqtrk.eu/?pid=58a76248-f101-4e52-b8f7-c4de9362ea12&src=www&type=100&sid=0&uid=5033829378062940454&gdpr_pd=0&gdpr=0&gdpr_consent=
Request Chain 424
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=140&gdpr=0&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/qmap?c=1389&tp=STSC&tpid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&gdpr=0&gdpr_consent=&d=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Fpush%3Fpartner_id%3D2499%26partner_device_id%3Db6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553%26partner_url%3Dhttps%253A%252F%252Fsync.go.sonobi.com%252Fus.gif%253Fnw%253Dbs%2526nuid%253Db6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553%2526gdpr%253D0%2526gdpr_consent%253D HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2499&partner_device_id=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&partner_url=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dbs%26nuid%3Db6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553%26gdpr%3D0%26gdpr_consent%3D HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=bs&nuid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&gdpr=0&gdpr_consent=
Request Chain 425
  • https://bh.contextweb.com/bh/rtset?do=add&pid=560606&ev=37e0b433-a139-49aa-b81e-736192785b62&daaqp=1&rurl=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dpp%26nuid%3D%25%25VGUID%25%25 HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
Request Chain 426
  • https://b1h.zemanta.com/usersync/prebid HTTP 302
  • https://b1h.zemanta.com/usersync/prebid?s=2
Request Chain 427
  • https://p.rfihub.com/cm?pub=35683&in=1 HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=zt&nuid=1977432099757787762
Request Chain 428
  • https://x.bidswitch.net/sync?ssp=sonobi&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=bidswitch_dbm&google_cm&google_sc&ssp=sonobi&bsw_param=44473d7f-146b-4d56-aac1-0838865cfa25&google_hm=NDQ0NzNkN2YtMTQ2Yi00ZDU2LWFhYzEtMDgzODg2NWNmYTI1&gdpr_consent=&gdpr=0 HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=16&user_id=CAESEAVEz6Uf4bG5tngCn01NPqc&google_cver=1&ssp=sonobi&bsw_param=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr_consent=&gdpr=0 HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=bidswitch&nuid=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr=0&gdpr_consent=&us_privacy=
Request Chain 429
  • https://cm.g.doubleclick.net/pixel?google_nid=sonobi&google_cm&google_hm=MzdlMGI0MzMtYTEzOS00OWFhLWI4MWUtNzM2MTkyNzg1YjYy HTTP 302
  • https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
Request Chain 431
  • https://pixel.rubiconproject.com/exchange/sync.php?p=pbs-vidoomy&gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=LWQHF0YD-F-3YJX&gdpr=0
Request Chain 432
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sonobi&ttd_tpi=1&ttd_puid=db8d61494a&gdpr=0&gdpr_consent= HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=td&nuid=5bd0543e-1516-41ce-8e0f-a61e663146fe&pubid=db8d61494a
Request Chain 433
  • https://bh.contextweb.com/bh/rtset?do=add&pid=560606&ev=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&daaqp=1&rurl=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dpp%26nuid%3D%25%25VGUID%25%25 HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
Request Chain 434
  • https://sync.mathtag.com/sync/img?cs_wd_sy=1&dp=43&redir=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dif%26nuid%3D[MM_UUID] HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=if&nuid=cd246655-e780-4000-ba4c-39351745637e
Request Chain 435
  • https://x.bidswitch.net/sync?ssp=vidoomy&gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://pr-bh.ybp.yahoo.com/sync/iponweb?bidswitch_ssp_id=vidoomy&ssp_user_id=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr=0&gdpr_consent= HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=74&&user_id=y-SAg04vJE2pn3DJi5yEmKJOzITiYyPLZmOrtpwA--~A&expires=5&ssp=vidoomy HTTP 302
  • https://a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=44473d7f-146b-4d56-aac1-0838865cfa25
Request Chain 436
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3061&partner_device_id=e5b82ed2-a27a-4119-a30f-bd23df1a7c02 HTTP 302
  • https://secure.adnxs.com/getuid?https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DAPPNEXUS%26partner_device_id%3D%24UID%26pt%3D8b9295b3-715d-4cf4-8e2c-6688206c4e63%252C%252C HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
Request Chain 438
  • https://cm.g.doubleclick.net/pixel?google_nid=sonobi&google_cm&google_hm=ZTViODJlZDItYTI3YS00MTE5LWEzMGYtYmQyM2RmMWE3YzAy HTTP 302
  • https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
Request Chain 439
  • https://sync.srv.stackadapt.com/sync?nid=286 HTTP 302
  • https://sync.go.sonobi.com/us.gif?nw=st&nuid=zVScQUXbVQ9daTpti8VsWmAJ-So
Request Chain 441
  • https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fa-prebid.vidoomy.com%2Fsetuid%3Fbidder%3Dadf%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24UID HTTP 302
  • https://a-prebid.vidoomy.com/setuid?bidder=adf&gdpr=0&gdpr_consent=&uid=5414751822788295032
Request Chain 442
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?&rd=https%3A%2F%2Frtb-csync.smartadserver.com%2Fredir%2F%3Fissi%3D1%26partnerid%3D91%26partneruserid%3D%23PM_USER_ID%26gdpr%3DPM_GDPR%26gdpr_consent%3DPM_CONSENT&gdpr=0&gdpr_consent= HTTP 302
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=91&partneruserid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent=
Request Chain 443
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3061&partner_device_id=37e0b433-a139-49aa-b81e-736192785b62 HTTP 302
  • https://secure.adnxs.com/getuid?https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DAPPNEXUS%26partner_device_id%3D%24UID%26pt%3D8b9295b3-715d-4cf4-8e2c-6688206c4e63%252C%252C HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
Request Chain 444
  • https://idsync.rlcdn.com/711892.gif?partner_uid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02 HTTP 307
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fidsync.rlcdn.com%2F52154.gif%3Fserved_by%3Devergreen%26partner_uid%3D%24UID HTTP 302
  • https://idsync.rlcdn.com/52154.gif?served_by=evergreen&partner_uid=7532885200230356581
Request Chain 445
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=120&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fa.vidoomy.com%2Fapi%2Frtbserver%2Fcookie%3Fi%3DCEN%26uid%3D%7BuserId%7D HTTP 302
  • https://a.vidoomy.com/api/rtbserver/cookie?i=CEN&uid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553
Request Chain 446
  • https://secure.adnxs.com/getuid?https%3A%2F%2Frtb-csync.smartadserver.com%2Fredir%2F%3Fissi%3D1%26partnerid%3D86%26partneruserid%3D$UID&gdpr=0&gdpr_consent= HTTP 302
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=86&partneruserid=7532885200230356581&gdpr=0&gdpr_consent=
Request Chain 448
  • https://idsync.rlcdn.com/711892.gif?partner_uid=37e0b433-a139-49aa-b81e-736192785b62 HTTP 307
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=liveramp&ttd_tpi=1 HTTP 302
  • https://idsync.rlcdn.com/362588.gif?partner_uid=5bd0543e-1516-41ce-8e0f-a61e663146fe

450 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
www.fiercepharma.com/pharma/
372 KB
61 KB
Document
General
Full URL
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9c5461a4006bd7fe9876358a7813344c04ec5b8b6ab8477150e93d126a1783a3
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
max-age=31536000, public
cf-cache-status
HIT
cf-ray
88aede74be5c39c3-YYZ
content-encoding
br
content-language
en
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
content-type
text/html; charset=UTF-8
date
Tue, 28 May 2024 14:17:34 GMT
expires
Sun, 19 Nov 1978 05:00:00 GMT
last-modified
Tue, 28 May 2024 14:05:56 GMT
referrer-policy
no-referrer-when-downgrade
server
cloudflare
strict-transport-security
max-age=31536000; includeSubDomains; preload
vary
Cookie, Accept-Encoding
x-content-type-options
nosniff
x-drupal-cache
HIT
x-drupal-dynamic-cache
UNCACHEABLE
get
vi.ml314.com/
264 B
388 B
Script
General
Full URL
https://vi.ml314.com/get?eid=66459&tk=NlORAP1pyT9TolCqYpofYXOR4do2bEnp0CI3bC62f2fFHw3d
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.104.135 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
135.104.201.35.bc.googleusercontent.com
Software
Google Frontend /
Resource Hash
9dffbd45ce48bf5e8eeb90b3d8567f8270f217c174de81fe3693d6dcdbaa1588
Security Headers
Name Value
Strict-Transport-Security max-age=2592000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=2592000
content-encoding
br
via
1.1 google
date
Tue, 28 May 2024 14:17:34 GMT
server
Google Frontend
vary
Accept-Encoding
content-type
application/javascript
cache-control
private,max-age=86400
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
147 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1234567890123456
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
b49d13271e9383649f09a83001bac328651ba42e406f6cf9f6122373109f07ed
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Origin
https://www.fiercepharma.com
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51239
x-xss-protection
0
server
cafe
etag
15247136458642850026
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 28 May 2024 14:17:34 GMT
boot.js
global.ketchcdn.com/web/v2/config/questex/fierce_pharma/
3 KB
1 KB
Script
General
Full URL
https://global.ketchcdn.com/web/v2/config/questex/fierce_pharma/boot.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a04:4e42:200::347 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
ee674765d46c5bca6d70a84d0ccee12cbfb7efb01502d5bd6d1937d2bc03f6a6
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=15724800; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self'
strict-transport-security
max-age=15724800; includeSubDomains
x-content-type-options
nosniff
date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
via
1.1 varnish
age
291
x-cache
HIT
request-id
afa0fa67-ddb8-4755-90a1-be146e149b89
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
874
x-xss-protection
1; mode=block
x-request-id
a1f9d92c-5b11-46ba-bd2a-c0fd99374be7
x-served-by
cache-nyc-kteb1890062-NYC
x-timer
S1716905855.537539,VS0,VE1
x-frame-options
deny
vary
Origin, Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=1200
access-control-allow-credentials
true
accept-ranges
bytes
x-cache-hits
1
hb_748754_18091.js
player.mediafuse.com/prebidlink/309522112437/
2 KB
1019 B
Script
General
Full URL
https://player.mediafuse.com/prebidlink/309522112437/hb_748754_18091.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
fe35993f957f311cf33f0247df8869dc3da295e20d068200abb977c76b8ad096

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
gzip
last-modified
Tue, 28 May 2024 14:15:50 GMT
server
nginx
etag
W/"6655e716-606"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Thu, 30 May 2024 14:17:34 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
93 KB
29 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
7ea86a85585ef048c6cf1244910806bb12f5d6e00c7b23fe6bcd314f52505536
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
30115
x-xss-protection
0
server
cafe
etag
148 / 19871 / 31083984 / config-hash: 2349943193236436899
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 28 May 2024 14:17:34 GMT
wrapper_hb_748754_18091.js
player.mediafuse.com/prebidlink/309522112437/
2 KB
1 KB
Script
General
Full URL
https://player.mediafuse.com/prebidlink/309522112437/wrapper_hb_748754_18091.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
146fbffb185f4b4194fbd7f477997dcbde55c4f981890e8f23e16da80c168907

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
gzip
last-modified
Tue, 28 May 2024 14:15:50 GMT
server
nginx
etag
W/"6655e716-9fd"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Thu, 30 May 2024 14:17:34 GMT
gtm.js
www.googletagmanager.com/
230 KB
78 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:809::2008 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
4708a3b143ace4ccfd6656d68057ca641d4264dc121bbf181b1e4507aa1691b3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79677
x-xss-protection
0
last-modified
Tue, 28 May 2024 12:00:00 GMT
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Tue, 28 May 2024 14:17:34 GMT
css_PlR9otmahjIozJJC6aQWFKkC_qdXAMi7toOr3i25pBE.css
www.fiercepharma.com/sites/qcloud5/files/css/
7 KB
2 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/qcloud5/files/css/css_PlR9otmahjIozJJC6aQWFKkC_qdXAMi7toOr3i25pBE.css?delta=0&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0dfe66dd14824544b2cb166e5b7130f848a074a85104d640da0b582adcca3853
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
2436246
cf-polished
origSize=7843
content-encoding
br
alt-svc
h3=":443"; ma=86400
referrer-policy
no-referrer-when-downgrade
cf-bgj
minify
last-modified
Thu, 04 Apr 2024 22:39:05 GMT
server
cloudflare
vary
Accept-Encoding
content-language
en
content-type
text/css; charset=UTF-8
cache-control
no-store, public
cf-ray
88aede76180139c3-YYZ
expires
Sun, 19 Nov 1978 05:00:00 GMT
css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css
www.fiercepharma.com/sites/qcloud5/files/css/
271 KB
25 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/qcloud5/files/css/css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css?delta=1&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
22fd68313c05d475c370ee1c325b045bc94ec1eea131a08b6ca642b1e21faddf
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
1008323
cf-polished
origSize=278107
content-encoding
br
alt-svc
h3=":443"; ma=86400
referrer-policy
no-referrer-when-downgrade
cf-bgj
minify
last-modified
Thu, 16 May 2024 22:11:41 GMT
server
cloudflare
vary
Accept-Encoding
content-language
en
content-type
text/css; charset=UTF-8
cache-control
no-store, private
cf-ray
88aede76180539c3-YYZ
expires
Sun, 19 Nov 1978 05:00:00 GMT
runtime.js
www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/
2 KB
1 KB
Script
General
Full URL
https://www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/runtime.js?v=8684
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8f3eeca467563d43e0cfd8aca8015e6db31faa5258f32eef9ad40f37f9b0f164

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 16 May 2024 22:06:34 GMT
server
cloudflare
age
1008323
etag
W/"6646836a-69b"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
88aede76180839c3-YYZ
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
Fierce%20Pharma%20Mix%20Logo.svg
qtxasset.com/quartz/qcloud5/logos/
3 KB
2 KB
Image
General
Full URL
https://qtxasset.com/quartz/qcloud5/logos/Fierce%20Pharma%20Mix%20Logo.svg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.16.151.166 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4a83174220c766e30431b9a667ed066173a074ce98e93f613094c5a2ffe4afef

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
x-amz-version-id
7sy_P28mg26Es9yMNPYj9VjtlUxwY1lE
content-encoding
br
cf-cache-status
HIT
x-amz-request-id
2EXVBZC5FGN6BYEJ
age
2436444
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400
x-amz-id-2
N7XuSTBDXir9cO+bp0tdCfT9gKF2JMEgTrwEJiZZwD5a34YwSClzPhOyzL+zOrUkS78xIWZ+7Ts=
last-modified
Mon, 26 Sep 2022 17:30:17 GMT
server
cloudflare
etag
W/"0c35151e9c2f5c8c50418367cfb2ff34"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=31536000
cf-ray
88aede765893ab28-YYZ
expires
Wed, 28 May 2025 14:17:34 GMT
bars-regular.svg
www.fiercepharma.com/themes/custom/quartz_barrio/images/icons/
617 B
575 B
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/quartz_barrio/images/icons/bars-regular.svg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
852b3532441a29f2ba7e869ecfbc38eb772c2a3051d4783e49f4dc68c185191e

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 25 May 2023 22:03:59 GMT
server
cloudflare
age
2436445
etag
W/"646fdb4f-269"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=315360000
cf-ray
88aede76180939c3-YYZ
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
xmark-solid.svg
www.fiercepharma.com/themes/custom/quartz_barrio/images/icons/
633 B
599 B
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/quartz_barrio/images/icons/xmark-solid.svg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cae2660518f22b45acda581d90ed118a6727785eb1e99075a5f5e09a2f918dc1

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 25 May 2023 22:03:59 GMT
server
cloudflare
age
2435454
etag
W/"646fdb4f-279"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=315360000
cf-ray
88aede76584d39c3-YYZ
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
omedaseg.js
www.fiercepharma.com/modules/custom/quartz_ads/js/
901 B
683 B
Script
General
Full URL
https://www.fiercepharma.com/modules/custom/quartz_ads/js/omedaseg.js?v=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
57e4d88b2d92e8e0555b21e5dedd98675181ef2e86da552c6577cf4091d6e4f6

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 12 Oct 2023 22:09:46 GMT
server
cloudflare
age
2436072
cf-polished
origSize=1126
etag
W/"65286eaa-466"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
88aede76788139c3-YYZ
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
global.js
www.fiercepharma.com/themes/custom/quartz_barrio/js/
7 KB
2 KB
Script
General
Full URL
https://www.fiercepharma.com/themes/custom/quartz_barrio/js/global.js?v=3.2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
04f0ce7c5d7079434eab7e1b1820d148b298bfef13a1a1db71572fb90fe794cc

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Fri, 19 Apr 2024 00:01:37 GMT
server
cloudflare
age
2196011
cf-polished
origSize=9877
etag
W/"6621b461-2695"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
88aede76788439c3-YYZ
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
nodearticle.js
www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/
593 KB
152 KB
Script
General
Full URL
https://www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/nodearticle.js?v=ca9e
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6c5cad7b156e34391c32209eb8f31dfe56cb8a64b9532b3934543b2e6a901f32

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
cf-cache-status
HIT
cf-bgj
minify
last-modified
Thu, 16 May 2024 22:06:33 GMT
server
cloudflare
age
1008323
cf-polished
origSize=607266
etag
W/"66468369-94422"
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
cache-control
max-age=315360000
cf-ray
88aede76788639c3-YYZ
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
js__KnvxI_i2Cq08xUTGKq2CCvIELcwETQPct14bECiCBc.js
www.fiercepharma.com/sites/qcloud5/files/js/
2 KB
1 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/qcloud5/files/js/js__KnvxI_i2Cq08xUTGKq2CCvIELcwETQPct14bECiCBc.js?scope=footer&delta=3&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
49bd6d55c4f8dec8bee5f9da82443c93284b5d125f13d38b4a48be53f12b8299
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
1008323
cf-polished
origSize=1761
content-encoding
br
alt-svc
h3=":443"; ma=86400
referrer-policy
no-referrer-when-downgrade
cf-bgj
minify
last-modified
Thu, 16 May 2024 22:11:41 GMT
server
cloudflare
vary
Accept-Encoding
content-language
en
content-type
text/javascript; charset=UTF-8
cache-control
no-store, private
cf-ray
88aede76788039c3-YYZ
expires
Sun, 19 Nov 1978 05:00:00 GMT
chevron-down-solid-dark.svg
www.fiercepharma.com/themes/custom/quartz_barrio/images/icons/custom/
432 B
494 B
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/quartz_barrio/images/icons/custom/chevron-down-solid-dark.svg?v=1.0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2b81d74611b86412eaacf368de07f273ab99505e5a80df3de33c4360f8dd9555

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 25 May 2023 22:03:59 GMT
server
cloudflare
age
7749529
etag
W/"646fdb4f-1b0"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=315360000
cf-ray
88aede76889739c3-YYZ
alt-svc
h3=":443"; ma=86400
expires
Thu, 31 Dec 2037 23:55:55 GMT
Fierce-23-Brand-Element.svg
qtxasset.com/quartz/qcloud5/
1 KB
903 B
Image
General
Full URL
https://qtxasset.com/quartz/qcloud5/Fierce-23-Brand-Element.svg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.16.151.166 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
befb55188d1fc6bfca46b1da87cce77f09058c0b7a00b67f7cf7233aa4b570d3

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
x-amz-version-id
bmuL8lQrt0nnsOMk1Jm4_VUq4.oCq3NS
content-encoding
br
cf-cache-status
HIT
x-amz-request-id
7AQYDS24JSEMSZ5J
age
7758163
x-amz-server-side-encryption
AES256
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400
x-amz-id-2
fECph8C5S3hWgocMVdjin8Al0iF7yVsZ5uiwL1S1WVaI8nduCytEQF/EM2oYiUrVbfiyZ34ihAw=
last-modified
Wed, 22 Feb 2023 14:52:08 GMT
server
cloudflare
etag
W/"70f8c7045215bb1368720bf699506d5f"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
public, max-age=31536000
cf-ray
88aede7688d0ab28-YYZ
expires
Wed, 28 May 2025 14:17:34 GMT
google.font.overpass.normal.500.woff2
qtxasset.com/quartz/theme/fonts/
38 KB
38 KB
Font
General
Full URL
https://qtxasset.com/quartz/theme/fonts/google.font.overpass.normal.500.woff2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/qcloud5/files/css/css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css?delta=1&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.16.151.166 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
26767f0b7032e460e8500deff8d9077a9f8fdc3f43fceb30d3a6ec067c5e8382

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/sites/qcloud5/files/css/css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css?delta=1&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Origin
https://www.fiercepharma.com
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
x-amz-version-id
MZL49AsH5wCUYIVlhOIF5Ssw8_Qo2r_e
cf-cache-status
HIT
x-amz-request-id
4DC3XEYG3K6TTP3W
age
1008272
x-amz-server-side-encryption
AES256
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400
content-length
38504
x-amz-id-2
GZzzuZLSZyD92trdxfOd0zqQa0OLrGEVs/GsMIoPncEU+uUBb9eO6uM4NZqJR6SAZ5Vp/wJfAzA=
last-modified
Wed, 15 May 2024 17:47:39 GMT
server
cloudflare
etag
"6befb21ce8f0458ec072681be509d02f"
access-control-max-age
3000
access-control-allow-methods
GET, DELETE, POST
content-type
font/woff2
access-control-allow-origin
*
access-control-expose-headers
ETag
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
88aede76e8dcabab-YYZ
expires
Wed, 28 May 2025 14:17:34 GMT
EJRVQgYoZZY2vCFuvAFWzr-_dSb_.woff2
fonts.gstatic.com/s/ptserif/v16/
13 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/ptserif/v16/EJRVQgYoZZY2vCFuvAFWzr-_dSb_.woff2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/qcloud5/files/css/css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css?delta=1&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:822::2003 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
af414f1b40ee5f8ed0364c9c2c27a6d6e40a5948d8e4792cf2f6eba161d5f192
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/sites/qcloud5/files/css/css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css?delta=1&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Origin
https://www.fiercepharma.com
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 24 May 2024 13:36:22 GMT
x-content-type-options
nosniff
age
348072
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
13300
x-xss-protection
0
last-modified
Wed, 26 Jan 2022 19:09:23 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 24 May 2025 13:36:22 GMT
google.font.overpass.italic.400.woff
qtxasset.com/quartz/theme/fonts/
20 KB
20 KB
Font
General
Full URL
https://qtxasset.com/quartz/theme/fonts/google.font.overpass.italic.400.woff
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/qcloud5/files/css/css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css?delta=1&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.16.151.166 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
c1d222778644925bcc3b323bc56b7564fc200e442c722de525fd8d030525addc

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/sites/qcloud5/files/css/css_lAw1DL0GakE1B_1kDrqp_qPV8Eq5fJEmUQQSgb88I9E.css?delta=1&language=en&theme=quartz_barrio&include=eJx9kWsOAiEMhC-0hCORLnSxChTbrsl6etdETfD1d-ZrJ52eVxC7hhlEiH03pyi0uIWbTefB4wtKB9XBg6SeKyYIirliMzDiNummhtXPoDjNzKYm0J-LcuEZilPbCrX8ljKa7qj__agvADotJGq-ccJdoVjwbfihfpt-EMadohPsLDZgBTZeLSTSeC9i89wwcvm87p7-qVZUhYwaCuWDTXjZqwpGFfcADPGEiYzFj_pPrJc1UwuL7J_AlsJRbzYetaY
Origin
https://www.fiercepharma.com
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
x-amz-version-id
lhQ0xvIZvBI8f3y0BXtsqYfIjV2hQ7ul
cf-cache-status
HIT
x-amz-request-id
4DC8W2XE8E0E0VQZ
age
1008272
x-amz-server-side-encryption
AES256
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400
content-length
20164
x-amz-id-2
/SKz0Q/BPmq4cofvWnBjZ13omzlf1TbpU6rkybcGd7l45JR7Dod9ZLS43xq6Ox2FO2Xm2KlfozYarbC8jqthuQ==
last-modified
Wed, 15 May 2024 17:49:52 GMT
server
cloudflare
etag
"997120d71a021e3f6fc3346657af3bf5"
access-control-max-age
3000
access-control-allow-methods
GET, DELETE, POST
content-type
font/woff
access-control-allow-origin
*
access-control-expose-headers
ETag
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
88aede76f8deabab-YYZ
expires
Wed, 28 May 2025 14:17:34 GMT
lanyard.js
cdn.ketchjs.com/lanyard/v2/
833 KB
178 KB
Script
General
Full URL
https://cdn.ketchjs.com/lanyard/v2/lanyard.js
Requested by
Host: global.ketchcdn.com
URL: https://global.ketchcdn.com/web/v2/config/questex/fierce_pharma/boot.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a04:4e42:400::347 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
1d0b444bfc73b610cd71a9a4d5da27bba8130b07a55841cf3fadabf7862cc08d
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=31557600; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self'
content-encoding
gzip
via
1.1 varnish, 1.1 varnish
x-content-type-options
nosniff
strict-transport-security
max-age=31557600; includeSubDomains; preload
age
1002
date
Tue, 28 May 2024 14:17:34 GMT
x-cache
HIT, HIT
request-id
e6985c86-a033-4542-b871-b8bb644bd032
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
181368
x-xss-protection
1; mode=block
x-served-by
cache-pdx12323-PDX, cache-lga21925-LGA
last-modified
Tue, 21 May 2024 21:55:34 GMT
x-timer
S1716905855.622858,VS0,VE0
etag
"a763858343e900ba427eb7759b39670c"
x-frame-options
deny
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=1200
accept-ranges
bytes
x-cache-hits
105739, 205
plugins.js
cdn.ketchjs.com/plugins/v1/
230 KB
47 KB
Script
General
Full URL
https://cdn.ketchjs.com/plugins/v1/plugins.js
Requested by
Host: global.ketchcdn.com
URL: https://global.ketchcdn.com/web/v2/config/questex/fierce_pharma/boot.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a04:4e42:400::347 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
44bf69c49cc41b0bcff2dbf7f3cc54ce3de61ca3c9f2a22ec552dfac5a865348
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=31557600; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self'
content-encoding
gzip
via
1.1 varnish, 1.1 varnish
x-content-type-options
nosniff
strict-transport-security
max-age=31557600; includeSubDomains; preload
age
354
date
Tue, 28 May 2024 14:17:34 GMT
x-cache
HIT, HIT
request-id
45e7bd79-aa36-431a-84ca-fc01df761a62
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
47969
x-xss-protection
1; mode=block
x-served-by
cache-pdx12331-PDX, cache-lga21925-LGA
last-modified
Tue, 26 Mar 2024 16:05:06 GMT
x-timer
S1716905855.622905,VS0,VE0
etag
"926c6cd19e38131f3dfdd50f0f0bb218"
x-frame-options
deny
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=1200
accept-ranges
bytes
x-cache-hits
171299, 221
ketch.js
cdn.ketchjs.com/ketchtag/stable/v2.12/
114 KB
29 KB
Script
General
Full URL
https://cdn.ketchjs.com/ketchtag/stable/v2.12/ketch.js
Requested by
Host: global.ketchcdn.com
URL: https://global.ketchcdn.com/web/v2/config/questex/fierce_pharma/boot.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a04:4e42:400::347 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
dda114313b2cf2455611383d53adf740a8619a715c5e90437cb580bf73e9c705
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=31557600; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self'
content-encoding
gzip
via
1.1 varnish, 1.1 varnish
x-content-type-options
nosniff
strict-transport-security
max-age=31557600; includeSubDomains; preload
age
32
date
Tue, 28 May 2024 14:17:34 GMT
x-cache
HIT, HIT
request-id
08ef7e61-5fd4-4807-8fd0-65989344cf7b
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
29167
x-xss-protection
1; mode=block
x-served-by
cache-pdx12320-PDX, cache-lga21925-LGA
last-modified
Sat, 18 May 2024 00:40:11 GMT
x-timer
S1716905855.623013,VS0,VE0
etag
"20d7042cf74603dc2e42a9a36c31d758"
x-frame-options
deny
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=1200
accept-ranges
bytes
x-cache-hits
1875, 12
5f99f765-c32d-4160-80ab-5c03ead02bbb
www.fiercepharma.com/jsonapi/media/image/
4 KB
2 KB
XHR
General
Full URL
https://www.fiercepharma.com/jsonapi/media/image/5f99f765-c32d-4160-80ab-5c03ead02bbb?include=field_media_image&fields[file--file]=uri,filemime,filename
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/nodearticle.js?v=ca9e
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5280b23fdc226b41b80f4569d7e2ed017bf718c03e6ac965910aa5ed5aaf4270
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json, text/plain, */*
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
276108
content-encoding
br
x-drupal-dynamic-cache
MISS
alt-svc
h3=":443"; ma=86400
referrer-policy
no-referrer-when-downgrade
last-modified
Sat, 25 May 2024 09:35:46 GMT
server
cloudflare
etag
W/"1716629746"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
cache-control
max-age=31536000, public
cf-ray
88aede77b9fb39c3-YYZ
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
omeda_iframe
www.fiercepharma.com/api/v1/config/
213 B
696 B
XHR
General
Full URL
https://www.fiercepharma.com/api/v1/config/omeda_iframe
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/nodearticle.js?v=ca9e
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e9809304b439dff1eca656e2e420610eed2a019dba6fa885b433ef47068eff4b
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json, text/plain, */*
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
343405
content-encoding
br
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 23 May 2024 03:32:49 GMT
server
cloudflare
etag
W/"1716435169"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
cache-control
max-age=31536000, public
cf-ray
88aede77c9fd39c3-YYZ
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
1362210
www.fiercepharma.com/api/v1/term-multi-sponsor-resources-node/
35 B
576 B
XHR
General
Full URL
https://www.fiercepharma.com/api/v1/term-multi-sponsor-resources-node/1362210
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/nodearticle.js?v=ca9e
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
66bf4c2d75c9ed6d00de0d5494f1e7120f55e8943f4fc41bd5cefccd6fe9d14e
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json, text/plain, */*
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
x-drupal-dynamic-cache
MISS
alt-svc
h3=":443"; ma=86400
content-length
35
referrer-policy
no-referrer-when-downgrade
last-modified
Tue, 28 May 2024 13:54:20 GMT
server
cloudflare
etag
"1716904460"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
cache-control
max-age=31536000, public
accept-ranges
bytes
cf-ray
88aede77ca0139c3-YYZ
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
parsely_site_id
www.fiercepharma.com/api/v1/config/
28 B
581 B
XHR
General
Full URL
https://www.fiercepharma.com/api/v1/config/parsely_site_id
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/nodearticle.js?v=ca9e
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f8eca570e92e273c4d9884f10e384d97feb26c69db70db1c6c201f34efa5de61
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json, text/plain, */*
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-cache-status
HIT
age
343405
x-drupal-dynamic-cache
UNCACHEABLE
alt-svc
h3=":443"; ma=86400
content-length
28
referrer-policy
no-referrer-when-downgrade
last-modified
Wed, 22 May 2024 03:17:24 GMT
server
cloudflare
etag
"1716347844"
vary
Cookie, Accept-Encoding
content-language
en
content-type
application/json
cache-control
max-age=31536000, public
accept-ranges
bytes
cf-ray
88aede77ca0639c3-YYZ
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
show_ads_impl_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202405230101/
424 KB
143 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202405230101/show_ads_impl_fy2021.js
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1234567890123456
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
d1095b3a75578e4897753e494e03ff95a230d23367e690862ba876edd547c753
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
146466
x-xss-protection
0
server
cafe
etag
9979235717601455683
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=1209600
timing-allow-origin
*
expires
Tue, 28 May 2024 14:17:34 GMT
related
api.parsely.com/v2/
5 KB
2 KB
XHR
General
Full URL
https://api.parsely.com/v2/related?apikey=fiercepharma.com&url=https:%2F%2Fwww.fiercepharma.com%2Fundefined&sort=_score&limit=4&exclude=authors:Staff&page=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/modules/custom/quartz_apifirst/compiled/nodearticle.js?v=ca9e
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.194.162.133 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-194-162-133.compute-1.amazonaws.com
Software
nginx /
Resource Hash
52720a5b02815cb03bdba75686b94ec9d1b7b92e1d55e6728c4fc90ddc8325b1

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json, text/plain, */*
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
gzip
server
nginx
x-cache-status
HIT
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=120
expires
Tue, 28 May 2024 14:19:34 GMT
GavelScale-g-BrianAJackson-800.jpg
qtxasset.com/cdn-cgi/image/w=850,h=478,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1645195802/GavelScale-g-BrianAJackson-800.jpg/
21 KB
21 KB
Image
General
Full URL
https://qtxasset.com/cdn-cgi/image/w=850,h=478,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1645195802/GavelScale-g-BrianAJackson-800.jpg/GavelScale-g-BrianAJackson-800.jpg?VersionId=kmraN4nl5L7fJj4gM3UiXYhNTGYiSLCL
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.16.151.166 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
55f04713ca95e883affe76b369741b400679b37ab526399418099da93ceb8a68
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'
x-content-type-options
nosniff
cf-cache-status
HIT
alt-svc
h3=":443"; ma=86400
content-length
21363
cf-resized
internal=ram/h q=0 n=0+279 c=2+440 v=2024.5.2 l=21363
last-modified
Fri, 25 Feb 2022 05:27:03 GMT
cf-bgj
imgq:85,h2pri
server
cloudflare
etag
"cfvfl3pzSnG8EI8EIORxMMZS4hqeoyMVBK7VyAnF90DQ:0a6fa1999cb3fffe8d54926c28417de8"
vary
Accept, Accept-Encoding
content-type
image/avif
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
88aede783ad5ab28-YYZ
hbw_master_748754_18091.js
player.hbmp.mediafuse.com/prebidlink/hH0M_/
153 KB
50 KB
Script
General
Full URL
https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/309522112437/wrapper_hb_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
d08ffd1da80b4fdbb086a0153d209bdbd7baa666520485f10d0ed0e85a1a8e11

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
gzip
last-modified
Tue, 28 May 2024 14:15:50 GMT
server
nginx
etag
W/"6655e716-2657e"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Thu, 30 May 2024 14:17:34 GMT
hbp_master_748754_18091.js
player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/
574 KB
183 KB
Script
General
Full URL
https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/309522112437/hb_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
5e3aa4076c1fd51f0c7529322477aefe362915a5e5331eed10203decee12eaf5

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
gzip
last-modified
Thu, 23 May 2024 15:18:55 GMT
server
nginx
etag
W/"664f5e5f-8f968"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=172800
expires
Thu, 30 May 2024 14:17:34 GMT
pubads_impl.js
securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/
452 KB
141 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
417c7e1b793dab1354daa456a61f7344f780ad31fff8e4fef024f4997f29942e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 15:35:19 GMT
content-encoding
br
x-content-type-options
nosniff
age
81735
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
144540
x-xss-protection
0
server
cafe
etag
8652273211762621675
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, immutable, max-age=31536000
timing-allow-origin
*
expires
Tue, 27 May 2025 15:35:19 GMT
p.js
cdn.parsely.com/keys/fiercepharma.com/
57 KB
21 KB
Script
General
Full URL
https://cdn.parsely.com/keys/fiercepharma.com/p.js?gtm_ver=3.1
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.164.101.60 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-164-101-60.jfk50.r.cloudfront.net
Software
nginx /
Resource Hash
103a473ebebeaa95bb10f3b510657de42e1827dc6e65660dde5378092d7675b0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
public
date
Tue, 28 May 2024 06:34:26 GMT
content-encoding
gzip
via
1.1 6e202b767e6bdee837ba15ada7e3120e.cloudfront.net (CloudFront)
last-modified
Thu, 08 Feb 2024 20:28:03 GMT
server
nginx
x-amz-cf-pop
JFK50-P5
age
29205
etag
W/"65c53953-e2c5"
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=86400, public
x-amz-cf-id
kLryoOW6oU3jsm1FxoXpNkKkcko_dld9NA44BROgHsQ111gcwSMfaw==
expires
Wed, 29 May 2024 06:10:49 GMT
roundtrip.js
s.adroll.com/j/
88 KB
27 KB
Script
General
Full URL
https://s.adroll.com/j/roundtrip.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:23cb:d000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
54034a97c2cd2fd617136446cef1993cfef5937fe2896ee7e4bd569cd18c94e5

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

X-Amz-Version-Id
e6sYwBOpzRqd5bOAndACb6fCQ4ER0PM6
Content-Encoding
gzip
Via
1.1 ed4584f7c263c11cf4adf75ba3a25764.cloudfront.net (CloudFront)
Date
Tue, 28 May 2024 13:50:22 GMT
Age
1633
X-Amz-Cf-Pop
JFK50-P1
X-Amz-Server-Side-Encryption
AES256
Transfer-Encoding
chunked
X-Cache
Hit from cloudfront
Connection
keep-alive
Last-Modified
Tue, 21 May 2024 20:50:40 GMT
Server
AmazonS3
Etag
W/"da9bcd3341c4a1872c566741252e0d5f"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
text/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Access-Control-Max-Age
600
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
xfaHJvVWXegtjh4rAuyOxLTjiLW_oM3zjK2kuzkxi2-SZqmfgs5PHQ==
dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
s.dpmsrv.com/
91 KB
15 KB
Script
General
Full URL
https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
18.164.96.73 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-164-96-73.jfk50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
8b33651638a6da3c64348c0338b97d812bbcd0661992503b2b73d42438ddd369

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Mon, 27 May 2024 18:25:10 GMT
Content-Encoding
gzip
Via
1.1 3b0649a8bee506c1d7498462d39e6c44.cloudfront.net (CloudFront)
Last-Modified
Thu, 09 May 2024 20:20:17 GMT
Server
AmazonS3
X-Amz-Cf-Pop
JFK50-P5
Age
71546
ETag
"5d9166036f80ccc436f56dda9dc2875c"
x-amz-server-side-encryption
AES256
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
14661
X-Amz-Cf-Id
DVDQ0yq6hIDJY0ezMygpyfnlBB4R8Uwu_Sbamx9jE45dzAp56sHf4A==
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/
247 KB
69 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26fa:6800:1e:5cef:3780:93a1 , United States, ASN (),
Reverse DNS
Software
Apache /
Resource Hash
9476829b95e258d910312ec7f2f30b425355061a2110d1e8f094b1c3a0587705
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 12:18:01 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
via
1.1 d256d517610f633eae85f1fada59368e.cloudfront.net (CloudFront)
x-amz-cf-pop
JFK52-P1
age
7962
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
last-modified
Fri, 10 May 2024 11:02:34 GMT
server
Apache
etag
W/"252633-1715338954000"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=21600
x-amz-cf-id
fTh6F6KTDy-Ku0r1G6jPRaF9bku7hhtguJUgh7rn_0uMhxMowneZAA==
expires
Sun, 26 May 2024 12:04:52 GMT
olytics.css
olytics.omeda.com/olytics/css/v3/p/
28 KB
3 KB
Stylesheet
General
Full URL
https://olytics.omeda.com/olytics/css/v3/p/olytics.css
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:26fa:6800:1e:5cef:3780:93a1 , United States, ASN (),
Reverse DNS
Software
Apache /
Resource Hash
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 12:34:09 GMT
content-encoding
br
x-content-type-options
nosniff
strict-transport-security
max-age=31536000
via
1.1 d256d517610f633eae85f1fada59368e.cloudfront.net (CloudFront)
x-amz-cf-pop
JFK52-P1
age
6204
x-cache
Hit from cloudfront
x-xss-protection
1; mode=block
referrer-policy
strict-origin-when-cross-origin
last-modified
Fri, 10 May 2024 11:02:34 GMT
server
Apache
etag
W/"28820-1715338954000"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=21600
x-amz-cf-id
1LPxhJgfrbS-a8rZu0uszRTObkxnLXNHoatEeimEeYz8pjZQ1shM0w==
expires
Sun, 26 May 2024 12:34:09 GMT
insight.min.js
snap.licdn.com/li.lms-analytics/
47 KB
17 KB
Script
General
Full URL
https://snap.licdn.com/li.lms-analytics/insight.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2600:141b:b000::173b:fbe2 Newark, United States, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
899d1ec3c095342571d3be2091ec6f984d4cc82390d1f61945c391fa035b00d9
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 06 May 2024 17:20:18 GMT
x-cdn
AKAM
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
application/javascript;charset=utf-8
cache-control
max-age=63331
accept-ranges
bytes
content-length
16683
js
www.googletagmanager.com/gtag/
288 KB
98 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-X6PEPHSF9L
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:809::2008 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
eb2dfc28bfe3a7ac11135ed7165db7f9255f381d00c04b986d7c2b18fe4d834e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
100573
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:34 GMT
blank.gif
rdcdn.com/images/
Redirect Chain
  • https://rdcdn.com/rt?aid=19932&e=1&img=1
  • https://rdcdn.com/eow
  • https://rdcdn.com/images/blank.gif
42 B
198 B
Image
General
Full URL
https://rdcdn.com/images/blank.gif
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.198.180.12 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-198-180-12.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 /
Resource Hash
47043e4823a6c21a8881de789b4185355330b5804629d23f6b43dd93f5265292

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
last-modified
Thu, 23 Dec 2021 21:40:20 GMT
server
Microsoft-IIS/10.0
accept-ranges
bytes
etag
"ec522af45f8d71:0"
content-length
42
content-type
image/gif

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
x-aspnetmvc-version
5.2
server
Microsoft-IIS/10.0
x-aspnet-version
4.0.30319
content-type
text/html; charset=utf-8
location
https://rdcdn.com/images/blank.gif
cache-control
private
content-length
151
tag.aspx
ml314.com/
33 KB
11 KB
Script
General
Full URL
https://ml314.com/tag.aspx?2842024
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.117.77.79 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
79.77.117.34.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
b65f414221cf068135ffc1d6b5a814da1b1a363325b451698c52a4064303a5bb

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 13:20:57 GMT
via
1.1 google
content-encoding
br
age
3397
x-guploader-uploadid
ABPtcPpsHORWGvc2xF4iqNa7CRIG8PAvBS2apHiyWnFEIKMjLl7kUGfdY5MhRunfXRQAaMzmo8lHJnTQbQ
x-goog-storage-class
STANDARD
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
10611
last-modified
Tue, 07 May 2024 22:27:04 GMT
server
UploadServer
vary
Accept-Encoding
x-goog-generation
1715120823907330
x-goog-hash
crc32c=10AurQ==, md5=zLoLKAsL6lcopoHLyCZEiw==
content-type
application/javascript
cache-id
LGA-991dec68
cache-control
public,max-age=3600
x-cache-hit
hit
x-goog-stored-content-length
34184
accept-ranges
bytes
ip
global.ketchcdn.com/web/v3/
51 B
438 B
Fetch
General
Full URL
https://global.ketchcdn.com/web/v3/ip
Requested by
Host: cdn.ketchjs.com
URL: https://cdn.ketchjs.com/ketchtag/stable/v2.12/ketch.js
Protocol
H3
Security
QUIC, , AES_256_GCM
Server
151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
Varnish /
Resource Hash
def3ea6d33c7840fb39bf0a18070e6c4dd04f66dd03e508c2964392843526504
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=31557600; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
via
1.1 varnish
content-security-policy
default-src 'self'
strict-transport-security
max-age=31557600; includeSubDomains; preload
x-cache
MISS
request-id
b3e950af-2409-4dbd-9665-80d50a270c9c
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
51
x-request-id
b3e950af-2409-4dbd-9665-80d50a270c9c
x-served-by
cache-yyz4569-YYZ
server
Varnish
x-timer
S1716905855.931365,VS0,VE0
vary
Origin, User-Agent
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=86400
accept-ranges
bytes
retry-after
0
x-cache-hits
0
config.json
global.ketchcdn.com/web/v3/config/questex/fierce_pharma/production/default/en/
120 KB
23 KB
Fetch
General
Full URL
https://global.ketchcdn.com/web/v3/config/questex/fierce_pharma/production/default/en/config.json?hash=16228596912762250037
Requested by
Host: cdn.ketchjs.com
URL: https://cdn.ketchjs.com/ketchtag/stable/v2.12/ketch.js
Protocol
H3
Security
QUIC, , AES_256_GCM
Server
151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
129240c1d16a519f94a5109ac27441664406ab594f1284b6327e03df022b76e6
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=31557600; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
application/json
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self'
content-encoding
br
via
1.1 varnish, 1.1 varnish
strict-transport-security
max-age=31557600; includeSubDomains; preload
date
Tue, 28 May 2024 14:17:34 GMT
age
611
x-cache
HIT, HIT
request-id
1fefce75-46f3-4f27-8719-0bc2ba8767c9
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
22947
x-request-id
1fefce75-46f3-4f27-8719-0bc2ba8767c9
x-served-by
cache-pdx12322-PDX, cache-yyz4569-YYZ
last-modified
Thu, 23 May 2024 16:26:48 GMT
x-timer
S1716905855.950046,VS0,VE1
etag
"ab60612286e63977354c1cba04888271"
vary
Origin, Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
public, max-age=1200
accept-ranges
bytes
x-cache-hits
35, 1
get
global.ketchcdn.com/web/v3/consent/questex/
167 B
525 B
Fetch
General
Full URL
https://global.ketchcdn.com/web/v3/consent/questex/get
Requested by
Host: cdn.ketchjs.com
URL: https://cdn.ketchjs.com/ketchtag/stable/v2.12/ketch.js
Protocol
H3
Security
QUIC, , AES_256_GCM
Server
151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
b1622ebe908ad2e4bdcea4e85057a065fcea4969cd6b1a87cfa3c0791b9a6a54
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=15724800; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Accept
application/json
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self'
strict-transport-security
max-age=15724800; includeSubDomains
x-content-type-options
nosniff
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 varnish
x-cache
MISS
request-id
5056a691-9ecf-4ffa-9005-762a2c2663b0
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
167
x-xss-protection
1; mode=block
x-request-id
9bf59413-78d8-44a5-becf-d83d4cc16e9b
x-served-by
cache-yyz4569-YYZ
x-timer
S1716905855.069741,VS0,VE81
x-frame-options
deny
vary
Origin, Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
accept-ranges
bytes
x-cache-hits
0
get
global.ketchcdn.com/web/v3/consent/questex/ Frame
0
0
Preflight
General
Full URL
https://global.ketchcdn.com/web/v3/consent/questex/get
Protocol
H3
Security
QUIC, , AES_256_GCM
Server
151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=15724800; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

accept-ranges
bytes
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Accept,Authorization
access-control-allow-methods
GET,HEAD,POST,PUT,DELETE
access-control-allow-origin
https://www.fiercepharma.com
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
0
content-security-policy
default-src 'self'
date
Tue, 28 May 2024 14:17:35 GMT
request-id
642ae31d-6d16-4d94-a0c5-74e9bc1cfc77
strict-transport-security
max-age=15724800; includeSubDomains
vary
Origin
via
1.1 varnish
x-cache
MISS
x-cache-hits
0
x-content-type-options
nosniff
x-frame-options
deny
x-request-id
413a645e-bca1-431d-8347-f3f9951accd8
x-served-by
cache-yyz4569-YYZ
x-timer
S1716905855.983025,VS0,VE70
x-xss-protection
1; mode=block
/
p1.parsely.com/plogger/
43 B
258 B
Image
General
Full URL
https://p1.parsely.com/plogger/?rand=1716905854995&plid=2da9304b-e6bb-432c-aa2a-41727873a6d7&idsite=fiercepharma.com&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&urlref=&screen=1600x1200%7C1600x1200%7C24&data=%7B%22parsely%3Ametadata-detection%22%3A%7B%22version%22%3A0%2C%22url%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%2C%22hash%22%3A-1241683914%7D%7D&sid=1&surl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&sref=&sts=1716905854987&slts=0&title=AZ+told+to+pay+Pfizer+%24107.5M+for+patent+infringement&date=Tue+May+28+2024+04%3A17%3A34+GMT-1000+(Hawaii-Aleutian+Standard+Time)&action=pageview&pvid=122d9772-954a-4e7e-ba89-6b3ca0f385c4&u=pid%3D0a2938fc-b3c9-45d1-bfa5-b44ece812a6f
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.205.167.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-205-167-202.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Cache-Control
no-cache
Last-Modified
Tuesday, 28-May-2024 14:17:35 GMT
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
config.json
player.adtelligent.com/exchange_rates/279934/
9 KB
4 KB
Fetch
General
Full URL
https://player.adtelligent.com/exchange_rates/279934/config.json?cb=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
7225361cd3a508f0028fc21b92e2849763e19802ec1f30fd5cef3b76a1fbb6cd

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

expires
Wed, 29 May 2024 14:17:35 GMT
date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
last-modified
Tue, 28 May 2024 12:01:41 GMT
server
nginx
etag
W/"6655c7a5-2217"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=86400
x-proxy-cache
HIT
publishertag.ids.js
static.criteo.net/js/ld/
41 KB
13 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.ids.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a00b::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
16eef82325d88bccb3f09d34d6155a3ee890edfdb479d44264212b5d5eca1af9
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Tue, 09 Apr 2024 12:20:57 GMT
server
nginx
etag
W/"661532a9-a5c1"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 29 May 2024 14:17:35 GMT
esp.js
oa.openxcdn.net/
24 KB
8 KB
Script
General
Full URL
https://oa.openxcdn.net/esp.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.102.146.192 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
192.146.102.34.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
544c55ca9f05d425f3beb90f287308d7a408b1f60d17728eff5c605a494bc1b9

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Sun, 26 May 2024 03:41:39 GMT
content-encoding
gzip
age
210956
x-guploader-uploadid
ABPtcPq5l-io_m3raDBS5V2yuD8GoWKSqb5fYG-H77RPVLl0Vj6Y63qruW_gbCjBkMqr9boOiBw
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
gzip
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
7927
last-modified
Thu, 27 May 2021 18:30:51 GMT
server
UploadServer
etag
"df5542b88bc0e368c6999754a5b9e2ba"
x-goog-generation
1622140251693895
x-goog-hash
crc32c=f21hYg==, md5=31VCuIvA42jGmZdUpbniug==
content-type
application/javascript
cache-control
no-transform
x-goog-stored-content-length
7927
accept-ranges
bytes
expires
Mon, 26 May 2025 03:41:39 GMT
ob.js
cdn-ima.33across.com/
18 KB
6 KB
Script
General
Full URL
https://cdn-ima.33across.com/ob.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.35.167 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6bf8a58f79b67bf9d1ea3eaf9fac1249d237da074b02cbc525379a42a4525d11

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Thu, 02 May 2024 16:10:14 GMT
server
cloudflare
age
415711
etag
W/"6633bae6-4987"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=259200
cf-ray
88aede7a9f783981-YYZ
expires
Fri, 31 May 2024 14:17:35 GMT
/
sghb.hbmp.mediafuse.com/geo/
166 B
440 B
XHR
General
Full URL
https://sghb.hbmp.mediafuse.com/geo/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.151.194 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
9443b1d2780187dcba9df87fc8132182e10042082e3fbe17903597475f3e8766

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Mediafuse
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
166
tracking
sghb.hbmp.mediafuse.com/adunit/
43 B
438 B
XHR
General
Full URL
https://sghb.hbmp.mediafuse.com/adunit/tracking?event=11&type=0&client_id=748754&site_id=18091&pbjsv=v8.33.6&full_page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&adid=qhf0ae.ez&features=5325152&vpbv=m242&tte=711&lifecycle_tte=948
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.151.194 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Mediafuse
Content-Type
image/gif
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
43
ads
securepubads.g.doubleclick.net/gampad/
785 B
370 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=1244452942474999&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=2&sfv=1-0-40&ists=1&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1716905855109&lmt=1716905156&adxs=160&adys=0&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=1&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=1310x0&msz=1310x0&fws=132&ohw=1600&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=false&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEhQKBW9wZW54GN-Qwfz7MUgAUgIIZA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D7%26refresh%3Dtrue&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=1585981893&frm=20&eoidce=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
22f89e7c5c4bc5d6a5305beca4bec1b0358bde9f3367996a1c5c6781ea6a5d54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
339
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
1 KB
593 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=2724607960003390&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=3&sfv=1-0-40&ists=1&fas=8&fsapi=1&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1716905855125&lmt=1716905156&adxs=-9&adys=-9&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=-1&ucis=2&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=0x-1&msz=0x-1&fws=2&ohw=0&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=false&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEhQKBW9wZW54GN-Qwfz7MUgAUgIIZA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D4%26refresh%3Dtrue&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=2938228967&frm=20&eoidce=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
63f9c8c15b586d30b21ac1e698f2203f8e43cf2d9e2a849447932a9cd26e2a45
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
563
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
785 B
375 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=604481746119554&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=4&sfv=1-0-40&ists=1&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1716905855128&lmt=1716905156&adxs=255&adys=1659&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=1&ucis=3&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=830x0&msz=830x0&fws=132&ohw=1600&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=false&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEhQKBW9wZW54GN-Qwfz7MUgAUgIIZA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D8%26refresh%3Dtrue&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=1373237453&frm=20&eoidce=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
9c337eb1b6e86fc259ea4251027f460629ecc38d916a308cfd16acab620243f6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
344
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
935 B
444 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=4172818605529171&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ifi=5&sfv=1-0-40&fas=1&eri=1&sc=1&cookie_enabled=1&abxe=1&dt=1716905855133&lmt=1716905156&adxs=-9&adys=-9&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=-1&ucis=4&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=0x-1&msz=0x-1&fws=2&ohw=0&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=false&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEhQKBW9wZW54GN-Qwfz7MUgAUgIIZA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D9%26refresh%3Dtrue&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=2938228767&frm=20&eoidce=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
e81328462cf671478801000c873db00cfeeb1bffe5738cdaaf56827014667ddc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
413
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame CF6C
0
0
Document
General
Full URL
https://690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81f::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ranges
bytes
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, immutable, max-age=31536000
content-encoding
br
content-length
2653
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Tue, 28 May 2024 14:17:35 GMT
expires
Wed, 28 May 2025 14:17:35 GMT
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
pubads_impl_page_level_ads.js
securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/
47 KB
15 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl_page_level_ads.js?cb=31083984
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
02f4d4d18c22b7ad116b8ad3f7edd35908f17eb6985b62ce2081758c698aa09a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 15:36:12 GMT
content-encoding
br
x-content-type-options
nosniff
age
81683
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15252
x-xss-protection
0
server
cafe
etag
17800242361209285575
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, immutable, max-age=31536000
timing-allow-origin
*
expires
Tue, 27 May 2025 15:36:12 GMT
utsync.ashx
ml314.com/
587 B
1 KB
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=66459&ct=js&pi=&fp=undefined&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&pv=1716905855143_wj1i36dui&bl=en-us&cb=5191449&return=&ht=&d=&dc=&si=1716905855143_wj1i36dui&cid=&s=1600x1200&rp=&v=2.7.2.162
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2842024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.117.77.79 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
79.77.117.34.bc.googleusercontent.com
Software
Google Frontend /
Resource Hash
f541802be6c06521b334e543f06a32c84aa87b6733739d52eed64de3bd634ba4

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google, 1.1 google
server
Google Frontend
content-type
application/javascript
p3p
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
cache-control
no-cache, no-store, must-revalidate
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
0
ud.ashx
in.ml314.com/
39 B
500 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=2842024&v=2.7.2.162
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2842024
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.86.216.206 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-86-216-206.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
fceb546d5245bf2ccd56b51a0ce18acc22c06f2d4bf1b99b8efc7fc06d694340

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
156
Expires
Wed, 29 May 2024 14:17:35 GMT
attribution_trigger
px.ads.linkedin.com/
2 B
764 B
XHR
General
Full URL
https://px.ads.linkedin.com/attribution_trigger?pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Requested by
Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept
*
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
gzip
x-li-pop
afd-prod-lor1-x
x-msedge-ref
Ref A: E3A861E97A4A4178BF2D40846F276064 Ref B: EWR311000102027 Ref C: 2024-05-28T14:17:35Z
access-control-allow-methods
GET, OPTIONS
x-li-fabric
prod-lor1
access-control-allow-origin
*
x-cache
CONFIG_NOCACHE
content-type
application/json
x-li-proto
http/2
x-restli-protocol-version
1.0.0
access-control-allow-headers
*
x-li-uuid
AAYZhEudubDx5HVLzqmcnQ==
x-fs-uuid
000619844b9db9b0f1e4754bcea99c9d
collect
px4.ads.linkedin.com/
Redirect Chain
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-paten...
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-paten...
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D4973674%26time%3D1716905855147%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%2...
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-paten...
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-pate...
0
490 B
Image
General
Full URL
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookiesTest=true&liSync=true&e_ipv6=AQImulZyW4HBPAAAAY-_kEpx9kD-KheRQCKfcZ1oTuAcmkko2EKj09NAbYxl3vWlPYQ2yg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 4314682ECF59445EA09D50943FD48FE5 Ref B: YTO01EDGE0517 Ref C: 2024-05-28T14:17:35Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
content-type
application/javascript
x-li-fabric
prod-ltx1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYZhEulCmcQOVqnmNVPmw==

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: EF50A1A0017D45CE82D630327FBFD4B7 Ref B: NYCEDGE1613 Ref C: 2024-05-28T14:17:35Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-ltx1
location
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4973674&time=1716905855147&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookiesTest=true&liSync=true&e_ipv6=AQImulZyW4HBPAAAAY-_kEpx9kD-KheRQCKfcZ1oTuAcmkko2EKj09NAbYxl3vWlPYQ2yg
x-li-proto
http/2
content-length
0
x-li-uuid
AAYZhEuirtcmzJvWTGRwEw==
collect
analytics.google.com/g/
0
249 B
Ping
General
Full URL
https://analytics.google.com/g/collect?v=2&tid=G-X6PEPHSF9L&gtm=45je45m0v894487360za200&_p=1716905854401&_gaz=1&gcs=G111&gcd=13t3t3t3l5&npa=0&dma=0&tcfd=10000&gdid=dN2JhM2&cid=1221635165.1716905855&ul=en-us&sr=1600x1200&uaa=x86&uab=64&uafvl=Google%2520Chrome%3B125.0.6422.112%7CChromium%3B125.0.6422.112%7CNot.A%252FBrand%3B24.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&are=1&frm=0&pscdl=noapi&_s=1&sid=1716905855&sct=1&seg=0&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&dt=AZ%20told%20to%20pay%20Pfizer%20%24107.5M%20for%20patent%20infringement&en=page_view&_fv=1&_ss=1&_ee=1&ep.content_group=Pharma&tfd=1041
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-X6PEPHSF9L
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::200e , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/g/
0
249 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-X6PEPHSF9L&cid=1221635165.1716905855&gtm=45je45m0v894487360za200&aip=1&dma=0&gcs=G111&gcd=13t3t3t3l5&npa=0&frm=0
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-X6PEPHSF9L
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4004:c06::9c Washington, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
zrt_lookup_fy2021.html
googleads.g.doubleclick.net/pagead/html/r20240522/r20110914/ Frame 3B6A
0
0
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/html/r20240522/r20110914/zrt_lookup_fy2021.html
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202405230101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.41.2 Queens, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s40-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

age
45002
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=1209600
content-encoding
br
content-length
4164
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 28 May 2024 01:47:33 GMT
etag
11731753506229902092
expires
Tue, 11 Jun 2024 01:47:33 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
ads
googleads.g.doubleclick.net/pagead/ Frame 49B0
0
0
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&client=ca-pub-1234567890123456&output=html&adk=1812271804&adf=3025194257&abgtt=6&lmt=1716905156&plat=1%3A64%2C2%3A64%2C8%3A64%2C9%3A32776%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C41%3A32%2C42%3A32&plas=140x675_l%7C140x675_r&format=0x0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&pra=5&wgl=1&easpi=1&aihb=0&asro=0&ailel=1~2~4~6~7~8~9~10~11~12~13~14~15~16~17~18~19~20~21~24&aslmct=0.7&asamct=0.7&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&dt=1716905854732&bpp=4&bdt=381&idt=467&shv=r20240522&mjsv=m202405230101&ptt=9&saldr=aa&abxe=1&cookie_enabled=1&eoidce=1&nras=1&correlator=58514614378&frm=20&pv=2&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=1&u_tz=-600&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&dmc=8&adx=-12245933&ady=-12245933&biw=1600&bih=1200&scr_x=0&scr_y=0&eid=44759876%2C44759927%2C44759837%2C31083869%2C31083908%2C42532524%2C44795922%2C95331696%2C95331983%2C31078668&oid=2&pvsid=60943146494634&tmod=196357801&uas=0&nvt=1&fsapi=1&fc=1920&brdim=50%2C50%2C50%2C50%2C1600%2C0%2C1600%2C1200%2C1600%2C1200&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=32768&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&nt=1&ifi=1&uci=a!1&fsb=1&dtd=506
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202405230101/show_ads_impl_fy2021.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.41.2 Queens, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s40-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
private
content-encoding
br
content-length
46
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Tue, 28 May 2024 14:17:35 GMT
expires
Tue, 28 May 2024 14:17:35 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
index.js
s.adroll.com/j/pre/
Redirect Chain
  • https://s.adroll.com/j/pre/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/fpconsent.js
  • https://s.adroll.com/j/pre/index.js
0
755 B
Script
General
Full URL
https://s.adroll.com/j/pre/index.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
2600:9000:23cb:d000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

X-Amz-Version-Id
nQEe8wQ7h0ROt7P4GJfDfstto6x684Hy
Date
Tue, 28 May 2024 11:49:56 GMT
Via
1.1 ed4584f7c263c11cf4adf75ba3a25764.cloudfront.net (CloudFront)
Age
8859
X-Amz-Cf-Pop
JFK50-P1
X-Amz-Server-Side-Encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
0
Last-Modified
Wed, 15 Jan 2020 23:54:18 GMT
Server
AmazonS3
Etag
"d41d8cd98f00b204e9800998ecf8427e"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Max-Age
600
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
pDK6QkqJ5Z93wT_NTfT56VbvLKtqxvAf652zvuTnvjADJk3UaVnVRg==

Redirect headers

Date
Mon, 27 May 2024 19:18:59 GMT
Via
1.1 ed4584f7c263c11cf4adf75ba3a25764.cloudfront.net (CloudFront)
Age
68316
X-Amz-Cf-Pop
JFK50-P1
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
0
Server
AmazonS3
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/xml
Location
https://s.adroll.com/j/pre/index.js
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
orGWpHzmcENPicVcOWkxmojMCoXFxszJ7mQn9yJVBBdj7mFAzlmRuA==
index.js
s.adroll.com/j/pre/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/
0
808 B
Script
General
Full URL
https://s.adroll.com/j/pre/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/index.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:23cb:d000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

X-Amz-Version-Id
b3gawv7Q_zP4blkqN.EgkR4cotlA2l_c
Date
Tue, 28 May 2024 14:10:55 GMT
Via
1.1 ed4584f7c263c11cf4adf75ba3a25764.cloudfront.net (CloudFront)
Age
402
X-Amz-Cf-Pop
JFK50-P1
X-Amz-Server-Side-Encryption
AES256
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
0
Last-Modified
Thu, 23 May 2024 12:26:00 GMT
Server
AmazonS3
Etag
"d41d8cd98f00b204e9800998ecf8427e"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Access-Control-Max-Age
600
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
IZDIY1gfN5uA8ce-ZtlWRUKtFY4MXdqvbMfWG_keieFDxVLmbje6_g==
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&zn%3D%26sn%3D%26q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D354724%26tzOffset%3D600%26url%3Dhttps%253A%252F%252Fww...
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26zn%253D%2526sn%253D%2526q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%25...
  • https://a.dpmsrv.com/dpmpxl/index.php?id=7532885200230356581&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=354724&tzOffset=600&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiar...
245 B
998 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?id=7532885200230356581&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=354724&tzOffset=600&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
54.157.213.254 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-157-213-254.compute-1.amazonaws.com
Software
/
Resource Hash
ae43e768649f80e1c1d16beb74fdb746be2c768a57fcf984182d88b8d4314cd1

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
Content-Type
text/javascript
Access-Control-Allow-Origin
*
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Access-Control-Allow-Headers
content-type, accept
Content-Length
219
Expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
an-x-request-uuid
f2d65968-04a6-4a43-bbaa-1d854aa0b325
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://a.dpmsrv.com/dpmpxl/index.php?id=7532885200230356581&zn=&sn=&q=xImp&v=1.x&cl=913&pixelIndex=0&r=354724&tzOffset=600&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
olytics
oqs.omeda.com/oqs/rest/ Frame
0
0
Preflight
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.165 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Headers
Access-Control-Request-Headers, Content-Type, Origin, Accept, Accept-Encoding, Accept-Language, HOST, User-Agent, Access-Control-Request-Method, Access-Control-Max-Age
Access-Control-Allow-Origin
*
Access-Control-Max-Age
600
Connection
keep-alive
Content-Length
0
Content-Type
text/plain
Date
Tue, 28 May 2024 14:17:35 GMT
Keep-Alive
timeout=5
Server
Apache
X-Content-Type-Options
nosniff
X-Frame-Options
SAMEORIGIN
X-XSS-Protection
1; mode=block
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51236
x-xss-protection
0
server
cafe
etag
3690563512934424185
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Tue, 28 May 2024 14:17:35 GMT
olytics
oqs.omeda.com/oqs/rest/
15 B
359 B
XHR
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.165 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
68330f6767efe4ea90f23cb4bb722810d19758395bc24f59c7c893c0d4ae69ce
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Vary
Accept-Encoding
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
15
X-XSS-Protection
1; mode=block
603368c0-80a5-43af-990d-4c9fe5e35e04
cdp.omeda.com/olytics/segments/o/5d6cdb41c83d4fb0a6a384e42aa46df6/c/null/a/
25 B
346 B
XHR
General
Full URL
https://cdp.omeda.com/olytics/segments/o/5d6cdb41c83d4fb0a6a384e42aa46df6/c/null/a/603368c0-80a5-43af-990d-4c9fe5e35e04
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
cd1707ff961932c5fe28a5722a31c9dbaad2b2e3dbc65ef5f28bcd101fbc1474
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
25
X-XSS-Protection
1; mode=block
update
global.ketchcdn.com/web/v3/consent/questex/
410 B
767 B
Fetch
General
Full URL
https://global.ketchcdn.com/web/v3/consent/questex/update
Requested by
Host: cdn.ketchjs.com
URL: https://cdn.ketchjs.com/ketchtag/stable/v2.12/ketch.js
Protocol
H3
Security
QUIC, , AES_256_GCM
Server
151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
fadbe7a57b0b6eb8f13f2e6fe4282a6a22ebe81d73abb079d8b001ec6d71bff4
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=15724800; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json
Accept
application/json
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self'
strict-transport-security
max-age=15724800; includeSubDomains
x-content-type-options
nosniff
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 varnish
x-cache
MISS
request-id
53dcc4be-02dc-4f15-acdb-11c485b9d012
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
410
x-xss-protection
1; mode=block
x-request-id
a68e84e3-ad42-4f91-a652-d15fe9ef280c
x-served-by
cache-yyz4569-YYZ
x-timer
S1716905855.426949,VS0,VE90
x-frame-options
deny
vary
Origin, Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
accept-ranges
bytes
x-cache-hits
0
update
global.ketchcdn.com/web/v3/consent/questex/ Frame
0
0
Preflight
General
Full URL
https://global.ketchcdn.com/web/v3/consent/questex/update
Protocol
H3
Security
QUIC, , AES_256_GCM
Server
151.101.65.91 San Francisco, United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Content-Security-Policy default-src 'self'
Strict-Transport-Security max-age=15724800; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options deny
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

accept-ranges
bytes
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Accept,Authorization
access-control-allow-methods
GET,HEAD,POST,PUT,DELETE
access-control-allow-origin
https://www.fiercepharma.com
alt-svc
h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-length
0
content-security-policy
default-src 'self'
date
Tue, 28 May 2024 14:17:35 GMT
request-id
c6473133-f415-4475-838b-39add2616f29
strict-transport-security
max-age=15724800; includeSubDomains
vary
Origin
via
1.1 varnish
x-cache
MISS
x-cache-hits
0
x-content-type-options
nosniff
x-frame-options
deny
x-request-id
553f637e-fc13-4f1f-b67f-d9a08b89a4b6
x-served-by
cache-yyz4569-YYZ
x-timer
S1716905855.341373,VS0,VE70
x-xss-protection
1; mode=block
esp
oajs.openx.net/
Redirect Chain
  • https://oajs.openx.net/esp?url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rid=esp
  • https://oajs.openx.net/esp?url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rid=esp&cc=1
85 B
203 B
Fetch
General
Full URL
https://oajs.openx.net/esp?url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rid=esp&cc=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.120.135.53 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
53.135.120.34.bc.googleusercontent.com
Software
/ Express
Resource Hash
524cb2055eff7f7a574e371f67b9743c0b22624b29b4b522922067f38ee27850

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
x-powered-by
Express
etag
W/"55-mK/VkdkOwLbjAmfc7V/8ZBnB4WI"
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
85

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
x-powered-by
Express
vary
Origin
access-control-allow-origin
https://www.fiercepharma.com
location
/esp?url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rid=esp&cc=1
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
syncframe
gum.criteo.com/ Frame 69D5
0
0
Document
General
Full URL
https://gum.criteo.com/syncframe?origin=publishertagids&topUrl=www.fiercepharma.com&gdpr=0&gdpr_consent=
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.ids.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a00b::12 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

cache-control
private, max-age=3600
content-encoding
gzip
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Tue, 28 May 2024 14:17:34 GMT
server
Kestrel
server-processing-duration-in-ticks
413112
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
x-robots-tag
noindex
demconf.jpg
dpm.demdex.net/
Redirect Chain
  • https://dpm.demdex.net/ibs:dpid=22052&dpuuid=3644478246682624013&redir=
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3644478246682624013&redir=
42 B
717 B
Image
General
Full URL
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3644478246682624013&redir=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
184.73.251.44 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-184-73-251-44.compute-1.amazonaws.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

dcs
dcs-prod-va6-2-v060-0441a4894.edge-va6.demdex.com 2 ms
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
strict-transport-security
max-age=31536000; includeSubDomains
x-content-type-options
nosniff
content-encoding
gzip
x-tid
VFZykQRQRaY=
content-type
image/gif
p3p
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
cache-control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
content-length
59
expires
Thu, 01 Jan 1970 00:00:00 UTC

Redirect headers

dcs
dcs-prod-va6-2-v060-01f6a99ee.edge-va6.demdex.com 0 ms
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
strict-transport-security
max-age=31536000; includeSubDomains
x-tid
r/SWeHVjRzw=
p3p
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
location
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=22052&dpuuid=3644478246682624013&redir=
cache-control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 UTC
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3644478246682624013
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzY0NDQ3ODI0NjY4MjYyNDAxMxAAGg0I_87XsgYSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=970d03b0b853457d33f36d5c029f60cdd1335e18ea8abc42211ff2d1b2cdc9eef4cb09cee1a4f8eb&person_id=3644478246682624013&eid=50082
43 B
56 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=970d03b0b853457d33f36d5c029f60cdd1335e18ea8abc42211ff2d1b2cdc9eef4cb09cee1a4f8eb&person_id=3644478246682624013&eid=50082
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
34.117.77.79 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
79.77.117.34.bc.googleusercontent.com
Software
Google Frontend /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

expires
Wed, 29 May 2024 14:17:35 GMT
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google, 1.1 google
server
Google Frontend
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-type
image/gif

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=970d03b0b853457d33f36d5c029f60cdd1335e18ea8abc42211ff2d1b2cdc9eef4cb09cee1a4f8eb&person_id=3644478246682624013&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=d0tro1j&ttd_tpi=1
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=d0tro1j&ttd_tpi=1
  • https://ml314.com/utsync.ashx?eid=53819&et=0&fp=5bd0543e-1516-41ce-8e0f-a61e663146fe&gdpr=0&gdpr_consent=
  • https://ml314.com/csync.ashx?fp=5bd0543e-1516-41ce-8e0f-a61e663146fe&person_id=3644478246682624013&eid=53819
43 B
56 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=5bd0543e-1516-41ce-8e0f-a61e663146fe&person_id=3644478246682624013&eid=53819
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
34.117.77.79 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
79.77.117.34.bc.googleusercontent.com
Software
Google Frontend /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

expires
Wed, 29 May 2024 14:17:35 GMT
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google, 1.1 google
server
Google Frontend
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google, 1.1 google
server
Google Frontend
content-type
image/gif
location
https://ml314.com/csync.ashx?fp=5bd0543e-1516-41ce-8e0f-a61e663146fe&person_id=3644478246682624013&eid=53819
p3p
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
cache-control
no-cache, no-store, must-revalidate
x-cloud-trace-context
600a492b3d5707727b6d9f9419b6e5eb
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
0,Wed, 29 May 2024 14:17:35 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3644478246682624013
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D3644478246682624013
  • https://ml314.com/csync.ashx?fp=7b3b6951c8d34345f65c3dff8743ea8f&eid=50146&person_id=3644478246682624013
43 B
56 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=7b3b6951c8d34345f65c3dff8743ea8f&eid=50146&person_id=3644478246682624013
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
34.117.77.79 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
79.77.117.34.bc.googleusercontent.com
Software
Google Frontend /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

expires
Wed, 29 May 2024 14:17:35 GMT
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google, 1.1 google
server
Google Frontend
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
server
Jetty(9.4.38.v20210224)
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
location
https://ml314.com/csync.ashx?fp=7b3b6951c8d34345f65c3dff8743ea8f&eid=50146&person_id=3644478246682624013
cache-control
no-cache
x-server
10.40.62.107
content-length
0
expires
0
5J7LBS7TXZCZDFENFCAXF7
d.adroll.com/consent/check/
494 B
1 KB
Script
General
Full URL
https://d.adroll.com/consent/check/5J7LBS7TXZCZDFENFCAXF7?pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&_s=160d27bdcdfb6b68374463464a1c16ce&_b=2
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:61c0:2204:84bf:7c00:afb4:646b Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
nginx/1.22.1 /
Resource Hash
5daf498df4ebf1cdbfa999dcf10eaa203b6630ecf44c39de6d99d1e630f6e46c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-type
application/javascript
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
494
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
gpt.js
securepubads.g.doubleclick.net/tag/js/
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:34 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
30115
x-xss-protection
0
server
cafe
etag
148 / 19871 / 31083984 / config-hash: 2349943193236436899
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 28 May 2024 14:17:34 GMT
hadronid
id.hadron.ad.gt/api/v1/
54 KB
55 KB
Script
General
Full URL
https://id.hadron.ad.gt/api/v1/hadronid?_it=prebid&partner_id=170&_it=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:445 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
027a2a1dc9044e78b8382a7522536ac3ac5a5401b148d7826e0f8eda3001cf2d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
cf-cache-status
DYNAMIC
server
cloudflare
access-control-allow-methods
HEAD,GET,POST,PUT,DELETE,OPTIONS
content-type
Content-Type; text/javascript; charset=UTF-8
access-control-allow-origin
*
access-control-allow-credentials
true
debug
NON-OPTIONS
access-control-allow-headers
authorization
content-length
55794
cf-ray
88aede7ddea84bcc-BUF
ads
securepubads.g.doubleclick.net/gampad/
44 KB
18 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=662381594593571&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=320x50&fluid=height&ifi=6&sfv=1-0-40&eri=1&sc=1&cookie=ID%3Da90cc3b714b67850%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MZR88u87xliHY2sIghUmnTQn-uaXQ&gpic=UID%3D00000a2952636e6d%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MZgpdt1MI56qze7Bfztc1DzkcI74A&abxe=1&dt=1716905855545&lmt=1716905156&adxs=255&adys=1658&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=2&ucis=5&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=830x1&msz=830x0&fws=132&ohw=1600&psts=AOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsluTb3R7OOWHWCNUUMCgPQB1O-s4jzCljj5eLrd6FbA%2CAOrYGslXqzWxZnMwa10HhsoG5C0a&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=true&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEhQKBW9wZW54GN-Qwfz7MUgAUgIIZA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D14%26refresh%3Dtrue%26hb_rfBid%3D0%26hb_div_id%3DnativeAdUnitPos141716905854669%26excl_cat%3DPREPOST&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=855652320&frm=20&eo_id_str=ID%3D1d889e4864143a21%3AT%3D1716905855%3ART%3D1716905855%3AS%3DAA-AfjYlqztGCVy0pjrKbMSeYNMi
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
e202c6d45a0d8ec8923accd71ed1443a655d6a99b60c3482fb748932176a29bc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
18719
x-xss-protection
0
google-lineitem-id
6730214341
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138476516030
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
csyncs
sghb.hbmp.mediafuse.com/
3 KB
1 KB
XHR
General
Full URL
https://sghb.hbmp.mediafuse.com/csyncs?aid1=852559&gdpr=0&gdpr_consent=undefined
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.151.194 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
f25b22cba5429647a1dbbc0cea8b1213ab2480249927e5277df64dee24f53924

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Content-Encoding
gzip
Server
Mediafuse
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
956
170
a.ad.gt/api/v1/u/matches/
13 KB
4 KB
Script
General
Full URL
https://a.ad.gt/api/v1/u/matches/170
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
89fc0c15d05825efa5a7cd1e80084ce47eb46469673e37de3eb2700be492f964

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Tue, 28 May 2024 14:14:44 GMT
server
cloudflare
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=14400
cross-origin-resource-policy
cross-origin
cf-ray
88aede7de8b74bd2-BUF
EM6JRDVVXJDHHMOGWQDHR4.js
s.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/
Redirect Chain
  • https://d.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fp...
  • https://s.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/EM6JRDVVXJDHHMOGWQDHR4.js
4 KB
2 KB
Script
General
Full URL
https://s.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/EM6JRDVVXJDHHMOGWQDHR4.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
2600:9000:23cb:d000:6:9280:1080:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
4acdfbea8df1057faa0c342d1d2af4fefae328c4cc29c4ede2a31bf31fdfa576

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

X-Amz-Version-Id
7zoIWcZVVSuFSLmEmeT3UtzB01PboF2E
Content-Encoding
gzip
Via
1.1 ed4584f7c263c11cf4adf75ba3a25764.cloudfront.net (CloudFront)
Date
Tue, 28 May 2024 14:14:36 GMT
Age
182
X-Amz-Cf-Pop
JFK50-P1
X-Amz-Server-Side-Encryption
AES256
Transfer-Encoding
chunked
X-Cache
Hit from cloudfront
Connection
keep-alive
Last-Modified
Wed, 29 Nov 2023 11:41:07 GMT
Server
AmazonS3
Etag
W/"3f6b4ae2b8bb9c70407abf1413dc6553"
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Access-Control-Max-Age
600
Access-Control-Allow-Headers
*
X-Amz-Cf-Id
MtbtRShAzyZFUU9Z3R_ZuNgbzYj9Yl8JNQt-vLg3Km0YwKCjOpIMRA==

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
x-segment-display-name
Visitors to Unsegmented Pages
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
x-rule-type
p
content-length
0
pragma
no-cache
x-conversion-value
0.00
server
nginx/1.22.1
x-rule
*
x-segment-eid
EM6JRDVVXJDHHMOGWQDHR4
location
https://s.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2/EM6JRDVVXJDHHMOGWQDHR4.js
cache-control
no-store, no-cache, must-revalidate
x-pixel-eid
LMLSTWRFS5G7NCBM7VFBI2
x-segment-name
*
x-advertisable-eid
5J7LBS7TXZCZDFENFCAXF7
x-conversion-currency
LMLSTWRFS5G7NCBM7VFBI2
ipv4.d.adroll.com/px4/5J7LBS7TXZCZDFENFCAXF7/
42 B
176 B
Image
General
Full URL
https://ipv4.d.adroll.com/px4/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookie=&adroll_s_ref=&keyw=&p0=898
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.211.183.138 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-211-183-138.compute-1.amazonaws.com
Software
nginx/1.22.1 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
42
content-type
image/gif
/
onetag-sys.com/usync/ Frame BEB5
0
0
Document
General
Full URL
https://onetag-sys.com/usync/?pubId=59a18369e249bfb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.184 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip184.ip-51-222-39.net
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
1651
content-type
text/html
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
strict-transport-security
max-age=15552000
/
hde.tynt.com/deb/ Frame B497
Redirect Chain
  • https://ssc-cms.33across.com/ps/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%...
  • https://de.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559...
  • https://hde.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D85255...
0
0
Document
General
Full URL
https://hde.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26extuid%3D33XUSERID33X&b=1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
67.202.105.34 , United States, ASN32748 (STEADFAST, US),
Reverse DNS
ip34.67-202-105.static.steadfastdns.net
Software
/
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Model, Sec-CH-UA-Full-Version-List, Sec-CH-UA, Sec-CH-UA-Mobile
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0, false
content-length
1900
content-type
text/html
date
Tue, 28 May 2024 14:17:35 GMT
expires
Sat, 26 Jul 1997 05:00:00 GMT
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
referrer-policy
unsafe-url

Redirect headers

accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Model, Sec-CH-UA-Full-Version-List, Sec-CH-UA, Sec-CH-UA-Mobile
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0, false
content-length
0
date
Tue, 28 May 2024 14:17:35 GMT
expires
Sat, 26 Jul 1997 05:00:00 GMT
location
https://hde.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26extuid%3D33XUSERID33X&b=1
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
referrer-policy
unsafe-url
csync
sync.hbmp.mediafuse.com/ Frame 8444
Redirect Chain
  • https://hbx.media.net/cksync.php?cs=1&type=pbs&ovsid=setstatuscode&gdpr=0&gdpr_consent=undefined&gpp={gpp}&gpp_sid={gpp_sid}&redirect=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D14...
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=142&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=764727&a=754412&extuid=3599074556634654000V10
0
0
Document
General
Full URL
https://sync.hbmp.mediafuse.com/csync?t=g&ep=142&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=764727&a=754412&extuid=3599074556634654000V10
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Content-Length
43
Content-Type
image/gif
Date
Tue, 28 May 2024 14:17:35 GMT
Etag
acd7258d8ae133c7
Server
Mediafuse

Redirect headers

alt-svc
h3=":443"; ma=93600
cache-control
max-age=0, no-cache, no-store
content-length
154
content-type
text/html
date
Tue, 28 May 2024 14:17:35 GMT
expires
Tue, 28 May 2024 14:17:35 GMT
location
https://sync.hbmp.mediafuse.com/csync?t=g&ep=142&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=764727&a=754412&extuid=3599074556634654000V10
p3p
CP="NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA" CP: NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA CP: NON DSP COR NID CUR ADMa DEVo TAI PSA PSDo HIS OUR BUS COM NAV INT STA
pragma
no-cache
server
Apache
strict-transport-security
max-age=86400 ; includeSubDomains max-age=604800
x-mnet-hl2
E
sync.html
s.console.adtarget.com.tr/ Frame E32B
0
0
Document
General
Full URL
https://s.console.adtarget.com.tr/sync.html?aid=748067
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2607:4f00:968::2 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtarget /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Credentials
true
Access-Control-Allow-Origin
https://www.fiercepharma.com
Connection
Keep-Alive
Date
Tue, 28 May 2024 14:17:35 GMT
Permissions-Policy
browsing-topics=()
Server
Adtarget
X-Robots-Tag
noindex
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame D072
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?gdpr=0&gdpr_consent=undefined&us_privacy={us_privacy}&predirect=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Da%26ep%3D558003%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D765040%26a%3D558003%26extuid%3D
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.51.57.13 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-51-57-13.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ranges
bytes
cache-control
max-age=69778
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 28 May 2024 14:17:35 GMT
expires
Wed, 29 May 2024 09:40:33 GMT
last-modified
Wed, 22 May 2024 00:02:24 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
cookie
cm.adform.net/ Frame 78B3
0
0
Document
General
Full URL
https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D50%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D764710%26a%3D743293%26extuid%3D%24UID
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.6.237 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
access-control-allow-methods
GET
access-control-allow-origin
*
access-control-max-age
86400
content-type
image/gif
date
Tue, 28 May 2024 14:17:35 GMT
server
nginx
csync
sync.hbmp.mediafuse.com/
Redirect Chain
  • https://cm-x.mgid.com/7d2fea400064b22652273d22c2e07bad.gif?puid=[UID]&redir=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D358%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%...
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=358&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765043&a=753378&extuid=fb4ec714-f08c-4bc1-a3c8-ad51a5f824f3
43 B
474 B
Image
General
Full URL
https://sync.hbmp.mediafuse.com/csync?t=g&ep=358&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765043&a=753378&extuid=fb4ec714-f08c-4bc1-a3c8-ad51a5f824f3
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Mediafuse
Etag
acd7258d8ae133c7
Content-Length
43
Content-Type
image/gif

Redirect headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:35 GMT
Transfer-Encoding
chunked
Location
https://sync.hbmp.mediafuse.com/csync?t=g&ep=358&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765043&a=753378&extuid=fb4ec714-f08c-4bc1-a3c8-ad51a5f824f3
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Keep-Alive
timeout=5
Expires
0
sync
vid.vidoomy.com/
0
0

csync
sync.hbmp.mediafuse.com/
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D32%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D770090%26a%3D75...
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=770090&a=758001&extuid=7532885200230356581
43 B
456 B
Image
General
Full URL
https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=770090&a=758001&extuid=7532885200230356581
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Mediafuse
Etag
acd7258d8ae133c7
Content-Length
43
Content-Type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
an-x-request-uuid
d8daa277-2886-41e5-b549-405d616f82cc
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=770090&a=758001&extuid=7532885200230356581
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
1px-matching-adtelligent.gif
t.trafmag.com/images/images/
35 B
349 B
Image
General
Full URL
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=acd7258d8ae133c7
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
193.200.65.5 Amsterdam, Netherlands, ASN6681 (GIVEME-CLOUD, PL),
Reverse DNS
t.trafmag.com
Software
nginx /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Content-Type
image/gif
Date
Tue, 28 May 2024 14:17:35 GMT
Server
nginx
Connection
keep-alive
Content-Length
35
P3P
CP="NON DSP COR CURa TIA"
csync
sync.hbmp.mediafuse.com/
Redirect Chain
  • https://ap.lijit.com/pixel?redir=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D13%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D675886%26a...
  • https://ap.lijit.com/pixel?redir=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D13%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D675886%26a...
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=13&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=675886&a=310570&extuid=Iu15ALZHFmXOcih3Q3CI14ZT
43 B
461 B
Image
General
Full URL
https://sync.hbmp.mediafuse.com/csync?t=g&ep=13&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=675886&a=310570&extuid=Iu15ALZHFmXOcih3Q3CI14ZT
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Mediafuse
Etag
acd7258d8ae133c7
Content-Length
43
Content-Type
image/gif

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
vary
Accept-Encoding
access-control-allow-methods
GET, POST, DELETE, PUT
location
https://sync.hbmp.mediafuse.com/csync?t=g&ep=13&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=675886&a=310570&extuid=Iu15ALZHFmXOcih3Q3CI14ZT
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
X-Requested-With, Content-Type
content-length
0
csync
sync.adtelligent.com/
Redirect Chain
  • https://sync.1rx.io/usersync2/rmpssp?sub=adtelligent
  • https://sync.1rx.io/usersync2/rmpssp?sub=adtelligent&zcc=1&cb=1716905854182
  • https://ad.turn.com/r/cs?pid=45&rndcb=8993946724
  • https://sync.1rx.io/usersync/turn/3393522997715204143?dspret=1&gdpr=&gdpr_consent=&us_privacy=
  • https://sync.targeting.unrulymedia.com/csync/RX-c1b27d11-0298-4776-8523-332ed0612207-005?redir=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D541630%26extuid%3DRX-c1b27d11-0298-4776-8523...
  • https://sync.adtelligent.com/csync?t=a&ep=541630&extuid=RX-c1b27d11-0298-4776-8523-332ed0612207-005
43 B
480 B
Image
General
Full URL
https://sync.adtelligent.com/csync?t=a&ep=541630&extuid=RX-c1b27d11-0298-4776-8523-332ed0612207-005
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Adtelligent
Etag
97b6bb00c3c60ab3
Content-Length
43
Content-Type
image/gif

Redirect headers

location
https://sync.adtelligent.com/csync?t=a&ep=541630&extuid=RX-c1b27d11-0298-4776-8523-332ed0612207-005
date
Tue, 28 May 2024 14:17:34 GMT
p3p
CP="This is not a P3P policy! See https://www.rhythmone.com/p3p to learn why"
etag
RXc1b27d11029847768523332ed0612207005
content-type
text/html
csync
sync.hbmp.mediafuse.com/
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D32%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D765041%26a%3D29...
  • https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765041&a=297253&extuid=7532885200230356581
43 B
456 B
Image
General
Full URL
https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765041&a=297253&extuid=7532885200230356581
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Mediafuse
Etag
acd7258d8ae133c7
Content-Length
43
Content-Type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
an-x-request-uuid
9bf50366-5fad-44af-855c-1a2eebf38b7d
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://sync.hbmp.mediafuse.com/csync?t=g&ep=32&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765041&a=297253&extuid=7532885200230356581
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
csync
sync.hbmp.mediafuse.com/
Redirect Chain
  • https://a4p.adpartner.pro/ssp/match?redirect=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Da%26ep%3D307558%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%...
  • https://sync.hbmp.mediafuse.com/csync?t=a&ep=307558&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765812&a=307558&extuid=961c6ad5-9512-4395-ae74-449abe757ba1
43 B
477 B
Image
General
Full URL
https://sync.hbmp.mediafuse.com/csync?t=a&ep=307558&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765812&a=307558&extuid=961c6ad5-9512-4395-ae74-449abe757ba1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Server
Mediafuse
Etag
acd7258d8ae133c7
Content-Length
43
Content-Type
image/gif

Redirect headers

location
https://sync.hbmp.mediafuse.com/csync?t=a&ep=307558&traffic_source=snippet&session=13CE245169C2C917&sp=852559&pb=753264&c=765812&a=307558&extuid=961c6ad5-9512-4395-ae74-449abe757ba1
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-store no-transform
server
nginx
content-length
279
content-type
text/html; charset=utf-8
Pug
simage2.pubmatic.com/AdServer/
Redirect Chain
  • https://prebid.a-mo.net/cchain/0?cb=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D737%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D764723...
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fprebid.a-mo.net%2Fcchain%2F0%2F7240%3Fgpp%3D%26gdpr_consent%3D%26gdpr%3D%26gpp_sid%3D%26us_privacy%3D%26A%3D794bc344-a4fa-440c-895e-7f9d938486d6%26bidder%3...
  • https://prebid.a-mo.net/cchain/0/7240?gpp=&gdpr_consent=&gdpr=&gpp_sid=&us_privacy=&A=794bc344-a4fa-440c-895e-7f9d938486d6&bidder=appnexus&cbx=aHR0cHM6Ly9zeW5jLmhibXAubWVkaWFmdXNlLmNvbS9jc3luYz90PW...
  • https://image8.pubmatic.com/AdServer/ImgSync?p=158355&gdpr=0&us_privacy=1---&pu=https%3A%2F%2Fimage4.pubmatic.com%2FAdServer%2FSPug%3Fp%3D158355%26pmc%3DPM_PMC%26pr%3Dhttps%253A%252F%252Fprebid.a-m...
  • https://pubmatic-match.dotomi.com/match/bounce/current?networkId=17100&version=1&nuid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent=
  • https://pubmatic-match.dotomi.com/match/bounce/current?DotomiTest=7acf054160a60506&is_secure=true&networkId=17100&version=1&nuid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent=
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AQAAzdFcyPINugIh58W8AQEBAQEBAQCOvpFMgwEBAI6-kUyD&expiration=1716992256&nuid=A1C42EB9-955D-48...
42 B
400 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AQAAzdFcyPINugIh58W8AQEBAQEBAQCOvpFMgwEBAI6-kUyD&expiration=1716992256&nuid=A1C42EB9-955D-4866-B405-509F11DA5631&is_secure=true&gdpr_consent=&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

content-type
image/gif; charset=utf-8
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
42
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTQ2MSZ0bD0xMDA4MA==&piggybackCookie=AQAAzdFcyPINugIh58W8AQEBAQEBAQCOvpFMgwEBAI6-kUyD&expiration=1716992256&nuid=A1C42EB9-955D-4866-B405-509F11DA5631&is_secure=true&gdpr_consent=&gdpr=0
pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache, private, max-age=0, no-store
server
nginx
content-length
0
expires
0
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=7532885200230356581&pixelIndex=0
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=7532885200230356581&pixelIndex=0&google_gid=CAESEJdcZcrZuSUBq3djmb_dCdE&google_cver=1
0
598 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=7532885200230356581&pixelIndex=0&google_gid=CAESEJdcZcrZuSUBq3djmb_dCdE&google_cver=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
54.157.213.254 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-157-213-254.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Pragma
no-cache
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Content-Type
text/javascript
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Access-Control-Allow-Headers
content-type, accept
Content-Length
0
Expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=7532885200230356581&pixelIndex=0&google_gid=CAESEJdcZcrZuSUBq3djmb_dCdE&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
348
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
db_sync
px.ads.linkedin.com/
Redirect Chain
  • https://idsync.rlcdn.com/423396.gif?partner_uid=7532885200230356581
  • https://pippio.com/api/sync?pid=5324&it=1&iv=968eaf830204b100b092706fd34c08a4cd6128dc6b37e86074810383de542d9e791426b5417dce21&_=2
  • https://px.ads.linkedin.com/db_sync?pid=10339&puuid=968eaf830204b100b092706fd34c08a4cd6128dc6b37e86074810383de542d9e791426b5417dce21&rand=06422672
0
143 B
Image
General
Full URL
https://px.ads.linkedin.com/db_sync?pid=10339&puuid=968eaf830204b100b092706fd34c08a4cd6128dc6b37e86074810383de542d9e791426b5417dce21&rand=06422672
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 269CE1F161F544BEAAC3CB0836E5F79F Ref B: NYCEDGE1613 Ref C: 2024-05-28T14:17:35Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-ltx1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYZhEunp4quIBPqNMzKvA==

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://px.ads.linkedin.com/db_sync?pid=10339&puuid=968eaf830204b100b092706fd34c08a4cd6128dc6b37e86074810383de542d9e791426b5417dce21&rand=06422672
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
pd
google-bidout-d.openx.net/w/1.0/ Frame 046E
0
0
Document
General
Full URL
https://google-bidout-d.openx.net/w/1.0/pd?plm=5
Requested by
Host: oa.openxcdn.net
URL: https://oa.openxcdn.net/esp.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-encoding
gzip
content-length
457
content-type
text/html
date
Tue, 28 May 2024 14:17:35 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
via
1.1 google
fbevents.js
connect.facebook.net/en_US/
218 KB
59 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: d.adroll.com
URL: https://d.adroll.com/pixel/5J7LBS7TXZCZDFENFCAXF7/LMLSTWRFS5G7NCBM7VFBI2?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&cookie=&adroll_s_ref=&keyw=&p0=898
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f07e:9:face:b00c:0:3 Somerville, United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
e9c370ea9070b144ed45ff5f35c9206112dd1091326ff898f414ef8c12ec85c0
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://*.google-analytics.com *.google.com;style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' https://*.google-analytics.com;img-src 'self' data: blob: * https://*.google-analytics.com;block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://*.google-analytics.com *.google.com;style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' https://*.google-analytics.com;img-src 'self' data: blob: * https://*.google-analytics.com;block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Tue, 28 May 2024 14:17:35 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
57845
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
x-fb-connection-quality
EXCELLENT; q=0.9, rtt=25, rtx=0, c=12, mss=1294, tbw=2765, tp=-1, tpl=-1, uplat=0, ullat=-1
pragma
public
x-fb-debug
m4K6h34SbHOqKAJweCWZbjUNJ6xm0zKydfE4uMi2SzeTKTmVC5X1+4Il3mga90k7ziyi/I4doZ2FeU6e/W+O/A==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), attribution-reporting=(), autoplay=(), battery=(self), bluetooth=(), camera=(), ch-device-memory=(), ch-downlink=(), ch-dpr=(), ch-ect=(), ch-rtt=(), ch-save-data=(), ch-ua-arch=(), ch-ua-bitness=(), ch-viewport-height=(), ch-viewport-width=(), ch-width=(), clipboard-read=(), clipboard-write=(), compute-pressure=(), display-capture=(), encrypted-media=(), fullscreen=(self), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), interest-cohort=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), picture-in-picture=(), private-state-token-issuance=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), shared-storage=(), shared-storage-select-url=(), private-state-token-redemption=(), usb=(), usb-unrestricted=(), unload=(self), window-management=(), xr-spatial-tracking=();report-to="permissions_policy"
timing-allow-origin
*
expires
Sat, 01 Jan 2000 00:00:00 GMT
sync
x.bidswitch.net/ul_cb/
Redirect Chain
  • https://d.adroll.com/cm/b/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m...
  • https://x.bidswitch.net/sync?dsp_id=44&user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
  • https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
43 B
510 B
Image
General
Full URL
https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
35.211.178.172 North Charleston, United States, ASN15169 (GOOGLE, US),
Reverse DNS
172.178.211.35.bc.googleusercontent.com
Software
nginx /
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif

Redirect headers

Location
https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
Date
Tue, 28 May 2024 14:17:35 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
in
d.adroll.com/cm/g/
Redirect Chain
  • https://d.adroll.com/cm/g/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m...
  • https://cm.g.doubleclick.net/pixel?google_sc&google_nid=artb&google_hm=kMcxeYwsG87Hi11R3aNYmw
  • https://d.adroll.com/cm/g/in
42 B
822 B
Image
General
Full URL
https://d.adroll.com/cm/g/in
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2600:1f18:61c0:2204:84bf:7c00:afb4:646b Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
nginx/1.22.1 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
server
nginx/1.22.1
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
content-type
image/gif
cache-control
no-store, no-cache, must-revalidate
content-length
42
x-result
g.-1.-1.-1

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://d.adroll.com/cm/g/in
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
225
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
rum
dsum-sec.casalemedia.com/
Redirect Chain
  • https://d.adroll.com/cm/index/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1...
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expiration=1748441855
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expiration=1748441855&C=1
43 B
730 B
Image
General
Full URL
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expiration=1748441855&C=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=wpMQaPHc8FA7QMxWhWgP%2Bhyvc4ohwIUXtWq59fUKXxROdQ6wMfZKN3TYjnEMCz5NRgvPN8byZx5Pn8tazQKnwth92iBmsmeowzm4BuWOa8ebX24uUwepluSi6tPvuCBbDlAIEeu3awyOoA%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
content-type
image/gif
cache-control
no-cache
cf-ray
88aede7edc64ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
43
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=yl3PHo%2Bw3P2%2BQvGYlNNYZHMOOmA%2F1pMyyo5mLjHnwMr1VyDppKWlJEPPsZYyEUUmmkgcpU43GdIMBq6tscn1wYjSsGhtrHBY%2FEEQBkh%2B3HjtTrGjiTm4icKBsHRCoryPpToWEYf4hKBypA%3D%3D"}],"group":"cf-nel","max_age":604800}
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
location
/rum?cm_dsp_id=105&external_user_id=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expiration=1748441855&C=1
cache-control
no-cache
cf-ray
88aede7e4bb4ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
0
expires
0
396846.gif
idsync.rlcdn.com/
Redirect Chain
  • https://d.adroll.com/cm/l/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m...
  • https://idsync.rlcdn.com/377928.gif?partner_uid=90c731798c2c1bcec78b5d51dda3589b
  • https://us-u.openx.net/w/1.0/cm?id=e508c905-ddce-4732-92a4-0b0f5b72a28f&r=https%3A%2F%2Fidsync.rlcdn.com%2F396846.gif%3Fserved_by%3Devergreen%26partner_uid%3D
  • https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=f29451ea-abb3-47f4-ab39-092fdea4367e
42 B
60 B
Image
General
Full URL
https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=f29451ea-abb3-47f4-ab39-092fdea4367e
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
35.244.154.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.154.244.35.bc.googleusercontent.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42

Redirect headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
via
1.1 google
server
OXGW/0.0.0
vary
Accept, Accept-Encoding
content-type
image/gif
location
https://idsync.rlcdn.com/396846.gif?served_by=evergreen&partner_uid=f29451ea-abb3-47f4-ab39-092fdea4367e
p3p
CP="CUR ADM OUR NOR STA NID"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
tap.php
pixel.rubiconproject.com/
Redirect Chain
  • https://d.adroll.com/cm/n/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m...
  • https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expires=365
42 B
980 B
Image
General
Full URL
https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expires=365
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
69.173.146.5 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Content-Type
image/gif
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
42
X-RPHost
772cc9037cd6dc6f19451a098a1a8570
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

location
https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&expires=365
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
124
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
sd
us-u.openx.net/w/1.0/
Redirect Chain
  • https://d.adroll.com/cm/o/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m...
  • https://us-u.openx.net/w/1.0/sd?id=537103138&val=90c731798c2c1bcec78b5d51dda3589b&gdpr=0&gdpr_consent=
43 B
273 B
Image
General
Full URL
https://us-u.openx.net/w/1.0/sd?id=537103138&val=90c731798c2c1bcec78b5d51dda3589b&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.98.64.218 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/0.0.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
server
OXGW/0.0.0
vary
Accept
content-type
image/gif
p3p
CP="CUR ADM OUR NOR STA NID"
cache-control
private, max-age=0, no-cache
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

location
https://us-u.openx.net/w/1.0/sd?id=537103138&val=90c731798c2c1bcec78b5d51dda3589b&gdpr=0&gdpr_consent=
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
108
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
cookie-sync
sync.outbrain.com/
Redirect Chain
  • https://d.adroll.com/cm/outbrain/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-win...
  • https://sync.outbrain.com/cookie-sync?p=adroll&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=&us_privacy=1---
0
360 B
Image
General
Full URL
https://sync.outbrain.com/cookie-sync?p=adroll&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=&us_privacy=1---
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
70.42.32.223 , United States, ASN22075 (AS-OUTBRAIN, US),
Reverse DNS
ny.outbrain.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:35 GMT
Cache-Control
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
X-TraceId
458a9479510204338f640b0358d8f959
Content-Length
0

Redirect headers

location
https://sync.outbrain.com/cookie-sync?p=adroll&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=&us_privacy=1---
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
137
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
Pug
image2.pubmatic.com/AdServer/
Redirect Chain
  • https://d.adroll.com/cm/pubmatic/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-win...
  • https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDYmdGw9MTI5NjAw&piggybackCookie=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENAkwAAAAXy...
42 B
543 B
Image
General
Full URL
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDYmdGw9MTI5NjAw&piggybackCookie=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENAkwAAAAXyACACYAIIA
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
8.28.7.83 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

content-type
image/gif; charset=utf-8
date
Tue, 28 May 2024 14:17:34 GMT
cache-control
no-store, no-cache, private
server
nginx
content-length
42
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"

Redirect headers

location
https://image2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTMzMDYmdGw9MTI5NjAw&piggybackCookie=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENAkwAAAAXyACACYAIIA
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
212
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
sync
ups.analytics.yahoo.com/ups/55980/
Redirect Chain
  • https://d.adroll.com/cm/r/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m...
  • https://ups.analytics.yahoo.com/ups/55980/sync?_origin=1&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA
  • https://ups.analytics.yahoo.com/ups/55980/sync?_origin=1&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&verify=true
0
121 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/55980/sync?_origin=1&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&verify=true
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.200.65.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-200-65-202.compute-1.amazonaws.com
Software
ATS/9.1.10.112 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.112
age
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/55980/sync?_origin=1&uid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&verify=true
date
Tue, 28 May 2024 14:17:35 GMT
strict-transport-security
max-age=31536000
server
ATS/9.1.10.112
age
0
content-length
0
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
rtb-h
sync.taboola.com/sg/adroll-network/1/
Redirect Chain
  • https://d.adroll.com/cm/taboola/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins...
  • https://sync.taboola.com/sg/adroll-network/1/rtb-h?taboola_hm=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
0
366 B
Image
General
Full URL
https://sync.taboola.com/sg/adroll-network/1/rtb-h?taboola_hm=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
141.226.224.48 , United States, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
access-control-allow-credentials
true
server
nginx
x-fastly-to-nlb-rtt
22249

Redirect headers

location
https://sync.taboola.com/sg/adroll-network/1/rtb-h?taboola_hm=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
111
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
xuid
eb2.3lift.com/
Redirect Chain
  • https://d.adroll.com/cm/triplelift/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-w...
  • https://eb2.3lift.com/xuid?mid=4714&xuid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&dongle=c85e
  • https://eb2.3lift.com/xuid?ld=1&mid=4714&xuid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&dongle=c85e&gdpr=0&cmp_cs=&us_privacy=
37 B
474 B
Image
General
Full URL
https://eb2.3lift.com/xuid?ld=1&mid=4714&xuid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&dongle=c85e&gdpr=0&cmp_cs=&us_privacy=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
52.223.22.214 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

content-type
image/gif
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"

Redirect headers

location
/xuid?ld=1&mid=4714&xuid=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&dongle=c85e&gdpr=0&cmp_cs=&us_privacy=
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
setuid
ib.adnxs.com/
Redirect Chain
  • https://d.adroll.com/cm/x/out?adroll_fpc=0110a2c029ee174a3f13fa6794780d6c-1716905855559&pv=78294935855.06044&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m...
  • https://ib.adnxs.com/setuid?entity=172&code=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/setuid?entity=172&code=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
an-x-request-uuid
dbca6b9b-c810-4eea-9b46-88eb67e925a0
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
image/gif
cache-control
no-store, no-cache, private
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
43
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

location
https://ib.adnxs.com/setuid?entity=172&code=OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, must-revalidate
server
nginx/1.22.1
content-length
93
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
container.html
690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com/safeframe/1-0-40/html/ Frame 4376
0
0
Document
General
Full URL
https://690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com/safeframe/1-0-40/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81f::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ranges
bytes
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, immutable, max-age=31536000
content-encoding
br
content-length
2653
content-type
text/html
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
cross-origin-resource-policy
cross-origin
date
Tue, 28 May 2024 14:17:35 GMT
expires
Wed, 28 May 2025 14:17:35 GMT
last-modified
Thu, 03 Nov 2022 19:10:08 GMT
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
server
sffe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
hadron.json
id.hadron.ad.gt/v1/
101 B
291 B
XHR
General
Full URL
https://id.hadron.ad.gt/v1/hadron.json?_it=prebid&partner_id=170&sync=0&domain=www.fiercepharma.com&url=
Requested by
Host: id.hadron.ad.gt
URL: https://id.hadron.ad.gt/api/v1/hadronid?_it=prebid&partner_id=170&_it=prebid
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:445 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4f6090e8f56ec0fb59cc0f78f2a3d6bdcccd0752579a6a02472ee26e5c341f54

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
cf-cache-status
DYNAMIC
server
cloudflare
access-control-allow-methods
HEAD,GET,POST,PUT,DELETE,OPTIONS
content-type
application/json
access-control-allow-origin
*
cache-control
private,max-age=30
access-control-allow-credentials
true
debug
NON-OPTIONS
access-control-allow-headers
authorization
cf-ray
88aede7f494b6aed-BUF
hadron.json
id.hadron.ad.gt/v1/ Frame
0
0
Preflight
General
Full URL
https://id.hadron.ad.gt/v1/hadron.json?_it=prebid&partner_id=170&sync=0&domain=www.fiercepharma.com&url=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:445 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
GET
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
access-control-allow-origin
*
allow
POST, OPTIONS, GET
cache-control
max-age=31536000 public, no-transform
cf-cache-status
DYNAMIC
cf-ray
88aede7ee8c56aed-BUF
content-length
0
content-type
application/json
date
Tue, 28 May 2024 14:17:35 GMT
debug
OPTIONS block
expires
Wed, 28 May 2025 14:17:35 GMT
server
cloudflare
170
p.ad.gt/api/v1/p/
40 KB
14 KB
Script
General
Full URL
https://p.ad.gt/api/v1/p/170
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:445 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1e615fc0b82c3508a3063390e578b6099c4f5f9f7c1d299bd579f53a7c3e968d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Tue, 28 May 2024 14:09:34 GMT
server
cloudflare
age
270
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=14400
cf-ray
88aede7f484f4bd3-BUF
halo_match
ids.ad.gt/api/v1/
43 B
173 B
Image
General
Full URL
https://ids.ad.gt/api/v1/halo_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&halo_id=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede7fd8824bd3-BUF
content-length
43
content-type
image/gif
match
ids.ad.gt/api/v1/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&adnxs_id=$UID&gdpr=0
  • https://ids.ad.gt/api/v1/match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&adnxs_id=7532885200230356581&gdpr=0
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&adnxs_id=7532885200230356581&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede7fd8834bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
an-x-request-uuid
a07da810-b7f1-4096-ae06-99cd7350b47d
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://ids.ad.gt/api/v1/match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&adnxs_id=7532885200230356581&gdpr=0
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
t_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&ttd_puid=AU1D-0100-001716905856-UP2ANVC2-NLBB&gdpr=0
  • https://ids.ad.gt/api/v1/t_match?tdid=5bd0543e-1516-41ce-8e0f-a61e663146fe&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
43 B
94 B
Image
General
Full URL
https://ids.ad.gt/api/v1/t_match?tdid=5bd0543e-1516-41ce-8e0f-a61e663146fe&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede7fd8804bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

location
https://ids.ad.gt/api/v1/t_match?tdid=5bd0543e-1516-41ce-8e0f-a61e663146fe&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
date
Tue, 28 May 2024 14:17:35 GMT
server
Kestrel
content-length
259
pbm_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3DAU1D-0100-001716905856-UP2ANVC2-NLBB
  • https://ids.ad.gt/api/v1/pbm_match?pbm=E4A7B065-4DC2-43F6-A8C4-5C5C45F703C1&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/pbm_match?pbm=E4A7B065-4DC2-43F6-A8C4-5C5C45F703C1&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede7fd8844bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

location
https://ids.ad.gt/api/v1/pbm_match?pbm=E4A7B065-4DC2-43F6-A8C4-5C5C45F703C1&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
rub_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://token.rubiconproject.com/token?pid=50242&puid=AU1D-0100-001716905856-UP2ANVC2-NLBB&gdpr=0
  • https://ids.ad.gt/api/v1/rub_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&rub=LWQHF0YD-F-3YJX&gdpr=0
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/rub_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&rub=LWQHF0YD-F-3YJX&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede80e8e14bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

Location
https://ids.ad.gt/api/v1/rub_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&rub=LWQHF0YD-F-3YJX&gdpr=0
Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
1c34e56f66d325760e494cbb7a93f50f
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
tapad_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3185&partner_device_id=AU1D-0100-001716905856-UP2ANVC2-NLBB&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001716905856...
  • https://pixel.tapad.com/idsync/ex/receive/check?partner_id=3185&partner_device_id=AU1D-0100-001716905856-UP2ANVC2-NLBB&partner_url=https://ids.ad.gt%2Fapi%2Fv1%2Ftapad_match%3Fid%3DAU1D-0100-001716...
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=tapad&ttd_tpi=1&ttd_puid=8b9295b3-715d-4cf4-8e2c-6688206c4e63%252Chttps%25253A%25252F%25252Fids.ad.gt%25252Fapi%25252Fv1%25252Ftapad_match%25253Fi...
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=1830&partner_device_id=5bd0543e-1516-41ce-8e0f-a61e663146fe&ttd_puid=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2Chttps%253A%252F%252Fids.ad.gt%252Fap...
  • https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&tapad_id=8b9295b3-715d-4cf4-8e2c-6688206c4e63
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&tapad_id=8b9295b3-715d-4cf4-8e2c-6688206c4e63
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede836a034bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
access-control-allow-origin
*
location
https://ids.ad.gt/api/v1/tapad_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&tapad_id=8b9295b3-715d-4cf4-8e2c-6688206c4e63
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
g_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
  • https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&google_gid=CAESEGdKy5wjygqFerowi0S0fOA&google_cver=1&google_ula=450542624,0
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&google_gid=CAESEGdKy5wjygqFerowi0S0fOA&google_cver=1&google_ula=450542624,0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede8058af4bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://ids.ad.gt/api/v1/g_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&google_gid=CAESEGdKy5wjygqFerowi0S0fOA&google_cver=1&google_ula=450542624,0
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
357
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ids.ad.gt/api/v1/g_hosted?id=AU1D-0100-001716905856-UP2ANVC2-NLBB
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcxNjkwNTg1Ni1VUDJBTlZDMi1OTEJC
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcxNjkwNTg1Ni1VUDJBTlZDMi1OTEJC
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
142.250.72.98 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s32-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=QVUxRC0wMTAwLTAwMTcxNjkwNTg1Ni1VUDJBTlZDMi1OTEJC
date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede7fd8814bd3-BUF
content-type
text/html; charset=utf-8
amo_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://d.turn.com/r/dd/id/L2NzaWQvMS9jaWQvMTc0ODI0MTY1OC90LzA/url/https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Famo_match%3Fturn_id%3D%24!%7BTURN_UUID%7D%26id%3DAU1D-0100-001716905856-UP2ANVC2-NLBB
  • https://ids.ad.gt/api/v1/amo_match?turn_id=4562344477781617569&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/amo_match?turn_id=4562344477781617569&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede80e8e34bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

location
https://ids.ad.gt/api/v1/amo_match?turn_id=4562344477781617569&id=AU1D-0100-001716905856-UP2ANVC2-NLBB
pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
content-length
0
p3p
policyref="/w3c/p3p.xml", CP="NOI CURa DEVa TAIa PSAa PSDa IVAa IVDa OUR IND UNI NAV"
ium
ssum-sec.casalemedia.com/
0
465 B
Image
General
Full URL
https://ssum-sec.casalemedia.com/ium?sourceid=15&uid=&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=zcnTWVSUPWEHCG8d6IUqmG2fmg29sRgvMj5vdPOrkt0b3fFmArj%2BYjeglLZ%2BuHHRYWx48G1htejc0TYTtuwnmu7VsadVu8VeaYpAFslZn9xtl5TBgZeR7OHGgKY0W9PFm5VJi9Hoy6b%2B9w%3D%3D"}],"group":"cf-nel","max_age":604800}
cache-control
max-age=0, no-cache, no-store
cf-ray
88aede7fdd96ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
0
expires
Tue, 28 May 2024 14:17:36 GMT
son_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&uid=[UID]&gdpr=0
  • https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&uid=37e0b433-a139-49aa-b81e-736192785b62&gdpr=0
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&uid=37e0b433-a139-49aa-b81e-736192785b62&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede81790b4bd3-BUF
content-length
43
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-6-178
content-type
text/plain; charset=utf8
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&uid=37e0b433-a139-49aa-b81e-736192785b62&gdpr=0
cache-control
no-cache, no-store, private
tcn
Choice
content-length
0
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
/
px.ads.linkedin.com/wa/
0
200 B
XHR
General
Full URL
https://px.ads.linkedin.com/wa/
Requested by
Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
text/plain;charset=UTF-8
Accept
*
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
x-li-pop
afd-prod-ltx1-x
x-msedge-ref
Ref A: 8C61D91834EC40F79FECA2EF128A6CAF Ref B: NYCEDGE1613 Ref C: 2024-05-28T14:17:35Z
linkedin-action
1
vary
Origin
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-ltx1
access-control-allow-origin
https://www.fiercepharma.com
x-li-proto
http/2
access-control-allow-credentials
true
x-li-uuid
AAYZhEumoPsFFTQhRy1Kpg==
analytics.js
www.google-analytics.com/
52 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:80c::200e , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
date
Tue, 28 May 2024 13:46:37 GMT
last-modified
Tue, 12 Dec 2023 18:09:08 GMT
server
Golfe2
age
1859
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20994
expires
Tue, 28 May 2024 15:46:37 GMT
js
www.googletagmanager.com/gtag/
248 KB
87 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-FVWZ0RM4DH&l=audDataLayer
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.72.104 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s32-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
942d52f1866bbeeeeafa6fd466fc7f33133d49e76638b68a5d5ced722d46b3b4
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
89481
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:35 GMT
collect
a.ad.gt/api/v1/
0
146 B
XHR
General
Full URL
https://a.ad.gt/api/v1/collect
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::ac43:17ea , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede7feb7d4bc6-BUF
vary
Origin
getpixels
pixels.ad.gt/api/v1/
0
88 B
Script
General
Full URL
https://pixels.ad.gt/api/v1/getpixels?tagger_id=e0fc5aa47bed062e265fc29d169e5770&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&code=%27none%27
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede817b614bcd-BUF
halo_match
ids.ad.gt/api/v1/
43 B
95 B
Image
General
Full URL
https://ids.ad.gt/api/v1/halo_match?id=AU1D-0100-001716905856-UP2ANVC2-NLBB&halo_id=060j9d88fihe9b8df9bkjcbjcaj9djfekefw6k44ousm6g4ko6gywigwiew6kwomy
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:545 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache
cf-cache-status
DYNAMIC
server
cloudflare
cf-ray
88aede80e8df4bd3-BUF
content-length
43
content-type
image/gif
1683404521931009
connect.facebook.net/signals/config/
56 KB
12 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1683404521931009?v=2.9.156&r=stable&domain=www.fiercepharma.com&hme=c3a545c63044e8e9102d4f32d84a1137594d024f28e801d670bc76dc5c075575&ex_m=67%2C112%2C99%2C103%2C58%2C3%2C93%2C66%2C15%2C91%2C84%2C49%2C51%2C158%2C161%2C172%2C168%2C169%2C171%2C28%2C94%2C50%2C73%2C170%2C153%2C156%2C165%2C166%2C173%2C121%2C14%2C48%2C178%2C177%2C123%2C17%2C33%2C38%2C1%2C41%2C62%2C63%2C64%2C68%2C88%2C16%2C13%2C90%2C87%2C86%2C100%2C102%2C37%2C101%2C29%2C25%2C154%2C157%2C130%2C27%2C10%2C11%2C12%2C5%2C6%2C24%2C21%2C22%2C54%2C59%2C61%2C71%2C95%2C26%2C72%2C8%2C7%2C76%2C46%2C20%2C97%2C96%2C9%2C19%2C18%2C81%2C53%2C79%2C32%2C70%2C0%2C89%2C31%2C78%2C83%2C45%2C44%2C82%2C36%2C4%2C85%2C77%2C42%2C39%2C34%2C80%2C2%2C35%2C60%2C40%2C98%2C43%2C75%2C65%2C104%2C57%2C56%2C30%2C92%2C55%2C52%2C47%2C74%2C69%2C23%2C105
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f07e:9:face:b00c:0:3 Somerville, United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
129b0a661b9a412d3da23aef46b8ef08dbfece3f0e6a46a17c43c9bbcbd74bb5
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://*.google-analytics.com *.google.com;style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' https://*.google-analytics.com;img-src 'self' data: blob: * https://*.google-analytics.com;block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

content-security-policy
default-src 'self' data: blob: *;script-src *.facebook.com *.fbcdn.net *.facebook.net 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://*.google-analytics.com *.google.com;style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' https://*.google-analytics.com;img-src 'self' data: blob: * https://*.google-analytics.com;block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Tue, 28 May 2024 14:17:35 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
11769
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
x-fb-connection-quality
EXCELLENT; q=0.9, rtt=26, rtx=0, c=61, mss=1294, tbw=63322, tp=-1, tpl=-1, uplat=1, ullat=-1
pragma
public
x-fb-debug
12nqSI0tTk6mSsQ4mBnR4kKATQYy+V7fNu7kcGmo+I2fuFvYFB0T1tLxj+egWFDFtrKTSTcttC0UBuPxkPbi4g==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), attribution-reporting=(), autoplay=(), battery=(self), bluetooth=(), camera=(), ch-device-memory=(), ch-downlink=(), ch-dpr=(), ch-ect=(), ch-rtt=(), ch-save-data=(), ch-ua-arch=(), ch-ua-bitness=(), ch-viewport-height=(), ch-viewport-width=(), ch-width=(), clipboard-read=(), clipboard-write=(), compute-pressure=(), display-capture=(), encrypted-media=(), fullscreen=(self), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), interest-cohort=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), picture-in-picture=(), private-state-token-issuance=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), shared-storage=(), shared-storage-select-url=(), private-state-token-redemption=(), usb=(), usb-unrestricted=(), unload=(self), window-management=(), xr-spatial-tracking=();report-to="permissions_policy"
timing-allow-origin
*
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/
0
274 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1683404521931009&ev=PageView&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rl=&if=false&ts=1716905856022&cd[segment_eid]=EM6JRDVVXJDHHMOGWQDHR4&sw=1600&sh=1200&v=2.9.156&r=stable&ec=0&o=4125&fbp=fb.1.1716905856015.784380957&ler=empty&cdl=API_unavailable&it=1716905855965&coo=false&dpo=LDU&dpoco=0&dpost=0&rqm=GET
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f172:81:face:b00c:0:25de Somerville, United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

x-fb-connection-quality
EXCELLENT; q=0.9, rtt=25, rtx=0, c=10, mss=1294, tbw=2791, tp=-1, tpl=-1, uplat=0, ullat=0
strict-transport-security
max-age=31536000; includeSubDomains
date
Tue, 28 May 2024 14:17:36 GMT
server
proxygen-bolt
content-type
text/plain
access-control-allow-origin
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
0
/
www.facebook.com/privacy_sandbox/pixel/register/trigger/
67 B
4 KB
Image
General
Full URL
https://www.facebook.com/privacy_sandbox/pixel/register/trigger/?id=1683404521931009&ev=PageView&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&rl=&if=false&ts=1716905856022&cd[segment_eid]=EM6JRDVVXJDHHMOGWQDHR4&sw=1600&sh=1200&v=2.9.156&r=stable&ec=0&o=4125&fbp=fb.1.1716905856015.784380957&ler=empty&cdl=API_unavailable&it=1716905855965&coo=false&dpo=LDU&dpoco=0&dpost=0&rqm=FGET
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f172:81:face:b00c:0:25de Somerville, United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
aa7b6c81e85551eeb5c4809f1e683efa0b780c33d12ddfc2067a1b136803e45a
Security Headers
Name Value
Content-Security-Policy default-src data: blob: 'self' https://*.fbsbx.com 'unsafe-inline' *.facebook.com *.fbcdn.net 'unsafe-eval';script-src *.facebook.com *.fbcdn.net *.facebook.net 127.0.0.1:* 'unsafe-inline' blob: data: 'self' connect.facebook.net 'unsafe-eval' https://*.google-analytics.com *.google.com;style-src *.fbcdn.net data: *.facebook.com 'unsafe-inline' https://fonts.googleapis.com;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' http://localhost:3103 wss://gateway.facebook.com wss://edge-chat.facebook.com wss://snaptu-d.facebook.com wss://kaios-d.facebook.com/ v.whatsapp.net *.fbsbx.com *.fb.com https://*.google-analytics.com;font-src data: *.facebook.com *.fbcdn.net *.fbsbx.com https://fonts.gstatic.com;img-src *.fbcdn.net *.facebook.com data: https://*.fbsbx.com facebook.com *.cdninstagram.com fbsbx.com fbcdn.net connect.facebook.net *.carriersignal.info blob: android-webview-video-poster: *.whatsapp.net *.fb.com *.oculuscdn.com *.tenor.co *.tenor.com *.giphy.com https://paywithmybank.com/ https://*.paywithmybank.com/ https://www.googleadservices.com https://googleads.g.doubleclick.net https://*.google-analytics.com;media-src *.cdninstagram.com blob: *.fbcdn.net *.fbsbx.com www.facebook.com *.facebook.com data: *.tenor.co *.tenor.com https://*.giphy.com;frame-src *.facebook.com *.fbsbx.com fbsbx.com data: www.instagram.com *.fbcdn.net https://paywithmybank.com/ https://*.paywithmybank.com/ https://www.googleadservices.com https://googleads.g.doubleclick.net https://www.google.com https://td.doubleclick.net *.google.com *.doubleclick.net;worker-src blob: *.facebook.com data:;block-all-mixed-content;upgrade-insecure-requests;
Strict-Transport-Security max-age=15552000; preload
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

attribution-reporting-register-trigger
{"event_trigger_data":[{"trigger_data":"0"}],"aggregatable_trigger_data":[{"key_piece":"0x1e1b7f4cce507567","source_keys":["1","2"]},{"key_piece":"0x942b65f6c1254576","source_keys":["1","2"]}],"aggregatable_values":{"1":1}}
content-encoding
zstd
x-content-type-options
nosniff
content-security-policy
default-src data: blob: 'self' https://*.fbsbx.com 'unsafe-inline' *.facebook.com *.fbcdn.net 'unsafe-eval';script-src *.facebook.com *.fbcdn.net *.facebook.net 127.0.0.1:* 'unsafe-inline' blob: data: 'self' connect.facebook.net 'unsafe-eval' https://*.google-analytics.com *.google.com;style-src *.fbcdn.net data: *.facebook.com 'unsafe-inline' https://fonts.googleapis.com;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' http://localhost:3103 wss://gateway.facebook.com wss://edge-chat.facebook.com wss://snaptu-d.facebook.com wss://kaios-d.facebook.com/ v.whatsapp.net *.fbsbx.com *.fb.com https://*.google-analytics.com;font-src data: *.facebook.com *.fbcdn.net *.fbsbx.com https://fonts.gstatic.com;img-src *.fbcdn.net *.facebook.com data: https://*.fbsbx.com facebook.com *.cdninstagram.com fbsbx.com fbcdn.net connect.facebook.net *.carriersignal.info blob: android-webview-video-poster: *.whatsapp.net *.fb.com *.oculuscdn.com *.tenor.co *.tenor.com *.giphy.com https://paywithmybank.com/ https://*.paywithmybank.com/ https://www.googleadservices.com https://googleads.g.doubleclick.net https://*.google-analytics.com;media-src *.cdninstagram.com blob: *.fbcdn.net *.fbsbx.com www.facebook.com *.facebook.com data: *.tenor.co *.tenor.com https://*.giphy.com;frame-src *.facebook.com *.fbsbx.com fbsbx.com data: www.instagram.com *.fbcdn.net https://paywithmybank.com/ https://*.paywithmybank.com/ https://www.googleadservices.com https://googleads.g.doubleclick.net https://www.google.com https://td.doubleclick.net *.google.com *.doubleclick.net;worker-src blob: *.facebook.com data:;block-all-mixed-content;upgrade-insecure-requests;
strict-transport-security
max-age=15552000; preload
document-policy
force-load-at-top
date
Tue, 28 May 2024 14:17:36 GMT
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", default="https://www.facebook.com/ajax/browser_error_reports/?device_level=unknown", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
x-fb-connection-quality
EXCELLENT; q=0.9, rtt=25, rtx=0, c=12, mss=1294, tbw=3109, tp=-1, tpl=-1, uplat=99, ullat=0
pragma
no-cache
x-fb-debug
zvrE0USTjzvtP1epbH09xJ0t4AolOjrbTmbzx1zz4v8dEAvX7kGR00p3+qjF9VEQBeCM5Fb6AKFe7gLQhPGo6w==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":259200,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/?device_level=unknown"}]}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
image/png
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
private, no-store, no-cache, must-revalidate
permissions-policy
accelerometer=(), attribution-reporting=(self), autoplay=(), battery=(self), bluetooth=(), camera=(self), ch-device-memory=(), ch-downlink=(), ch-dpr=(), ch-ect=(), ch-rtt=(), ch-save-data=(), ch-ua-arch=(), ch-ua-bitness=(), ch-viewport-height=(), ch-viewport-width=(), ch-width=(), clipboard-read=(self), clipboard-write=(self), compute-pressure=(), display-capture=(self), encrypted-media=(self), fullscreen=(self), gamepad=*, geolocation=(self), gyroscope=(), hid=(), idle-detection=(), interest-cohort=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(self), midi=(), otp-credentials=(), payment=(), picture-in-picture=(self), private-state-token-issuance=(), publickey-credentials-get=(self), screen-wake-lock=(), serial=(), shared-storage=(), shared-storage-select-url=(), private-state-token-redemption=(), usb=(), usb-unrestricted=(), unload=(self), window-management=(), xr-spatial-tracking=(self);report-to="permissions_policy"
expires
Sat, 01 Jan 2000 00:00:00 GMT
unruly_prebid
targeting.unrulymedia.com/ Frame
0
0
Preflight
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Accept-Encoding,Origin,Accept-Language,X-CSRF-Token,x-unruly-override
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
access-control-max-age
1728000
content-length
0
content-type
text/plain charset=UTF-8
date
Tue, 28 May 2024 14:17:34 GMT
adreq
ads.servenobid.com/
909 B
770 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=5270
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
488bde8cfe3768819d0e5dc7bec1a201de5134de76612e394b3046936ddb10dc

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
ortb
bid.contextweb.com/header/
0
176 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
x-no-bid-reason
Passback by decision
openrtb
adx.adform.net/adx/
0
628 B
Fetch
General
Full URL
https://adx.adform.net/adx/openrtb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.6.233 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=31536000; includeSubDomains
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
POST,OPTIONS
p3p
CP="NOI DSP COR NID CURa ADMa DEVa TAIa PSAa PSDa OUR LEG NAV INT"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate, no-transform
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
expires
-1
prebid
ssp.disqus.com/bid/
0
288 B
Fetch
General
Full URL
https://ssp.disqus.com/bid/prebid?sid=710
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.197.117.43 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-197-117-43.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-store
access-control-allow-credentials
true
vary
origin
expires
0
/
ghb.adtelligent.com/v2/auction/
5 KB
1 KB
Fetch
General
Full URL
https://ghb.adtelligent.com/v2/auction/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
107.151.11.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
478361e6e8ca04ea1f92bf98b680c5fa130539a1c8d35a0a95e9cbe190d95f0d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
Content-Encoding
gzip
Server
Adtelligent
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
1068
prebid
ib.adnxs.com/ut/v3/
145 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
56008bc079a6f5763cda94476434e11182e7b61be10c0214b83958d4677e63b8
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
aa3a5658-1b6a-42fb-826c-e7d31d87b7f0
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
145
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
prebid.media.net/rtb/
2 KB
1 KB
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CU816538
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
b3402fa33fa49c93f294084720dd0497dcd1ac652c190a8736de24d9d75c8808

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
2
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
translator
hbopenbid.pubmatic.com/
0
61 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
unruly_prebid
targeting.unrulymedia.com/
11 B
283 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
pbjs
htlb.casalemedia.com/openrtb/
37 B
492 B
Fetch
General
Full URL
https://htlb.casalemedia.com/openrtb/pbjs?s=843072
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9b66a625201ed9074baa79e1ab3a7c78458a1743f270cbe81b6a51cd1457579b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=D4RJ%2F5xgT9dzXso5ryqnT%2BWb9fA2tyFjE%2B8SwypzDFoaaI2yl7yCAx3DEyD1HVhKF9AEwRgNVN79Z3HR9pgHHOCBf%2Fi3hHuT9z6WIoYREm6H%2Bx3wbVivtjtTBBnTqoBUFv6oLKfN"}],"group":"cf-nel","max_age":604800}
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache
access-control-allow-credentials
true
cf-ray
88aede80bea7ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
37
expires
0
prebid
prebid.ad.smaato.net/oapi/
0
401 B
Fetch
General
Full URL
https://prebid.ad.smaato.net/oapi/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
52.90.26.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-90-26-195.compute-1.amazonaws.com
Software
SOMA /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
X-SMT-DivId,X-SMT-SessionId,X-SMT-ADTYPE,X-SMT-Impression-Measurement,X-SMT-MESSAGE,X-SMT-Expires
date
Tue, 28 May 2024 14:17:35 GMT
access-control-allow-credentials
true
server
SOMA
x-smt-sessionid
bc80c585-5b34-bc05-e815-db2480699613
x-smt-trace
https://tracing.smaato.net/api/traces/f0516387a83081f684b3d1868bf2e9c3?prettyPrint=true
cdb
bidder.criteo.com/
0
528 B
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=84276099708&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=31536000; preload;
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Kestrel
vary
Origin
v1
prg.smartadserver.com/prebid/
1 KB
2 KB
Fetch
General
Full URL
https://prg.smartadserver.com/prebid/v1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
147.135.119.114 , United States, ASN16276 (OVH, FR),
Reverse DNS
ip114.ip-147-135-119.us
Software
/
Resource Hash
518a087b8b7e9a29520a2aa6f4a400a3719033e03ddb557010d3618422fa1c42

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
transfer-encoding
chunked
vary
Accept-Encoding, Origin
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
cache-control
no-cache,no-store
access-control-allow-credentials
true
auction
tlx.3lift.com/header/
19 B
673 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.33.6&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tmax=2000
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.206.91.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-206-91-202.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
trinity.json
apex.go.sonobi.com/
2 KB
2 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%2232e5c1d7bc6ab11%22%3A%226af9de6bbe34255426d7%7C1600x1000%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=952ecbb1-2622-4a32-8b11-f016d8b55990&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
fd0a8e32809c524ebb33e2d544a949c106c4f203f0a2f869067aa08f459ff2dc
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-6-95
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
759
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
bids
prebid-eu.creativecdn.com/bidder/prebid/
0
182 B
Fetch
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.90 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, CY),
Reverse DNS
ip-185-184-8-90.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
c
prebid.a-mo.net/a/
0
214 B
Fetch
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.28.129.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
27
server
envoy
vary
origin, accept-encoding, Accept-Encoding
prebid
prebid.media.net/rtb/
2 KB
909 B
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
8638a04be882703f934f4f2e06c6ae0763d4503a585e527e6d46b1e0a1929de3

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
29
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
prebid
ib.adnxs.com/ut/v3/
226 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
59a7be1893957e08219b6a3a37c5c995d146304d841eb1faa2ac8a5b74ca2d87
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
008e5751-4a76-4cfa-9146-38f848721271
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
226
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
hb-mm-multi
hb.minutemedia-prebid.com/
84 B
434 B
Fetch
General
Full URL
https://hb.minutemedia-prebid.com/hb-mm-multi
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
44.216.173.212 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-216-173-212.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
15d222d7f89a2e0e920b8306e1ddc64af26a0b22267418b421b824548c9ebee1

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
server
istio-envoy
x-reason
maxmind hosting provider
access-control-allow-methods
GET, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
access-control-allow-credentials
true
x-envoy-upstream-service-time
2
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF, X-Requested-With
content-length
84
hb
ssc.33across.com/api/v1/
118 B
191 B
Fetch
General
Full URL
https://ssc.33across.com/api/v1/hb?guid=b-64TSyTCr7RPcrkHcnnVW
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.149.20.76 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
76.20.149.34.bc.googleusercontent.com
Software
/ 33Across
Resource Hash
c590c511c43baa86e8e5c9da795ddb9b273a69a14bfe1c93d2244565da6827a9

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
status
200 OK
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:34 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
prebid
ib.adnxs.com/ut/v3/
139 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
521dc0284661145925ceb88d6b97168f85f383cc957eabc1057b03b672c2e76f
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
91c73aab-da0d-4d82-99c1-5806c7509b59
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
139
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
translator
hbopenbid.pubmatic.com/
0
117 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
unruly_prebid
targeting.unrulymedia.com/ Frame
0
0
Preflight
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Accept-Encoding,Origin,Accept-Language,X-CSRF-Token,x-unruly-override
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
access-control-max-age
1728000
content-length
0
content-type
text/plain charset=UTF-8
date
Tue, 28 May 2024 14:17:34 GMT
unruly_prebid
targeting.unrulymedia.com/ Frame
0
0
Preflight
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Accept-Encoding,Origin,Accept-Language,X-CSRF-Token,x-unruly-override
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
access-control-max-age
1728000
content-length
0
content-type
text/plain charset=UTF-8
date
Tue, 28 May 2024 14:17:35 GMT
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
prebid
ib.adnxs.com/ut/v3/
145 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
9e6b86e78a792f1503cc5ee6e855d0a7d9d69b40e3b03f3df35171f9d68b6e51
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
01798e15-8a4c-463a-a394-1ca726a9e697
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
145
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
596 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=20086&site_id=475620&zone_id=2822914&size_id=55&alt_size_ids=57&rp_schain=1.0,1!orangeclickmedia.com,ach5lxtq1pmgjoz4,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=60822a9ee582eb&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.9384324030936722
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
06cb7f15697d104cd6a50a8e51fdadcb91d2787abcacbb1e608f39f0a6af144b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
translator
hbopenbid.pubmatic.com/
0
61 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
openrtb
adx.adform.net/adx/
0
627 B
Fetch
General
Full URL
https://adx.adform.net/adx/openrtb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.6.233 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=31536000; includeSubDomains
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
POST,OPTIONS
p3p
CP="NOI DSP COR NID CURa ADMa DEVa TAIa PSAa PSDa OUR LEG NAV INT"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate, no-transform
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
expires
-1
trinity.json
apex.go.sonobi.com/
2 KB
2 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%226656e2c5af30e5a%22%3A%226af9de6bbe34255426d7%7C970x90%2C970x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=6d904e79-182b-4f0d-b6ba-9ab0c798194b&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
40cde42ede2bf42f0823fa02da963e1188c4fb5137b414b1b248188ad01683f5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
755
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
auction
tlx.3lift.com/header/
19 B
672 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.33.6&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tmax=2000
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.206.91.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-206-91-202.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
ortb
bid.contextweb.com/header/
0
920 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-7hznp
cwdl
22/135
bids
prebid-eu.creativecdn.com/bidder/prebid/
0
183 B
Fetch
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.90 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, CY),
Reverse DNS
ip-185-184-8-90.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/
2 KB
2 KB
Fetch
General
Full URL
https://rtb.adxpremium.services/openrtb2/auction
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.106.140.18 , Netherlands, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
nginx /
Resource Hash
9a79cc38aae43243d5ebe9e35ec906708aeef263a9dce22fc1f5db49f774429a

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
X-Prebid
pbs-go/unknown
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
2011
Expires
0
prebid-request
onetag-sys.com/
15 B
557 B
Fetch
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
cache-control
no-transform, no-cache
access-control-allow-credentials
true
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=43580689260&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
8323f5985e2cb9c2a50a43ac84bd530990f284c0d9d0420510b7c89786032519
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
translator
hbopenbid.pubmatic.com/
0
61 B
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
pb
ad.360yield.com/1628/
0
374 B
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
pb
ad.360yield.com/1628/
0
375 B
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
hbjson
grid.bidswitch.net/
24 B
269 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
e97b9f44361a039b1c05bff1cd9554881fa40a0793d4ea7e62ec1f2396b9e85b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
49
prebid
ssp.disqus.com/bid/
0
287 B
Fetch
General
Full URL
https://ssp.disqus.com/bid/prebid?sid=710
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.197.117.43 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-197-117-43.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-store
access-control-allow-credentials
true
vary
origin
expires
0
v1
prg.smartadserver.com/prebid/
1 KB
2 KB
Fetch
General
Full URL
https://prg.smartadserver.com/prebid/v1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
147.135.119.114 , United States, ASN16276 (OVH, FR),
Reverse DNS
ip114.ip-147-135-119.us
Software
/
Resource Hash
7c96a54dd372f4d7b5f28a50c3ef5cf74a02f2d27f099dc5496be9b538c611a9

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
transfer-encoding
chunked
vary
Accept-Encoding, Origin
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
cache-control
no-cache,no-store
access-control-allow-credentials
true
prebid
prebid.media.net/rtb/
2 KB
927 B
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CU816538
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
3c0cd9f2d4b51e540063c3fd5214d6e84b7c8d3131a00e67239ffa4d9ae07c6e

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
51
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
pbjs
htlb.casalemedia.com/openrtb/
37 B
489 B
Fetch
General
Full URL
https://htlb.casalemedia.com/openrtb/pbjs?s=843072
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
87788935ef3c1867bd027fe988046fca04166f79d9ec1a573710b848b844cd92

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=sz2jQtMZiTfplh66IVbCa66yLcCqaq%2Bd%2FkMjhYBYQ4jPUHL%2BgDnKp8p5gfkR0WOK5EVcEHUqllPdxOvmAk8GmomJDX9qxws0L1SqmMfGVeYnhcG1FPapMpayVJ2PhFo%2FdGm2GpRR"}],"group":"cf-nel","max_age":604800}
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache
access-control-allow-credentials
true
cf-ray
88aede814f49ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
37
expires
0
bid
ap.lijit.com/rtb/
95 B
458 B
Fetch
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_8.33.6
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.201.41.85 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-201-41-85.compute-1.amazonaws.com
Software
/
Resource Hash
0f48bd710e8aa1a35ecd164406847ae8d15572f01af4bcf61e1e3a655081380e

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET, POST, DELETE, PUT
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
access-control-allow-headers
X-Requested-With, Content-Type
content-length
100
prebid
prebid.media.net/rtb/
2 KB
901 B
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
497c65a99d94ef5021e1aff216cd9fecef34927722ed85e128539210feb03bb4

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
65
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
351 B
727 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=100d53f499bfa2fb&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=970,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223361%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
82db4397e65672568c62c4175f1176161d94d1e06f5e1a7c9c8faba962dae744
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
76af920b-2115-4650-910a-79395c23abac
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=100d53f499bfa2fb&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=970,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3361"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
351 B
418 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=101a28add0e57218&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=970,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223362%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
d81b28a221946bd24a1f044dbabf3c7071f7829c059a93a42c36d093eb6b4d4d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
a7d7af99-3163-4ed8-b0ac-d047cc65cd43
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856118&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=99f09e16b5a5b98&adUnitCode=header-ad&auctionId=null&bidId=101a28add0e57218&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=970,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3362"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
775 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=24434&site_id=419860&zone_id=2376656&size_id=55&alt_size_ids=57&rp_schain=1.0,1!mediafuse.com,358,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=103a4fa6eca94f25&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.322509516907284
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
00d96f374edb6ba6e38cfd3e80d1f60a353f9d44e491efd6fde125b1af4a2851

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
adreq
ads.servenobid.com/
909 B
848 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=3042
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
c0bf91105069a00c87add3665cd26be3129758fd860dd3adae5dad1003a78bb1

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
hb
ssc.33across.com/api/v1/
119 B
370 B
Fetch
General
Full URL
https://ssc.33across.com/api/v1/hb?guid=b-64TSyTCr7RPcrkHcnnVW
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.149.20.76 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
76.20.149.34.bc.googleusercontent.com
Software
/ 33Across
Resource Hash
9c5c69440b13c676c22866761037fff95fc19c343570af3b261ad2accea9b523

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
status
200 OK
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=630761211&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
195524441f7e276f7c8500a8c7f0590585f93074ebad49e79aebc07518cef796
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
prebid
ib.adnxs.com/ut/v3/
22 KB
12 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
af1f74b37f7eb1c4a1d027bb91abf73a28c5d6bc815253f2e907df90d45ebc40
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
an-x-request-uuid
7a7a5fd0-be21-42e9-aed2-8ce88475317f
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
vary
Accept-Encoding
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
adreq
ads.servenobid.com/
909 B
849 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=6230
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
e41a5cb53307f91f13d0f1f04e76568f3e0d8d7d2d7ac99ef90ce236f2682f36

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:14 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
c
prebid.a-mo.net/a/
0
134 B
Fetch
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.28.129.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:35 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
30
server
envoy
vary
origin, accept-encoding, Accept-Encoding
hb-mm-multi
hb.minutemedia-prebid.com/
85 B
434 B
Fetch
General
Full URL
https://hb.minutemedia-prebid.com/hb-mm-multi
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
44.216.173.212 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-216-173-212.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
a2ee4dceb8f0aa3e5e0a8ad08d7357f1405948d3f0285d73996785d2cea14e0d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
server
istio-envoy
x-reason
maxmind hosting provider
access-control-allow-methods
GET, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
access-control-allow-credentials
true
x-envoy-upstream-service-time
2
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF, X-Requested-With
content-length
85
prebid
ib.adnxs.com/ut/v3/
228 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
ee96eb295d58a88949a293bc61bfec1eba2caac3b44c80ebbcac62e257b665f6
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
6b41d6b8-66c6-4ec9-93ad-4c9e21b04acd
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
228
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
prebid.ad.smaato.net/oapi/
0
400 B
Fetch
General
Full URL
https://prebid.ad.smaato.net/oapi/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
52.90.26.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-90-26-195.compute-1.amazonaws.com
Software
SOMA /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
X-SMT-DivId,X-SMT-SessionId,X-SMT-ADTYPE,X-SMT-Impression-Measurement,X-SMT-MESSAGE,X-SMT-Expires
date
Tue, 28 May 2024 14:17:35 GMT
access-control-allow-credentials
true
server
SOMA
x-smt-sessionid
4bf51de2-ec2f-fa55-5a8b-32f0e5c9fe43
x-smt-trace
https://tracing.smaato.net/api/traces/08897579238637546b4b3b533d9cd41c?prettyPrint=true
/
d.vidoomy.com/api/rtbserver/prebid/
0
370 B
Fetch
General
Full URL
https://d.vidoomy.com/api/rtbserver/prebid/?id=56105&adtype=banner&auc=header-ad&w=970&h=90&pos=1&ua=Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36&l=en&dt=1&pid=62183&requestId=1316b6f995363009&schain=&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&bidfloor=0&d=fiercepharma.com&sp=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&usp=&coppa=false&videoContext=&bcat=&badv=&bapp=&btype=&battr=
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
212.36.83.246 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb2.vdmy.dtic.es
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
Access-Control-Allow-Methods
HEAD,GET,POST,PUT,DELETE,PATCH,OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Expose-Headers
X-VD-C
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
trinity.json
apex.go.sonobi.com/
2 KB
2 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%22133237696c244894%22%3A%2255f3dde57d605f7ad35c%7C970x250%2C970x90%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=a2356e98-5b66-471c-977e-daa22d98a791&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22adtelligent.com%22%2C%22sid%22%3A%22307946%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
0dfed7a6faf7c0fcffc462131208e093db1e8b752cb2d616d70cc5d4efa26e63
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-6-178
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
704
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
ortb
bid.contextweb.com/header/
0
921 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-sqggk
cwdl
22/4211
/
ghb1.adtelligent.com/v2/auction/
5 KB
1 KB
Fetch
General
Full URL
https://ghb1.adtelligent.com/v2/auction/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.151.242 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
e082c08cba195b2cdbeade513c35ab322f6de4f6cd3151260cd7457a13177cff

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:37 GMT
Content-Encoding
gzip
Server
Adtelligent
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
1056
unruly_prebid
targeting.unrulymedia.com/ Frame
0
0
Preflight
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Accept-Encoding,Origin,Accept-Language,X-CSRF-Token,x-unruly-override
access-control-allow-methods
GET, POST, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
access-control-max-age
1728000
content-length
0
content-type
text/plain charset=UTF-8
date
Tue, 28 May 2024 14:17:32 GMT
ecommerce.js
www.google-analytics.com/plugins/ua/
1 KB
962 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ecommerce.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:80c::200e , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 13:18:49 GMT
content-encoding
br
x-content-type-options
nosniff
age
3527
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
630
x-xss-protection
0
last-modified
Thu, 20 Jul 2023 22:48:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 28 May 2024 14:18:49 GMT
ec.js
www.google-analytics.com/plugins/ua/
3 KB
1 KB
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ec.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:80c::200e , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 13:47:39 GMT
content-encoding
br
x-content-type-options
nosniff
age
1797
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1129
x-xss-protection
0
last-modified
Tue, 27 Jun 2023 17:28:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 28 May 2024 14:47:39 GMT
p
cdp.omeda.com/olytics/segments/
5 KB
6 KB
XHR
General
Full URL
https://cdp.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
426623ebc6a0b2910217e5859b56a3f3462e88df73b46cd7685af17d54997b1a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json;charset=UTF-8

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
5558
X-XSS-Protection
1; mode=block
p
cdp.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://cdp.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Origin
*
Access-Control-Max-Age
1800
Connection
keep-alive
Content-Length
0
Date
Tue, 28 May 2024 14:17:35 GMT
Keep-Alive
timeout=5
Server
Apache
vary
access-control-request-method,Access-Control-Request-Headers
openrtb
adx.adform.net/adx/
0
627 B
Fetch
General
Full URL
https://adx.adform.net/adx/openrtb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.6.233 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=31536000; includeSubDomains
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
POST,OPTIONS
p3p
CP="NOI DSP COR NID CURa ADMa DEVa TAIa PSAa PSDa OUR LEG NAV INT"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate, no-transform
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
expires
-1
prebid
ib.adnxs.com/ut/v3/
234 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
10955c3ffd135462f15a287348e08d747ce31fa9c123803afa72399d3e9f56de
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
216823d0-dcd4-4c19-b699-deba3f4a844f
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
234
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
/
b1h.zemanta.com/api/bidder/prebid/bid/
0
199 B
Fetch
General
Full URL
https://b1h.zemanta.com/api/bidder/prebid/bid/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
70.42.32.223 , United States, ASN22075 (AS-OUTBRAIN, US),
Reverse DNS
ny.outbrain.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Access-Control-Allow-Credentials
true
translator
hbopenbid.pubmatic.com/
16 KB
7 KB
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
2417b180e85b281e607a6c3f0136cd75a2915f3e0a48cf4f7ec39de1813b9853

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
x-openrtb-version
2.3
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=79539816575&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
6d3876e181cbc4caa2c28fcf966397d80a00c9f3320674e1d415f4eb5f3ecc8d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:35 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
/
ghb2.adtelligent.com/v2/auction/
5 KB
1 KB
Fetch
General
Full URL
https://ghb2.adtelligent.com/v2/auction/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c87:5241::2 Brent, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
87f26f6a486cb367b38874e7d694db49717cd0f48e1cfc9f6cb15f7b321d221c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
Content-Encoding
gzip
Server
Adtelligent
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
1046
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
596 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=24434&site_id=419860&zone_id=2376656&size_id=15&alt_size_ids=10&rp_schain=1.0,1!mediafuse.com,358,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=15608f4dea47597b&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.8237000092504108
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
7a90f071adfa3e2d628513bc024d7678925c946473564cafd0bc64c7b3f9da5d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
trinity.json
apex.go.sonobi.com/
1 KB
1 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%22158aba721f26ba0d%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=cdba99bf-b391-43f6-8903-90a853420a88&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
260e601daec9ea58b9804fdc51ee574617bde744e573e62ac2afd9bfc51a46f6
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
635
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
prebid-request
onetag-sys.com/
15 B
556 B
Fetch
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
cache-control
no-transform, no-cache
access-control-allow-credentials
true
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
prebid
ssp.disqus.com/bid/
0
287 B
Fetch
General
Full URL
https://ssp.disqus.com/bid/prebid?sid=710
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.197.117.43 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-197-117-43.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-store
access-control-allow-credentials
true
vary
origin
expires
0
bids
prebid-eu.creativecdn.com/bidder/prebid/
0
182 B
Fetch
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.90 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, CY),
Reverse DNS
ip-185-184-8-90.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:38 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
prebid
lockerdome.com/ladbid/
11 B
340 B
Fetch
General
Full URL
https://lockerdome.com/ladbid/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.154.142.214 Council Bluffs, United States, ASN15169 (GOOGLE, US),
Reverse DNS
214.142.154.104.bc.googleusercontent.com
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 28 May 2024 14:17:36 GMT
Cache-Control
no-cache, max-age=0, must-revalidate, no-store
Access-Control-Allow-Credentials
true
Content-Encoding
gzip
Content-Length
31
Content-Type
application/json; charset=utf-8
adreq
ads.servenobid.com/
909 B
768 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=9408
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
675a8a83bfcc95fd006ce6455dfba5cdf0cee6a89d9261eae89d33ada9f0d3f0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
c
prebid.a-mo.net/a/
0
135 B
Fetch
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.28.129.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
266
server
envoy
vary
origin, accept-encoding, Accept-Encoding
prebid
prebid.ad.smaato.net/oapi/
0
400 B
Fetch
General
Full URL
https://prebid.ad.smaato.net/oapi/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
52.90.26.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-90-26-195.compute-1.amazonaws.com
Software
SOMA /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
X-SMT-DivId,X-SMT-SessionId,X-SMT-ADTYPE,X-SMT-Impression-Measurement,X-SMT-MESSAGE,X-SMT-Expires
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
server
SOMA
x-smt-sessionid
d1f2af60-fd2f-a4cf-5bc1-0939d707225a
x-smt-trace
https://tracing.smaato.net/api/traces/c1af4c9906969f33922315573dee43f0?prettyPrint=true
ortb
bid.contextweb.com/header/
0
791 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-6fvsd
cwdl
22/4211
prebid
ib.adnxs.com/ut/v3/
146 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
c0320fc6250740a052a625a45195b12676eb31c7306a35562925615a634b4847
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
0d12065b-7105-4e61-bfc1-7a5aad169893
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
146
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
auction
rtb.adxpremium.services/openrtb2/
2 KB
2 KB
Fetch
General
Full URL
https://rtb.adxpremium.services/openrtb2/auction
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.106.140.18 , Netherlands, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
nginx /
Resource Hash
fce10e00ee922049dd2aa0aef8d57cd1ffbddda1f6cecd76224cbc8dc51388de

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
X-Prebid
pbs-go/unknown
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
2012
Expires
0
prebid
ib.adnxs.com/ut/v3/
144 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
e810b53c7dda66b99b7bf7b68bce6693facee4a055c82c13cc45058c787b9987
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
8c2bd2c8-1e9a-46ea-a92e-7ca648d10415
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
144
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
ortb
bid.contextweb.com/header/
0
791 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-ngvst
cwdl
22/4211
hb-mm-multi
hb.minutemedia-prebid.com/
85 B
434 B
Fetch
General
Full URL
https://hb.minutemedia-prebid.com/hb-mm-multi
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
44.216.173.212 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-216-173-212.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
040d9720727b2b33c570b59f3e2c653b7b876e8b367826b995ea794f5aee22e1

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
server
istio-envoy
x-reason
maxmind hosting provider
access-control-allow-methods
GET, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
access-control-allow-credentials
true
x-envoy-upstream-service-time
2
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF, X-Requested-With
content-length
85
/
d.vidoomy.com/api/rtbserver/prebid/
0
370 B
Fetch
General
Full URL
https://d.vidoomy.com/api/rtbserver/prebid/?id=56105&adtype=banner&auc=sidebar-ad&w=300&h=250&pos=1&ua=Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36&l=en&dt=1&pid=62183&requestId=189ce0539a6942c2&schain=&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&bidfloor=0&d=fiercepharma.com&sp=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&usp=&coppa=false&videoContext=&bcat=&badv=&bapp=&btype=&battr=
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
212.36.83.246 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb2.vdmy.dtic.es
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
Access-Control-Allow-Methods
HEAD,GET,POST,PUT,DELETE,PATCH,OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Expose-Headers
X-VD-C
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=68668909737&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
67bd7be9fa303e20962c21fab11c531e91e1489ff8ebde2932d2849e7de50a9d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
auction
tlx.3lift.com/header/
19 B
672 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.33.6&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tmax=2000
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.206.91.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-206-91-202.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
prebid
prebid.media.net/rtb/
2 KB
927 B
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CU816538
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
46e4332f776a235f3da1ae3c9578189adb69a5e50048fe7b0eb16f6ef1539c33

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
62
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
prebid
prebid.media.net/rtb/
25 KB
12 KB
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
defdaeca8894f86fe9b7eca7f9e3a2b7018bd3dd443ff4abd548088f773c4c76

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
325
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
pbjs
htlb.casalemedia.com/openrtb/
38 B
490 B
Fetch
General
Full URL
https://htlb.casalemedia.com/openrtb/pbjs?s=843072
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
45e323153503f15fa7645000296ad0e0d24924fbc8fa3279b75c919be8012b0b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=VrM147Fx1L9j8WoZPztSsn0oD%2FF5TlQ7cXqbR8cwYMFiHPAEbntpdz4np%2F4cwaSeDb9J83wYSZNG47yFA%2BhIJrO8f4FIB4qA09liMlAPtbZfTgMN%2BNOwgrU7x4h18XP1iV2U2FKF"}],"group":"cf-nel","max_age":604800}
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache
access-control-allow-credentials
true
cf-ray
88aede830947ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
38
expires
0
trinity.json
apex.go.sonobi.com/
1 KB
1 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%2220657a5105978eaf%22%3A%2255f3dde57d605f7ad35c%7C300x250%2C300x600%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=63396eaa-88cb-4b73-b172-20ab50403d69&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22adtelligent.com%22%2C%22sid%22%3A%22307946%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
1efaab641c05e860e6fa633fc2a2654c9bae4ede3e36adb762e986cf18947ed9
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
584
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
hb
ssc.33across.com/api/v1/
119 B
204 B
Fetch
General
Full URL
https://ssc.33across.com/api/v1/hb?guid=b-64TSyTCr7RPcrkHcnnVW
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.149.20.76 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
76.20.149.34.bc.googleusercontent.com
Software
/ 33Across
Resource Hash
64316b53228e2c9130017d4a98a675084eee9089db070a0cb9a26d683f0acf57

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
status
200 OK
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
pb
ad.360yield.com/1628/
864 B
1 KB
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
f908cb1ecd75e41282bed49a9dd1059bb41abfcbe3513f4905b2a6ea8be5ac53

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
content-type
application/json; charset=UTF-8
content-length
864
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
pb
ad.360yield.com/1628/
0
172 B
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
596 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=20086&site_id=475620&zone_id=2822914&size_id=15&alt_size_ids=10&rp_schain=1.0,1!orangeclickmedia.com,ach5lxtq1pmgjoz4,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=214a44133aba207c&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.44704518593902365
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
860c40590289807e4633c45fd09fd5da85be7aeb1484b5fa4353e492ba77803f

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
adreq
ads.servenobid.com/
909 B
770 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=534
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
681d075830d58a01d38265bb554ea149e59a23c776499b7149928477de3e3c3c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
translator
hbopenbid.pubmatic.com/
14 KB
6 KB
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
a823bee642bdde6a5c3d895fb6bd9d7ac59931775fb6572e3c335a7223064ebc

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
x-openrtb-version
2.3
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
v1
prg.smartadserver.com/prebid/
1 KB
1 KB
Fetch
General
Full URL
https://prg.smartadserver.com/prebid/v1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
147.135.119.114 , United States, ASN16276 (OVH, FR),
Reverse DNS
ip114.ip-147-135-119.us
Software
/
Resource Hash
e9d18109526ef8cc0117dc97053210330a35d7bc03acfa6b4636e60b5828b471

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
transfer-encoding
chunked
vary
Accept-Encoding, Origin
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
cache-control
no-cache,no-store
access-control-allow-credentials
true
hbjson
grid.bidswitch.net/
25 B
269 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
0eb363a0de44b8d94dfb3e2a40befa1d33b0bdc3e797ad072196d1274a37ec07
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
349 B
416 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=22556416f223472&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223271%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
67a96c2d486b619ad6a5e6f21d1a0247fbe91906273978da545ed8a6204826e3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
bc8b5573-b006-420d-a44a-b6822a7c157b
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=22556416f223472&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3271"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
351 B
418 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=226996940196f19f&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223272%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
31803b2349050bd9d794d2d751a0c9faa43ba0edefdabe0a428f625609f3db2a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
40902a3f-2974-4855-b568-e24b9b9ce961
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856187&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=224c39fe938fa402&adUnitCode=sidebar-ad&auctionId=null&bidId=226996940196f19f&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3272"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
bid
ap.lijit.com/rtb/
94 B
456 B
Fetch
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_8.33.6
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.201.41.85 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-201-41-85.compute-1.amazonaws.com
Software
/
Resource Hash
9692d366fdde6e1b0584427295336074d159bbae98498e16ab5e5ae5582b9e6b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET, POST, DELETE, PUT
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
access-control-allow-headers
X-Requested-With, Content-Type
content-length
99
ads
securepubads.g.doubleclick.net/gampad/
430 B
185 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=976806789680275&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1600x1000&ifi=7&sfv=1-0-40&eri=1&sc=1&cookie=ID%3D50aa374d6f0d6a81%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MaMzw9I0MkDCIt6Ve4ZEEIxN60nSw&gpic=UID%3D00000a2951ea5df8%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MbZ33g1rb0CP4Omw1laFksTlU7mGg&abxe=1&dt=1716905856549&lmt=1716905156&adxs=160&adys=0&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=6&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=1310x1&msz=1310x0&fws=132&ohw=1600&psts=AOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsluTb3R7OOWHWCNUUMCgPQB1O-s4jzCljj5eLrd6FbA%2CAOrYGslTu-Y-m5CEXkRfKEW2etYWu7rNJzaWqZ_zW_sXsy6hXkSkdxozG2zkA-JWPW4-BZrPJlPTq0c7Lu9cY9ff-35P98w1dLu29g%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsk2Fi8mdtsnWNAsCdhuzXeo89osu-PqMaIGAxyxLCCA&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=true&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEj4KBW9wZW54EixleUpwSWpvaVpGQTBVakZqT1hwVWJVOTFiR3RGTUdkNGFHdFhkejA5SW4wPRj-lMH8-zFIAA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D5%26refresh%3Dtrue%26hb_rfBid%3D0%26hb_div_id%3Dwallpaper%26excl_cat%3DPREPOST&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=3786707769&frm=20&eo_id_str=ID%3D6c39a613d9661c8d%3AT%3D1716905855%3ART%3D1716905855%3AS%3DAA-AfjYcumk822wqp4dsZlsIqGeW
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
923da971f3526425e84ab6bc71d8ce06e9a9211b76e248487627eebadf20f37f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
155
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
adreq
ads.servenobid.com/
909 B
768 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=112
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
49b11f1540273c8239ed7261cd867659aac005250ebbfc708a82029a449e6967

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=35707909514&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
a4a2998eb4b49aa0bd53e1cd3a36f68f6057b90a05c90d13a8b56bf1cd090c60
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
translator
hbopenbid.pubmatic.com/
16 KB
7 KB
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
73c6cd5a498ac26211a265790889bf60d0170cb44239c778b670f2c06eb02754

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
x-openrtb-version
2.3
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
auction
tlx.3lift.com/header/
19 B
672 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.33.6&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tmax=2000
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.206.91.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-206-91-202.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
prebid
ib.adnxs.com/ut/v3/
234 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
09be90d7291b9e4d779fd092ce109062ae51466cadaf5253b62b1c32184ae0c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
c63bf4ee-f169-40b8-ab5a-c237cfbdc837
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
234
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
auction
rtb.adxpremium.services/openrtb2/
2 KB
2 KB
Fetch
General
Full URL
https://rtb.adxpremium.services/openrtb2/auction
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.106.140.18 , Netherlands, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
nginx /
Resource Hash
506e448ac11e79b1d4847da80840c3e1f78646be28bb78b613bb1682939595e8

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
X-Prebid
pbs-go/unknown
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
2012
Expires
0
prebid-request
onetag-sys.com/
15 B
556 B
Fetch
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
cache-control
no-transform, no-cache
access-control-allow-credentials
true
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
openrtb
adx.adform.net/adx/
0
627 B
Fetch
General
Full URL
https://adx.adform.net/adx/openrtb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.6.233 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=31536000; includeSubDomains
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
POST,OPTIONS
p3p
CP="NOI DSP COR NID CURa ADMa DEVa TAIa PSAa PSDa OUR LEG NAV INT"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate, no-transform
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
expires
-1
prebid
prebid.ad.smaato.net/oapi/
0
400 B
Fetch
General
Full URL
https://prebid.ad.smaato.net/oapi/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
52.90.26.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-90-26-195.compute-1.amazonaws.com
Software
SOMA /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
X-SMT-DivId,X-SMT-SessionId,X-SMT-ADTYPE,X-SMT-Impression-Measurement,X-SMT-MESSAGE,X-SMT-Expires
date
Tue, 28 May 2024 14:17:37 GMT
access-control-allow-credentials
true
server
SOMA
x-smt-sessionid
03814576-21bc-88a4-d689-6ee2bfc18d41
x-smt-trace
https://tracing.smaato.net/api/traces/36efb4134daac81cb4730a1868290ba6?prettyPrint=true
/
ghb.adtelligent.com/v2/auction/
5 KB
1 KB
Fetch
General
Full URL
https://ghb.adtelligent.com/v2/auction/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
107.151.11.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
f67f7ccf0ce617be44da9fc6b4b9f75bf3dbfcbc82441282b28a1c9438e6c675

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:37 GMT
Content-Encoding
gzip
Server
Adtelligent
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
1047
pb
ad.360yield.com/1628/
0
172 B
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
pb
ad.360yield.com/1628/
0
172 B
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
ortb
bid.contextweb.com/header/
0
791 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-6fvsd
cwdl
22/4211
prebid
lockerdome.com/ladbid/
11 B
340 B
Fetch
General
Full URL
https://lockerdome.com/ladbid/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.154.142.214 Council Bluffs, United States, ASN15169 (GOOGLE, US),
Reverse DNS
214.142.154.104.bc.googleusercontent.com
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 28 May 2024 14:17:36 GMT
Cache-Control
no-cache, max-age=0, must-revalidate, no-store
Access-Control-Allow-Credentials
true
Content-Encoding
gzip
Content-Length
31
Content-Type
application/json; charset=utf-8
pbjs
htlb.casalemedia.com/openrtb/
38 B
493 B
Fetch
General
Full URL
https://htlb.casalemedia.com/openrtb/pbjs?s=843072
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
0ee8666d0e9b11f43e4ee146f9e6c6e4de220a4b714526659b90b39db872b502

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=3CWCJcEm7RSwf%2Fua9MdW4MEtU1uvpgqXgVtetCu3crdb3J%2B3e%2FIyKtXgjgtdFl7iqWBlL7Ko55U8%2BR%2FID8w6l9Ev6mAJIRJPJtAuKbkn1SOj5AD2Xbo6cu%2BYll24UPDTN%2BN0atVu"}],"group":"cf-nel","max_age":604800}
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache
access-control-allow-credentials
true
cf-ray
88aede83da47ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
38
expires
0
trinity.json
apex.go.sonobi.com/
1 KB
1 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%222669a2e7b6bf9c2e%22%3A%2255f3dde57d605f7ad35c%7C300x250%2C300x600%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=1b08022e-1719-4573-aa3f-2fff524729f8&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22adtelligent.com%22%2C%22sid%22%3A%22307946%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
99c2d88bb1dbb61bac0a4d806b5b18b93492130ceaea6fecd9f775e2d929c352
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
584
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
596 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=20086&site_id=475620&zone_id=2822914&size_id=15&alt_size_ids=10&rp_schain=1.0,1!orangeclickmedia.com,ach5lxtq1pmgjoz4,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=268e36cad3548be4&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.07559660994721673
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
f2fa27235fa94a4e567bad6deeb14e2bdd2b3eb376ee8c9dc74868d5d4496800

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
hb-mm-multi
hb.minutemedia-prebid.com/
85 B
435 B
Fetch
General
Full URL
https://hb.minutemedia-prebid.com/hb-mm-multi
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
44.216.173.212 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-216-173-212.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
812a5928731d1f7ea2eee246649c4c98e857bd86898df023cb260e598c1086cb

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
server
istio-envoy
x-reason
maxmind hosting provider
access-control-allow-methods
GET, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
access-control-allow-credentials
true
x-envoy-upstream-service-time
10
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF, X-Requested-With
content-length
85
/
b1h.zemanta.com/api/bidder/prebid/bid/
0
199 B
Fetch
General
Full URL
https://b1h.zemanta.com/api/bidder/prebid/bid/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
70.42.32.223 , United States, ASN22075 (AS-OUTBRAIN, US),
Reverse DNS
ny.outbrain.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Access-Control-Allow-Credentials
true
adreq
ads.servenobid.com/
909 B
769 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=7341
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
9d2adf2cd7d4c9677620558f89c5d689d2962c481a44c4bdf4aca5f3703777a5

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
596 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=24434&site_id=419860&zone_id=2376656&size_id=15&alt_size_ids=10&rp_schain=1.0,1!mediafuse.com,358,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=27695f7a8141a776&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.4836080979058921
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
5187b3e90f3b3b10a207830232d89a283496806bd734a115c13ed72119c49201

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
prebid
prebid.media.net/rtb/
26 KB
12 KB
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
85c44c66e849ada14ef181a2d41d585fd8cbce0ad66e3f6563a7f4fed3cb9084

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
176
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
trinity.json
apex.go.sonobi.com/
1 KB
1 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%222806f74fc2ac0b6a%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=9c2ffe71-b934-4cfe-9b63-a998a19f2f3f&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
f9cc58edee80608bddfd45d055c65f48a8a0800a9f47104c819711ac10b07aa6
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
636
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
hbjson
grid.bidswitch.net/
25 B
269 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
d7ad611d1027a59360a1dee87dc82dab44eb9ae0f359b18082921301a1275d14
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
ortb
bid.contextweb.com/header/
0
791 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-crmkz
cwdl
22/4211
prebid
ssp.disqus.com/bid/
0
287 B
Fetch
General
Full URL
https://ssp.disqus.com/bid/prebid?sid=710
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.197.117.43 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-197-117-43.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-store
access-control-allow-credentials
true
vary
origin
expires
0
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=30898947921&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
2efb594d00beae1166cd81453c6ab69e3cf442d9fcb870fed134daea715835c3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
prebid
ib.adnxs.com/ut/v3/
146 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
39162db59028429145e552783018e8630618065620f78f677c4f62078973f6d7
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
an-x-request-uuid
fd49d69a-dbac-4e08-a5a7-b03ea1260baf
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
146
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
hb
ssc.33across.com/api/v1/
119 B
151 B
Fetch
General
Full URL
https://ssc.33across.com/api/v1/hb?guid=b-64TSyTCr7RPcrkHcnnVW
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.149.20.76 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
76.20.149.34.bc.googleusercontent.com
Software
/ 33Across
Resource Hash
7058c181e092c80881f00d02f42b79e4d387ba4bb77d08182ee383bce74ef203

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
status
200 OK
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
351 B
418 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=29649fd8642b63b9&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223271%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
1292b6be31847d5eaa4d408f1765a03fb33bf21ed5c854ba127202edb540ffce
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
0eb60d5c-bddd-4684-a841-c3ac36167f6b
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=29649fd8642b63b9&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3271"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
351 B
418 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=297bf352112d90df&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223272%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
3d89fee4795e58e4359c01281869d63398c097e9cf3c7d78809cd54bbbb60103
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
a0e981a5-0da6-4c70-a8f2-ff7ebc5480fe
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856207&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=2957fa43a9345205&adUnitCode=sidebar-ad2&auctionId=null&bidId=297bf352112d90df&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3272"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
/
d.vidoomy.com/api/rtbserver/prebid/
0
370 B
Fetch
General
Full URL
https://d.vidoomy.com/api/rtbserver/prebid/?id=56105&adtype=banner&auc=sidebar-ad2&w=300&h=250&pos=1&ua=Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36&l=en&dt=1&pid=62183&requestId=299e14f9ca8af859&schain=&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&bidfloor=0&d=fiercepharma.com&sp=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&usp=&coppa=false&videoContext=&bcat=&badv=&bapp=&btype=&battr=
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
212.36.83.246 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb2.vdmy.dtic.es
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
Access-Control-Allow-Methods
HEAD,GET,POST,PUT,DELETE,PATCH,OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Expose-Headers
X-VD-C
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
bid
ap.lijit.com/rtb/
95 B
456 B
Fetch
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_8.33.6
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.201.41.85 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-201-41-85.compute-1.amazonaws.com
Software
/
Resource Hash
7baac67c6bac86eb231b9401f6b98c25e200739ebbd61af889d3629bd4ab864f

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET, POST, DELETE, PUT
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
access-control-allow-headers
X-Requested-With, Content-Type
content-length
99
v1
prg.smartadserver.com/prebid/
1 KB
1 KB
Fetch
General
Full URL
https://prg.smartadserver.com/prebid/v1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
147.135.119.114 , United States, ASN16276 (OVH, FR),
Reverse DNS
ip114.ip-147-135-119.us
Software
/
Resource Hash
38a4016a5c4c5581747c6674f6aa24770abc9e2fb9630db4173217802e5b5099

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
transfer-encoding
chunked
vary
Accept-Encoding, Origin
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
cache-control
no-cache,no-store
access-control-allow-credentials
true
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:35 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
prebid
prebid.media.net/rtb/
2 KB
802 B
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CU816538
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
934b1d7b036022ca21a483f37bc0a9b8aff59f1e22dd6dc6e39b3376a393ceb7

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
34
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
c
prebid.a-mo.net/a/
0
158 B
Fetch
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.28.129.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
29
server
envoy
vary
origin, accept-encoding, Accept-Encoding
prebid
ib.adnxs.com/ut/v3/
22 KB
12 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
6487fac39f5df2c417979d039dd0ed9b36928e6a0f82fca90cb7c160ed035e24
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
an-x-request-uuid
8182e7d1-5f90-4278-8f09-e60728a22356
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
vary
Accept-Encoding
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
bids
prebid-eu.creativecdn.com/bidder/prebid/
0
182 B
Fetch
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.90 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, CY),
Reverse DNS
ip-185-184-8-90.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
translator
hbopenbid.pubmatic.com/
14 KB
6 KB
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
c4ac88bae5a5a1245f7ca90a44ded5886380f100a0da1db11711c548272df489

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
x-openrtb-version
2.3
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
imp
cdp.omeda.com/olytics/segments/
20 B
341 B
XHR
General
Full URL
https://cdp.omeda.com/olytics/segments/imp
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
a8e427db11a8744bebbcdfd050f7b9d0a84b5a1754d086f1787c40db21955264
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
application/json;charset=UTF-8

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=5
Content-Length
20
X-XSS-Protection
1; mode=block
DP-Engage-white.svg
s3.amazonaws.com/publicaudience.qtxasset.com/Life+Science/Pharma/
7 KB
7 KB
Image
General
Full URL
https://s3.amazonaws.com/publicaudience.qtxasset.com/Life+Science/Pharma/DP-Engage-white.svg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.216.215.120 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
cabeed9d9baa263a3d0b306cbd6ffc734a71b27afee0e15aaf61eb66dabf5346

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:37 GMT
Last-Modified
Fri, 03 Feb 2023 19:17:28 GMT
Server
AmazonS3
x-amz-request-id
1KJE136014S8V21N
ETag
"da8d247a406d6a88f57e98c168ac8e96"
x-amz-server-side-encryption
AES256
Content-Type
image/svg+xml
Accept-Ranges
bytes
Content-Length
6741
x-amz-id-2
PooLN8csa6ZsrC/OkyL7NDSToySv2Mge/LbnTNy1uUQC10HB3xpimFqhw5xpGR2yaineJXwygzc=
imp
cdp.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://cdp.omeda.com/olytics/segments/imp
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
204.180.130.159 Lincolnshire, United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Origin
*
Access-Control-Max-Age
1800
Connection
keep-alive
Content-Length
0
Date
Tue, 28 May 2024 14:17:36 GMT
Keep-Alive
timeout=5
Server
Apache
vary
access-control-request-method,Access-Control-Request-Headers
DPEngage23_5210+(1).jpg
s3.amazonaws.com/publicaudience.qtxasset.com/Life+Science/
61 KB
61 KB
Image
General
Full URL
https://s3.amazonaws.com/publicaudience.qtxasset.com/Life+Science/DPEngage23_5210+(1).jpg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
52.216.215.120 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
70ed6b625fe8d2ad97eb6ad1983b4acb2009280b12010c7c5bec327c6e2ca41d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Tue, 28 May 2024 14:17:37 GMT
Last-Modified
Mon, 08 Jan 2024 15:14:38 GMT
Server
AmazonS3
x-amz-request-id
1KJ5K76BZRA66MA5
ETag
"77786af0f8bb66c9ddd2f336bb052e4b"
x-amz-server-side-encryption
AES256
Content-Type
image/jpeg
Accept-Ranges
bytes
Content-Length
62061
x-amz-id-2
y8LLEpTZgzSmTDYhHb6qB21xmWxj/Avgl6EpgPr78vwGr5mYw8H39EcY3efI6iYIpqVWrldFhd0=
/
b1h.zemanta.com/api/bidder/prebid/bid/
0
199 B
Fetch
General
Full URL
https://b1h.zemanta.com/api/bidder/prebid/bid/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
70.42.32.223 , United States, ASN22075 (AS-OUTBRAIN, US),
Reverse DNS
ny.outbrain.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Access-Control-Allow-Credentials
true
c
prebid.a-mo.net/a/
0
134 B
Fetch
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.28.129.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
17
server
envoy
vary
origin, accept-encoding, Accept-Encoding
ortb
bid.contextweb.com/header/
0
791 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-vw9h9
cwdl
22/4211
/
d.vidoomy.com/api/rtbserver/prebid/
0
370 B
Fetch
General
Full URL
https://d.vidoomy.com/api/rtbserver/prebid/?id=56105&adtype=banner&auc=sidebar-ad3&w=300&h=250&pos=1&ua=Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36&l=en&dt=1&pid=62183&requestId=32635d9839d8bd47&schain=&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&bidfloor=0&d=fiercepharma.com&sp=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&usp=&coppa=false&videoContext=&bcat=&badv=&bapp=&btype=&battr=
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
212.36.83.246 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb2.vdmy.dtic.es
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
Access-Control-Allow-Methods
HEAD,GET,POST,PUT,DELETE,PATCH,OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Expose-Headers
X-VD-C
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
prebid
ib.adnxs.com/ut/v3/
146 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
41f54f464cc2770a967b53fd37f6c5d00344d9fc973838c3d643f5a259285155
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
an-x-request-uuid
0b9ea49a-f01a-47d5-a64d-409900fa794d
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
146
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
trinity.json
apex.go.sonobi.com/
1 KB
1 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%223307536c3c4718eb%22%3A%2255f3dde57d605f7ad35c%7C300x250%2C300x600%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=08455ab2-3fa4-486d-92bb-708d1c11d88d&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22adtelligent.com%22%2C%22sid%22%3A%22307946%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
604c563a09608440530f5d74cfe3f20d8c47bdd09e8b1447df493b59d362b8c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
584
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
pbjs
htlb.casalemedia.com/openrtb/
38 B
489 B
Fetch
General
Full URL
https://htlb.casalemedia.com/openrtb/pbjs?s=843072
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.64.151.101 San Francisco, United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6cf991c8f280204e14b65dad4fbdb7af12c3b57478078d89db2a6719af9f2089

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
server
cloudflare
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=nNVBClzlCATUAveIy9rysWGFwVs2C9I5E9i9JgLVdMPtiN2xgqdqcf90Ie7HmxSBIlOnMgKf%2BpxpAOIwVg3BfFPx4VsDwP4C58%2FagHO9RdAIkePI4FACwSrZ0g5SZ8isAE0EY1X%2F"}],"group":"cf-nel","max_age":604800}
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache
access-control-allow-credentials
true
cf-ray
88aede850ba5ac12-YYZ
alt-svc
h3=":443"; ma=86400
content-length
38
expires
0
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
596 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=24434&site_id=419860&zone_id=2376656&size_id=15&alt_size_ids=10&rp_schain=1.0,1!mediafuse.com,358,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=334d6ef124f826c8&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.2677158934863386
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
eb0422c19bd0db3b95e12ece9ff4768796c04055c42908ff52c450e9e33f2678

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
prebid
prebid.ad.smaato.net/oapi/
0
400 B
Fetch
General
Full URL
https://prebid.ad.smaato.net/oapi/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
52.90.26.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-90-26-195.compute-1.amazonaws.com
Software
SOMA /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
X-SMT-DivId,X-SMT-SessionId,X-SMT-ADTYPE,X-SMT-Impression-Measurement,X-SMT-MESSAGE,X-SMT-Expires
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
server
SOMA
x-smt-sessionid
373c9995-898a-c32e-e66e-be3c9bfbd427
x-smt-trace
https://tracing.smaato.net/api/traces/860670e20a16bd007c0d34637cddb8d7?prettyPrint=true
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=70374846370&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
1708037b7ecf03af84945128dfc6655d49a37a602674639456e1643eb6c8c417
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
translator
hbopenbid.pubmatic.com/
16 KB
7 KB
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
c289cddfc196c29c13fc1e48da3bbccd92ac1b5521f6886930c978ea51df4f2b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
x-openrtb-version
2.3
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
openrtb
adx.adform.net/adx/
0
627 B
Fetch
General
Full URL
https://adx.adform.net/adx/openrtb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.157.6.233 , Denmark, ASN198622 (ADFORM, DK),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
strict-transport-security
max-age=31536000; includeSubDomains
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
POST,OPTIONS
p3p
CP="NOI DSP COR NID CURa ADMa DEVa TAIa PSAa PSDa OUR LEG NAV INT"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate, no-transform
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
expires
-1
hbjson
grid.bidswitch.net/
25 B
269 B
Fetch
General
Full URL
https://grid.bidswitch.net/hbjson
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
bcb82bf9202096e63d983dd968ed82642827b89216f3517d2ba86303d6ce2a9a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:37 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
server
nginx
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
50
cdb
bidder.criteo.com/
2 KB
2 KB
Fetch
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=36&wv=8.33.6&cb=80955210309&lsavail=1&bundle=XJaJVl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZoZzRPMEtielhMYmp3TDVjU0JxcEg3YTR5WHd4QU5McXc2cHJWRFNkWU9hSGQ5VXNKQTY4Rkl4RDFURm90Q2lOV3JQNE1yVkZOYUd1ZmRvQjVVTE81a2JtU2Y2ajFvZ2VmYnFJNmJvRUVETlBHZyUyQmgxN1RWcDNhd2FNc3RtJTJCTHJWWUN1QldPRXZhSUw2b2olMkJYZm9IOTlRJTNE
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.6 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
eb713d87817953d49184f6f19262349a70f20db72dcce067b28fa3759348caae
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
strict-transport-security
max-age=31536000; preload;
server
Kestrel
vary
Accept-Encoding, Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
adreq
ads.servenobid.com/
909 B
768 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=5007
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
57a4f8278a24af8df83f62b723cebdfe137b91e01d98ede15ee8a4b0d65b8297

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
hb
ssc.33across.com/api/v1/
119 B
153 B
Fetch
General
Full URL
https://ssc.33across.com/api/v1/hb?guid=b-64TSyTCr7RPcrkHcnnVW
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.149.20.76 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
76.20.149.34.bc.googleusercontent.com
Software
/ 33Across
Resource Hash
ab1caebdf6a26950de987bb2eecd7c3e62d4ae5f0be200cbb1d471ab0eeaf589

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
status
200 OK
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:34 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
prebid
ib.adnxs.com/ut/v3/
146 B
1 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
ab03c696312fd33b6273ac10937d16865fbd1565fbdc9aa4dccd6937a15a1bc5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
an-x-request-uuid
6fc02994-109c-45df-bdad-ccaedb170ffc
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
146
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
translator
hbopenbid.pubmatic.com/
14 KB
6 KB
Fetch
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
207.65.37.179 , United States, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
65125dff9fe56e1c79505c48616d80a36f9356616ffb5eb213d34e3f855f9e63

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
x-openrtb-version
2.3
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
auction
rtb.adxpremium.services/openrtb2/
2 KB
2 KB
Fetch
General
Full URL
https://rtb.adxpremium.services/openrtb2/auction
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.106.140.18 , Netherlands, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
nginx /
Resource Hash
bc5bfde57caeada100d8b0588df2a973772ff0a75cfa0327149a8de20bbadc79

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:36 GMT
Server
nginx
X-Prebid
pbs-go/unknown
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
2012
Expires
0
adreq
ads.servenobid.com/
909 B
767 B
Fetch
General
Full URL
https://ads.servenobid.com/adreq?cb=6305
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.193.219.68 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-219-68.compute-1.amazonaws.com
Software
/
Resource Hash
6d54be447c5ffd1ace3eaa6eab667ac4ac498bacde05d8ce2a12d921b26b1436

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
349 B
372 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=3657fdbcc27d4ea&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223271%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
7fa1122f450009de8e0e9842a7e7a89bd87ab3c26b30148a2acdc6c9f969911b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
c01ed6b5-56a8-42e2-9822-eed6cf60fc74
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=3657fdbcc27d4ea&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3271"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
request
trc.lhmos.com/prebid/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payou...
  • https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagriss...
351 B
374 B
Fetch
General
Full URL
https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=36633953aabfd85f&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={%22adUnitId%22:%223272%22}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
34.102.246.198 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
0c08e15566afb915fa48f09d4fb413694fd309ed10bc63d02113a654f911455f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
null
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
x-frame-options
DENY
access-control-allow-headers
x-requested-with
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
an-x-request-uuid
a8c69a6c-80ef-4cae-b029-6063dfa075f6
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://trc.lhmos.com/prebid/request?auctionStart=1716905856224&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&bidderRequestId=36419b0075ac4377&adUnitCode=sidebar-ad3&auctionId=null&bidId=36633953aabfd85f&transactionId=undefined&device=%7B%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22width%22%3A1600%2C%22height%22%3A1200%2C%22browserLanguage%22%3A%22en-US%22%7D&sizes=300,250&aimXR=null&uid=7532885200230356581&params={"adUnitId":"3272"}&crumbs=undefined&prebidVersion=8.33.6&version=3&coppa=0&ccpa=undefined
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
prebid.media.net/rtb/
25 KB
11 KB
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
6f42db585289bfdd10b6fbad2702092c89cb65d373afcbe39f4fed687ba6c787

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
120
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
prebid
lockerdome.com/ladbid/
11 B
340 B
Fetch
General
Full URL
https://lockerdome.com/ladbid/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.154.142.214 Council Bluffs, United States, ASN15169 (GOOGLE, US),
Reverse DNS
214.142.154.104.bc.googleusercontent.com
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 28 May 2024 14:17:36 GMT
Cache-Control
no-cache, max-age=0, must-revalidate, no-store
Access-Control-Allow-Credentials
true
Content-Encoding
gzip
Content-Length
31
Content-Type
application/json; charset=utf-8
auction
tlx.3lift.com/header/
19 B
672 B
Fetch
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=8.33.6&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tmax=2000
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.206.91.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-206-91-202.compute-1.amazonaws.com
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json; charset=utf-8
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
562 B
596 B
Fetch
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=20086&site_id=475620&zone_id=2822914&size_id=15&alt_size_ids=10&rp_schain=1.0,1!orangeclickmedia.com,ach5lxtq1pmgjoz4,1,,,&eid_pubcid.org=fa6a9e20-bfdc-4788-8dda-54542ccff32b%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&tg_i.domain=fiercepharma.com&tg_i.page=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&tg_i.pbadslot=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&tk_flint=pbjs_lite_v8.33.6&l_pb_bid_id=375d957f838fda34&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&p_gpid=%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9&m_ch_ua=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_full_ver=%22Google%20Chrome%22%7Cv%3D%22125%22%2C%22Not%3AA-Brand%22%7Cv%3D%228%22%2C%22Chromium%22%7Cv%3D%22125%22&m_ch_mobile=%3F0&m_ch_platform=Win32&slots=1&rand=0.7975526052042392
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2602:803:c002:200::32 , United States, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.21.4 /
Resource Hash
f59bf2906bf7905decf351f98f1341a0b14a0b91f4cbac3919f8ea217f259f20

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
server
nginx/1.21.4
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-length
562
expires
Wed, 17 Sep 1975 21:32:10 GMT
hb-mm-multi
hb.minutemedia-prebid.com/
85 B
434 B
Fetch
General
Full URL
https://hb.minutemedia-prebid.com/hb-mm-multi
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
44.216.173.212 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-44-216-173-212.compute-1.amazonaws.com
Software
istio-envoy /
Resource Hash
c9aeb6e362ef18ca4fbc2e438f6ac27835b9e6a11545935f6e9edf52dbf1112d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
server
istio-envoy
x-reason
maxmind hosting provider
access-control-allow-methods
GET, OPTIONS
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
access-control-allow-credentials
true
x-envoy-upstream-service-time
3
access-control-allow-headers
Accept, Content-Type, Content-Length, Accept-Encoding, X-CSRF-Token, Authorization, X-WL-CONF, X-Requested-With
content-length
85
bids
prebid-eu.creativecdn.com/bidder/prebid/
0
182 B
Fetch
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.90 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, CY),
Reverse DNS
ip-185-184-8-90.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
prebid-request
onetag-sys.com/
15 B
556 B
Fetch
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.186 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip186.ip-51-222-39.net
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
cache-control
no-transform, no-cache
access-control-allow-credentials
true
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
v1
prg.smartadserver.com/prebid/
1 KB
1 KB
Fetch
General
Full URL
https://prg.smartadserver.com/prebid/v1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
147.135.119.114 , United States, ASN16276 (OVH, FR),
Reverse DNS
ip114.ip-147-135-119.us
Software
/
Resource Hash
786065fe087e7af622fd8c9f62b8cfd343ca95ac954de40c189fa4d7f95f64ba

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
br
transfer-encoding
chunked
vary
Accept-Encoding, Origin
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
cache-control
no-cache,no-store
access-control-allow-credentials
true
/
ghb1.adtelligent.com/v2/auction/
5 KB
1 KB
Fetch
General
Full URL
https://ghb1.adtelligent.com/v2/auction/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.151.242 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash
7983af2d231a115c8af9e1a88647c58aeafe8e1da6e4f98a4ad7a91909ee2d83

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

Date
Tue, 28 May 2024 14:17:37 GMT
Content-Encoding
gzip
Server
Adtelligent
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
X-Robots-Tag
noindex
Content-Length
1042
trinity.json
apex.go.sonobi.com/
1 KB
1 KB
Fetch
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%223876550abb0ba28%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%23gpt_unit_%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma_9%2Cc%3Dd%2C%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&s=b1305112-4b56-46cc-9e2a-3e1ec944016b&pv=e6a07294-1a61-4ba1-a422-4e1273f06c72&vp=desktop&lib_name=prebid&lib_v=8.33.6&us=0&iqid=%7B%22pcid%22%3A%223ea616d5-8064-4df9-b76a-bc4cc96720a3%22%2C%22pcidDate%22%3A1716905856093%7D&fpd=%7B%22source%22%3A%7B%7D%2C%22site%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%2C%22keywords%22%3A%22Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma%22%2C%22publisher%22%3A%7B%22domain%22%3A%22fiercepharma.com%22%7D%2C%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%7D%2C%22device%22%3A%7B%22w%22%3A1600%2C%22h%22%3A1200%2C%22dnt%22%3A0%2C%22ua%22%3A%22Mozilla%2F5.0%20(Windows%20NT%2010.0%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F125.0.0.0%20Safari%2F537.36%22%2C%22language%22%3A%22en%22%2C%22sua%22%3A%7B%22source%22%3A1%2C%22platform%22%3A%7B%22brand%22%3A%22Win32%22%7D%2C%22browsers%22%3A%5B%7B%22brand%22%3A%22Google%20Chrome%22%2C%22version%22%3A%5B%22125%22%5D%7D%2C%7B%22brand%22%3A%22Not%3AA-Brand%22%2C%22version%22%3A%5B%228%22%5D%7D%2C%7B%22brand%22%3A%22Chromium%22%2C%22version%22%3A%5B%22125%22%5D%7D%5D%2C%22mobile%22%3A0%7D%7D%7D&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22fa6a9e20-bfdc-4788-8dda-54542ccff32b%22%2C%22atype%22%3A1%7D%5D%7D%5D&kw=Pfizer%2CWyeth%2CPumaBiotechnologies%2CAstraZeneca%2CTagrisso%2CNerlynx%2CFiercePharmaHomepage%2CPharma&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f350:3:2569:0:10:0:200a , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
c15bd5a2526b58492028e66aa3b381ef05f4e22d7e644cd4cdd2749d51fc6297
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, private
access-control-allow-credentials
true
tcn
Choice
content-length
635
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT
bid
ap.lijit.com/rtb/
95 B
674 B
Fetch
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_8.33.6
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.201.41.85 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-201-41-85.compute-1.amazonaws.com
Software
/
Resource Hash
5c41b5f53f407f76dfe6855216a1a510578555c56861bcee82a90a3a1fedf70b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET, POST, DELETE, PUT
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
access-control-allow-headers
X-Requested-With, Content-Type
content-length
99
prebid
ib.adnxs.com/ut/v3/
15 KB
8 KB
Fetch
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
e9941d952ed517a54edf0feb02f83089bcc7de03f3f0cd0e5a32c5367dd004c0
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
an-x-request-uuid
fa94f39a-ee88-4c82-8664-cacffb4c11f4
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
vary
Accept-Encoding
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
pb
ad.360yield.com/1628/
855 B
1 KB
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
9ef196219b86091cb4d0e9ffee8404a5bd81fa999be865f09d8992d37702fee7

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
content-type
application/json; charset=UTF-8
content-length
855
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
pb
ad.360yield.com/1628/
0
172 B
Fetch
General
Full URL
https://ad.360yield.com/1628/pb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.237.106.71 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-237-106-71.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:36 GMT
access-control-allow-credentials
true
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
unruly_prebid
targeting.unrulymedia.com/
11 B
282 B
Fetch
General
Full URL
https://targeting.unrulymedia.com/unruly_prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
69.194.240.11 , United States, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
/
Resource Hash
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
Security Headers
Name Value
Strict-Transport-Security max-age=63072000

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
application/json

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
strict-transport-security
max-age=63072000
observe-browsing-topics
?1
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=900
content-length
11
ortb
bid.contextweb.com/header/
0
791 B
Fetch
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.214.194.131 Amsterdam, Netherlands, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
cw-server
bid-deployment-7f9d9c89bb-24746
cwdl
22/4211
prebid
ssp.disqus.com/bid/
0
287 B
Fetch
General
Full URL
https://ssp.disqus.com/bid/prebid?sid=710
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.197.117.43 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-197-117-43.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
cache-control
no-store
access-control-allow-credentials
true
vary
origin
expires
0
prebid
prebid.media.net/rtb/
2 KB
804 B
Fetch
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CU816538
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
34.120.63.153 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
153.63.120.34.bc.googleusercontent.com
Software
envoy /
Resource Hash
c2ebb45ccbd0b64de608c75136935bfaa85500e7221bc3064179c88cb5152652

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:36 GMT
content-encoding
gzip
via
1.1 google
accept-ch
Sec-CH-UA-Mobile,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Model
server
envoy
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
407
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Tue, 28 May 2024 14:17:36 GMT
ads
securepubads.g.doubleclick.net/gampad/
64 KB
24 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=491349336052850&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&ifi=8&sfv=1-0-40&eri=1&sc=1&cookie=ID%3D50aa374d6f0d6a81%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MaMzw9I0MkDCIt6Ve4ZEEIxN60nSw&gpic=UID%3D00000a2951ea5df8%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MbZ33g1rb0CP4Omw1laFksTlU7mGg&abxe=1&dt=1716905857120&lmt=1716905156&adxs=1135&adys=953&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=7&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=320x250&msz=320x0&fws=132&ohw=1600&psts=AOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsluTb3R7OOWHWCNUUMCgPQB1O-s4jzCljj5eLrd6FbA%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGslTu-Y-m5CEXkRfKEW2etYWu7rNJzaWqZ_zW_sXsy6hXkSkdxozG2zkA-JWPW4-BZrPJlPTq0c7Lu9cY9ff-35P98w1dLu29g%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsk2Fi8mdtsnWNAsCdhuzXeo89osu-PqMaIGAxyxLCCA&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=true&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEj4KBW9wZW54EixleUpwSWpvaVpGQTBVakZqT1hwVWJVOTFiR3RGTUdkNGFHdFhkejA5SW4wPRj-lMH8-zFIAA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D1%26refresh%3Dtrue%26hb_rfBid%3D0%26hb_div_id%3Dsidebar-ad%26excl_cat%3DPREPOST&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=3263208563&frm=20&eo_id_str=ID%3D6c39a613d9661c8d%3AT%3D1716905855%3ART%3D1716905855%3AS%3DAA-AfjYcumk822wqp4dsZlsIqGeW
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
114af611fbb0ff21ac9efdd92e351fb3c796bf649adbf564bddc63a38cc956b0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:37 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24727
x-xss-protection
0
google-lineitem-id
6722841749
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138474833934
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame CBE8
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvNeT03nldGxevCtpq5krYlZuzL87eTXDdzeJYUqybVhiR4ciBEmVvD9ONfVXkp1bXt7HcG3KOjNBZ9GuQ1XOh2mD3SwZ0NPsDYSiahjXBOhYQow40TYvEQofWpNJsi7A56tGmD0vFv4wNh2nqIj11_Tz5dwBU0Z6u4hv5T5-M7dMc1_hJCpkwF_OxXDRdaToD0QMyN47r5vtEjQKDaVH9seNm775zNkJkVR1pJxrgge9aBLUNEmmWb2VpeD_0hxuVuQWeH04iV5hT_M0KbeL7FncN9mppCPjxXCfNHccnr732EcuiX_VHnRtuBRqyMxDBcUL92pQa4zxHndkzWaHnkXsX7GBD-WUyuAT3bMOPy5WHRMdpJfRfwKpUqy7qpyalF1_BzLxYr3KUTF-f-iMZ20WB7g-7_bJ-o52Rx&sai=AMfl-YTTmvz-jNgrY3AtdI4tcPDdwtivIMHg2gu-5DuT1R-m-u3lXfNK1q0-qZfOpvu1nqh5LnszQtexE8Bt_T1ktIu-ewENh2epVqfNQ8dWYhbBWZfbpuAblO48JMU-pQ&sig=Cg0ArKJSzKPmp4rTggTEEAE&uach_m=%5BUACH%5D&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:37 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
abg_lite_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/ Frame CBE8
23 KB
9 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/abg_lite_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36ea295580b6ae83e3e1d6b4bdf7564af630736a9d46e3a7e8b7aacaf96b1dcd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 17:06:25 GMT
content-encoding
br
x-content-type-options
nosniff
age
76272
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
9129
x-xss-protection
0
server
cafe
etag
17088485272571348730
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 17:06:25 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/ Frame CBE8
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/window_focus_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 19:37:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
67208
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 19:37:29 GMT
ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame CBE8
214 KB
65 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
42bbd0012a46493c1ca8e228b118806d03bb60bb93ecb05d40413dc0401722f0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:10:12 GMT
content-encoding
br
x-content-type-options
nosniff
age
445
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66456
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 28 May 2024 15:10:12 GMT
14276714841728287956
tpc.googlesyndication.com/simgad/ Frame CBE8
57 KB
57 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/14276714841728287956
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
df318ce60e0d7e9b976d12b05f9806978206c0829e7be15c49ca1c4212b0880e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

expires
Sat, 24 May 2025 05:28:41 GMT
date
Fri, 24 May 2024 05:28:41 GMT
x-content-type-options
nosniff
age
377336
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
58233
x-xss-protection
0
last-modified
Fri, 10 May 2024 19:53:47 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
allow-fenced-frame-automatic-beacons
true
l
www.google.com/ads/measurement/ Frame CBE8
0
0

truncated
/ Frame CBE8
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
cda3e6ebee10fc5018a2b5f601502640f19c1adff3dafaacc7cf518114743bc9

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Content-Type
image/png
gen_204
pagead2.googlesyndication.com/pagead/ Frame CBE8
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=av-js&type=reach&proto=CAlgAWACaAM%3D
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:37 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame CBE8
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstZpQTZraWJzOaDhFb2i5FbubIMmuN1oe1YRezs6yZY5Spo7xhCtIyksI4chtg_NAcpvoojFV6fw6Lpo5G1U7b4BIz4R4L16sk0KHt0xJGoiTl3MwX5vkpoM3v5_PlM30QR2dP8n4H7dKVRt4Umelz_y2U6otOQvrwr6znvFFodETp3ppMuDP5qzJT9wJKt1o9iJu6xWhmYrL-dSjqAq231CWcU8hcYGWHFQxJsivbmX-EcZGdVV4R5fvu3Lk1U-1Zq_gQlQrKlSJN6Pxqq8wLyuegMD1k-6dFxBzSYcrLsCpg-5rOL94K9TtaBomWGz_J3-oUqkLhFTvjVst4LaGYxJX1lGP77PQZGGz2d4LcYEOw9aq0l-cuaWM27GeLzNvoALvmsNw9ZWRB-orKqk_IVtd7jShelf8wPTdFR9R0&sai=AMfl-YQckZ5vTcsndtmjAOiPJBaZMWXsiRAd6GbNEBFjD2UUKfydCzaZQwuFvDY9pZ0hns8d6VygY7uWPFe86LgjyHDKn0UMshYZO90EWuMwb8naGAJx4rC9DerP7a8GJA&sig=Cg0ArKJSzCDWciW88RiqEAE&uach_m=%5BUACH%5D&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ%3D%3D&adurl=
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:37 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 28 May 2024 14:17:37 GMT
ads
securepubads.g.doubleclick.net/gampad/
64 KB
24 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=386524633607482&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=970x90%7C970x250&ifi=9&sfv=1-0-40&eri=1&sc=1&cookie=ID%3D50aa374d6f0d6a81%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MaMzw9I0MkDCIt6Ve4ZEEIxN60nSw&gpic=UID%3D00000a2951ea5df8%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MbZ33g1rb0CP4Omw1laFksTlU7mGg&abxe=1&dt=1716905857810&lmt=1716905156&adxs=160&adys=141&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=0&ucis=8&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=1310x1&msz=1310x0&fws=132&ohw=1600&psts=AOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsluTb3R7OOWHWCNUUMCgPQB1O-s4jzCljj5eLrd6FbA%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGslTu-Y-m5CEXkRfKEW2etYWu7rNJzaWqZ_zW_sXsy6hXkSkdxozG2zkA-JWPW4-BZrPJlPTq0c7Lu9cY9ff-35P98w1dLu29g%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGskKs5XfleOtNG9ZXLEdubLtVnZ3R-J-MgKKnDpoY8qw5ynA1_fziwOoT7XtedCdjCaMtBgkYLVn4wlSmEn4r9PPRoY%2CAOrYGsk2Fi8mdtsnWNAsCdhuzXeo89osu-PqMaIGAxyxLCCA&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=true&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEj4KBW9wZW54EixleUpwSWpvaVpGQTBVakZqT1hwVWJVOTFiR3RGTUdkNGFHdFhkejA5SW4wPRj-lMH8-zFIAA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D0%26refresh%3Dtrue%26hb_rfBid%3D0%26hb_div_id%3Dheader-ad%26excl_cat%3DPREPOST&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=1054140177&frm=20&eo_id_str=ID%3D6c39a613d9661c8d%3AT%3D1716905855%3ART%3D1716905855%3AS%3DAA-AfjYcumk822wqp4dsZlsIqGeW
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
0b0099e01e269b6767b1e781b1362542882e16b00e3387ab1a9848fbb3480725
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24715
x-xss-protection
0
google-lineitem-id
6706077048
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138472100850
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
64 KB
24 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=4201061844224188&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&ifi=10&sfv=1-0-40&eri=1&sc=1&cookie=ID%3D50aa374d6f0d6a81%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MaMzw9I0MkDCIt6Ve4ZEEIxN60nSw&gpic=UID%3D00000a2951ea5df8%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MbZ33g1rb0CP4Omw1laFksTlU7mGg&abxe=1&dt=1716905858056&lmt=1716905156&adxs=1120&adys=1249&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=3&ucis=9&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=350x1&msz=350x0&fws=644&ohw=1600&psts=AOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsluTb3R7OOWHWCNUUMCgPQB1O-s4jzCljj5eLrd6FbA%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGslTu-Y-m5CEXkRfKEW2etYWu7rNJzaWqZ_zW_sXsy6hXkSkdxozG2zkA-JWPW4-BZrPJlPTq0c7Lu9cY9ff-35P98w1dLu29g%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGskKs5XfleOtNG9ZXLEdubLtVnZ3R-J-MgKKnDpoY8qw5ynA1_fziwOoT7XtedCdjCaMtBgkYLVn4wlSmEn4r9PPRoY%2CAOrYGsk2Fi8mdtsnWNAsCdhuzXeo89osu-PqMaIGAxyxLCCA&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=true&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEj4KBW9wZW54EixleUpwSWpvaVpGQTBVakZqT1hwVWJVOTFiR3RGTUdkNGFHdFhkejA5SW4wPRj-lMH8-zFIAA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D1%26refresh%3Dtrue%26hb_rfBid%3D0%26hb_div_id%3Dsidebar-ad3%26excl_cat%3DPREPOST&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=2184391132&frm=20&eo_id_str=ID%3D6c39a613d9661c8d%3AT%3D1716905855%3ART%3D1716905855%3AS%3DAA-AfjYcumk822wqp4dsZlsIqGeW
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
3cc43a384ef3145068f3a78f72ca520826ed62a34d788c8d67f3301af77c8a0b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24696
x-xss-protection
0
google-lineitem-id
6719924794
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138474549164
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
publishertag.prebid.144.js
static.criteo.net/js/ld/
96 KB
31 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.144.js
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a00b::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
66776998b10e583a72f8fd29391a50e2c80eb3bc9a65b0dafe97e576d7d88507
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
content-encoding
gzip
strict-transport-security
max-age=31536000; preload;
last-modified
Fri, 27 Oct 2023 06:43:26 GMT
server
nginx
etag
W/"653b5c0e-1811e"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 29 May 2024 14:17:38 GMT
ads
securepubads.g.doubleclick.net/gampad/
64 KB
24 KB
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?pvsid=60943146494634&correlator=601998411991440&eid=44809527%2C31083898%2C31083014%2C31083984%2C95333933%2C31078668&output=ldjh&gdfp_req=1&vrg=202405220101&ptt=17&impl=fifs&gdpr=0&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&ifi=11&sfv=1-0-40&eri=1&sc=1&cookie=ID%3D50aa374d6f0d6a81%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MaMzw9I0MkDCIt6Ve4ZEEIxN60nSw&gpic=UID%3D00000a2951ea5df8%3AT%3D1716905855%3ART%3D1716905855%3AS%3DALNI_MbZ33g1rb0CP4Omw1laFksTlU7mGg&abxe=1&dt=1716905858145&lmt=1716905156&adxs=1120&adys=1233&biw=1600&bih=1200&scr_x=0&scr_y=0&btvi=4&ucis=a&oid=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&u_tz=-600&dmc=8&bc=31&nvt=1&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ..&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&vis=1&psz=350x1&msz=350x0&fws=132&ohw=1600&psts=AOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGsluTb3R7OOWHWCNUUMCgPQB1O-s4jzCljj5eLrd6FbA%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGslTu-Y-m5CEXkRfKEW2etYWu7rNJzaWqZ_zW_sXsy6hXkSkdxozG2zkA-JWPW4-BZrPJlPTq0c7Lu9cY9ff-35P98w1dLu29g%2CAOrYGslXqzWxZnMwa10HhsoG5C0a%2CAOrYGskKs5XfleOtNG9ZXLEdubLtVnZ3R-J-MgKKnDpoY8qw5ynA1_fziwOoT7XtedCdjCaMtBgkYLVn4wlSmEn4r9PPRoY%2CAOrYGsk2Fi8mdtsnWNAsCdhuzXeo89osu-PqMaIGAxyxLCCA&ga_vid=1221635165.1716905855&ga_sid=1716905855&ga_hid=1811961581&ga_fc=true&a3p=EhsKDDMzYWNyb3NzLmNvbRjfkMH8-zFIAFICCGQSHQoOZXNwLmNyaXRlby5jb20Y35DB_PsxSABSAghkEj4KBW9wZW54EixleUpwSWpvaVpGQTBVakZqT1hwVWJVOTFiR3RGTUdkNGFHdFhkejA5SW4wPRj-lMH8-zFIAA..&nt=1&psd=WzIsbnVsbCxudWxsLDNd&dlt=1716905854352&idt=571&prev_scp=pos%3D1%26refresh%3Dtrue%26hb_rfBid%3D0%26hb_div_id%3Dsidebar-ad2%26excl_cat%3DPREPOST&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D1362210%26topic%3D%26keyword%3DPfizerWyethPuma%2520BiotechnologiesAstraZenecaTagrissoNerlynx%26tag%3DPfizer%252CWyeth%252CPuma%2520Biotechnologies%252CAstraZeneca%252CTagrisso%252CNerlynx%252CFierce%2520Pharma%2520Homepage%252CPharma%26path%3D%252Fpharma%252Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26browserLargerThan1460%3D1&adks=2184391133&frm=20&eo_id_str=ID%3D6c39a613d9661c8d%3AT%3D1716905855%3ART%3D1716905855%3AS%3DAA-AfjYcumk822wqp4dsZlsIqGeW
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
832a962df982b1dd84394c6bb09879e72ca60b80489301d69e5fba189da39d41
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
content-encoding
br
x-content-type-options
nosniff
observe-browsing-topics
?1
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
24732
x-xss-protection
0
google-lineitem-id
6719924794
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138474549164
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
publishertag.prebid.144.js
static.criteo.net/js/ld/
96 KB
0
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.144.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.144.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a00b::4 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
nginx /
Resource Hash
66776998b10e583a72f8fd29391a50e2c80eb3bc9a65b0dafe97e576d7d88507

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
content-encoding
gzip
last-modified
Fri, 27 Oct 2023 06:43:26 GMT
server
nginx
etag
W/"653b5c0e-1811e"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 29 May 2024 14:17:38 GMT
index.php
a.dpmsrv.com/dpmpxl/
5 B
1 KB
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?zn=&sn=&q=xSeg&v=1.x&ep%5Bids%5D=29315642%2C29315652%2C16013439%2C16671093&cl=913&pixelIndex=0&r=329820&tzOffset=600&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&id=7532885200230356581
Requested by
Host: s.dpmsrv.com
URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.157.213.254 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-157-213-254.compute-1.amazonaws.com
Software
/
Resource Hash
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
Content-Type
text/javascript
Access-Control-Allow-Origin
*
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Access-Control-Allow-Headers
content-type, accept
Content-Length
31
Expires
0
seg
ib.adnxs.com/
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/seg?member=827&add=29315642,29315652,16013439,16671093
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
68.67.161.182 Colonia, United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net
Software
nginx/1.23.4 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:38 GMT
an-x-request-uuid
a119f392-5ace-40d8-afd3-56b5ee939654
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
image/gif
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
43
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 6283
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvczJlM49elCQ5VwndO6Lo_bRvzBP5hAfKmBwWPxN-iY5XEJBjo1TsYZshtd-m25Il5ozzoXi0WBPjgf3dOKm9f7l4x9lnpZv7lwmdEDUkv6sjE0nb5BuuOKldLmqQUWm85uysgsa5d4UwGw2sBM-OmqUPrBv2yltXz7R52OcGgVEFwvhCcL3BscfmWWchniMaRSmfM6TaIAxeY6qTHWsI-O5_G49ME6WZms6Kobr2Czvto-ZuHWOb9sIyR1ALaPDf-SOHT8tR1DMDjQR5W9tHwSV5yZx3pgZhrIX0tDDdSWxSEsAxvl-HGdbq3kqZPEATOTp2ISBr9_3cTgi19g8GyxXbHM4PXhiYJnbh0knU2wzIBcwzSW5sObajo07vNqXvcGsUVZnBFG2vX0VcOk4IkrpFChC3q5NZ6VySS&sai=AMfl-YRVKweY0R82IAorX0ey2IYvP0QbzAZJsUgKwjMalxoffcgE4FOL_05YkXhIWPDX52_8WV0eHelM2vbQUbZxaMwThF8MyUE0X-YeUcF_u1XvmtZm0JXkvJV7MQMU7Q&sig=Cg0ArKJSzEvOA6aJonJ_EAE&uach_m=%5BUACH%5D&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
abg_lite_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/ Frame 6283
23 KB
0
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/abg_lite_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36ea295580b6ae83e3e1d6b4bdf7564af630736a9d46e3a7e8b7aacaf96b1dcd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 17:06:25 GMT
content-encoding
br
x-content-type-options
nosniff
age
76272
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
9129
x-xss-protection
0
server
cafe
etag
17088485272571348730
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 17:06:25 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/ Frame 6283
3 KB
0
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/window_focus_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 19:37:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
67208
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 19:37:29 GMT
ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame 6283
214 KB
0
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
42bbd0012a46493c1ca8e228b118806d03bb60bb93ecb05d40413dc0401722f0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:10:12 GMT
content-encoding
br
x-content-type-options
nosniff
age
445
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66456
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 28 May 2024 15:10:12 GMT
15561618828584832224
tpc.googlesyndication.com/simgad/ Frame 6283
271 KB
271 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/15561618828584832224
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1f2b57178d466db347718e3cf27f55024e32c7a0e5cd1a03b245bb8c0e74c69e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

expires
Thu, 22 May 2025 14:37:03 GMT
date
Wed, 22 May 2024 14:37:03 GMT
x-content-type-options
nosniff
age
517235
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
277211
x-xss-protection
0
last-modified
Thu, 18 Apr 2024 14:07:37 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
allow-fenced-frame-automatic-beacons
true
l
www.google.com/ads/measurement/ Frame 6283
0
0

gen_204
pagead2.googlesyndication.com/pagead/ Frame 6283
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=av-js&type=reach&proto=CAlgAWACaAM%3D
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame 6283
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
adf250cddb40da6f628519d2e06935f6871dee60b84f60687dc960aa4ed6ab95

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 6283
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssuqO9TcM0eEKBMofIC9oAFzSFtuaBB9l-lwtlbjg4kfir8KVNx0hq_a_toH1_DDMs7j_D_BaSJ875okKEefm2OIUhNY-x2oo1U_Mmajl5OSkVi4k0u0Jwv4yBtDIPR2DRa6RI12cJwIHN5nHdS6zcY2VMN-aAVYc5NlFllC0WNciK8NEiMESV67QN1hIRnDwtWIpzD3rXVrfH9-QOKMFKEhrFf0HmAycyh1b2THLxM9a2B6RNKTWu621MxLxDAiPM4kfTDxrUkY00gLWmkZxKLfRPDVdeCl3wnllg4yTjF8kx3z67wMjNjf_YX_vSF3UT0IcjFZROXeHhm60_LGA8UzGEt80sLgJohmIk04eskAUbX9KN6I6n17tEAZGdH7RxA4Q9Q0w62DSs2dknqi_68MhlvNuIWkTL28RAnTFA&sai=AMfl-YTyJFtT0RqZmY-j-cvjnoukS08jvh2U8z7idgcYUTWhVETEiQGlMW2QswWgZCc0aJkjbenMOEi2Pe01Whml6XGo8htD0Up1JytNiE_hQcRLbOI2hmxdOzP6nPgLxQ&sig=Cg0ArKJSzA2ChxWz66ggEAE&uach_m=%5BUACH%5D&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ%3D%3D&adurl=
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 28 May 2024 14:17:38 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 146B
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuKZYqm683g24l47Za6cTHy7t0jJUG1IMskzlVevtX_rnJ9WP5WXyF9KVKt-jxG3TD2q5GXYbMdxwKpBNNw28z7ZeRSFx7ZuooEJiqdNuM_Q-qv3Wl42uZxoAwfOUY5mdl8NMI3UDDlze_vGbT6h12tvoxXaVu-O6qSfr7vuylwRop95C8kB41h8I2WNiVS7SLV6NozzP-OdErTFwd3-vqMHsO0LS-dmWWFqkszDvNkntKDXazIKxO8yvoqGn9gqfhowT-E9NySU-qaQyzBQ296lMVOmkSSFJmbWzZsT_reNweys6beooIotS5W22zuPEEPyT_JbTMypwZCW7ccM6vcCHg9haemIqvsOp22irpOLT-SQEq9rKg_JnFHArWxkhPVy-EAkS0xs34F2F4dTb36isAgTD4sdu7GKjPJ&sai=AMfl-YQTkgmGoZ9q7dU1OF3_Qiwmbnj27KWltMitZe4qvcHE_UtHvinEkC56YMQDrbtQ0yJOwbAA6hzqZaBzVK4utA7r0IkYPPmg1dTBoqxTlqKfeLG9V2CA_FWWnZIS1g&sig=Cg0ArKJSzIgJcqwpDSEKEAE&uach_m=%5BUACH%5D&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
abg_lite_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/ Frame 146B
23 KB
0
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/abg_lite_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36ea295580b6ae83e3e1d6b4bdf7564af630736a9d46e3a7e8b7aacaf96b1dcd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 17:06:25 GMT
content-encoding
br
x-content-type-options
nosniff
age
76272
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
9129
x-xss-protection
0
server
cafe
etag
17088485272571348730
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 17:06:25 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/ Frame 146B
3 KB
0
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/window_focus_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 19:37:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
67208
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 19:37:29 GMT
ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame 146B
214 KB
0
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
42bbd0012a46493c1ca8e228b118806d03bb60bb93ecb05d40413dc0401722f0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:10:12 GMT
content-encoding
br
x-content-type-options
nosniff
age
445
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66456
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 28 May 2024 15:10:12 GMT
8935351078445769690
tpc.googlesyndication.com/simgad/ Frame 146B
223 KB
223 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/8935351078445769690
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.72.97 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s32-in-f1.1e100.net
Software
sffe /
Resource Hash
10bc2a1611214a5da5494de1793213e5b394bc40bda5d39ee1c08585d65634fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

expires
Wed, 21 May 2025 20:12:39 GMT
date
Tue, 21 May 2024 20:12:39 GMT
x-content-type-options
nosniff
age
583499
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
228012
x-xss-protection
0
last-modified
Tue, 07 May 2024 19:56:31 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
allow-fenced-frame-automatic-beacons
true
l
www.google.com/ads/measurement/ Frame 146B
0
0

gen_204
pagead2.googlesyndication.com/pagead/ Frame 146B
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=av-js&type=reach&proto=CAlgAWACaAM%3D
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame 146B
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
a5472caddbae8d97e187e21c0cee13a86d99fea9e882cf30136c1c351ca47f96

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 9139
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssJiLL0yEtJ7cMQyFyUuMLKONzdujRD8u5phTJ2zd3EaKGdAqWKPil88OlpByivPtRt9dk_MiEmGta2g2Qx_XTeq9GJdrVDba3H4VNrh1TO0vSA6lFjlhdaZKYtbOB_Rfx6OwDZUxh2EpxzSKOHLr6HF-Rr134XTNotTyf4QFd-zDcsvNRX7LwhIQwH6eqo2LZsUOuZCk0_fRJ5K-DIhnfXsf7kAxxK1mH1krhmB6uJYNRps8yfcy6h5ioZvp9YrZ6uOySfRyZ41O9ZGK5u8StyKZZ7yUTuzfAD_rXnzR5Hl84CfFbsJDbd-X9OCql8HgXqWPpwgMPLadzvrRw_2JhMI-BnTSHL0zfGryUyQB41LCt3IF5_EySPNcxyRJdCO-Y-6OmrFKBBxhdup4mbv3NRO7ZFV6MCrCim16M7&sai=AMfl-YQd4Zw6AChoKVW-MSHD7h2gngh6Pg0qQvVZufCKdkPRGgKrtCj0dbQdm6elRN_x3Xw4BEdvzwiZQcQazdvQSJr5mkTDfnWwBar4ZY8aLEjvrnPAqD_De7tY4jJLmQ&sig=Cg0ArKJSzMKR7Pq5hkbNEAE&uach_m=%5BUACH%5D&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
8935351078445769690
tpc.googlesyndication.com/simgad/ Frame 9139
223 KB
0
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/8935351078445769690
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.72.97 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s32-in-f1.1e100.net
Software
sffe /
Resource Hash
10bc2a1611214a5da5494de1793213e5b394bc40bda5d39ee1c08585d65634fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

expires
Wed, 21 May 2025 20:12:39 GMT
date
Tue, 21 May 2024 20:12:39 GMT
x-content-type-options
nosniff
age
583499
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
228012
x-xss-protection
0
last-modified
Tue, 07 May 2024 19:56:31 GMT
server
sffe
report-to
{"group":"content-ads-owners","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/content-ads-owners"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="content-ads-owners"
allow-fenced-frame-automatic-beacons
true
abg_lite_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/ Frame 9139
23 KB
0
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/abg_lite_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36ea295580b6ae83e3e1d6b4bdf7564af630736a9d46e3a7e8b7aacaf96b1dcd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 17:06:25 GMT
content-encoding
br
x-content-type-options
nosniff
age
76272
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
9129
x-xss-protection
0
server
cafe
etag
17088485272571348730
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 17:06:25 GMT
window_focus_fy2021.js
tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/ Frame 9139
3 KB
0
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20240522/r20110914/client/window_focus_fy2021.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::2001 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Mon, 27 May 2024 19:37:29 GMT
content-encoding
br
x-content-type-options
nosniff
age
67208
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1236
x-xss-protection
0
server
cafe
etag
15004572836499977866
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 10 Jun 2024 19:37:29 GMT
ufs_web_display.js
pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ Frame 9139
214 KB
0
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202405220101/pubads_impl.js?cb=31083984
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
42bbd0012a46493c1ca8e228b118806d03bb60bb93ecb05d40413dc0401722f0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:10:12 GMT
content-encoding
br
x-content-type-options
nosniff
age
445
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
66456
x-xss-protection
0
server
cafe
etag
vary
Accept-Encoding
content-type
text/javascript; charset=ISO-8859-1
cache-control
public, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 28 May 2024 15:10:12 GMT
l
www.google.com/ads/measurement/ Frame 9139
0
0

gen_204
pagead2.googlesyndication.com/pagead/ Frame 9139
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=av-js&type=reach&proto=CAlgAWACaAM%3D
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame 9139
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
a277f81590c6f6d9d2542875953b726f1af22d463699e9637c8eaaa7f481f4e8

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Content-Type
image/png
activeview
pagead2.googlesyndication.com/pcs/ Frame CBE8
42 B
65 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjst1wpNcIyA_b0DmzB0Q1uoIKpMVywTiJFAWFP2wW6FU2Ivq4fvqG8FFKY6OpSx-vyKuZq51Vx3ZidiB8hDf03D7xOr4RAvO2WqHklG8H7FRbBLU4AdtB-OOoQgQLM3D6l_sdnV7AZENXROCQ-El00TI-fxK3KoyzY8x_8un7g&sig=Cg0ArKJSzC299e3Ir21yEAE&id=lidar2&mcvt=1006&p=953,1130,1203,1430&mtos=0,1006,1006,1006,1006&tos=0,1006,0,0,0&v=20240522&bin=7&avms=nio&bs=1600,1200&mc=0.99&vu=1&app=0&itpl=3&adk=3263208563&rs=4&la=0&cr=0&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ%3D%3D&vs=4&r=v&co=1283865700&rst=1716905857540&rpt=160&isd=0&lsd=0&met=mue&wmsd=0&pbe=0&fle=0&vae=0&spb=0&sfl=0&ffslot=0&reach=8&io2=0
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 146B
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuKuTUErAzINwZCfdrecF6nm17cApBSyawpBmSXBdSn27m4hl9kK_Mbs6x_guTBIQ6VzAKbAOEnii3viYdeTrQN3mLtG8_zDGf1hCtxZXWkJDIXKz2QA9NNo-kAuvQMCEj9lF8d5sF1QZXbx43SFF3riAY8susRE4YeKNsmXu3sA47HWxEJDEchgSndAbyESidNiKNDHDGvedPbykH-5UMhcz3Smwo-sDCR2DX4C2UCridMrgU-l33CR5LxbLxKIY-M1Pq5DB0gZcxWq6eoiQbiFdqEPqD79bMoPnNHEtiG-MaYNpaRphVcj5Dfdhh25fg8UIn1qjMbZArQ1tGd_2HZo5bWMX-iDmmjl8wWmwvxU4xSpMUxdE1sY8WeGhTHfKxkS052WdOwzz7e57kmJpS3R46Tet9qmmYEV2dKq3E&sai=AMfl-YSWfM9vFpaHOIwGTF8BqTeNyNA7iMbU6pNMW1cXbnzn_5W_hSJxL9sKvUWuW178RJqptk8mG3_8Yix9kKP5FO-QCvibP48MRUmytaEWXG20llZh-prqJ0kldIkEHA&sig=Cg0ArKJSzPE1P9wql4QlEAE&uach_m=%5BUACH%5D&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ%3D%3D&adurl=
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 28 May 2024 14:17:38 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 9139
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjst0dKxT0GaoVC4RSVO91RWlsVu_H6E_fguLvNFsvpRZ0Wv3ZPFByjLBxdMA_2SxvNCDoSOKHjomS8EmEgYP0c5gpeIa9CwNRG8f_mL24XtBVXDLqrJAAXyM4QC0UznkBCgLga65BKtBBJQoIQ03BcUAR45jXpLNHZ4iGxFuYPz0dTtGBvpAIjqRb4nVKYFsmzqPmFLFO-LLtXDS5sAWf943VVJtzUlyZrdyIJi3scuJe9yDqzT0kA5KlvZPlwZJDApF49IszYLMKDimefg7r18Eafa8MKEs37RrHn6m6F0z6xmUG0HH7XASlgnQfhQ1XWNgwmCEezuJys8NZGSQAYhHJraFuIQ2lFEdVxSNW0J5PAuyvB_IEGIUni42f28mGKgx-INTU2vnB_4Lv9SDdmtfwPuBOoXoBFzAf7Z5uys&sai=AMfl-YQgR1kOONLBjOr2g5QtnnEXEupZ9iweLPAgY_7wecPwj-ReuSKskrdmggyBDiaNInXHvVsglWpQPxVv46xzg2SExDy3n79lEVYRH0OEJKKoYfJGD1ByCga6uWgd5A&sig=Cg0ArKJSzAb-zGF3Ry1GEAE&uach_m=%5BUACH%5D&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ%3D%3D&adurl=
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.176.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s37-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:38 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 28 May 2024 14:17:38 GMT
multitracking
sghb.hbmp.mediafuse.com/adunit/
0
229 B
XHR
General
Full URL
https://sghb.hbmp.mediafuse.com/adunit/multitracking
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/hH0M_/hbw_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.151.194 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Mediafuse /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 28 May 2024 14:17:38 GMT
Access-Control-Allow-Credentials
true
Server
Mediafuse
Connection
Keep-Alive
X-Robots-Tag
noindex
activeview
pagead2.googlesyndication.com/pcs/ Frame 6283
42 B
65 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsu8LXkNuRjTKXOId8oJed0O7KDyI2x0ODKbaKD7Mp_sU42oHgg8pQnw8QDRtQqO9Y2GPGf2zDC3JSMol42xiVVhaKtsiOHapYfulflUOakGMMf4QOjvAtv18EGX_GgkAY8aLRCX90nX_OHJ9UmbY9YRaV1VkHtu7uyWrcnToQ&sig=Cg0ArKJSzGjunjq5Zo11EAE&id=lidar2&mcvt=1004&p=16,315,266,1285&mtos=1004,1004,1004,1004,1004&tos=1004,0,0,0,0&v=20240522&bin=7&avms=nio&bs=1600,1200&mc=1&vu=1&app=0&itpl=3&adk=1054140177&rs=4&la=1&cr=0&uach=WyJXaW4zMiIsIjEwLjAuMCIsIng4NiIsIiIsIjEyNS4wLjY0MjIuMTEyIixudWxsLDAsbnVsbCwiNjQiLFtbIkdvb2dsZSBDaHJvbWUiLCIxMjUuMC42NDIyLjExMiJdLFsiQ2hyb21pdW0iLCIxMjUuMC42NDIyLjExMiJdLFsiTm90LkEvQnJhbmQiLCIyNC4wLjAuMCJdXSwwXQ%3D%3D&vs=4&r=v&co=1283865800&rst=1716905858326&rpt=134&isd=0&lsd=0&met=mue&wmsd=0&pbe=0&fle=0&vae=0&spb=0&sfl=0&ffslot=0&reach=8&io2=0
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.64.66 Plainview, United States, ASN15169 (GOOGLE, US),
Reverse DNS
lga34s30-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
access-control-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
json
gum.criteo.com/sid/ Frame
0
0
Preflight
General
Full URL
https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2620:100:a00b::12 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
GET
Origin
https://www.fiercepharma.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
content-encoding
gzip
content-type
application/json; charset=utf-8
date
Tue, 28 May 2024 14:17:39 GMT
expires
0
pragma
no-cache
server
Kestrel
server-processing-duration-in-ticks
243657
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
envelope
lexicon.33across.com/v1/
42 B
247 B
Fetch
General
Full URL
https://lexicon.33across.com/v1/envelope?pid=001Pg000002HAjeIAG&gdpr=0&src=pbjs&ver=8.33.6&coppa=0
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.193.51 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
51.193.244.35.bc.googleusercontent.com
Software
/
Resource Hash
435b1ece4a55f4f8d06866b32c1aee3cc4661eb905265894795f15a57bf1b33d

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:39 GMT
via
1.1 google
vary
origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, must-revalidate, max-age=28800
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
sid
mug.criteo.com/
Redirect Chain
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
  • https://mug.criteo.com/sid?cpp=8yUVtHwyV0c1WTNxOXNyemtaaDdSa05NbXR0Qk1xM3FRaXRRbmd6ZjRGU05CZnF5bGVBcENuV29nQnljY3JTUjdEQlZBcVErMlRYU0Z5Y1F4RUYvdFNMZEpxbHhQTjc1UzJDanJ6ZU4vRENWR2k4RlMzRk5GbGs4YkxPWE...
487 B
739 B
Fetch
General
Full URL
https://mug.criteo.com/sid?cpp=8yUVtHwyV0c1WTNxOXNyemtaaDdSa05NbXR0Qk1xM3FRaXRRbmd6ZjRGU05CZnF5bGVBcENuV29nQnljY3JTUjdEQlZBcVErMlRYU0Z5Y1F4RUYvdFNMZEpxbHhQTjc1UzJDanJ6ZU4vRENWR2k4RlMzRk5GbGs4YkxPWEdwVVdnMEQyeGRTR2tvTmh3eDIyeFRxSFpJYVhuSC9VOWMzd2I5SnJabERuR2p0SEk5eDlId3JOYjZrMnVkcmRqeUJDOEZxSXhvSUczR0l4OHVyOEVvQWdBb0ZORk5ybzhENzl3RXAwZXRkU1VMcTNaRnU5V1FMTGhEemtOd3pVc2laTkVDZVNlTXpxR0x5VVZDaW5qeG9BcTlLRFo4c0JiZjF4R0JPcEJobGZ4Z1ZxWGQwT3lKYXJUZnFGM0pwR0JoS2N6SWhMd3w&cppv=2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
74.119.117.17 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
0202190042213a1fa848dbd2a38623c515411b6328787f20c97787649aefa70e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
server
Kestrel
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
null
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
785317
expires
0

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
strict-transport-security
max-age=31536000; preload;
server
Kestrel
access-control-allow-methods
GET
access-control-allow-origin
https://www.fiercepharma.com
location
https://mug.criteo.com/sid?cpp=8yUVtHwyV0c1WTNxOXNyemtaaDdSa05NbXR0Qk1xM3FRaXRRbmd6ZjRGU05CZnF5bGVBcENuV29nQnljY3JTUjdEQlZBcVErMlRYU0Z5Y1F4RUYvdFNMZEpxbHhQTjc1UzJDanJ6ZU4vRENWR2k4RlMzRk5GbGs4YkxPWEdwVVdnMEQyeGRTR2tvTmh3eDIyeFRxSFpJYVhuSC9VOWMzd2I5SnJabERuR2p0SEk5eDlId3JOYjZrMnVkcmRqeUJDOEZxSXhvSUczR0l4OHVyOEVvQWdBb0ZORk5ybzhENzl3RXAwZXRkU1VMcTNaRnU5V1FMTGhEemtOd3pVc2laTkVDZVNlTXpxR0x5VVZDaW5qeG9BcTlLRFo4c0JiZjF4R0JPcEJobGZ4Z1ZxWGQwT3lKYXJUZnFGM0pwR0JoS2N6SWhMd3w&cppv=2
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
338401
content-length
0
expires
0
prebid
id5-sync.com/api/config/
167 B
453 B
Fetch
General
Full URL
https://id5-sync.com/api/config/prebid
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.19.138.116 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31533567.ip-162-19-138.eu
Software
/
Resource Hash
a604d269f0e90cdbc41a214caf22ce642c97c130b17e314868b6bfba47e7c255
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:39 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
access-control-allow-credentials
true
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
id
id.crwdcntrl.net/
152 B
822 B
Fetch
General
Full URL
https://id.crwdcntrl.net/id
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.195.242.242 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-195-242-242.compute-1.amazonaws.com
Software
Jetty(9.4.38.v20210224) /
Resource Hash
a32427c74de3ac3f80dd59f953b6257515aff637964cf5ac55f3a63c78b8c21c

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
Jetty(9.4.38.v20210224)
content-type
application/json;charset=utf-8
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache
x-server
10.40.8.224
access-control-allow-credentials
true
content-length
152
expires
0
/
de.tynt.com/deb/ Frame F7CF
Redirect Chain
  • https://ssc-cms.33across.com/ps/?m=xch&rt=html&ru=deb&id=b-64TSyTCr7RPcrkHcnnVW&gdpr_consent=undefined&us_privacy=undefined&gpp=&gpp_sid=
  • https://de.tynt.com/deb/?m=xch&rt=html&ru=deb&id=b-64TSyTCr7RPcrkHcnnVW&gdpr_consent=undefined&us_privacy=undefined&gpp=&gpp_sid=
0
0
Document
General
Full URL
https://de.tynt.com/deb/?m=xch&rt=html&ru=deb&id=b-64TSyTCr7RPcrkHcnnVW&gdpr_consent=undefined&us_privacy=undefined&gpp=&gpp_sid=
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
67.202.105.34 , United States, ASN32748 (STEADFAST, US),
Reverse DNS
ip34.67-202-105.static.steadfastdns.net
Software
/
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Model, Sec-CH-UA-Full-Version-List, Sec-CH-UA, Sec-CH-UA-Mobile
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0, false
content-length
1787
content-type
text/html
date
Tue, 28 May 2024 14:17:39 GMT
expires
Sat, 26 Jul 1997 05:00:00 GMT
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
referrer-policy
unsafe-url

Redirect headers

cache-control
no-store, no-cache, must-revalidate
content-length
0
date
Tue, 28 May 2024 14:17:39 GMT
expires
Thu, 01-Jan-70 00:00:01 GMT
location
https://de.tynt.com/deb/?m=xch&rt=html&ru=deb&id=b-64TSyTCr7RPcrkHcnnVW&gdpr_consent=undefined&us_privacy=undefined&gpp=&gpp_sid=
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
pragma
no-cache
referrer-policy
unsafe-url
server
33XP009
x-33x-status
8340000A
async_usersync.html
acdn.adnxs.com/dmp/ Frame 6139
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.199.48.215 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-199-48-215.deploy.static.akamaitechnologies.com
Software
nginx/1.18.0 (Ubuntu) /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Origin
*
Cache-Control
max-age=86402
Connection
keep-alive
Content-Encoding
gzip
Content-Length
17053
Content-Type
text/html
Date
Tue, 28 May 2024 14:17:39 GMT
ETag
"623de86a-cf34"
Expires
Wed, 29 May 2024 14:17:41 GMT
Last-Modified
Fri, 25 Mar 2022 16:06:02 GMT
Server
nginx/1.18.0 (Ubuntu)
Vary
Accept-Encoding
async_usersync.html
acdn.adnxs.com/dmp/ Frame 7EFF
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.199.48.215 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-199-48-215.deploy.static.akamaitechnologies.com
Software
nginx/1.18.0 (Ubuntu) /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Origin
*
Cache-Control
max-age=86402
Content-Encoding
gzip
Content-Length
17053
Content-Type
text/html
Date
Tue, 28 May 2024 14:17:39 GMT
ETag
"623de86a-cf34"
Expires
Wed, 29 May 2024 14:17:41 GMT
Last-Modified
Fri, 25 Mar 2022 16:06:02 GMT
Server
nginx/1.18.0 (Ubuntu)
Vary
Accept-Encoding
ixmatch.html
js-sec.indexww.com/um/ Frame 89C4
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.38.76 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

age
768
cache-control
public, max-age=14400
cf-cache-status
HIT
cf-ray
88aede97ffaaac2a-YYZ
content-encoding
gzip
content-type
text/html; charset=UTF-8
date
Tue, 28 May 2024 14:17:39 GMT
expires
Tue, 28 May 2024 18:17:39 GMT
last-modified
Mon, 25 Jul 2022 19:18:19 GMT
p3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
server
cloudflare
vary
Accept-Encoding
isyn
prebid.a-mo.net/ Frame FD90
0
0
Document
General
Full URL
https://prebid.a-mo.net/isyn?gdpr_consent=&gdpr=0&us_privacy=&gpp=&gpp_sid=
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.28.129.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

cache-control
max-age=0, private, must-revalidate
content-encoding
gzip
content-length
567
content-type
text/html; charset=utf-8
date
Tue, 28 May 2024 14:17:39 GMT
server
envoy
vary
accept-encoding
x-envoy-upstream-service-time
1
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame A6FE
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=159302
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.51.57.13 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-51-57-13.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ranges
bytes
cache-control
max-age=69774
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 28 May 2024 14:17:39 GMT
expires
Wed, 29 May 2024 09:40:33 GMT
last-modified
Wed, 22 May 2024 00:02:24 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
csync
sync.adtelligent.com/ Frame 4497
Redirect Chain
  • https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D50%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D7647...
  • https://sync.adtelligent.com/csync?t=g&ep=50&traffic_source=snippet&session=41CE24396FE8317E&sp=852559&pb=753264&c=764710&a=743293&domain=https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiar...
0
0
Document
General
Full URL
https://sync.adtelligent.com/csync?t=g&ep=50&traffic_source=snippet&session=41CE24396FE8317E&sp=852559&pb=753264&c=764710&a=743293&domain=https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&extuid=5414751822788295032
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.146.18 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtelligent /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Content-Length
43
Content-Type
image/gif
Date
Tue, 28 May 2024 14:17:39 GMT
Etag
97b6bb00c3c60ab3
Server
Adtelligent

Redirect headers

accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
access-control-allow-methods
GET
access-control-allow-origin
*
access-control-max-age
86400
content-length
0
date
Tue, 28 May 2024 14:17:39 GMT
location
https://sync.adtelligent.com/csync?t=g&ep=50&traffic_source=snippet&session=41CE24396FE8317E&sp=852559&pb=753264&c=764710&a=743293&domain=https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&extuid=5414751822788295032
server
nginx
checksync.php
contextual.media.net/ Frame EAF9
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?vsSync=1&cs=8&cv=31&https=1&cid=8CU816538&prvid=2034%2C2033%2C2110%2C2030%2C590%2C273%2C2107%2C233%2C2027%2C2026%2C2025%2C237%2C556%2C117%2C359%2C97%2C2109%2C55%2C99%2C3012%2C3011%2C3010%2C3007%2C246%2C4%2C521%2C126%2C203%2C2113%2C446%2C404%2C9%2C2090%2C2011%2C2055%2C2099%2C3022%2C3020%2C251%2C175%2C450%2C2009%2C178%2C255%2C3018%2C3017%2C214%2C3014%2C459%2C77%2C38%2C2022%2C182%2C261%2C141%2C262%2C461%2C222%2C542%2C301%2C345%2C225%2C468%2C10000%2C80%2C108%2C229&itype=PREBID&purpose1=1&gdprconsent=1&gdpr=0&coppa=0&usp_status=0&usp_consent=1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.47.168.66 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-47-168-66.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=93600
cache-control
max-age=172800
content-encoding
gzip
content-length
12386
content-type
text/html; charset=UTF-8
date
Tue, 28 May 2024 14:17:39 GMT
expires
Thu, 30 May 2024 14:17:39 GMT
server
Apache
strict-transport-security
max-age=31536000
vary
Accept-Encoding
x-mnet-hl2
E
sync
ssp.disqus.com/ Frame 17B5
0
0
Document
General
Full URL
https://ssp.disqus.com/sync?type=iframe
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.197.117.43 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-197-117-43.compute-1.amazonaws.com
Software
/
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

cache-control
no-store
content-encoding
gzip
content-length
276
date
Tue, 28 May 2024 14:17:39 GMT
expires
0
pragma
no-cache
checksync.php
contextual.media.net/ Frame 1AF0
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?vsSync=1&cs=8&cv=31&https=1&cid=8CUO2I9ST&prvid=2034%2C590%2C159%2C236%2C237%2C117%2C359%2C97%2C55%2C99%2C3012%2C3010%2C244%2C201%2C3007%2C246%2C4%2C521%2C126%2C203%2C446%2C9%2C208%2C173%2C294%2C251%2C175%2C450%2C178%2C255%2C3018%2C3017%2C214%2C3016%2C337%2C338%2C459%2C70%2C77%2C2022%2C182%2C261%2C141%2C262%2C186%2C461%2C222%2C10000%2C80%2C108%2C229%2C109%2C307&itype=PREBID&purpose1=1&gdprconsent=1&gdpr=0&coppa=0&usp_status=0&usp_consent=1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.47.168.66 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-47-168-66.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=93600
cache-control
max-age=172800
content-encoding
gzip
content-length
12315
content-type
text/html; charset=UTF-8
date
Tue, 28 May 2024 14:17:39 GMT
expires
Thu, 30 May 2024 14:17:39 GMT
server
Apache
strict-transport-security
max-age=31536000
vary
Accept-Encoding
x-mnet-hl2
E
/
de.tynt.com/deb/ Frame 1435
Redirect Chain
  • https://ssc-cms.33across.com/ps/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D8...
  • https://de.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26...
0
0
Document
General
Full URL
https://de.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D33XUSERID33X
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
67.202.105.34 , United States, ASN32748 (STEADFAST, US),
Reverse DNS
ip34.67-202-105.static.steadfastdns.net
Software
/
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Model, Sec-CH-UA-Full-Version-List, Sec-CH-UA, Sec-CH-UA-Mobile
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0, false
content-length
1985
content-type
text/html
date
Tue, 28 May 2024 14:17:39 GMT
expires
Sat, 26 Jul 1997 05:00:00 GMT
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
referrer-policy
unsafe-url

Redirect headers

cache-control
no-store, no-cache, must-revalidate
content-length
0
date
Tue, 28 May 2024 14:17:39 GMT
expires
Thu, 01-Jan-70 00:00:01 GMT
location
https://de.tynt.com/deb/?m=xch&rt=html&id=0010b00002T3JniAAF&ru=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Dg%26ep%3D58%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D763280%26a%3D304056%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D33XUSERID33X
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
pragma
no-cache
referrer-policy
unsafe-url
server
33XP020
x-33x-status
8340000A
sync-all.html
adxbid.info/ Frame AF62
0
0
Document
General
Full URL
https://adxbid.info/sync-all.html?gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.67.138.13 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
88aede97e93c4bc3-BUF
content-encoding
br
content-type
text/html; charset=utf-8
date
Tue, 28 May 2024 14:17:40 GMT
last-modified
Thu, 26 Jan 2023 09:50:58 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=2G8G%2BBemzBv26fubzaA1WxMhv5%2B5Zzc2wiDOlzYn51kZEXqNvI10ATPBKdZlCTu%2BGaYQMJXbcd4La9fX8MxM%2FBg%2ByIPTHxRvXURO3pkdiKwQNANAY4qEGRyTDDdqiw%3D%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
/
onetag-sys.com/usync/ Frame 093E
0
0
Document
General
Full URL
https://onetag-sys.com/usync/?pubId=59a18369e249bfb
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.184 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip184.ip-51-222-39.net
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
1482
content-type
text/html
strict-transport-security
max-age=15552000
visitormatch
bh.contextweb.com/ Frame FCEA
0
0
Document
General
Full URL
https://bh.contextweb.com/visitormatch
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.131 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
cache-control
private, max-age=0, no-cache, no-store
content-language
en-US
content-length
3877
content-type
text/html;charset=iso-8859-1
cw-server
bh-deployment-5ddc6bc9fd-8x5v9
expires
-1
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
server
Jetty(10.0.14)
strict-transport-security
max-age=15768000
async_usersync.html
acdn.adnxs.com/dmp/ Frame FA05
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.199.48.215 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-199-48-215.deploy.static.akamaitechnologies.com
Software
nginx/1.18.0 (Ubuntu) /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Origin
*
Cache-Control
max-age=86402
Content-Encoding
gzip
Content-Length
17053
Content-Type
text/html
Date
Tue, 28 May 2024 14:17:39 GMT
ETag
"623de86a-cf34"
Expires
Wed, 29 May 2024 14:17:41 GMT
Last-Modified
Fri, 25 Mar 2022 16:06:02 GMT
Server
nginx/1.18.0 (Ubuntu)
Vary
Accept-Encoding
beacon
ce.lijit.com/ Frame 13A6
Redirect Chain
  • https://ap.lijit.com/beacon?informer=13459965
  • https://ce.lijit.com/beacon?informer=13459965
0
0
Document
General
Full URL
https://ce.lijit.com/beacon?informer=13459965
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.81.175.178 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-81-175-178.compute-1.amazonaws.com
Software
/
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

cache-control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
content-encoding
gzip
content-length
1176
content-type
text/html
date
Tue, 28 May 2024 14:17:40 GMT
expires
Fri, 20 Mar 2009 00:00:00 GMT
p3p
CP="CUR ADM OUR NOR STA NID"
pragma
no-cache
vary
Accept-Encoding

Redirect headers

content-length
110
content-type
text/html
date
Tue, 28 May 2024 14:17:39 GMT
location
https://ce.lijit.com:443/beacon?informer=13459965
server
awselb/2.0
sync.html
s.console.adtarget.com.tr/ Frame 69DD
0
0
Document
General
Full URL
https://s.console.adtarget.com.tr/sync.html?aid=748067
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2607:4f00:968::2 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
Adtarget /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Credentials
true
Access-Control-Allow-Origin
https://www.fiercepharma.com
Connection
Keep-Alive
Date
Tue, 28 May 2024 14:17:39 GMT
Permissions-Policy
browsing-topics=()
Server
Adtarget
X-Robots-Tag
noindex
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame 6580
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?kdntuid=1&p=159302
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.51.57.13 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-51-57-13.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ranges
bytes
cache-control
max-age=69774
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 28 May 2024 14:17:39 GMT
expires
Wed, 29 May 2024 09:40:33 GMT
last-modified
Wed, 22 May 2024 00:02:24 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
/
onetag-sys.com/usync/ Frame 8665
0
0
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1716905856400
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.222.39.184 , Canada, ASN16276 (OVH, FR),
Reverse DNS
ip184.ip-51-222-39.net
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=900, h3-29=":443"; ma=900
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
1441
content-type
text/html
strict-transport-security
max-age=15552000
sync
eb2.3lift.com/ Frame 59E6
0
0
Document
General
Full URL
https://eb2.3lift.com/sync?
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.223.22.214 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
afb83dd09526a6517.awsglobalaccelerator.com
Software
/
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

cache-control
no-cache, no-store, must-revalidate
content-length
1115
content-type
text/html; charset=utf-8
date
Tue, 28 May 2024 14:17:39 GMT
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
visitormatch
bh.contextweb.com/ Frame 5D3A
0
0
Document
General
Full URL
https://bh.contextweb.com/visitormatch
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.131 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(10.0.14) /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
cache-control
private, max-age=0, no-cache, no-store
content-language
en-US
content-length
455
content-type
text/html;charset=iso-8859-1
cw-server
bh-deployment-5ddc6bc9fd-8x5v9
expires
-1
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
server
Jetty(10.0.14)
strict-transport-security
max-age=15768000
user_sync.html
ads.pubmatic.com/AdServer/js/ Frame E39B
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?gdpr=0&gdpr_consent={gdpr_consent}&us_privacy={us_privacy}&predirect=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D558003%26traffic_source%3Dsnippet%26session%3D41CE24396FE8317E%26sp%3D852559%26pb%3D753264%26c%3D765040%26a%3D558003%26domain%3Dhttps%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%26extuid%3D
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.51.57.13 Secaucus, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-51-57-13.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ranges
bytes
cache-control
max-age=69774
content-encoding
gzip
content-length
5685
content-type
text/html
date
Tue, 28 May 2024 14:17:39 GMT
expires
Wed, 29 May 2024 09:40:33 GMT
last-modified
Wed, 22 May 2024 00:02:24 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
server
Apache
vary
Accept-Encoding
sync.html
public.servenobid.com/ Frame EEF1
0
0
Document
General
Full URL
https://public.servenobid.com/sync.html
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.164.116.122 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-164-116-122.jfk50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

age
19328
cache-control
max-age=86400
content-encoding
br
content-type
text/html
date
Tue, 28 May 2024 08:55:32 GMT
etag
W/"ff07c8e3bd68ae557c7783f563f2e16b"
last-modified
Thu, 11 Apr 2024 21:40:36 GMT
server
AmazonS3
vary
Accept-Encoding Origin
via
1.1 b863f5ba2fad5306016f04b0ec05bd82.cloudfront.net (CloudFront)
x-amz-cf-id
K1oB5XgUpo7h8vmB9is2r4ZaI4r_6jvgodSwbrHBBypmRMH3TXdaNQ==
x-amz-cf-pop
JFK50-P6
x-amz-meta-codebuild-buildarn
arn:aws:codebuild:us-east-1:559734745816:build/adserver-public-prod:69374897-8ebf-443f-b8c0-1cc68fdce58a
x-amz-meta-codebuild-content-md5
7222d9b5c21ee453bec6e6836a76e694
x-amz-meta-codebuild-content-sha256
0046597e275c679c7baf4bc17a16f7541f9f38f204ecbef154219cfbfe8dbe01
x-amz-server-side-encryption
AES256
x-amz-version-id
null
x-cache
Hit from cloudfront
pixel
capi.connatix.com/us/
Redirect Chain
  • https://capi.connatix.com/us/pixel?puid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&pId=43&gdpr_consent=&callback=&us_privacy=
  • https://capi.connatix.com/us/pixel?puid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&pId=43&gdpr_consent=&callback=&us_privacy=&final=true
82 B
82 B
Image
General
Full URL
https://capi.connatix.com/us/pixel?puid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&pId=43&gdpr_consent=&callback=&us_privacy=&final=true
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
104.18.41.104 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:39 GMT
content-encoding
gzip
cf-cache-status
DYNAMIC
server
cloudflare
surrogate-control
no-cache, no-store, must-revalidate, max-age=0
vary
Accept-Encoding
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate, max-age=0
cf-ray
88aede97cf6bac2a-YYZ
access-control-allow-headers
x-sec-ch-ua-platform-version, x-sec-ch-ua-full-version-list, x-sec-ch-ua-arch, x-sec-ch-ua-bitness, x-sec-ch-ua-model
content-length
95
alt-svc
h3=":443"; ma=86400

Redirect headers

date
Tue, 28 May 2024 14:17:39 GMT
cf-cache-status
DYNAMIC
server
cloudflare
location
https://capi.connatix.com/us/pixel?puid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&pId=43&gdpr_consent=&callback=&us_privacy=&final=true
cache-control
no-cache, no-store, must-revalidate, max-age=0
cf-ray
88aede96be54ac2a-YYZ
access-control-allow-headers
x-sec-ch-ua-platform-version, x-sec-ch-ua-full-version-list, x-sec-ch-ua-arch, x-sec-ch-ua-bitness, x-sec-ch-ua-model
content-length
0
alt-svc
h3=":443"; ma=86400
dcm
aax-eu.amazon-adsystem.com/s/
Redirect Chain
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=135&partneruserid=TAM_OK&redirurl=https%3A%2F%2Faax-eu.amazon-adsystem.com%2Fs%2Fdcm%3Fpid%3Df7a5db36-1d5c-4c26-81b6-b4d0807faffb%26id%3D...
  • https://aax-eu.amazon-adsystem.com/s/dcm?pid=f7a5db36-1d5c-4c26-81b6-b4d0807faffb&id=5033829378062940454&gdpr=0&gdpr_consent=
43 B
855 B
Image
General
Full URL
https://aax-eu.amazon-adsystem.com/s/dcm?pid=f7a5db36-1d5c-4c26-81b6-b4d0807faffb&id=5033829378062940454&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
67.220.226.233 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
Security Headers
Name Value
Strict-Transport-Security max-age=47474747; includeSubDomains; preload

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:40 GMT
Strict-Transport-Security
max-age=47474747; includeSubDomains; preload
Server
Server
x-amz-rid
GG8JN0YFG5NGGN26QBCY
Vary
Content-Type,Accept-Encoding,User-Agent
Content-Type
image/gif
p3p
policyref="https://www.amazon.com/w3c/p3p.xml", CP="PSAo PSDo OUR SAM OTR DSP COR"
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

location
https://aax-eu.amazon-adsystem.com/s/dcm?pid=f7a5db36-1d5c-4c26-81b6-b4d0807faffb&id=5033829378062940454&gdpr=0&gdpr_consent=
pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
cache-control
no-cache,no-store
content-length
0
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
/
wt.rqtrk.eu/
Redirect Chain
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=150&partneruserid=0&redirurl=https%3A%2F%2Fwt.rqtrk.eu%3Fpid%3D58a76248-f101-4e52-b8f7-c4de9362ea12%26src%3Dwww%26type%3D100%26sid%3D0%26...
  • https://wt.rqtrk.eu/?pid=58a76248-f101-4e52-b8f7-c4de9362ea12&src=www&type=100&sid=0&uid=5033829378062940454&gdpr_pd=0&gdpr=0&gdpr_consent=
43 B
350 B
Image
General
Full URL
https://wt.rqtrk.eu/?pid=58a76248-f101-4e52-b8f7-c4de9362ea12&src=www&type=100&sid=0&uid=5033829378062940454&gdpr_pd=0&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
51.222.241.106 , Canada, ASN16276 (OVH, FR),
Reverse DNS
haproxy-ca-012.roqad.pl
Software
istio-envoy /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
server
istio-envoy
p3p
CP="NOI DSP COR DEVa PSAa PSDa OUR BUS UNI COM NAV STA"
content-type
image/gif
cache-control
no-cache,private
x-envoy-upstream-service-time
0
content-length
43
expires
Tue, 28 May 2024 14:17:39 GMT

Redirect headers

location
https://wt.rqtrk.eu?pid=58a76248-f101-4e52-b8f7-c4de9362ea12&src=www&type=100&sid=0&uid=5033829378062940454&gdpr_pd=0&gdpr=0&gdpr_consent=
pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
cache-control
no-cache,no-store
content-length
0
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=140&gdpr=0&gdpr_consent=
  • https://sync.crwdcntrl.net/qmap?c=1389&tp=STSC&tpid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&gdpr=0&gdpr_consent=&d=https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Fpush%3Fpartner_id%3D2499%...
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2499&partner_device_id=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&partner_url=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dbs%26nuid%3D...
  • https://sync.go.sonobi.com/us.gif?nw=bs&nuid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&gdpr=0&gdpr_consent=
49 B
782 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=bs&nuid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 28 May 2024 14:17:40 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
access-control-allow-origin
*
location
https://sync.go.sonobi.com/us.gif?nw=bs&nuid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&gdpr=0&gdpr_consent=
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?do=add&pid=560606&ev=37e0b433-a139-49aa-b81e-736192785b62&daaqp=1&rurl=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dpp%26nuid%3D%25%25VGUID%25%25
  • https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
49 B
818 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
location
https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-5ddc6bc9fd-8x5v9
expires
-1
prebid
b1h.zemanta.com/usersync/
Redirect Chain
  • https://b1h.zemanta.com/usersync/prebid
  • https://b1h.zemanta.com/usersync/prebid?s=2
26 B
388 B
Image
General
Full URL
https://b1h.zemanta.com/usersync/prebid?s=2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
70.42.32.223 , United States, ASN22075 (AS-OUTBRAIN, US),
Reverse DNS
ny.outbrain.com
Software
/
Resource Hash
3b7b8a4b411ddf8db9bacc2f3aabf406f8e4c0c087829b336ca331c40adfdff1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

P3p
CP="We do not support P3P header."
Date
Tue, 28 May 2024 14:17:39 GMT
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Content-Length
26
Content-Type
image/gif

Redirect headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:39 GMT
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
Content-Type
text/html; charset=utf-8
Location
/usersync/prebid?s=2
P3p
CP="We do not support P3P header."
Cache-Control
no-cache, no-store, must-revalidate
Content-Length
43
Expires
Thu, 01 Dec 1994 16:00:00 GMT
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://p.rfihub.com/cm?pub=35683&in=1
  • https://sync.go.sonobi.com/us.gif?nw=zt&nuid=1977432099757787762
49 B
750 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=zt&nuid=1977432099757787762
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

Location
https://sync.go.sonobi.com/us.gif?nw=zt&nuid=1977432099757787762
Date
Tue, 28 May 2024 14:17:39 GMT
Server
Jetty(9.4.51.v20230217)
Content-Length
0
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=sonobi&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=bidswitch_dbm&google_cm&google_sc&ssp=sonobi&bsw_param=44473d7f-146b-4d56-aac1-0838865cfa25&google_hm=NDQ0NzNkN2YtMTQ2Yi00ZDU2LWFhYzEtMDgzODg2NWNmYTI1&...
  • https://x.bidswitch.net/sync?dsp_id=16&user_id=CAESEAVEz6Uf4bG5tngCn01NPqc&google_cver=1&ssp=sonobi&bsw_param=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr_consent=&gdpr=0
  • https://sync.go.sonobi.com/us.gif?nw=bidswitch&nuid=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr=0&gdpr_consent=&us_privacy=
49 B
768 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=bidswitch&nuid=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr=0&gdpr_consent=&us_privacy=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

Location
//sync.go.sonobi.com/us.gif?nw=bidswitch&nuid=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr=0&gdpr_consent=&us_privacy=
Date
Tue, 28 May 2024 14:17:40 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
usg.gif
sync.go.sonobi.com/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=sonobi&google_cm&google_hm=MzdlMGI0MzMtYTEzOS00OWFhLWI4MWUtNzM2MTkyNzg1YjYy
  • https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
49 B
837 B
Image
General
Full URL
https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
288
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
7318ffc0e8fa1d771446
s.amazon-adsystem.com/x/
0
0

cookie
a.vidoomy.com/api/rtbserver/
Redirect Chain
  • https://pixel.rubiconproject.com/exchange/sync.php?p=pbs-vidoomy&gdpr=0&gdpr_consent=&us_privacy=
  • https://a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=LWQHF0YD-F-3YJX&gdpr=0
43 B
622 B
Image
General
Full URL
https://a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=LWQHF0YD-F-3YJX&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
212.36.83.245 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb1.vdmy.dtic.es
Software
nginx /
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:40 GMT
Content-Encoding
none
Server
nginx
Access-Control-Allow-Methods
HEAD,GET,POST,PUT,DELETE,PATCH,OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
X-VD-C
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
Content-Length
43

Redirect headers

Pragma
no-cache
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Content-Type
text/html
Location
https://a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=LWQHF0YD-F-3YJX&gdpr=0
Cache-Control
no-cache,no-store,must-revalidate
content-length
0
X-RPHost
772cc9037cd6dc6f19451a098a1a8570
Expires
0
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=sonobi&ttd_tpi=1&ttd_puid=db8d61494a&gdpr=0&gdpr_consent=
  • https://sync.go.sonobi.com/us.gif?nw=td&nuid=5bd0543e-1516-41ce-8e0f-a61e663146fe&pubid=db8d61494a
49 B
844 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=td&nuid=5bd0543e-1516-41ce-8e0f-a61e663146fe&pubid=db8d61494a
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

location
https://sync.go.sonobi.com/us.gif?nw=td&nuid=5bd0543e-1516-41ce-8e0f-a61e663146fe&pubid=db8d61494a
date
Tue, 28 May 2024 14:17:39 GMT
server
Kestrel
content-length
227
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?do=add&pid=560606&ev=e5b82ed2-a27a-4119-a30f-bd23df1a7c02&daaqp=1&rurl=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dpp%26nuid%3D%25%25VGUID%25%25
  • https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
49 B
818 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

strict-transport-security
max-age=15768000
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Platform-Version
server
Jetty(10.0.14)
content-language
en-US
location
https://sync.go.sonobi.com/us.gif?nw=pp&nuid=e4ym7CSbzvEQ
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-5ddc6bc9fd-8x5v9
expires
-1
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://sync.mathtag.com/sync/img?cs_wd_sy=1&dp=43&redir=https%3A%2F%2Fsync.go.sonobi.com%2Fus.gif%3Fnw%3Dif%26nuid%3D[MM_UUID]
  • https://sync.go.sonobi.com/us.gif?nw=if&nuid=cd246655-e780-4000-ba4c-39351745637e
49 B
768 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=if&nuid=cd246655-e780-4000-ba4c-39351745637e
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

Date
Tue, 28 May 2024 14:17:39 GMT
Server
MT3 1624 115fb92 master ord ord-pixel-x56 config_version:"1904"
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Access-Control-Allow-Origin
*
location
https://sync.go.sonobi.com/us.gif?nw=if&nuid=cd246655-e780-4000-ba4c-39351745637e
Content-Type
image/gif
Cache-Control
no-cache
Connection
keep-alive
Keep-Alive
timeout=360
Content-Length
0
Expires
Tue, 28 May 2024 14:17:38 GMT
cookie
a.vidoomy.com/api/rtbserver/
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=vidoomy&gdpr=0&gdpr_consent=&us_privacy=
  • https://pr-bh.ybp.yahoo.com/sync/iponweb?bidswitch_ssp_id=vidoomy&ssp_user_id=44473d7f-146b-4d56-aac1-0838865cfa25&gdpr=0&gdpr_consent=
  • https://x.bidswitch.net/sync?dsp_id=74&&user_id=y-SAg04vJE2pn3DJi5yEmKJOzITiYyPLZmOrtpwA--~A&expires=5&ssp=vidoomy
  • https://a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=44473d7f-146b-4d56-aac1-0838865cfa25
43 B
650 B
Image
General
Full URL
https://a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=44473d7f-146b-4d56-aac1-0838865cfa25
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
212.36.83.245 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb1.vdmy.dtic.es
Software
nginx /
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:41 GMT
Content-Encoding
none
Server
nginx
Access-Control-Allow-Methods
HEAD,GET,POST,PUT,DELETE,PATCH,OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
X-VD-C
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
Content-Length
43

Redirect headers

Location
//a.vidoomy.com/api/rtbserver/cookie?i=BS&uid=44473d7f-146b-4d56-aac1-0838865cfa25
Date
Tue, 28 May 2024 14:17:40 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
nginx
Connection
keep-alive
Content-Length
0
receive
pixel.tapad.com/idsync/ex/
Redirect Chain
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3061&partner_device_id=e5b82ed2-a27a-4119-a30f-bd23df1a7c02
  • https://secure.adnxs.com/getuid?https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DAPPNEXUS%26partner_device_id%3D%24UID%26pt%3D8b9295b3-715d-4cf4-8e2c-6688206c4e63%252C%252C
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:39 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
an-x-request-uuid
7097e029-5163-458e-85ce-b31ef35817e6
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
pixel
capi.connatix.com/us/
82 B
82 B
Image
General
Full URL
https://capi.connatix.com/us/pixel?puid=37e0b433-a139-49aa-b81e-736192785b62&pId=43&gdpr_consent=&callback=&us_privacy=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.41.104 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Tue, 28 May 2024 14:17:40 GMT
content-encoding
gzip
cf-cache-status
DYNAMIC
server
cloudflare
surrogate-control
no-cache, no-store, must-revalidate, max-age=0
vary
Accept-Encoding
content-type
image/gif
cache-control
no-cache, no-store, must-revalidate, max-age=0
cf-ray
88aede98d86dac2a-YYZ
access-control-allow-headers
x-sec-ch-ua-platform-version, x-sec-ch-ua-full-version-list, x-sec-ch-ua-arch, x-sec-ch-ua-bitness, x-sec-ch-ua-model
content-length
95
alt-svc
h3=":443"; ma=86400
usg.gif
sync.go.sonobi.com/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=sonobi&google_cm&google_hm=ZTViODJlZDItYTI3YS00MTE5LWEzMGYtYmQyM2RmMWE3YzAy
  • https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
49 B
837 B
Image
General
Full URL
https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
server
HTTP server (unknown)
content-type
text/html; charset=UTF-8
location
https://sync.go.sonobi.com/usg.gif?google_gid=CAESEPTIQ05gw6BA1vDolnHAWug&google_cver=1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
288
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
us.gif
sync.go.sonobi.com/
Redirect Chain
  • https://sync.srv.stackadapt.com/sync?nid=286
  • https://sync.go.sonobi.com/us.gif?nw=st&nuid=zVScQUXbVQ9daTpti8VsWmAJ-So
49 B
759 B
Image
General
Full URL
https://sync.go.sonobi.com/us.gif?nw=st&nuid=zVScQUXbVQ9daTpti8VsWmAJ-So
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
2607:f350:3:2569:0:10:0:200c , United States, ASN27630 (AS-XFERNET, US),
Reverse DNS
Software
sonobi-go /
Resource Hash
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
server
sonobi-go
vary
negotiate,Accept-Encoding
x-go-server
go-iad-2-5-81
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store, private
tcn
Choice
content-length
49
x-xss-protection
0
expires
Sat, 26 Jul 1997 05:00:00 GMT

Redirect headers

Location
https://sync.go.sonobi.com/us.gif?nw=st&nuid=zVScQUXbVQ9daTpti8VsWmAJ-So
Date
Tue, 28 May 2024 14:17:40 GMT
Connection
keep-alive
Content-Length
99
Content-Type
text/html; charset=utf-8
e09bad714a425a93d6dea503dcf9c528.gif
cs.admanmedia.com/
0
0

setuid
a-prebid.vidoomy.com/
Redirect Chain
  • https://cm.adform.net/cookie?redirect_url=https%3A%2F%2Fa-prebid.vidoomy.com%2Fsetuid%3Fbidder%3Dadf%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24UID
  • https://a-prebid.vidoomy.com/setuid?bidder=adf&gdpr=0&gdpr_consent=&uid=5414751822788295032
86 B
555 B
Image
General
Full URL
https://a-prebid.vidoomy.com/setuid?bidder=adf&gdpr=0&gdpr_consent=&uid=5414751822788295032
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
212.36.83.246 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb2.vdmy.dtic.es
Software
nginx /
Resource Hash
c2ecff291918a3caf0b7e470323e89f2a1f05b92e12a10649e598cacebe62acf

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 28 May 2024 14:17:41 GMT
Server
nginx
Vary
Origin
Content-Type
image/png
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Length
86
Expires
0

Redirect headers

date
Tue, 28 May 2024 14:17:40 GMT
server
nginx
accept-ch
Sec-CH-UA,Sec-CH-UA-Arch,Sec-CH-UA-Bitness,Sec-CH-UA-Full-Version-List,Sec-CH-UA-Mobile,Sec-CH-UA-Model,Sec-CH-UA-Platform,Sec-CH-UA-Platform-Version
access-control-max-age
86400
access-control-allow-methods
GET
location
https://a-prebid.vidoomy.com/setuid?bidder=adf&gdpr=0&gdpr_consent=&uid=5414751822788295032
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type,Cache-Control,Accept-Encoding,X-Requested-With
content-length
0
/
rtb-csync.smartadserver.com/redir/
Redirect Chain
  • https://image6.pubmatic.com/AdServer/UCookieSetPug?&rd=https%3A%2F%2Frtb-csync.smartadserver.com%2Fredir%2F%3Fissi%3D1%26partnerid%3D91%26partneruserid%3D%23PM_USER_ID%26gdpr%3DPM_GDPR%26gdpr_conse...
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=91&partneruserid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent=
43 B
394 B
Image
General
Full URL
https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=91&partneruserid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
216.22.16.73 Manassas, United States, ASN30633 (LEASEWEB-USA-WDC, US),
Reverse DNS
Software
/
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

content-type
image/gif
pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
cache-control
no-cache,no-store
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"

Redirect headers

location
https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=91&partneruserid=A1C42EB9-955D-4866-B405-509F11DA5631&gdpr=0&gdpr_consent=
date
Tue, 28 May 2024 14:17:39 GMT
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
content-length
0
content-type
text/html; charset=UTF-8
receive
pixel.tapad.com/idsync/ex/
Redirect Chain
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=3061&partner_device_id=37e0b433-a139-49aa-b81e-736192785b62
  • https://secure.adnxs.com/getuid?https%3A%2F%2Fpixel.tapad.com%2Fidsync%2Fex%2Freceive%3Fpartner_id%3DAPPNEXUS%26partner_device_id%3D%24UID%26pt%3D8b9295b3-715d-4cf4-8e2c-6688206c4e63%252C%252C
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
95 B
124 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
34.111.113.62 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
62.113.111.34.bc.googleusercontent.com
Software
Jetty(11.0.13) /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:40 GMT
strict-transport-security
max-age=31536000
via
1.1 google
accept-ch
Sec-CH-UA, Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-WoW64
server
Jetty(11.0.13)
content-type
image/png
access-control-allow-origin
*
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
95

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
an-x-request-uuid
de4cf6ba-0f50-493f-8de0-1703450ae429
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://pixel.tapad.com/idsync/ex/receive?partner_id=APPNEXUS&partner_device_id=7532885200230356581&pt=8b9295b3-715d-4cf4-8e2c-6688206c4e63%2C%2C
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
52154.gif
idsync.rlcdn.com/
Redirect Chain
  • https://idsync.rlcdn.com/711892.gif?partner_uid=e5b82ed2-a27a-4119-a30f-bd23df1a7c02
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fidsync.rlcdn.com%2F52154.gif%3Fserved_by%3Devergreen%26partner_uid%3D%24UID
  • https://idsync.rlcdn.com/52154.gif?served_by=evergreen&partner_uid=7532885200230356581
42 B
60 B
Image
General
Full URL
https://idsync.rlcdn.com/52154.gif?served_by=evergreen&partner_uid=7532885200230356581
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
35.244.154.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.154.244.35.bc.googleusercontent.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:40 GMT
via
1.1 google
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:39 GMT
an-x-request-uuid
d0950e69-2e0f-4fc3-a048-b0c299d466a1
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://idsync.rlcdn.com/52154.gif?served_by=evergreen&partner_uid=7532885200230356581
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
cookie
a.vidoomy.com/api/rtbserver/
Redirect Chain
  • https://pixel-sync.sitescout.com/dmp/pixelSync?nid=120&gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fa.vidoomy.com%2Fapi%2Frtbserver%2Fcookie%3Fi%3DCEN%26uid%3D%7BuserId%7D
  • https://a.vidoomy.com/api/rtbserver/cookie?i=CEN&uid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553
43 B
738 B
Image
General
Full URL
https://a.vidoomy.com/api/rtbserver/cookie?i=CEN&uid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
HTTP/1.1
Server
212.36.83.245 Barcelona, Spain, ASN15699 (AS_ADAM Adam Datacenter, ES),
Reverse DNS
lb1.vdmy.dtic.es
Software
nginx /
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

Date
Tue, 28 May 2024 14:17:40 GMT
Content-Encoding
none
Server
nginx
Access-Control-Allow-Methods
HEAD,GET,POST,PUT,DELETE,PATCH,OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
X-VD-C
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
*
Content-Length
43

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
via
1.1 google
server
A
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
location
https://a.vidoomy.com/api/rtbserver/cookie?i=CEN&uid=b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553
cache-control
max-age=0,no-cache,no-store
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Tue, 11 Oct 1977 12:34:56 GMT
/
rtb-csync.smartadserver.com/redir/
Redirect Chain
  • https://secure.adnxs.com/getuid?https%3A%2F%2Frtb-csync.smartadserver.com%2Fredir%2F%3Fissi%3D1%26partnerid%3D86%26partneruserid%3D$UID&gdpr=0&gdpr_consent=
  • https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=86&partneruserid=7532885200230356581&gdpr=0&gdpr_consent=
43 B
336 B
Image
General
Full URL
https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=86&partneruserid=7532885200230356581&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H2
Server
216.22.16.73 Manassas, United States, ASN30633 (LEASEWEB-USA-WDC, US),
Reverse DNS
Software
/
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

content-type
image/gif
pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
cache-control
no-cache,no-store
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"

Redirect headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
an-x-request-uuid
867831f4-865d-40a6-8127-56be77516cf6
server
nginx/1.23.4
accept-ch
Sec-CH-UA-Full-Version-List,Sec-CH-UA-Arch,Sec-CH-UA-Model,Sec-CH-UA-Platform-Version,Sec-CH-UA-Bitness
p3p
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-type
text/html; charset=utf-8
access-control-allow-origin
*
cache-control
no-store, no-cache, private
access-control-allow-credentials
true
location
https://rtb-csync.smartadserver.com/redir/?issi=1&partnerid=86&partneruserid=7532885200230356581&gdpr=0&gdpr_consent=
x-proxy-origin
96.9.249.42; 96.9.249.42; 797.bm-nginx-loadbalancer.mgmt.nym2.adnexus.net; adnxs.com
content-length
0
x-xss-protection
0
expires
Sat, 15 Nov 2008 16:00:00 GMT
user_sync.html
ads.pubmatic.com/AdServer/js/
0
0

362588.gif
idsync.rlcdn.com/
Redirect Chain
  • https://idsync.rlcdn.com/711892.gif?partner_uid=37e0b433-a139-49aa-b81e-736192785b62
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=liveramp&ttd_tpi=1
  • https://idsync.rlcdn.com/362588.gif?partner_uid=5bd0543e-1516-41ce-8e0f-a61e663146fe
42 B
60 B
Image
General
Full URL
https://idsync.rlcdn.com/362588.gif?partner_uid=5bd0543e-1516-41ce-8e0f-a61e663146fe
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Protocol
H3
Server
35.244.154.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.154.244.35.bc.googleusercontent.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Accept-Language
en-US,en;q=0.9;q=0.9
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

date
Tue, 28 May 2024 14:17:40 GMT
via
1.1 google
content-type
image/gif
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42

Redirect headers

location
https://idsync.rlcdn.com/362588.gif?partner_uid=5bd0543e-1516-41ce-8e0f-a61e663146fe
date
Tue, 28 May 2024 14:17:39 GMT
server
Kestrel
content-length
199
sid
mug.criteo.com/ Frame
0
0
Preflight
General
Full URL
https://mug.criteo.com/sid?cpp=8yUVtHwyV0c1WTNxOXNyemtaaDdSa05NbXR0Qk1xM3FRaXRRbmd6ZjRGU05CZnF5bGVBcENuV29nQnljY3JTUjdEQlZBcVErMlRYU0Z5Y1F4RUYvdFNMZEpxbHhQTjc1UzJDanJ6ZU4vRENWR2k4RlMzRk5GbGs4YkxPWEdwVVdnMEQyeGRTR2tvTmh3eDIyeFRxSFpJYVhuSC9VOWMzd2I5SnJabERuR2p0SEk5eDlId3JOYjZrMnVkcmRqeUJDOEZxSXhvSUczR0l4OHVyOEVvQWdBb0ZORk5ybzhENzl3RXAwZXRkU1VMcTNaRnU5V1FMTGhEemtOd3pVc2laTkVDZVNlTXpxR0x5VVZDaW5qeG9BcTlLRFo4c0JiZjF4R0JPcEJobGZ4Z1ZxWGQwT3lKYXJUZnFGM0pwR0JoS2N6SWhMd3w&cppv=2
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
74.119.117.17 , United States, ASN19750 (AS-CRITEO, US),
Reverse DNS
Software
Kestrel /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
GET
Origin
null
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
GET
access-control-allow-origin
null
cache-control
no-cache, no-store, must-revalidate
content-encoding
gzip
content-type
application/json; charset=utf-8
date
Tue, 28 May 2024 14:17:39 GMT
expires
0
pragma
no-cache
server
Kestrel
server-processing-duration-in-ticks
200906
strict-transport-security
max-age=31536000; preload;
vary
Accept-Encoding
v1
lb.eu-1-id5-sync.com/lb/
33 B
280 B
Fetch
General
Full URL
https://lb.eu-1-id5-sync.com/lb/v1
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
141.95.98.65 , France, ASN16276 (OVH, FR),
Reverse DNS
ns3216659.ip-141-95-98.eu
Software
/
Resource Hash
663eae4309895d3cd613c6ec3a6898ce1b6e1bf230c21a92f4d8056e24156f51
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 28 May 2024 14:17:40 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers, Origin
content-type
application/json;charset=UTF-8
collect
analytics.google.com/g/
0
45 B
Ping
General
Full URL
https://analytics.google.com/g/collect?v=2&tid=G-X6PEPHSF9L&gtm=45je45m0v894487360z876943195za200&_p=1716905854401&gcs=G111&gcd=13v3v3v3l6&npa=0&dma=0&tcfd=10000&gdid=dN2JhM2&cid=1221635165.1716905855&ul=en-us&sr=1600x1200&uaa=x86&uab=64&uafvl=Google%2520Chrome%3B125.0.6422.112%7CChromium%3B125.0.6422.112%7CNot.A%252FBrand%3B24.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&are=1&frm=0&pscdl=noapi&_s=2&sid=1716905855&sct=1&seg=0&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso&dt=AZ%20told%20to%20pay%20Pfizer%20%24107.5M%20for%20patent%20infringement&en=Bombora_Informer&ep.content_group=Pharma&_et=201&tfd=6245
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-X6PEPHSF9L
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4006:81e::200e , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Tue, 28 May 2024 14:17:40 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
692.json
id5-sync.com/g/v2/
586 B
1 KB
Fetch
General
Full URL
https://id5-sync.com/g/v2/692.json
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/31ee76261d87fed8cb9d4c465c48158c/hbp_master_748754_18091.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
162.19.138.116 Frankfurt am Main, Germany, ASN16276 (OVH, FR),
Reverse DNS
ns31533567.ip-162-19-138.eu
Software
/
Resource Hash
4d05f76ea29dced7becc90937f67a6109d3a037570991291ecf8f93a533bc106
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

sec-ch-ua
"Google Chrome";v="125", "Not:A-Brand";v="8", "Chromium";v="125"
sec-ch-ua-platform
"Win32"
Referer
https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Accept-Language
en-US,en;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36
content-type
text/plain

Response headers

date
Tue, 28 May 2024 14:17:40 GMT
strict-transport-security
max-age=63072000; includeSubDomains; preload
vary
Origin
p3p
CP="CAO PSA OUR"
access-control-allow-origin
https://www.fiercepharma.com
content-type
application/json
access-control-allow-credentials
true
expires
Thu, 01 Jan 1970 00:00:00 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
vid.vidoomy.com
URL
https://vid.vidoomy.com/sync?gdpr=0&gdpr_consent=undefined&us_privacy={us_privacy}&redirect=https%3A%2F%2Fsync.hbmp.mediafuse.com%2Fcsync%3Ft%3Dg%26ep%3D380%26traffic_source%3Dsnippet%26session%3D13CE245169C2C917%26sp%3D852559%26pb%3D753264%26c%3D764707%26a%3D556847%26extuid%3D%7B%7BVID%7D%7D
Domain
www.google.com
URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRUgEliKF-_MfZriBIOZWwIS0k5-FiZrwu1UluFyxn-90UPTyXo79WFhkYSGIXWer6hzyzTFd609aJoKiCxvmJPp0EfLg
Domain
www.google.com
URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRIDhxTiI1cH0_bvx4v-KrdU3tKyF3hK0eyrjNz6_t6nhuiT9Vu-R_Olt_D1Fh16DxK2oEB4W_1kEPVjlDbu7k8Cn7Uiw
Domain
www.google.com
URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRCRn60SG7xLbmGFneQtVZzisI7RqbKtX55DCKYQCBeJQ4FeV3F1sol5N3uDunIZVBIFHNmJcO5hnTsYEP0VSlpsvcFbA
Domain
www.google.com
URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaTKF_9u1_aaJ_Q5wdQxUHCUwh3vIzQltjS5yI5MMdWQ_r465OdDNP5SrRPx0jHdF3OSJKCi18P9pckn3AllkQk0fOF0Qw
Domain
s.amazon-adsystem.com
URL
https://s.amazon-adsystem.com/x/7318ffc0e8fa1d771446
Domain
cs.admanmedia.com
URL
https://cs.admanmedia.com/e09bad714a425a93d6dea503dcf9c528.gif?redir=https%3A%2F%2Frtb-csync.smartadserver.com%2Fredir%2F%3Fissi%3D1%26partnerid%3D130%26partneruserid%3D%5BUID%5D%26gdpr%3D%5BGDPR%5D%26gdpr_consent%3D%5BGDPR_CONSENT%5D&gdpr=0&gdpr_consent=
Domain
ads.pubmatic.com
URL
https://ads.pubmatic.com/AdServer/js/user_sync.html?gdpr=0&gdpr_consent=&us_privacy=&predirect=https%3A%2F%2Fa-prebid.vidoomy.com%2Fsetuid%3Fbidder%3Dpubmatic%26gdpr%3D{{GDPR}}%26gdpr_consent%3D{{GDPR_CONSENT}}%26uid%3D

Verdicts & Comments Add Verdict or Comment

174 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| 11 object| 12 object| 13 object| 14 object| 15 object| 16 object| 17 object| 18 object| 19 object| 20 object| 21 object| 22 object| 23 object| 24 object| 25 object| 26 object| 27 object| 28 object| 29 object| 30 object| 31 object| 32 object| 33 object| 34 object| 35 object| 36 object| 37 object| 38 function| mobileCheck object| dataLayerValues object| dataLayer boolean| loadExternal function| _bmb object| semaphore function| ketch object| googletag object| vmpbjs object| vpb function| initGam function| bomboraDependentInitWithTimeout object| meta string| gamPath object| pubAds object| adUnits object| webpackChunkquartz_vuejs function| setCookie function| getOlyticsGamSegments function| olyticsDfpSegments function| loadOlyticsSegmentsFromOmeda number| lastScroll function| floatMainMenuOnScroll function| closeMobileSubNavs function| getClosest object| __VUE_INSTANCE_SETTERS__ object| __VUE_SSR_SETTERS__ boolean| __VUE__ object| google_js_reporting_queue number| google_srt object| google_persistent_state_async object| google_logging_queue number| tmod object| google_ad_modifications object| ggeac boolean| google_measure_js_timing object| google_tag_data object| google_reactive_ads_global_state object| adsbygoogle object| google_sa_queue function| google_process_slots function| google_spfd number| google_unique_id object| google_sv_map number| google_rum_task_id_counter string| google_user_agent_client_hint object| google_tag_manager function| OptanonWrapper object| gtmConsentListeners string| adroll_adv_id string| adroll_pix_id boolean| __adroll_loaded object| zi string| ZIProjectKey string| method string| bid string| oid object| olytics object| a string| qtxSection string| _linkedin_partner_id object| _linkedin_data_partner_ids function| lintrk object| _ml function| __tcfapi function| _typeof object| PARSELY object| vmpbjsChunk object| mnet string| nobidVersion object| nobid object| gaGlobal boolean| _already_called_lintrk function| gtag object| configOptions function| onYouTubeIframeAPIReady function| google_sa_impl number| google_global_correlator object| google_prev_clients object| ampInaboxIframes object| ampInaboxPendingMessages string| adroll_sid object| adroll object| __adroll boolean| adroll_optout object| adroll_loaded object| adroll_ext_network object| adroll_callbacks undefined| adroll_tpc_callback object| dpmPixels boolean| ga-disable-G-X6PEPHSF9L object| ketchConsent object| regeneratorRuntime object| ox_esp object| criteo_syncframe_state object| criteo_pubtag object| criteo_identitytag_153 object| Criteo object| Criteo_identitytag_153 object| _33across object| __adroll_consent_data function| pubHadronCb object| adroll_exp_list boolean| __adroll_consent boolean| __adroll_consent_is_gdpr string| __adroll_consent_user_country string| __adroll_consent_adv_country number| adroll_lex33_called object| adroll_currency object| adroll_conversion_value object| adroll_conversion_value_in_dollars string| adroll_seg_eid boolean| adroll_sendrolling_cross_device object| adroll_form_fields object| adroll_third_party_forms object| adroll_third_party_detected object| adroll_snippet_errors string| adroll_rule_type function| fbq function| _fbq object| hadron boolean| __halo_loaded__ object| auvars object| ORIBILI function| docReady object| au object| autag string| GoogleAnalyticsObject function| ga object| audDataLayer function| audGtag object| gaplugins object| gaData object| criteo_pubtag_prebid_144 object| Criteo_prebid_144

382 Cookies

Domain/Path Name / Value
.3lift.com/sync Name: sync
Value: CgoIoQEQkLXB_PsxCgoI5gEQkLXB_PsxCgoIhwIQkLXB_PsxCgoItwIQkLXB_PsxCgkIOhCQtcH8-zEKCQgbEJC1wfz7MQoKCIwCEJC1wfz7MQoKCKwCEJC1wfz7MQoKCK0CEJC1wfz7MQoJCF8QkLXB_Psx
.fiercepharma.com/ Name: _swb
Value: 56c4a3f6-925d-4382-804b-a8402d5808e1
.fiercepharma.com/ Name: _parsely_session
Value: {%22sid%22:1%2C%22surl%22:%22https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso%22%2C%22sref%22:%22%22%2C%22sts%22:1716905854987%2C%22slts%22:0}
.fiercepharma.com/ Name: _parsely_visitor
Value: {%22id%22:%22pid=0a2938fc-b3c9-45d1-bfa5-b44ece812a6f%22%2C%22session_count%22:1%2C%22last_session_ts%22:1716905854987}
rdcdn.com/ Name: aid
Value: 19932
rdcdn.com/ Name: ref
Value: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
rdcdn.com/ Name: img
Value: http://rdcdn.com/rt?aid=19932&e=1&img=1
.fiercepharma.com/ Name: _pubcid
Value: fa6a9e20-bfdc-4788-8dda-54542ccff32b
.fiercepharma.com/ Name: _pubcid_cst
Value: zix7LPQsHA%3D%3D
.ml314.com/ Name: u
Value: aHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9waGFybWEvcGZpemVycy13eWV0aC1zdWJzaWRpYXJ5LXdpbnMtMTA3NW0tcGF5b3V0LWFzdHJhemVuZWNhLXN0ZXBwaW5nLXBhdGVudHMtaXRzLXRhZ3Jpc3Nv
.ml314.com/ Name: pi
Value: 3644478246682624013
.ml314.com/ Name: tp
Value: 4%253B05%252F28%252F2024%2B14%253A17%253A35%253B0
www.fiercepharma.com/ Name: dpm_url_count
Value: 1
.fiercepharma.com/ Name: oly_fire_id
Value: 6678I9124356A5P
.fiercepharma.com/ Name: oly_anon_id
Value: 603368c0-80a5-43af-990d-4c9fe5e35e04
.linkedin.com/ Name: li_sugr
Value: 76e1fd64-7f5f-423a-aae6-5b325272032d
.linkedin.com/ Name: bcookie
Value: "v=2&97bc188f-5ede-4cde-8cb6-cba67ce2de94"
.linkedin.com/ Name: lidc
Value: "b=TGST05:s=T:r=T:a=T:p=T:g=3037:u=1:x=1:i=1716905855:t=1716992255:v=2:sig=AQEaYcdsTRXKTAr8VbCTzd9nEHkCs1xy"
.fiercepharma.com/ Name: _ketch_consent_v1_
Value: eyJhbmFseXRpY3MiOnsic3RhdHVzIjoiZ3JhbnRlZCIsImNhbm9uaWNhbFB1cnBvc2VzIjpbImFuYWx5dGljcyJdfSwiYmVoYXZpb3JhbF9hZHZlcnRpc2luZyI6eyJzdGF0dXMiOiJncmFudGVkIiwiY2Fub25pY2FsUHVycG9zZXMiOlsiYmVoYXZpb3JhbF9hZHZlcnRpc2luZyJdfSwiZXNzZW50aWFsX3NlcnZpY2VzIjp7InN0YXR1cyI6ImdyYW50ZWQiLCJjYW5vbmljYWxQdXJwb3NlcyI6WyJlc3NlbnRpYWxfc2VydmljZXMiXX19
.adnxs.com/ Name: XANDR_PANID
Value: qN0Dxo1vSLggJHPhfcnRKruRNRz5mUIqBXZFM91ZgzRWmpLACIHz7zmFbhXL_e7rlLNZIJQz63CvG7qIo3sKMDL4nfqSH-Q7cYnflfeoFic.
.adnxs.com/ Name: receive-cookie-deprecation
Value: 1
.adnxs.com/ Name: uuid2
Value: 7532885200230356581
.fiercepharma.com/ Name: _ga_X6PEPHSF9L
Value: GS1.1.1716905855.1.0.1716905855.60.0.0
.linkedin.com/ Name: UserMatchHistory
Value: AQLTMUDVRa-fFgAAAY-_kEmG7iRMGc-UHiPbxAv2CzLWj_Q3iZeG46u4fhMPJNO73RODuVypixcYDA
.linkedin.com/ Name: AnalyticsSyncHistory
Value: AQJgqqk4CbxTiAAAAY-_kEmGUPJTFgJ3bSXmD4zufh-DnRywzgy7vlZSMMYNdgMYnQ34nvFYt6fCGcT_nrlw1Q
.doubleclick.net/ Name: IDE
Value: AHWqTUkhYwGDPUJba3fjeQceIupS4Q0wKLSZUblWXapzS4A0KfKIXA9p20d3zPmGTZs
.d.adroll.com/ Name: receive-cookie-deprecation
Value: 1
.adroll.com/ Name: receive-cookie-deprecation
Value: 1
.www.linkedin.com/ Name: bscookie
Value: "v=1&202405281417353077fc24-e6dd-48e4-8c22-54ffc6ff4fecAQGDPVQBXcd3N5l9VpSxfvkbuAgg8QIb"
.criteo.com/ Name: receive-cookie-deprecation
Value: 1
.criteo.com/ Name: uid
Value: 8a35f9a2-15c4-44cd-a479-5073e7bdaf6b
.demdex.net/ Name: demdex
Value: 76371068620533472121417628706340878377
.adsrvr.org/ Name: TDID
Value: 5bd0543e-1516-41ce-8e0f-a61e663146fe
.openx.net/ Name: i
Value: 74fe11d5-cf73-4e63-ae96-41348318645b|1716905855
www.fiercepharma.com/ Name: _oly_seg
Value: []
.fiercepharma.com/ Name: _swb_consent_
Value: 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%3D%3D
.www.fiercepharma.com/ Name: __adroll_fpc
Value: 0110a2c029ee174a3f13fa6794780d6c-1716905855559
.hbmp.mediafuse.com/ Name: vmuid
Value: acd7258d8ae133c7
.dpmsrv.com/ Name: dpm_pxl
Value: b5b2cdb41cd04e94fb4b5aba95bc4171eff8867e
.dpmsrv.com/ Name: dpm_pxl_aid
Value: 7532885200230356581
.dpm.demdex.net/ Name: dpm
Value: 76371068620533472121417628706340878377
www.fiercepharma.com/ Name: hasLiveRampMatch
Value: true
.crwdcntrl.net/ Name: _cc_dc
Value: 0
.crwdcntrl.net/ Name: _cc_id
Value: 7b3b6951c8d34345f65c3dff8743ea8f
.www.fiercepharma.com/ Name: __ar_v4
Value: %7C5J7LBS7TXZCZDFENFCAXF7%3A20240527%3A1%7CLMLSTWRFS5G7NCBM7VFBI2%3A20240527%3A1%7CEM6JRDVVXJDHHMOGWQDHR4%3A20240527%3A1
.33across.com/ Name: 33x_ps
Value: u%3D212624696638906%3As1%3D1716905855674%3Ats%3D1716905855674
.media.net/ Name: visitor-id
Value: 3599074556634654000V10
.media.net/ Name: data-pbs
Value: setstatuscode~~1
.mgid.com/ Name: lmg_usr
Value: fb4ec714-f08c-4bc1-a3c8-ad51a5f824f3
.mgid.com/ Name: lmg_r
Value: 25
.onetag-sys.com/ Name: OTP
Value: slkRavkLWHYYLb5L0oaZY3mbLesSS4AQH-6f-moTMSg
.fiercepharma.com/ Name: _au_1d
Value: AU1D-0100-001716905856-UP2ANVC2-NLBB
.casalemedia.com/ Name: CMID
Value: ZlXnf0t3uSoAAC9YAVBEJQAA
.casalemedia.com/ Name: CMPS
Value: 019
.casalemedia.com/ Name: CMPRO
Value: 019
.doubleclick.net/ Name: test_cookie
Value: CheckForPermission
.openx.net/ Name: pd
Value: v2|1716905855|vMgavPkWgy
.fiercepharma.com/ Name: __gads
Value: ID=50aa374d6f0d6a81:T=1716905855:RT=1716905855:S=ALNI_MaMzw9I0MkDCIt6Ve4ZEEIxN60nSw
.fiercepharma.com/ Name: __gpi
Value: UID=00000a2951ea5df8:T=1716905855:RT=1716905855:S=ALNI_MbZ33g1rb0CP4Omw1laFksTlU7mGg
.fiercepharma.com/ Name: __eoi
Value: ID=6c39a613d9661c8d:T=1716905855:RT=1716905855:S=AA-AfjYcumk822wqp4dsZlsIqGeW
.hbmp.mediafuse.com/ Name: g32
Value: 7532885200230356581
.hbmp.mediafuse.com/ Name: g142
Value: 3599074556634654000V10
.taboola.com/ Name: t_gid
Value: 995132d4-27f8-4c19-9135-5011950678c2-tuctd4f6cff
.taboola.com/ Name: t_pt_gid
Value: 995132d4-27f8-4c19-9135-5011950678c2-tuctd4f6cff
.tynt.com/ Name: uid
Value: Vz/bJWZV53/Mu3ZvHf/WNA==
.hbmp.mediafuse.com/ Name: g358
Value: fb4ec714-f08c-4bc1-a3c8-ad51a5f824f3
.rubiconproject.com/ Name: receive-cookie-deprecation
Value: 1
.pubmatic.com/ Name: KRTBCOOKIE_10
Value: 22808-OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&KRTB&22883-OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI&KRTB&23504-OTBjNzMxNzk4YzJjMWJjZWM3OGI1ZDUxZGRhMzU4OWI
.prebid.a-mo.net/ Name: _sv3_0
Value: 1
.a-mo.net/ Name: amuid2
Value: 794bc344-a4fa-440c-895e-7f9d938486d6
.prebid.a-mo.net/ Name: sd_amuid2
Value: 794bc344-a4fa-440c-895e-7f9d938486d6
.lijit.com/ Name: ljt_reader
Value: Iu15ALZHFmXOcih3Q3CI14ZT
.3lift.com/ Name: tluidp
Value: 131648406576292320395
.3lift.com/ Name: tluid
Value: 131648406576292320395
.bidswitch.net/ Name: tuuid
Value: 44473d7f-146b-4d56-aac1-0838865cfa25
.bidswitch.net/ Name: c
Value: 1716905855
.bidswitch.net/ Name: tuuid_lu
Value: 1716905855
.pippio.com/ Name: did
Value: YFRL5DOMdvotPCVA
.pippio.com/ Name: didts
Value: 1716905855
.pippio.com/ Name: nnls
Value:
.pippio.com/ Name: pxrc
Value: CP/O17IGEgYIgr0rEAA=
.mathtag.com/ Name: uuid
Value: cd246655-e780-4000-ba4c-39351745637e
.d.adroll.com/ Name: __adroll
Value: 90c731798c2c1bcec78b5d51dda3589b-g_1716905855-a_1716905855
.adroll.com/ Name: __adroll_shared
Value: 90c731798c2c1bcec78b5d51dda3589b-g_1716905855-a_1716905855
.rubiconproject.com/ Name: khaos
Value: LWQHF0YD-F-3YJX
.trafmag.com/ Name: vid
Value: 3211067221364426
.prebid.a-mo.net/ Name: _sv3_4
Value: 1
.hbmp.mediafuse.com/ Name: g13
Value: Iu15ALZHFmXOcih3Q3CI14ZT
.pubmatic.com/ Name: KADUSERCOOKIE
Value: A1C42EB9-955D-4866-B405-509F11DA5631
.hbmp.mediafuse.com/ Name: a558003
Value: A1C42EB9-955D-4866-B405-509F11DA5631
.adform.net/ Name: uid
Value: 5414751822788295032
.mfadsrvr.com/ Name: tuuid
Value: 02c663be-2609-45f0-bab8-f17e71d7cf56
.mfadsrvr.com/ Name: c
Value: 1716905855
.fiercepharma.com/ Name: _fbp
Value: fb.1.1716905856015.784380957
.hbmp.mediafuse.com/ Name: g58
Value: 212624696638906
.contextweb.com/ Name: V
Value: e4ym7CSbzvEQ
.contextweb.com/ Name: VP
Value: part_e4ym7CSbzvEQ
bh.contextweb.com/ Name: INGRESSCOOKIE
Value: 7a6d901af29def27
.mfadsrvr.com/ Name: tuuid_lu
Value: 1716905856
.deepintent.com/ Name: CDIUSER
Value: di_651e838072964c8e8ea17
.amazon-adsystem.com/ Name: ad-id
Value: A8qae6sl0Usst3gncwwRnaA
.amazon-adsystem.com/ Name: ad-privacy
Value: 0
.turn.com/ Name: uid
Value: 4562344477781617569
.yahoo.com/ Name: A3
Value: d=AQABBH_nVWYCEAdSI_LuEERH0avUbiattjEFEgEBAQE4V2ZfZgAAAAAA_eMAAA&S=AQAAAjVGqSLqNXrnKf3Izjm0IB8
a4p.adpartner.pro/ Name: apuid
Value: 961c6ad5-9512-4395-ae74-449abe757ba1
.tapad.com/ Name: TapAd_TS
Value: 1716905856087
.tapad.com/ Name: TapAd_DID
Value: 8b9295b3-715d-4cf4-8e2c-6688206c4e63
.ipredictive.com/ Name: cu
Value: 492afe47-71f6-4ceb-8af5-749c304e5feb|1716905856134
.hbmp.mediafuse.com/ Name: a307558
Value: 961c6ad5-9512-4395-ae74-449abe757ba1
.adx.opera.com/ Name: UID
Value: OPUb28d26b16faa4c709b2d0eccc3948456
.pubmatic.com/ Name: KRTBCOOKIE_377
Value: 6810-5bd0543e-1516-41ce-8e0f-a61e663146fe&KRTB&22918-5bd0543e-1516-41ce-8e0f-a61e663146fe&KRTB&22926-5bd0543e-1516-41ce-8e0f-a61e663146fe&KRTB&23031-5bd0543e-1516-41ce-8e0f-a61e663146fe
.pubmatic.com/ Name: KRTBCOOKIE_80
Value: 22987-CAESEEJ45nJvmVededLyYAWSmLY&KRTB&23025-CAESEEJ45nJvmVededLyYAWSmLY&KRTB&23386-CAESEEJ45nJvmVededLyYAWSmLY
.simpli.fi/ Name: suid
Value: CA665912813240129391849F90BF0E7F
.1rx.io/ Name: _rxuuid
Value: %7B%22rx_uuid%22%3A%22RX-c1b27d11-0298-4776-8523-332ed0612207-005%22%2C%22nxtrdr%22%3Afalse%7D
.pubmatic.com/ Name: KRTBCOOKIE_279
Value: 22890-492afe47-71f6-4ceb-8af5-749c304e5feb&KRTB&23011-492afe47-71f6-4ceb-8af5-749c304e5feb&KRTB&23355-492afe47-71f6-4ceb-8af5-749c304e5feb
.adtelligent.com/ Name: vmuid
Value: 97b6bb00c3c60ab3
.adtelligent.com/ Name: a306279
Value: slkRavkLWHYYLb5L0oaZY3mbLesSS4AQH-6f-moTMSg
.contextweb.com/ Name: VP
Value: part_e4ym7CSbzvEQ
.contextweb.com/ Name: wf
Value: 0
.servenobid.com/ Name: cap_908
Value: 10
.pubmatic.com/ Name: KRTBCOOKIE_148
Value: 19421-uid:CA665912813240129391849F90BF0E7F&KRTB&23486-uid:CA665912813240129391849F90BF0E7F&KRTB&23489-uid:CA665912813240129391849F90BF0E7F&KRTB&23539-uid:CA665912813240129391849F90BF0E7F
.disqus.com/ Name: zeta-ssp-user-id
Value: ua-d6c1e3ac-1e01-3149-a124-8c889bb7ffc7
prebid.media.net/ Name: receive-cookie-deprecation
Value: 1
.go.sonobi.com/ Name: _usd_fiercepharma.com
Value: e6a07294-1a61-4ba1-a422-4e1273f06c72
apex.go.sonobi.com/ Name:
Value: receive-cookie-deprecation: 1
.go.sonobi.com/ Name: __uih
Value: 1
.go.sonobi.com/ Name: __uin_z1
Value: 1
.go.sonobi.com/ Name: __uir_z1
Value: 44371055
.go.sonobi.com/ Name: __uin_tp
Value: 1
.go.sonobi.com/ Name: __uir_tp
Value: 44371055
.go.sonobi.com/ Name: __uin_cx
Value: 1
.go.sonobi.com/ Name: __uir_cx
Value: 44371055
.go.sonobi.com/ Name: __uis
Value: 37e0b433-a139-49aa-b81e-736192785b62
.3lift.com/ Name: receive-cookie-deprecation
Value: 1
.targeting.unrulymedia.com/ Name: _rxuuid
Value: %7B%22rx_uuid%22%3A%22RX-c1b27d11-0298-4776-8523-332ed0612207-005%22%7D
.fiercepharma.com/ Name: _ga
Value: GA1.2.1221635165.1716905855
.360yield.com/ Name: tuuid_lu
Value: 1716905856
.360yield.com/ Name: tuuid
Value: 1b7b8400-4a4b-442f-9708-a6ba530e7631
.fiercepharma.com/ Name: _gid
Value: GA1.2.1528552209.1716905856
.smartadserver.com/ Name: pbw
Value: %24b%3d16999%3b%24o%3d11100
.smartadserver.com/ Name: vs
Value: 630134=5998457
.smartadserver.com/ Name: TestIfCookie
Value: ok
.smartadserver.com/ Name: TestIfCookieP
Value: ok
.smartadserver.com/ Name: sasd
Value: %24qc%3D1312541377%3B%24ql%3DHigh%3B%24qpc%3D14202%3B%24qt%3D152_1829_10507t%3B%24dma%3D514%3B%24qo%3D6
.adtelligent.com/ Name: a541630
Value: RX-c1b27d11-0298-4776-8523-332ed0612207-005
.pubmatic.com/ Name: KRTBCOOKIE_22
Value: 14911-4562344477781617569&KRTB&23150-4562344477781617569&KRTB&23527-4562344477781617569
.pubmatic.com/ Name: KRTBCOOKIE_32
Value: 11175-AQAAzdFcyPINugIh58W8AQEBAQEBAQCOvpFMgwEBAI6-kUyD&KRTB&22715-AQAAzdFcyPINugIh58W8AQEBAQEBAQCOvpFMgwEBAI6-kUyD&KRTB&23519-AQAAzdFcyPINugIh58W8AQEBAQEBAQCOvpFMgwEBAI6-kUyD
.smartadserver.com/ Name: pid
Value: 5033829378062940454
.smartadserver.com/ Name: sasd2
Value: q=%24qc%3D1312541377%3B%24ql%3DHigh%3B%24qpc%3D14202%3B%24qt%3D152_1829_10507t%3B%24dma%3D514%3B%24qo%3D6&c=1&l&lo&lt=638525026563294941&o=1
.bidr.io/ Name: bito
Value: AACkZk7Mq88AABJm5njsdw
.bidr.io/ Name: bitoIsSecure
Value: ok
.primis.tech/ Name: csuuid
Value: 6655e780c2e4d
.contextweb.com/ Name: vf
Value: 4
.prebid.a-mo.net/ Name: __amc
Value: 4_1716905856_1716905856
.sharethrough.com/ Name: stx_user_id
Value: 392c748a-3165-49b5-9e4b-5197f09f430e
.intentiq.com/ Name: intentIQ
Value: UEYytn7DW7
.intentiq.com/ Name: IQver
Value: 1.9
.criteo.com/ Name: cto_bundle
Value: f2o8R19ldWRzazhmQUJoS2Fld3RqZmdRejZXUWtDUnQ1cWZFT0NVMEVlYUFnRkNLUTE0S0Y2Vk1JQ0dZNllYUTE4NGJYOHFydnYlMkY1eHdFdnBTcHc2MDglMkZkaVpNTyUyRnBjUWElMkZ4ZTRLcEdseWh1V2JLUWM3Q2VGdm96NjdzMDE2MiUyRnFUSWR5S2ZiQUtsJTJCZU9zY2dCVmRqUjVzOFElM0QlM0Q
.intentiq.com/ Name: CSDT
Value: UEQ6MTUxMDZfMCZVRTR3ME9L
.intentiq.com/ Name: intentIQCDate
Value: 1716905857043
.intentiq.com/ Name: IQPData
Value: 1611266346#1716905857042#0#1716905857042
.intentiq.com/ Name: ASDT
Value: 0
.adnxs.com/ Name: icu
Value: ChgIwONtEAoYASABKAEwgM_XsgY4AUABSAEKGAiTjX0QChgBIAEoATCBz9eyBjgBQAFIAQoZCKr5jAEQChgBIAEoATCAz9eyBjgBQAFIARCBz9eyBhgC
.dpmsrv.com/ Name: xdpm_segsid_913
Value: 16013439%2C16671093%2C29315652%2C29315642
.dpmsrv.com/ Name: xdpm_segs_913
Value:
.adnxs.com/ Name: anj
Value: dTM7k!M4/0CxrEQF']wIg2Illrj[mH!^.fSYiTXL`)Nb%d)IY:Z@tEfTn_!1BR(^OH'c#8U2wyUTsg('G`GR]Fh/vIAvXo?Tn8lbGBuC)1MiErtmF9<%nugO%v4VB%nu0j.+v<a
.mxptint.net/ Name: mxpim
Value: R33646_1163B5076_281A7D58.1.00000000000000006655E782
.sitescout.com/ Name: ssi
Value: b6299297-f649-4789-b2b7-baa2213b878a#1716905859024
.pubmatic.com/ Name: KRTBCOOKIE_52
Value: 22772-R33646_1163B5076_281A7D58&KRTB&23092-R33646_1163B5076_281A7D58
.quantserve.com/ Name: mc
Value: 6655e783-0a948-e62c1-f322b
.kargo.com/ Name: ktcid
Value: 2beed8d7-41f7-0954-581d-429362f8da6b
.pubmatic.com/ Name: KRTBCOOKIE_153
Value: 19420--SoBvaorDLviLFWx-yQZ7fkuV7niege6_X7hw8e7&KRTB&23462--SoBvaorDLviLFWx-yQZ7fkuV7niege6_X7hw8e7
.thrtle.com/ Name: mc
Value: eyJpZCI6ImE4OGFjYjQ1LTBmOWItNGY5Mi05YzU0LTcyOTM1MTk5ZGUzMCIsImwiOjE3MTY5MDU4NTkwNzAsInQiOjF9
.w55c.net/ Name: wfivefivec
Value: 5DlxiJwI1SbXDZ5
.adgrx.com/ Name: ADGRX_UID
Value: 09f14b2c-1cfd-11ef-9d1d-a2307d35ffdd
.pubmatic.com/ Name: KRTBCOOKIE_188
Value: 3189-b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553&KRTB&23418-b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553
.pubmatic.com/ Name: SyncRTB3
Value: 1718064000%3A99_96_8_54_250_233_56_249_238_22_46_7_166_178_21_5_266_220_176_48_55_231_264_81_13_104_267_165_71_214_243_3_240_234%7C1717459200%3A38_223_2_15%7C1722038400%3A69%7C1717718400%3A63%7C1719446400%3A224%7C1718150400%3A268_35
.w55c.net/ Name: matchpubmatic
Value: 5
.adgrx.com/ Name: ADGRX_CM_PUBMATIC_BRIDGED
Value: 1
.pubmatic.com/ Name: KRTBCOOKIE_107
Value: 1471-uid:5DlxiJwI1SbXDZ5&KRTB&23421-uid:5DlxiJwI1SbXDZ5
.pubmatic.com/ Name: KRTBCOOKIE_1003
Value: 22761-09f14b2c-1cfd-11ef-9d1d-a2307d35ffdd&KRTB&23275-09f14b2c-1cfd-11ef-9d1d-a2307d35ffdd
.rfihub.com/ Name: ruds
Value: H4sIAAAAAAAA_-MSNrQ0NzcxNjKwtDQ3NTe3MDc3MxLiM9T1cQsvdg5KTMkJynIFAMlgOFklAAAA
.rfihub.com/ Name: rud
Value: H4sIAAAAAAAA_-MSNrQ0NzcxNjKwtDQ3NTe3MDc3MxLiM9T1cQsvdg5KTMkJynIFAMlgOFklAAAA
.pubmatic.com/ Name: KRTBCOOKIE_27
Value: 16735-uid:cd246655-e780-4000-ba4c-39351745637e
.pubmatic.com/ Name: KRTBCOOKIE_18
Value: 22947-1977432099757787762
.pubmatic.com/ Name: KRTBCOOKIE_1323
Value: 23480-OPUb28d26b16faa4c709b2d0eccc3948456&KRTB&23485-OPUb28d26b16faa4c709b2d0eccc3948456&KRTB&23575-OPUb28d26b16faa4c709b2d0eccc3948456
.iqzone.com/ Name: iq_u_key
Value: a95b5f76-79cc-4019-a78d-097828ceedd8
.pubmatic.com/ Name: KRTBCOOKIE_594
Value: 17105-OPTOUT&KRTB&17107-OPTOUT
.owneriq.net/ Name: p2
Value: pmc
.owneriq.net/ Name: si
Value: Q7701922591569562609P
.owneriq.net/ Name: pmc
Value: 1
sync.srv.stackadapt.com/ Name: sa-user-id
Value: s%3A0-cd549c41-45db-550f-5d69-3a6d8bc56c5a.W9t%2FkUwPPoZPB6QyJSWNTmLzOHYbaoeNR8Zt5ZfhGt0
.srv.stackadapt.com/ Name: sa-user-id
Value: s%3A0-cd549c41-45db-550f-5d69-3a6d8bc56c5a.W9t%2FkUwPPoZPB6QyJSWNTmLzOHYbaoeNR8Zt5ZfhGt0
sync.srv.stackadapt.com/ Name: sa-user-id-v2
Value: s%3AzVScQUXbVQ9daTpti8VsWmAJ-So.AvKFBFZ25g284ZBabKHdUCMTsPXidP0vBYAkpL7MZ1g
.srv.stackadapt.com/ Name: sa-user-id-v2
Value: s%3AzVScQUXbVQ9daTpti8VsWmAJ-So.AvKFBFZ25g284ZBabKHdUCMTsPXidP0vBYAkpL7MZ1g
sync.srv.stackadapt.com/ Name: sa-user-id-v3
Value: s%3AAQAKINpyOBL1OjPClppkMM43asH_ViYXZW1-XXmWbGjDLes3EGcYBCCDz9eyBjABOgRfEgSuQgRE9vH3.wM10CH1h9p6yvx%2Fx93%2B46GHMZytV5vew1vW8QOv6UqM
.srv.stackadapt.com/ Name: sa-user-id-v3
Value: s%3AAQAKINpyOBL1OjPClppkMM43asH_ViYXZW1-XXmWbGjDLes3EGcYBCCDz9eyBjABOgRfEgSuQgRE9vH3.wM10CH1h9p6yvx%2Fx93%2B46GHMZytV5vew1vW8QOv6UqM
.pubmatic.com/ Name: KRTBCOOKIE_391
Value: 22924-5414751822788295032&KRTB&23263-5414751822788295032&KRTB&23481-5414751822788295032
.pubmatic.com/ Name: KRTBCOOKIE_1278
Value: 23329-831cc73a-76b8-45d1-b71f-83c8e2139b27&KRTB&23340-831cc73a-76b8-45d1-b71f-83c8e2139b27&KRTB&23498-831cc73a-76b8-45d1-b71f-83c8e2139b27
.pubmatic.com/ Name: KRTBCOOKIE_860
Value: 16335-zVScQUXbVQ9daTpti8VsWmAJ-So&KRTB&23334-zVScQUXbVQ9daTpti8VsWmAJ-So&KRTB&23417-zVScQUXbVQ9daTpti8VsWmAJ-So&KRTB&23426-zVScQUXbVQ9daTpti8VsWmAJ-So
beacon.lynx.cognitivlabs.com/ Name: UID
Value: fbb0be7a-a194-489e-8718-382b8bcb02a4
beacon.lynx.cognitivlabs.com/ Name: ss
Value: 4Eei5%2BFMN9bPm5UGbuSNnP5wKMN7jtPb%2BjNJbOOOzBo6tUiRcDg6dQanFDC6unt8U6xPwE5x3dzLh5yLl4VCQg%3D%3D
.adsby.bidtheatre.com/ Name: __kuid
Value: fc8af365-5796-48da-ac9a-1a08c816526d.486119859
.creativecdn.com/ Name: g
Value: lpNWK0grXcR0rL960oi7_1716905859421
.creativecdn.com/ Name: ts
Value: 1716905859
.csync.loopme.me/ Name: viewer_token
Value: 363b017d-41dc-40c0-9dc9-7bb6f3c5cbfd
.tribalfusion.com/ Name: ANON_ID
Value: auntuJwl6h7bQQwbPBqU6fOrhkdy3OuFNtlv3Jrbn14TBN3TP2X8uYoUYlB3i54gqw9hg2ZclhC3H3g9bTvS0yAa5
.crwdcntrl.net/ Name: _cc_cc
Value: "ACZ4nGNQME8yTjKzNDVMtkgxNjE2MU0zM002TklLszA3MU5NtEhjYGBgSAt93syAAABX6Asc"
.crwdcntrl.net/ Name: _cc_aud
Value: "ABR4nGNgYGBIC33ezAAHABpsAiY%3D"
.fiercepharma.com/ Name: panoramaId_expiry
Value: 1716992259579
.pubmatic.com/ Name: KRTBCOOKIE_632
Value: 23041-w6lf_wdVg3AKkb4MsUSWHS3m3-Y9vbx-BWSLu_A_l4M&KRTB&23047-w6lf_wdVg3AKkb4MsUSWHS3m3-Y9vbx-BWSLu_A_l4M&KRTB&23234-w6lf_wdVg3AKkb4MsUSWHS3m3-Y9vbx-BWSLu_A_l4M&KRTB&23361-w6lf_wdVg3AKkb4MsUSWHS3m3-Y9vbx-BWSLu_A_l4M
.fiercepharma.com/ Name: _cc_id
Value: 7b3b6951c8d34345f65c3dff8743ea8f
.fiercepharma.com/ Name: panoramaId
Value: 2a4ce37280a075a067732160028da9fb927a24a29813793a7edfeee5627ecb55
.zemanta.com/ Name: zuid
Value: IpGLR74DPECkvIVEoDmo
.tynt.com/ Name: pids
Value: %5B%7B%22p%22%3A%22797f54a72d%22%2C%22f%22%3A1%2C%22ts%22%3A1716905855884%7D%2C%7B%22p%22%3A%22f46c881bee%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859671%7D%2C%7B%22p%22%3A%22632381c622%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859671%7D%2C%7B%22p%22%3A%224bee518595%22%2C%22f%22%3A1%2C%22ts%22%3A1716905855884%7D%2C%7B%22p%22%3A%226f27415d53%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859640%7D%2C%7B%22p%22%3A%227daaa56bb0%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859640%7D%2C%7B%22p%22%3A%227912d88d74%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859640%7D%2C%7B%22p%22%3A%22f5b8438f72%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859640%7D%2C%7B%22p%22%3A%22baebe6454b%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859671%7D%2C%7B%22p%22%3A%22029cc11ae7%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859640%7D%2C%7B%22p%22%3A%220f90caf3cf%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859671%7D%2C%7B%22p%22%3A%2224c05c7b76%22%2C%22f%22%3A1%2C%22ts%22%3A1716905855884%7D%2C%7B%22p%22%3A%2295c591d034%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859671%7D%2C%7B%22p%22%3A%22d26852f088%22%2C%22f%22%3A1%2C%22ts%22%3A1716905855884%7D%2C%7B%22p%22%3A%2222833ea406%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859640%7D%2C%7B%22p%22%3A%225cb91279ed%22%2C%22f%22%3A1%2C%22ts%22%3A1716905859671%7D%2C%7B%22p%22%3A%22f9a4a8fd15%22%2C%22f%22%3A1%2C%22ts%22%3A1716905855884%7D%2C%7B%22p%22%3A%22008c314e8f%22%2C%22f%22%3A1%2C%22ts%22%3A1716905855884%7D%5D
.connatix.com/ Name: cnx_userId
Value: ff0d40bfca7c4bb6a5a4cf553283caff
.adtelligent.com/ Name: g58
Value: 212624696638906
.adtelligent.com/ Name: g50
Value: 5414751822788295032
.pubmatic.com/ Name: KRTBCOOKIE_1030
Value: 23330-e4ym7CSbzvEQ
.go.sonobi.com/ Name: __uir_td
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_td
Value: 5bd0543e-1516-41ce-8e0f-a61e663146fe
.go.sonobi.com/ Name: HAPLB8G
Value: s8581|ZlXnh
.go.sonobi.com/ Name: __uir_pp
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_pp
Value: e4ym7CSbzvEQ
.go.sonobi.com/ Name: __uir_eb
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_eb
Value: CAESEPTIQ05gw6BA1vDolnHAWug||1
.media.net/ Name: data-p
Value: e4ym7CSbzvEQ~~3
.lijit.com/ Name: _ljtrtb_273657
Value: 273657
prebid.a-mo.net/ Name: amdgt_lk%40cfs
Value: 1
.go.sonobi.com/ Name: __uir_zt
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_zt
Value: 1977432099757787762
.lijit.com/ Name: ljtrtbexp
Value: eJxlkLkVxEAIQ3uZ2MGI5dzW%2FNy7r0mQwy8QCPZRMf4IJGDqcxvSEZOEADf8WPAu6KchaeRrCLusN1etUF4lshTyAJyDt1bnpBSpxEZM84T8liui1nzqThx0VPvjcQIjp0l9
.pxl.iqm.com/ Name: ttacross
Value: MTcxODExNTQ2MDA3NA==
.pxl.iqm.com/ Name: iqm.retarget.uid
Value: bcd4aa8f-3b96-4953-a1b2-e306b8e5dac0
.w55c.net/ Name: matchmedianet
Value: 5
.smaato.net/ Name: SCMsovrn
Value: 61d86edabb
.pubmatic.com/ Name: KRTBCOOKIE_699
Value: 22727-AACkZk7Mq88AABJm5njsdw
.pubmatic.com/ Name: KRTBCOOKIE_904
Value: 23554-OddOBiO_CE-KcZ2sg-dVZg&KRTB&23557-OddOBiO_CE-KcZ2sg-dVZg&KRTB&23586-OddOBiO_CE-KcZ2sg-dVZg
.pubmatic.com/ Name: PugT
Value: 1716905859
.yellowblue.io/ Name: wrvUserID
Value: D-Bn2Te-kp_s
.go.sonobi.com/ Name: __uir_if
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_if
Value: cd246655-e780-4000-ba4c-39351745637e
.gumgum.com/ Name: vst
Value: u_125a09b4-a154-421d-8d90-41852fe5cba8
.cdn.dxkulture.com/ Name: __cf_bm
Value: JfP1tAazw9cX3ZZoLEwRPLlPY3jpU35Ab2W613gUbRY-1716905860-1.0.1.1-wZvU3wyQ1MqizwZJNh3aau4IRMneYH0dik280LxV2sHAX_1RNXuEpEG3QbjUWWnbsd6aMHQQjWmIGDN.ZStfPw
.yieldmo.com/ Name: yieldmo_id
Value: VIA0BVV8A0VBP3jKoxuU%7C1716854400000%7C0
.ads.yieldmo.com/ Name: ptrpp
Value: e4ym7CSbzvEQ
.teads.tv/ Name: tt_viewer
Value: 97ed38c7-01a9-471d-ac0e-d8d9281aa54f
.rqtrk.eu/ Name: browser_id
Value: 1:4dd3f9f6-ec0f-41a4-a423-1a345b190bad
.ctnsnet.com/ Name: cid
Value: d8005368d0774ce7bf6f8874a6145e9e
.smaato.net/ Name: SCM
Value: e4057dc375
.smaato.net/ Name: SCMo
Value: e4057dc375
.smaato.net/ Name: SCM1001299
Value: e4057dc375
.media.net/ Name: data-o
Value: 6f7e4713-cdf4-4b74-970f-f7b255d0c57a~~8
.rfihub.com/ Name: eud
Value: H4sIAAAAAAAA_9vEyGtobmhmaWBqYWppaGq4ShSJb2FmfEociW9paQ4AaG5tOzAAAAA
.omnitagjs.com/ Name: ayl_visitor
Value: 624a0aea786daf004a535bb9d97507de
.media.net/ Name: data-xu
Value: 5DlxiJwI1SbXDZ5~~8
.sitescout.com/ Name: _ssuma
Value: eyI0NSI6MTcxNjkwNTg1OTA1OCwiNDgiOjE3MTY5MDU4NjAzMjIsIjM5IjoxNzE2OTA1ODU5ODI5LCIxNyI6MTcxNjkwNTg1OTk5MCwiNyI6MTcxNjkwNTg1OTgyOX0
.media.net/ Name: data-exp
Value: setstatuscode~~1
.media.net/ Name: data-g
Value: CAESEFEaa9G61Z0M_849OZTeJVo~~8
.deepintent.com/ Name: CDIPARTNERS
Value: %7B%221%22%3A%2220240528%22%2C%22149%22%3A%2220240528%22%2C%22142%22%3A%2220240528%22%7D
.lijit.com/ Name: _ljtrtb_76
Value: cbbcf04c-8c40-4b99-b3fc-3f7a9f8e68f4
.lijit.com/ Name: _ljtrtb_49
Value: e4ym7CSbzvEQ
.lijit.com/ Name: _ljtrtb_106
Value: 5033829378062940454
.lijit.com/ Name: _ljtrtb_43
Value: e05b3ChPVtpgSA_QeUBDjHtKDdhgHl3bfxrXOFqg
.lijit.com/ Name: _ljtrtb_2
Value: CA665912813240129391849F90BF0E7F
.adsrvr.org/ Name: TDCPM
Value: CAESFgoHZDB0cm8xahILCMLuu8Xeyv88EAUSFwoIcHVibWF0aWMSCwietMDJ3sr_PBAFEhgKCWJpZHN3aXRjaBILCNLoisveyv88EAUSFAoFdGFwYWQSCwi8lYDO3sr_PBAFEhYKB3J1Ymljb24SCwig3_HO3sr_PBAFEhYKB3N2eDl0NTASCwisz6Pu3sr_PBAFEhUKBmNhc2FsZRILCKiq3PTeyv88EAUYASACKAIyCwj4xaab9cr_PBAFOAFaB3N2eDl0NTBgAg..
.go.sonobi.com/ Name: __uir_bw
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_bw
Value: 44473d7f-146b-4d56-aac1-0838865cfa25
.go.sonobi.com/ Name: __uir_bs
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_bs
Value: b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553
.servenobid.com/ Name: pid_317
Value: 5033829378062940454
.servenobid.com/ Name: pid_324
Value: 1977432099757787762
.servenobid.com/ Name: pid_351
Value: 392c748a-3165-49b5-9e4b-5197f09f430e
.servenobid.com/ Name: pid_333
Value: ZlXnf0t3uSoAAC9YAVBEJQAAABMAAAIB
.servenobid.com/ Name: pid_353
Value: 3599074556634654000V10
.servenobid.com/ Name: pid_318
Value: slkRavkLWHYYLb5L0oaZY3mbLesSS4AQH-6f-moTMSg
.quantserve.com/ Name: d
Value: EK4BFwH6K_ijDejbEJ-SAA
.prebid-server.rubiconproject.com/ Name: uids
Value: eyJ0ZW1wVUlEcyI6eyJhbXgiOnsidWlkIjoiNzk0YmMzNDQtYTRmYS00NDBjLTg5NWUtN2Y5ZDkzODQ4NmQ2IiwiZXhwaXJlcyI6IjIwMjQtMDYtMTFUMTQ6MTc6NDAuNTM2NjA5OTc1WiJ9LCJydWJpY29uIjp7InVpZCI6IkxXUUhGMFlELUYtM1lKWCIsImV4cGlyZXMiOiIyMDI0LTA2LTExVDE0OjE3OjQwLjUzNTIxNDIwNVoifX19
.media.net/ Name: data-ttd
Value: 5bd0543e-1516-41ce-8e0f-a61e663146fe~~1
.lijit.com/ Name: _ljtrtb_16
Value: b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553
.lijit.com/ Name: _ljtrtb_108
Value: 61d86edabb
.lijit.com/ Name: _ljtrtb_97
Value: OPTOUT
.lijit.com/ Name: _ljtrtb_85
Value: AACkZk7Mq88AABJm5njsdw
.lijit.com/ Name: _ljtrtb_27
Value: 5bd0543e-1516-41ce-8e0f-a61e663146fe
.lijit.com/ Name: _ljtrtb_86
Value: w6lf_wdVg3AKkb4MsUSWHS3m3-Y9vbx-BWSLu_A_l4M
.lijit.com/ Name: _ljtrtb_83
Value: LWQHF0YD-F-3YJX
.servenobid.com/ Name: pid_352
Value: D-Bn2Te-kp_s
.servenobid.com/ Name: pid_309
Value: u_125a09b4-a154-421d-8d90-41852fe5cba8
.servenobid.com/ Name: pid_310
Value: Iu15ALZHFmXOcih3Q3CI14ZT
.servenobid.com/ Name: pid_321
Value: OPTOUT
.krushmedia.com/ Name: krm_usr
Value: 4b1d9c7f-8933-5f9e-867d-dde9dbfb9791
.krushmedia.com/ Name: krm_r
Value: 572
.ow.pubmatic.com/ Name: uids
Value: eyJ0ZW1wVUlEcyI6eyJhbXgiOnsidWlkIjoiNzk0YmMzNDQtYTRmYS00NDBjLTg5NWUtN2Y5ZDkzODQ4NmQ2IiwiZXhwaXJlcyI6IjIwMjQtMDYtMTFUMTQ6MTc6NDAuNjA1NTk5NDkyWiJ9fX0=
.clickagy.com/ Name: cb
Value: ZlXnhMrlaEEkrobO3eMSiLrs
aorta.clickagy.com/ Name: chs
Value: [{"ch":"185","t":"2024-05-28 14:17:40"}]
.servenobid.com/ Name: pid_332
Value: 37e0b433-a139-49aa-b81e-736192785b62
.smadex.com/ Name: smxtrack
Value: 1a6b0f6f-efe5-443d-af6f-620ec05a1fbd
.smadex.com/ Name: smxbds
Value: 1
.fiercepharma.com/ Name: cto_bundle
Value: GWpObl9udzlZdDk2cmFiSSUyQnFsTE91NmQlMkZobDRJV0NjaDNIakh1UVRacDUxVjlHeU5Zd2h6TUhVVHJrb2d1bSUyRjlaTmN4QyUyRnRrelJDWFdRQnNpa1o0N0tvNTBmR0JVaHRrNiUyRmVFVHhaS0JRa0o3V0NndjdIc3BWMG5vMCUyQnRDY2tBREpQaDY2UmM4YkhCQ0xTMlR4amxha3RaOUZ2cEJBd3JtbWIlMkJFR3lHJTJCV00wTlVrJTNE
.fiercepharma.com/ Name: cto_bidid
Value: _WyS5F9UZlZLVXRBcTlFQ2JEd1Vib3EwYSUyQmZTM2NXVSUyRnBXelQlMkZnZkJqaCUyQlFrNzJod01wdGx6WlNCNG1hTnBncTRBYTFCRlJvTEhCNVVOMlNZVWZPdG5TTFFINlloOHY4TE40Z3FuaFFUSyUyRmhWUmpqVGdkZ2g1cHUxc05IUldPdnRtWDM
.mfadsrvr.com/ Name: ssh
Value: !onetag=1716905860!medianet=1716905860
.a-mx.com/ Name: amdt_t
Value: p::1716905860627
.a-mx.com/ Name: amuid2
Value: 794bc344-a4fa-440c-895e-7f9d938486d6
.media.net/ Name: data-ris
Value: {{APID}}~~25
.media.net/ Name: data-so
Value: 37e0b433-a139-49aa-b81e-736192785b62~~8
.iqzone.com/ Name: iq_r_key
Value: 277|264
.aniview.com/ Name: 1_C_10
Value: e4ym7CSbzvEQ
sync.aniview.com/ Name: 1_C_10
Value: e4ym7CSbzvEQ
.lijit.com/ Name: _ljtrtb_102
Value: 4b1d9c7f-8933-5f9e-867d-dde9dbfb9791
.lijit.com/ Name: _ljtrtb_103
Value: OPUb28d26b16faa4c709b2d0eccc3948456
.lijit.com/ Name: _ljtrtb_84
Value: ZlXnhMrlaEEkrobO3eMSiLrs
.media.net/ Name: data-c
Value: 8a35f9a2-15c4-44cd-a479-5073e7bdaf6b~~1
.media.net/ Name: data-c-ts
Value: 1716905860
.media.net/ Name: data-r1
Value: OPTOUT~~8
.go.sonobi.com/ Name: __uir_st
Value: 190572247338257523
.go.sonobi.com/ Name: __uin_st
Value: zVScQUXbVQ9daTpti8VsWmAJ-So
.dotomi.com/ Name: DotomiTest
Value: 1e7fdd225a5d2303
.dxkulture.com/ Name: mtuid
Value: 342dd9f1-9289-47aa-917f-b13b570ee886
.media.net/ Name: data-mf
Value: 02c663be-2609-45f0-bab8-f17e71d7cf56~~1
.servenobid.com/ Name: pid_323
Value: LWQHF0YD-F-3YJX
.lijit.com/ Name: ljtrtb
Value: eJxtkk1zGjEMhv%2FLnusZ25I%2F1NvyscMkMITZECAXZrW2oQHSBtIkbab%2FvTbTY2%2B23kfSK9mflbLV14qtJtLkRLJIAp0nwZqd4K7TWgF75zthrTHReRDGGKi%2BVEg5M%2BKvkxu2%2FPttvMgx7XLMcJAGIQpllBWo%2Bih8lEl0VkVrQaFNsbAZHda5KintFWiUShOQ8kgNyUEjx67JmJIFRFaBepeEJ8gOEuWa1gURQqTAicmRusKQ4fndkrUP2rKyqeuwd5JYBxn7vgdCj8Ze2TK6kQA%2B93Ve5iWgRINZ8zJL09Vi0sjNSDQCNjfra4rPcauCtzF0zIWE%2F5LagTVlGf8OGcR8ezyun%2Fez87Ebjw%2Fn7zyHOGu%2FTc%2BXopus1%2FXw8Hhwsxfv63pwczLPT5fwnlVy17nu58v7whbn7%2FaYtu%2FhYQf17YFxdlm2q0kLJxAbeuMPMVi105%2FbenvEWXmt4jNKwzDc3z28%2Fti19XYRl4PR0%2BT1dhT2u8kROH2c1%2FPmZZd5V1r0zH2S2AvfoxTIlP8FpF5Ach0lH61PWP35Cx2ylgQ%3D
.lijit.com/ Name: _ljtrtb_26
Value: 44473d7f-146b-4d56-aac1-0838865cfa25
.sportradarserving.com/ Name: zuuid
Value: 7bba2606-3abb-4930-bf8c-cc8e2aa642e8
.sportradarserving.com/ Name: c
Value: 1716905860
.sportradarserving.com/ Name: zuuid_lu
Value: 1716905860
.tapad.com/ Name: TapAd_3WAY_SYNCS
Value: 1!3590-2!3590-3!3590
.technoratimedia.com/ Name: tads_uidp_16
Value: 1549172725125
.technoratimedia.com/ Name: tads_uidp_37
Value: aff00fba-b509-3d4d-af8c-ab8ce4e38684
.technoratimedia.com/ Name: tads_uidp_44
Value: LWQGX27A-1P-39UZ
.technoratimedia.com/ Name: tads_uidp_45
Value: 1D6A39B0-37D9-44AD-B32D-66928B1B306D
.technoratimedia.com/ Name: tads_uidp_48
Value: 9f0b7830-9d06-462e-a4e4-4182bd3ea835
.technoratimedia.com/ Name: tads_uidp_49
Value: AQAHAP4oDTrfawIwWELZAQEBAQEBAQCOvoKIUwEBAI6-gohT
.technoratimedia.com/ Name: tads_uidp_50
Value: fd65f052-f7bb-4da7-bece-aaa13a5e8e24
.technoratimedia.com/ Name: tads_uidp_61
Value: 212626203150143
.technoratimedia.com/ Name: tads_uidp_62
Value: 3599066186634143000V10
.technoratimedia.com/ Name: tads_uidp_64
Value: v0ETMSHLn68JLshhb5SFMAMvrmrycJUj
.technoratimedia.com/ Name: tads_uidp_7
Value: cf338c3a-9014-4743-9ac7-ad88a4fc9277
.technoratimedia.com/ Name: tads_uidp_70
Value: 1670646038087-955011302607-007242-002-000574
.technoratimedia.com/ Name: tads_uidp_73
Value: AACkZk7Mq88AABJm5njsdw
.technoratimedia.com/ Name: tads_uidp_77
Value: MbfxWfVAK1PizujjgNTHPRpCLky_8oaTJsSQox_pQcU
.technoratimedia.com/ Name: tads_uidp_79
Value: dc27dd01-fb3e-449b-ae0b-6f77523cb9c8
.technoratimedia.com/ Name: tads_uidp_80
Value: y-Fr312_JE2uGYB13_TiBVaybIynPAJrpA~A
.technoratimedia.com/ Name: tads_uidp_82
Value: ZlXkOkt3uUkAAHXoAUkHawAA&074
.technoratimedia.com/ Name: tads_uidp_83
Value: BzKIS13TXEMI
.technoratimedia.com/ Name: tads_uidp_88
Value: 619401298374932733708
.technoratimedia.com/ Name: tads_uidp_90
Value: 4ceb69ec-600e-47a9-9b1e-3a4adb6cfe84
.technoratimedia.com/ Name: tads_uidp_91
Value: 6036790348656135630brt77751645033995481903ac
.technoratimedia.com/ Name: tads_uid
Value: 88DC07C9169346F3A3D222DFC6E4FA5F
.technoratimedia.com/ Name: tads_uid_cd
Value: 20240504022915+0000
.technoratimedia.com/ Name: tads_zora
Value: 2
.technoratimedia.com/ Name: envelope_liveramp.com
Value: 1693142250488
.sportradarserving.com/ Name: zuuid_k
Value: 1
.sportradarserving.com/ Name: zuuid_k_lu
Value: 1716905860
.id5-sync.com/ Name: id5
Value: 2adcfcda-e28b-7167-9853-ac5c66125fe9#1716905860803#1
.media.net/ Name: data-rk
Value: 1977432099757787762~~8
.smartadserver.com/ Name: csync
Value: 31:44473d7f-146b-4d56-aac1-0838865cfa25|127:AACkZk7Mq88AABJm5njsdw|147:392c748a-3165-49b5-9e4b-5197f09f430e|150:0
.socdm.com/ Name: SOC
Value: ZlXnhMCo8YUAAFfv3joAAAAA
.contextweb.com/ Name: pb_rtb_ev
Value: 3-1rm9|8px.0|8tI.0|7Nq.0|7Bj.0.CAESEEVrxaaW5o2N-KtQF5Mp0FI|8iH.0|8hH.0|7TY.0|7fJ.0|7TZ.0|7LJ.0.e5b82ed2-a27a-4119-a30f-bd23df1a7c02|8fr.0|8jz.0|88e.0|7bq.0.1|7br.0|7bs.0|8fP.0|6zB.0.44473d7f-146b-4d56-aac1-0838865cfa25|8gU.0|80p.0.1|8dQ.0|87G.0|8bO.0|7dW.0.1|2N.0.AQAAyebtD66TsAIK0RglAQEBAQEBAQCOvpFaxAEBAI6-kVrE|7RY.0|8kT.0|7dN.0.AACkZk7Mq88AABJm5njsdw|4is.0.CAESEIsc_ING9hdCzVSo7KzbBQc|7Xz.0|7I7.0|8rx.0.LWQHF0YD-F-3YJX|3oy.0.b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553|82A.0|8ro.0|86L.0|8i8.0.1
.contextweb.com/ Name: pb_rtb_ev_part
Value: 3-1rm9|8px.0|8tI.0|7Nq.0|7Bj.0.CAESEEVrxaaW5o2N-KtQF5Mp0FI|8iH.0|8hH.0|7TY.0|7fJ.0|7TZ.0|7LJ.0.e5b82ed2-a27a-4119-a30f-bd23df1a7c02|8fr.0|8jz.0|88e.0|7bq.0.1|7br.0|7bs.0|8fP.0|6zB.0.44473d7f-146b-4d56-aac1-0838865cfa25|8gU.0|80p.0.1|8dQ.0|87G.0|8bO.0|7dW.0.1|2N.0.AQAAyebtD66TsAIK0RglAQEBAQEBAQCOvpFaxAEBAI6-kVrE|7RY.0|8kT.0|7dN.0.AACkZk7Mq88AABJm5njsdw|4is.0.CAESEIsc_ING9hdCzVSo7KzbBQc|7Xz.0|7I7.0|8rx.0.LWQHF0YD-F-3YJX|3oy.0.b6299297-f649-4789-b2b7-baa2213b878a-6655e783-5553|82A.0|8ro.0|86L.0|8i8.0.1
.vidoomy.com/ Name: vidoomy-uids
Value: eyJ1aWRzIjp7IkJTIjp7InVpZCI6IjQ0NDczZDdmLTE0NmItNGQ1Ni1hYWMxLTA4Mzg4NjVjZmEyNSIsImV4cGlyZXMiOjE3MTk0OTc4NjF9fX0=
.media.net/ Name: data-bs
Value: 44473d7f-146b-4d56-aac1-0838865cfa25~~1
.media.net/ Name: data-r
Value: LWQHF0YD-F-3YJX~~1
.media.net/ Name: data-ze
Value: IpGLR74DPECkvIVEoDmo~~1
.pubmatic.com/ Name: SPugT
Value: 1716905859
.vidoomy.com/ Name: uids
Value: eyJ0ZW1wVUlEcyI6eyJhZGYiOnsidWlkIjoiNTQxNDc1MTgyMjc4ODI5NTAzMiIsImV4cGlyZXMiOiIyMDI0LTA2LTExVDE0OjE3OjQxLjE2OTUxMzIwMVoifX19
.media.net/ Name: data-co
Value: AQAAyebtD66TxgJ16zNFAQEBAQEBAQCOvpFcuAEBAI6-kVy4~~8
.pubmatic.com/ Name: chkChromeAb67Sec
Value: 10
.pubmatic.com/ Name: pi
Value: 0:3
.pubmatic.com/ Name: DPSync3
Value: 1716940800%3A255_248%7C1717459200%3A265_253_252%7C1718064000%3A263_201_259_258_262_260_245_236_261_256%7C1717891200%3A257
.ads.pubmatic.com/ Name: pubsyncexp
Value: 1716927461330
io.narrative.io/ Name: io.narrative.guid.v2
Value: 0b5a8500-1cfd-11ef-8b68-0e4944db8eab
.rubiconproject.com/ Name: audit
Value: 1|dyyUTrj4Q5HFPdBFqEWViiIXOwT4PbgMQg2k/iHPBfV+xL8LlrcUaIOXlC0C6ZxIrPGiSaUZrHaM1KxoLazIt6NWShwHx7KI6rocrMY9/A8ZHa+Tpz745lfVjPBQWFbDk0fp3UoQ1hHKjyaILfAMpHdoS6M5DbSxBJWffKJK+T5OEKfbbx296c9sdGeFC9lF
.adxpremium.services/ Name: uids
Value: 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
.servenobid.com/ Name: pid_369
Value: 342dd9f1-9289-47aa-917f-b13b570ee886
.adkernel.com/ Name: SSPR_40
Value: aHR0cHM6Ly9zc3AuZGlzcXVzLmNvbS9tYXRjaD9iaWRkZXI9MjcmYnV5ZXJ1aWQ9QTM3MzMwNjcwMDEwODg1OTMxNDMmcj1DaWQxWVMxa05tTXhaVE5oWXkweFpUQXhMVE14TkRrdFlURXlOQzA0WXpnNE9XSmlOMlptWXpjcVdHaDBkSEJ6T2k4dllXUnpMbVI0YTNWc2RIVnlaUzVqYjIwdmMyVjBkV2xrUDJKcFpHUmxjajE2WlhSaEpuVnBaRDExWVMxa05tTXhaVE5oWXkweFpUQXhMVE14TkRrdFlURXlOQzA0WXpnNE9XSmlOMlptWXpjeUFoc3BPQUU9
.adkernel.com/ Name: SSPZ
Value: 176971
.adkernel.com/ Name: DSP2F_40
Value: 649146
.adkernel.com/ Name: ADKUID
Value: A3733067001088593143
.rlcdn.com/ Name: rlas3
Value: QXe1AKFiLQxzYbBuLjVSdb0zrBd9nJHZJah3vBmSd0c=
.rlcdn.com/ Name: pxrc
Value: CP/O17IGEgUI6EcQABIGCLbqARAEEgYIuuoBEAQSBgjC6gEQBRIGCPLqARAHEgYIuOsBEAASBgjq3CoQBQ==
.analytics.yahoo.com/ Name: IDSYNC
Value: "190u~2ioe:18za~2ioe:196y~2ioe:19cg~2ioe"
www.fiercepharma.com/ Name: dpm_time_site
Value: 7.003

1001 Console Messages

Source Level URL
Text
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso(Line 115)
Message:
<link rel=preload> must have a valid `as` value
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso(Line 116)
Message:
<link rel=preload> must have a valid `as` value
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.fiercepharma.com/pharma/pfizers-wyeth-subsidiary-wins-1075m-payout-astrazeneca-stepping-patents-its-tagrisso
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy frame-ancestors 'self' https://*.qtx.dev https://*.dev.qtxquartz.com https://*.stage.qtxquartz.com https://www.fiercewireless.com https://www.fiercetelecom.com https://sample.dragonforms.com https://*.questexinfo.com http://resources.questex.com https://resources.questex.com
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

690ff98835fbe42a008f3d2c0841e7c5.safeframe.googlesyndication.com
a-prebid.vidoomy.com
a.ad.gt
a.dpmsrv.com
a.vidoomy.com
a4p.adpartner.pro
aax-eu.amazon-adsystem.com
acdn.adnxs.com
ad.360yield.com
ad.turn.com
ads.pubmatic.com
ads.servenobid.com
adx.adform.net
adxbid.info
analytics.google.com
ap.lijit.com
apex.go.sonobi.com
api.parsely.com
b1h.zemanta.com
bh.contextweb.com
bid.contextweb.com
bidder.criteo.com
capi.connatix.com
cdn-ima.33across.com
cdn.ketchjs.com
cdn.parsely.com
cdp.omeda.com
ce.lijit.com
cm-x.mgid.com
cm.adform.net
cm.g.doubleclick.net
connect.facebook.net
contextual.media.net
cs.admanmedia.com
d.adroll.com
d.turn.com
d.vidoomy.com
de.tynt.com
dpm.demdex.net
dsum-sec.casalemedia.com
eb2.3lift.com
fastlane.rubiconproject.com
fonts.gstatic.com
ghb.adtelligent.com
ghb1.adtelligent.com
ghb2.adtelligent.com
global.ketchcdn.com
google-bidout-d.openx.net
googleads.g.doubleclick.net
grid.bidswitch.net
gum.criteo.com
hb.minutemedia-prebid.com
hbopenbid.pubmatic.com
hbx.media.net
hde.tynt.com
htlb.casalemedia.com
ib.adnxs.com
id.crwdcntrl.net
id.hadron.ad.gt
id5-sync.com
ids.ad.gt
idsync.rlcdn.com
image2.pubmatic.com
image6.pubmatic.com
image8.pubmatic.com
in.ml314.com
ipv4.d.adroll.com
js-sec.indexww.com
lb.eu-1-id5-sync.com
lexicon.33across.com
lockerdome.com
match.adsrvr.org
ml314.com
mug.criteo.com
oa.openxcdn.net
oajs.openx.net
olytics.omeda.com
onetag-sys.com
oqs.omeda.com
p.ad.gt
p.rfihub.com
p1.parsely.com
pagead2.googlesyndication.com
pippio.com
pixel-sync.sitescout.com
pixel.rubiconproject.com
pixel.tapad.com
pixels.ad.gt
player.adtelligent.com
player.hbmp.mediafuse.com
player.mediafuse.com
pr-bh.ybp.yahoo.com
prebid-eu.creativecdn.com
prebid.a-mo.net
prebid.ad.smaato.net
prebid.media.net
prg.smartadserver.com
public.servenobid.com
pubmatic-match.dotomi.com
px.ads.linkedin.com
px4.ads.linkedin.com
qtxasset.com
rdcdn.com
rtb-csync.smartadserver.com
rtb.adxpremium.services
s.adroll.com
s.amazon-adsystem.com
s.console.adtarget.com.tr
s.dpmsrv.com
s3.amazonaws.com
secure.adnxs.com
securepubads.g.doubleclick.net
sghb.hbmp.mediafuse.com
simage2.pubmatic.com
snap.licdn.com
ssc-cms.33across.com
ssc.33across.com
ssp.disqus.com
ssum-sec.casalemedia.com
static.criteo.net
stats.g.doubleclick.net
sync.1rx.io
sync.adtelligent.com
sync.crwdcntrl.net
sync.go.sonobi.com
sync.hbmp.mediafuse.com
sync.mathtag.com
sync.outbrain.com
sync.srv.stackadapt.com
sync.taboola.com
sync.targeting.unrulymedia.com
t.trafmag.com
targeting.unrulymedia.com
tlx.3lift.com
token.rubiconproject.com
tpc.googlesyndication.com
trc.lhmos.com
ups.analytics.yahoo.com
us-u.openx.net
vi.ml314.com
vid.vidoomy.com
wt.rqtrk.eu
www.facebook.com
www.fiercepharma.com
www.google-analytics.com
www.google.com
www.googletagmanager.com
www.linkedin.com
x.bidswitch.net
ads.pubmatic.com
cs.admanmedia.com
s.amazon-adsystem.com
vid.vidoomy.com
www.google.com
104.154.142.214
104.16.151.166
104.18.14.141
104.18.35.167
104.18.38.76
104.18.41.104
107.151.11.18
107.178.254.65
13.107.42.14
141.226.224.48
141.95.98.65
142.250.176.194
142.250.64.66
142.250.72.104
142.250.72.97
142.250.72.98
142.251.41.2
147.135.119.114
147.28.129.140
151.101.65.91
162.19.138.116
172.64.151.101
172.67.138.13
18.164.101.60
18.164.116.122
18.164.96.73
184.73.251.44
185.106.140.18
185.184.8.90
193.200.65.5
198.148.27.131
198.8.71.131
204.180.130.159
204.180.130.165
207.65.37.179
212.36.83.245
212.36.83.246
216.200.232.249
216.22.16.73
23.195.92.23
23.199.48.215
23.227.146.18
23.227.151.194
23.227.151.242
23.47.168.66
23.51.57.13
2600:141b:b000::173b:fbe2
2600:1f18:4e9:5a02:d760:f85d:f4a6:cd88
2600:1f18:61c0:2204:84bf:7c00:afb4:646b
2600:9000:23cb:d000:6:9280:1080:93a1
2600:9000:26fa:6800:1e:5cef:3780:93a1
2602:803:c002:200::32
2606:4700:10::6816:445
2606:4700:10::6816:545
2606:4700:10::ac43:17ea
2606:ae80:1471:16::760
2607:4f00:968::2
2607:f350:3:2569:0:10:0:200a
2607:f350:3:2569:0:10:0:200c
2607:f8b0:4004:c06::9c
2607:f8b0:4006:809::2008
2607:f8b0:4006:80c::200e
2607:f8b0:4006:81e::2001
2607:f8b0:4006:81e::200e
2607:f8b0:4006:81f::2001
2607:f8b0:4006:822::2003
2620:100:a00b::12
2620:100:a00b::4
2620:112:f008:200::101
2620:1ec:21::14
2a03:2880:f07e:9:face:b00c:0:3
2a03:2880:f172:81:face:b00c:0:25de
2a04:4e42:200::347
2a04:4e42:400::347
2a0c:5c87:5241::2
3.227.67.62
3.33.220.150
3.81.175.178
34.102.146.192
34.102.246.198
34.111.113.62
34.117.77.79
34.120.135.53
34.120.63.153
34.149.20.76
34.193.219.68
34.194.162.133
34.195.242.242
34.198.180.12
34.200.65.202
34.206.91.202
34.237.106.71
34.36.216.150
34.98.64.218
35.201.104.135
35.211.178.172
35.244.154.8
35.244.159.8
35.244.193.51
37.157.6.233
37.157.6.237
37.157.6.254
44.216.173.212
45.133.44.3
51.222.241.106
51.222.39.184
51.222.39.186
51.83.220.94
52.201.41.85
52.205.167.202
52.216.215.120
52.223.22.214
52.86.216.206
52.90.26.195
54.157.213.254
54.197.117.43
54.204.12.49
54.211.183.138
67.202.105.24
67.202.105.34
67.220.226.233
68.67.161.182
69.173.146.5
69.194.240.11
69.194.240.13
70.42.32.223
74.119.117.17
74.119.117.6
74.214.194.131
8.2.110.161
8.28.7.81
8.28.7.82
8.28.7.83
00d96f374edb6ba6e38cfd3e80d1f60a353f9d44e491efd6fde125b1af4a2851
0202190042213a1fa848dbd2a38623c515411b6328787f20c97787649aefa70e
027a2a1dc9044e78b8382a7522536ac3ac5a5401b148d7826e0f8eda3001cf2d
02f4d4d18c22b7ad116b8ad3f7edd35908f17eb6985b62ce2081758c698aa09a
040d9720727b2b33c570b59f3e2c653b7b876e8b367826b995ea794f5aee22e1
04f0ce7c5d7079434eab7e1b1820d148b298bfef13a1a1db71572fb90fe794cc
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
06cb7f15697d104cd6a50a8e51fdadcb91d2787abcacbb1e608f39f0a6af144b
09be90d7291b9e4d779fd092ce109062ae51466cadaf5253b62b1c32184ae0c5
0b0099e01e269b6767b1e781b1362542882e16b00e3387ab1a9848fbb3480725
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
0c08e15566afb915fa48f09d4fb413694fd309ed10bc63d02113a654f911455f
0dfe66dd14824544b2cb166e5b7130f848a074a85104d640da0b582adcca3853
0dfed7a6faf7c0fcffc462131208e093db1e8b752cb2d616d70cc5d4efa26e63
0eb363a0de44b8d94dfb3e2a40befa1d33b0bdc3e797ad072196d1274a37ec07
0ee8666d0e9b11f43e4ee146f9e6c6e4de220a4b714526659b90b39db872b502
0f48bd710e8aa1a35ecd164406847ae8d15572f01af4bcf61e1e3a655081380e
103a473ebebeaa95bb10f3b510657de42e1827dc6e65660dde5378092d7675b0
10955c3ffd135462f15a287348e08d747ce31fa9c123803afa72399d3e9f56de
10bc2a1611214a5da5494de1793213e5b394bc40bda5d39ee1c08585d65634fb
114af611fbb0ff21ac9efdd92e351fb3c796bf649adbf564bddc63a38cc956b0
129240c1d16a519f94a5109ac27441664406ab594f1284b6327e03df022b76e6
1292b6be31847d5eaa4d408f1765a03fb33bf21ed5c854ba127202edb540ffce
129b0a661b9a412d3da23aef46b8ef08dbfece3f0e6a46a17c43c9bbcbd74bb5
146fbffb185f4b4194fbd7f477997dcbde55c4f981890e8f23e16da80c168907
15d222d7f89a2e0e920b8306e1ddc64af26a0b22267418b421b824548c9ebee1
16eef82325d88bccb3f09d34d6155a3ee890edfdb479d44264212b5d5eca1af9
1708037b7ecf03af84945128dfc6655d49a37a602674639456e1643eb6c8c417
195524441f7e276f7c8500a8c7f0590585f93074ebad49e79aebc07518cef796
1d0b444bfc73b610cd71a9a4d5da27bba8130b07a55841cf3fadabf7862cc08d
1e615fc0b82c3508a3063390e578b6099c4f5f9f7c1d299bd579f53a7c3e968d
1efaab641c05e860e6fa633fc2a2654c9bae4ede3e36adb762e986cf18947ed9
1f2b57178d466db347718e3cf27f55024e32c7a0e5cd1a03b245bb8c0e74c69e
22f89e7c5c4bc5d6a5305beca4bec1b0358bde9f3367996a1c5c6781ea6a5d54
22fd68313c05d475c370ee1c325b045bc94ec1eea131a08b6ca642b1e21faddf
2417b180e85b281e607a6c3f0136cd75a2915f3e0a48cf4f7ec39de1813b9853
260e601daec9ea58b9804fdc51ee574617bde744e573e62ac2afd9bfc51a46f6
26767f0b7032e460e8500deff8d9077a9f8fdc3f43fceb30d3a6ec067c5e8382
2b81d74611b86412eaacf368de07f273ab99505e5a80df3de33c4360f8dd9555
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363
2efb594d00beae1166cd81453c6ab69e3cf442d9fcb870fed134daea715835c3
3164db7ef9efc7121ce85192340a653c6cb87e34caa05849c8fd47b7872f9fc5
31803b2349050bd9d794d2d751a0c9faa43ba0edefdabe0a428f625609f3db2a
36ea295580b6ae83e3e1d6b4bdf7564af630736a9d46e3a7e8b7aacaf96b1dcd
38a4016a5c4c5581747c6674f6aa24770abc9e2fb9630db4173217802e5b5099
39162db59028429145e552783018e8630618065620f78f677c4f62078973f6d7
3b7b8a4b411ddf8db9bacc2f3aabf406f8e4c0c087829b336ca331c40adfdff1
3c0cd9f2d4b51e540063c3fd5214d6e84b7c8d3131a00e67239ffa4d9ae07c6e
3cc43a384ef3145068f3a78f72ca520826ed62a34d788c8d67f3301af77c8a0b
3d89fee4795e58e4359c01281869d63398c097e9cf3c7d78809cd54bbbb60103
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
40cde42ede2bf42f0823fa02da963e1188c4fb5137b414b1b248188ad01683f5
417c7e1b793dab1354daa456a61f7344f780ad31fff8e4fef024f4997f29942e
41f54f464cc2770a967b53fd37f6c5d00344d9fc973838c3d643f5a259285155
426623ebc6a0b2910217e5859b56a3f3462e88df73b46cd7685af17d54997b1a
42bbd0012a46493c1ca8e228b118806d03bb60bb93ecb05d40413dc0401722f0
435b1ece4a55f4f8d06866b32c1aee3cc4661eb905265894795f15a57bf1b33d
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
44bf69c49cc41b0bcff2dbf7f3cc54ce3de61ca3c9f2a22ec552dfac5a865348
45e323153503f15fa7645000296ad0e0d24924fbc8fa3279b75c919be8012b0b
46e4332f776a235f3da1ae3c9578189adb69a5e50048fe7b0eb16f6ef1539c33
47043e4823a6c21a8881de789b4185355330b5804629d23f6b43dd93f5265292
4708a3b143ace4ccfd6656d68057ca641d4264dc121bbf181b1e4507aa1691b3
478361e6e8ca04ea1f92bf98b680c5fa130539a1c8d35a0a95e9cbe190d95f0d
488bde8cfe3768819d0e5dc7bec1a201de5134de76612e394b3046936ddb10dc
497c65a99d94ef5021e1aff216cd9fecef34927722ed85e128539210feb03bb4
49b11f1540273c8239ed7261cd867659aac005250ebbfc708a82029a449e6967
49bd6d55c4f8dec8bee5f9da82443c93284b5d125f13d38b4a48be53f12b8299
4a83174220c766e30431b9a667ed066173a074ce98e93f613094c5a2ffe4afef
4acdfbea8df1057faa0c342d1d2af4fefae328c4cc29c4ede2a31bf31fdfa576
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
4d05f76ea29dced7becc90937f67a6109d3a037570991291ecf8f93a533bc106
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49
4f6090e8f56ec0fb59cc0f78f2a3d6bdcccd0752579a6a02472ee26e5c341f54
506e448ac11e79b1d4847da80840c3e1f78646be28bb78b613bb1682939595e8
5187b3e90f3b3b10a207830232d89a283496806bd734a115c13ed72119c49201
518a087b8b7e9a29520a2aa6f4a400a3719033e03ddb557010d3618422fa1c42
521dc0284661145925ceb88d6b97168f85f383cc957eabc1057b03b672c2e76f
524cb2055eff7f7a574e371f67b9743c0b22624b29b4b522922067f38ee27850
52720a5b02815cb03bdba75686b94ec9d1b7b92e1d55e6728c4fc90ddc8325b1
5280b23fdc226b41b80f4569d7e2ed017bf718c03e6ac965910aa5ed5aaf4270
54034a97c2cd2fd617136446cef1993cfef5937fe2896ee7e4bd569cd18c94e5
544c55ca9f05d425f3beb90f287308d7a408b1f60d17728eff5c605a494bc1b9
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87
55f04713ca95e883affe76b369741b400679b37ab526399418099da93ceb8a68
56008bc079a6f5763cda94476434e11182e7b61be10c0214b83958d4677e63b8
57a4f8278a24af8df83f62b723cebdfe137b91e01d98ede15ee8a4b0d65b8297
57e4d88b2d92e8e0555b21e5dedd98675181ef2e86da552c6577cf4091d6e4f6
59a7be1893957e08219b6a3a37c5c995d146304d841eb1faa2ac8a5b74ca2d87
5c41b5f53f407f76dfe6855216a1a510578555c56861bcee82a90a3a1fedf70b
5daf498df4ebf1cdbfa999dcf10eaa203b6630ecf44c39de6d99d1e630f6e46c
5e3aa4076c1fd51f0c7529322477aefe362915a5e5331eed10203decee12eaf5
604c563a09608440530f5d74cfe3f20d8c47bdd09e8b1447df493b59d362b8c5
63f9c8c15b586d30b21ac1e698f2203f8e43cf2d9e2a849447932a9cd26e2a45
64316b53228e2c9130017d4a98a675084eee9089db070a0cb9a26d683f0acf57
6487fac39f5df2c417979d039dd0ed9b36928e6a0f82fca90cb7c160ed035e24
65125dff9fe56e1c79505c48616d80a36f9356616ffb5eb213d34e3f855f9e63
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
663eae4309895d3cd613c6ec3a6898ce1b6e1bf230c21a92f4d8056e24156f51
66776998b10e583a72f8fd29391a50e2c80eb3bc9a65b0dafe97e576d7d88507
66bf4c2d75c9ed6d00de0d5494f1e7120f55e8943f4fc41bd5cefccd6fe9d14e
675a8a83bfcc95fd006ce6455dfba5cdf0cee6a89d9261eae89d33ada9f0d3f0
67a96c2d486b619ad6a5e6f21d1a0247fbe91906273978da545ed8a6204826e3
67bd7be9fa303e20962c21fab11c531e91e1489ff8ebde2932d2849e7de50a9d
681d075830d58a01d38265bb554ea149e59a23c776499b7149928477de3e3c3c
68330f6767efe4ea90f23cb4bb722810d19758395bc24f59c7c893c0d4ae69ce
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992
6bf8a58f79b67bf9d1ea3eaf9fac1249d237da074b02cbc525379a42a4525d11
6c5cad7b156e34391c32209eb8f31dfe56cb8a64b9532b3934543b2e6a901f32
6cf991c8f280204e14b65dad4fbdb7af12c3b57478078d89db2a6719af9f2089
6d3876e181cbc4caa2c28fcf966397d80a00c9f3320674e1d415f4eb5f3ecc8d
6d54be447c5ffd1ace3eaa6eab667ac4ac498bacde05d8ce2a12d921b26b1436
6f42db585289bfdd10b6fbad2702092c89cb65d373afcbe39f4fed687ba6c787
7058c181e092c80881f00d02f42b79e4d387ba4bb77d08182ee383bce74ef203
70ed6b625fe8d2ad97eb6ad1983b4acb2009280b12010c7c5bec327c6e2ca41d
7225361cd3a508f0028fc21b92e2849763e19802ec1f30fd5cef3b76a1fbb6cd
73c6cd5a498ac26211a265790889bf60d0170cb44239c778b670f2c06eb02754
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
786065fe087e7af622fd8c9f62b8cfd343ca95ac954de40c189fa4d7f95f64ba
7983af2d231a115c8af9e1a88647c58aeafe8e1da6e4f98a4ad7a91909ee2d83
7a90f071adfa3e2d628513bc024d7678925c946473564cafd0bc64c7b3f9da5d
7baac67c6bac86eb231b9401f6b98c25e200739ebbd61af889d3629bd4ab864f
7c96a54dd372f4d7b5f28a50c3ef5cf74a02f2d27f099dc5496be9b538c611a9
7ea86a85585ef048c6cf1244910806bb12f5d6e00c7b23fe6bcd314f52505536
7fa1122f450009de8e0e9842a7e7a89bd87ab3c26b30148a2acdc6c9f969911b
812a5928731d1f7ea2eee246649c4c98e857bd86898df023cb260e598c1086cb
82db4397e65672568c62c4175f1176161d94d1e06f5e1a7c9c8faba962dae744
8323f5985e2cb9c2a50a43ac84bd530990f284c0d9d0420510b7c89786032519
832a962df982b1dd84394c6bb09879e72ca60b80489301d69e5fba189da39d41
846949c5a40e3ffbb702473e54dfac0646541aa624a844369b6e24e51ddaf96b
852b3532441a29f2ba7e869ecfbc38eb772c2a3051d4783e49f4dc68c185191e
85c44c66e849ada14ef181a2d41d585fd8cbce0ad66e3f6563a7f4fed3cb9084
860c40590289807e4633c45fd09fd5da85be7aeb1484b5fa4353e492ba77803f
8638a04be882703f934f4f2e06c6ae0763d4503a585e527e6d46b1e0a1929de3
87788935ef3c1867bd027fe988046fca04166f79d9ec1a573710b848b844cd92
87f26f6a486cb367b38874e7d694db49717cd0f48e1cfc9f6cb15f7b321d221c
899d1ec3c095342571d3be2091ec6f984d4cc82390d1f61945c391fa035b00d9
89fc0c15d05825efa5a7cd1e80084ce47eb46469673e37de3eb2700be492f964
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7
8b33651638a6da3c64348c0338b97d812bbcd0661992503b2b73d42438ddd369
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
8f3eeca467563d43e0cfd8aca8015e6db31faa5258f32eef9ad40f37f9b0f164
8f69e10876805b747a3ad08a818d46ac7e731b1af417ea6e259d9b6b7deb65c5
923da971f3526425e84ab6bc71d8ce06e9a9211b76e248487627eebadf20f37f
934b1d7b036022ca21a483f37bc0a9b8aff59f1e22dd6dc6e39b3376a393ceb7
942d52f1866bbeeeeafa6fd466fc7f33133d49e76638b68a5d5ced722d46b3b4
9443b1d2780187dcba9df87fc8132182e10042082e3fbe17903597475f3e8766
9476829b95e258d910312ec7f2f30b425355061a2110d1e8f094b1c3a0587705
9692d366fdde6e1b0584427295336074d159bbae98498e16ab5e5ae5582b9e6b
99c2d88bb1dbb61bac0a4d806b5b18b93492130ceaea6fecd9f775e2d929c352
9a79cc38aae43243d5ebe9e35ec906708aeef263a9dce22fc1f5db49f774429a
9b66a625201ed9074baa79e1ab3a7c78458a1743f270cbe81b6a51cd1457579b
9c337eb1b6e86fc259ea4251027f460629ecc38d916a308cfd16acab620243f6
9c5461a4006bd7fe9876358a7813344c04ec5b8b6ab8477150e93d126a1783a3
9c5c69440b13c676c22866761037fff95fc19c343570af3b261ad2accea9b523
9d2adf2cd7d4c9677620558f89c5d689d2962c481a44c4bdf4aca5f3703777a5
9dffbd45ce48bf5e8eeb90b3d8567f8270f217c174de81fe3693d6dcdbaa1588
9e6b86e78a792f1503cc5ee6e855d0a7d9d69b40e3b03f3df35171f9d68b6e51
9ef196219b86091cb4d0e9ffee8404a5bd81fa999be865f09d8992d37702fee7
a277f81590c6f6d9d2542875953b726f1af22d463699e9637c8eaaa7f481f4e8
a2ee4dceb8f0aa3e5e0a8ad08d7357f1405948d3f0285d73996785d2cea14e0d
a32427c74de3ac3f80dd59f953b6257515aff637964cf5ac55f3a63c78b8c21c
a4a2998eb4b49aa0bd53e1cd3a36f68f6057b90a05c90d13a8b56bf1cd090c60
a5472caddbae8d97e187e21c0cee13a86d99fea9e882cf30136c1c351ca47f96
a604d269f0e90cdbc41a214caf22ce642c97c130b17e314868b6bfba47e7c255
a823bee642bdde6a5c3d895fb6bd9d7ac59931775fb6572e3c335a7223064ebc
a8e427db11a8744bebbcdfd050f7b9d0a84b5a1754d086f1787c40db21955264
aa7b6c81e85551eeb5c4809f1e683efa0b780c33d12ddfc2067a1b136803e45a
ab03c696312fd33b6273ac10937d16865fbd1565fbdc9aa4dccd6937a15a1bc5
ab1caebdf6a26950de987bb2eecd7c3e62d4ae5f0be200cbb1d471ab0eeaf589
adf250cddb40da6f628519d2e06935f6871dee60b84f60687dc960aa4ed6ab95
ae43e768649f80e1c1d16beb74fdb746be2c768a57fcf984182d88b8d4314cd1
af1f74b37f7eb1c4a1d027bb91abf73a28c5d6bc815253f2e907df90d45ebc40
af414f1b40ee5f8ed0364c9c2c27a6d6e40a5948d8e4792cf2f6eba161d5f192
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b
b1622ebe908ad2e4bdcea4e85057a065fcea4969cd6b1a87cfa3c0791b9a6a54
b3402fa33fa49c93f294084720dd0497dcd1ac652c190a8736de24d9d75c8808
b49d13271e9383649f09a83001bac328651ba42e406f6cf9f6122373109f07ed
b65f414221cf068135ffc1d6b5a814da1b1a363325b451698c52a4064303a5bb
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96
bc5bfde57caeada100d8b0588df2a973772ff0a75cfa0327149a8de20bbadc79
bcb82bf9202096e63d983dd968ed82642827b89216f3517d2ba86303d6ce2a9a
befb55188d1fc6bfca46b1da87cce77f09058c0b7a00b67f7cf7233aa4b570d3
c0320fc6250740a052a625a45195b12676eb31c7306a35562925615a634b4847
c0bf91105069a00c87add3665cd26be3129758fd860dd3adae5dad1003a78bb1
c15bd5a2526b58492028e66aa3b381ef05f4e22d7e644cd4cdd2749d51fc6297
c1d222778644925bcc3b323bc56b7564fc200e442c722de525fd8d030525addc
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e
c289cddfc196c29c13fc1e48da3bbccd92ac1b5521f6886930c978ea51df4f2b
c2ebb45ccbd0b64de608c75136935bfaa85500e7221bc3064179c88cb5152652
c2ecff291918a3caf0b7e470323e89f2a1f05b92e12a10649e598cacebe62acf
c4ac88bae5a5a1245f7ca90a44ded5886380f100a0da1db11711c548272df489
c590c511c43baa86e8e5c9da795ddb9b273a69a14bfe1c93d2244565da6827a9
c9aeb6e362ef18ca4fbc2e438f6ac27835b9e6a11545935f6e9edf52dbf1112d
cabeed9d9baa263a3d0b306cbd6ffc734a71b27afee0e15aaf61eb66dabf5346
cae2660518f22b45acda581d90ed118a6727785eb1e99075a5f5e09a2f918dc1
cd1707ff961932c5fe28a5722a31c9dbaad2b2e3dbc65ef5f28bcd101fbc1474
cda3e6ebee10fc5018a2b5f601502640f19c1adff3dafaacc7cf518114743bc9
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
d08ffd1da80b4fdbb086a0153d209bdbd7baa666520485f10d0ed0e85a1a8e11
d1095b3a75578e4897753e494e03ff95a230d23367e690862ba876edd547c753
d7ad611d1027a59360a1dee87dc82dab44eb9ae0f359b18082921301a1275d14
d81b28a221946bd24a1f044dbabf3c7071f7829c059a93a42c36d093eb6b4d4d
dda114313b2cf2455611383d53adf740a8619a715c5e90437cb580bf73e9c705
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
def3ea6d33c7840fb39bf0a18070e6c4dd04f66dd03e508c2964392843526504
defdaeca8894f86fe9b7eca7f9e3a2b7018bd3dd443ff4abd548088f773c4c76
df318ce60e0d7e9b976d12b05f9806978206c0829e7be15c49ca1c4212b0880e
e082c08cba195b2cdbeade513c35ab322f6de4f6cd3151260cd7457a13177cff
e202c6d45a0d8ec8923accd71ed1443a655d6a99b60c3482fb748932176a29bc
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e41a5cb53307f91f13d0f1f04e76568f3e0d8d7d2d7ac99ef90ce236f2682f36
e810b53c7dda66b99b7bf7b68bce6693facee4a055c82c13cc45058c787b9987
e81328462cf671478801000c873db00cfeeb1bffe5738cdaaf56827014667ddc
e97b9f44361a039b1c05bff1cd9554881fa40a0793d4ea7e62ec1f2396b9e85b
e9809304b439dff1eca656e2e420610eed2a019dba6fa885b433ef47068eff4b
e9941d952ed517a54edf0feb02f83089bcc7de03f3f0cd0e5a32c5367dd004c0
e9c370ea9070b144ed45ff5f35c9206112dd1091326ff898f414ef8c12ec85c0
e9d18109526ef8cc0117dc97053210330a35d7bc03acfa6b4636e60b5828b471
eb0422c19bd0db3b95e12ece9ff4768796c04055c42908ff52c450e9e33f2678
eb2dfc28bfe3a7ac11135ed7165db7f9255f381d00c04b986d7c2b18fe4d834e
eb713d87817953d49184f6f19262349a70f20db72dcce067b28fa3759348caae
ee674765d46c5bca6d70a84d0ccee12cbfb7efb01502d5bd6d1937d2bc03f6a6
ee96eb295d58a88949a293bc61bfec1eba2caac3b44c80ebbcac62e257b665f6
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
f25b22cba5429647a1dbbc0cea8b1213ab2480249927e5277df64dee24f53924
f2fa27235fa94a4e567bad6deeb14e2bdd2b3eb376ee8c9dc74868d5d4496800
f541802be6c06521b334e543f06a32c84aa87b6733739d52eed64de3bd634ba4
f59bf2906bf7905decf351f98f1341a0b14a0b91f4cbac3919f8ea217f259f20
f67f7ccf0ce617be44da9fc6b4b9f75bf3dbfcbc82441282b28a1c9438e6c675
f8eca570e92e273c4d9884f10e384d97feb26c69db70db1c6c201f34efa5de61
f908cb1ecd75e41282bed49a9dd1059bb41abfcbe3513f4905b2a6ea8be5ac53
f9cc58edee80608bddfd45d055c65f48a8a0800a9f47104c819711ac10b07aa6
fadbe7a57b0b6eb8f13f2e6fe4282a6a22ebe81d73abb079d8b001ec6d71bff4
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b
fce10e00ee922049dd2aa0aef8d57cd1ffbddda1f6cecd76224cbc8dc51388de
fceb546d5245bf2ccd56b51a0ce18acc22c06f2d4bf1b99b8efc7fc06d694340
fd0a8e32809c524ebb33e2d544a949c106c4f203f0a2f869067aa08f459ff2dc
fe35993f957f311cf33f0247df8869dc3da295e20d068200abb977c76b8ad096